{
"company_details": [
{
"company_id": "0000711377",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000711377.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000711377.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000711377.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000711377_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000711377_main_keyfigs.svg",
"name": "Neogen CORP",
"rank": 1,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000711377.svg",
"report_text": "The relative strengths and weaknesses of Neogen CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Neogen CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 69% points.The greatest weakness of Neogen CORP is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 9.3% points.
The company's Economic Capital Ratio, given in the ranking table, is 266%, being 107% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000711377_2022_Neogen_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "46.8",
"Liabilities": "58.2",
"Stockholders Equity": "75.5",
"ECR before LimitedLiability": "161",
"Liabilities, Non-Current": "16.5",
"Property, Plant and Equipment, Net": "-0.558",
"Assets": "8.68",
"Assets, Non-Current": "11.8",
"Other Assets": "-6.01",
"Goodwill": "4.29",
"Assets, Current": "2.07",
"General and Administrative Expense": "38.8",
"Expenses": "22.5",
"Revenues": "33.8",
"Net Income": "48.0",
"Research and Development": "11.6",
"Other Expenses": "-30.7",
"Other Revenues": "33.8",
"Comprehensive Net Income": "48.3",
"Other Net Income": "-7.82",
"Economic Capital Ratio": "99.4"
},
"2012": {
"Liabilities, Current": "33.2",
"Liabilities": "54.6",
"Stockholders Equity": "73.6",
"ECR before LimitedLiability": "128",
"Liabilities, Non-Current": "16.3",
"Other Liabilities": "12.8",
"Assets, Current": "3.17",
"Assets": "8.82",
"Other Assets": "-6.41",
"Assets, Non-Current": "10.0",
"Goodwill": "4.58",
"Other Expenses": "23.3",
"Expenses": "23.2",
"Revenues": "27.8",
"Net Income": "49.2",
"Research and Development": "13.0",
"General and Administrative Expense": "-13.6",
"Other Revenues": "27.8",
"Other Net Income": "-0.548",
"Comprehensive Net Income": "49.1",
"Economic Capital Ratio": "95.3"
},
"2013": {
"Liabilities, Current": "45.4",
"Liabilities": "66.4",
"Stockholders Equity": "82.9",
"ECR before LimitedLiability": "146",
"Other Liabilities": "6.02",
"Liabilities, Non-Current": "24.5",
"Goodwill": "3.48",
"Assets": "7.39",
"Assets, Non-Current": "8.31",
"Other Assets": "-5.65",
"Assets, Current": "3.34",
"General and Administrative Expense": "-16.1",
"Expenses": "20.2",
"Revenues": "34.0",
"Net Income": "50.1",
"Research and Development": "10.7",
"Other Expenses": "24.7",
"Other Revenues": "34.0",
"Other Net Income": "-3.01",
"Comprehensive Net Income": "50.0",
"Economic Capital Ratio": "106"
},
"2014": {
"Liabilities, Non-Current": "27.6",
"Liabilities": "82.3",
"Stockholders Equity": "106",
"ECR before LimitedLiability": "175",
"Liabilities, Current": "60.7",
"Other Liabilities": "6.66",
"Assets, Current": "3.02",
"Assets": "9.76",
"Goodwill": "4.14",
"Other Assets": "-5.85",
"Assets, Non-Current": "10.4",
"Other Expenses": "18.2",
"Expenses": "21.2",
"Revenues": "34.6",
"Net Income": "55.6",
"Research and Development": "13.3",
"General and Administrative Expense": "-10.6",
"Other Revenues": "34.6",
"Other Net Income": "1.53",
"Comprehensive Net Income": "56.0",
"Economic Capital Ratio": "125"
},
"2015": {
"Other Liabilities": "15.4",
"Liabilities": "89.5",
"Stockholders Equity": "101",
"ECR before LimitedLiability": "171",
"Liabilities, Current": "60.1",
"Liabilities, Non-Current": "32.0",
"Assets, Current": "4.32",
"Assets": "6.65",
"Other Assets": "-6.55",
"Goodwill": "3.96",
"Assets, Non-Current": "8.56",
"Research and Development": "9.64",
"Expenses": "14.6",
"Revenues": "41.8",
"Net Income": "55.7",
"General and Administrative Expense": "-24.3",
"Other Expenses": "27.5",
"Other Revenues": "41.8",
"Comprehensive Net Income": "55.6",
"Other Net Income": "0.768",
"Economic Capital Ratio": "125"
},
"2016": {
"Liabilities, Non-Current": "30.0",
"Liabilities": "79.1",
"Stockholders Equity": "82.6",
"ECR before LimitedLiability": "135",
"Liabilities, Current": "56.8",
"Other Liabilities": "4.49",
"Assets": "4.70",
"Other Assets": "-5.93",
"Assets, Non-Current": "9.36",
"Assets, Current": "1.17",
"Goodwill": "5.02",
"Research and Development": "14.8",
"Expenses": "13.6",
"Revenues": "38.1",
"Net Income": "48.1",
"General and Administrative Expense": "-31.1",
"Other Expenses": "27.4",
"Other Revenues": "38.1",
"Comprehensive Net Income": "48.2",
"Other Net Income": "-2.70",
"Economic Capital Ratio": "115"
},
"2017": {
"Other Liabilities": "9.21",
"Liabilities": "79.1",
"Stockholders Equity": "85.4",
"ECR before LimitedLiability": "128",
"Liabilities, Current": "52.1",
"Liabilities, Non-Current": "31.8",
"Assets, Non-Current": "9.71",
"Assets": "5.52",
"Other Assets": "-6.19",
"Assets, Current": "3.53",
"Goodwill": "4.69",
"Research and Development": "14.3",
"Expenses": "9.97",
"Revenues": "38.3",
"Net Income": "42.9",
"Other Expenses": "20.1",
"General and Administrative Expense": "-26.2",
"Other Revenues": "38.3",
"Comprehensive Net Income": "42.1",
"Other Net Income": "-5.04",
"Economic Capital Ratio": "107"
},
"2018": {
"Liabilities, Non-Current": "27.2",
"Liabilities": "72.0",
"Stockholders Equity": "84.1",
"ECR before LimitedLiability": "144",
"Other Liabilities": "11.4",
"Liabilities, Current": "46.1",
"Property, Plant and Equipment, Net": "-0.652",
"Assets": "5.25",
"Assets, Current": "4.06",
"Goodwill": "-2.09",
"Assets, Non-Current": "4.60",
"Other Expenses": "12.2",
"Expenses": "17.2",
"Revenues": "33.8",
"Net Income": "50.1",
"Research and Development": "12.9",
"General and Administrative Expense": "-8.03",
"Other Revenues": "33.8",
"Comprehensive Net Income": "50.1",
"Other Net Income": "0.689",
"Economic Capital Ratio": "124"
},
"2019": {
"Liabilities, Non-Current": "31.0",
"Liabilities": "75.4",
"Stockholders Equity": "89.6",
"ECR before LimitedLiability": "163",
"Other Liabilities": "14.9",
"Liabilities, Current": "44.3",
"Assets, Non-Current": "2.90",
"Assets": "5.33",
"Goodwill": "-2.04",
"Property, Plant and Equipment, Net": "-0.694",
"Assets, Current": "5.85",
"Research and Development": "8.99",
"Expenses": "18.1",
"Revenues": "30.7",
"Net Income": "52.4",
"Other Expenses": "8.96",
"General and Administrative Expense": "0.438",
"Other Revenues": "30.7",
"Other Net Income": "5.70",
"Comprehensive Net Income": "52.3",
"Economic Capital Ratio": "133"
},
"2020": {
"Liabilities, Current": "35.8",
"Liabilities": "71.2",
"Stockholders Equity": "80.2",
"ECR before LimitedLiability": "156",
"Liabilities, Non-Current": "38.7",
"Other Liabilities": "9.38",
"Goodwill": "2.05",
"Assets": "5.18",
"Assets, Current": "6.60",
"Assets, Non-Current": "-1.87",
"Property, Plant and Equipment, Net": "-1.17",
"Other Expenses": "7.06",
"Expenses": "7.37",
"Revenues": "25.5",
"Net Income": "38.4",
"Research and Development": "6.21",
"General and Administrative Expense": "-6.01",
"Other Revenues": "25.5",
"Comprehensive Net Income": "37.8",
"Other Net Income": "6.58",
"Economic Capital Ratio": "119"
},
"2021": {
"Liabilities, Non-Current": "34.1",
"Liabilities": "65.4",
"Stockholders Equity": "69.1",
"ECR before LimitedLiability": "112",
"Liabilities, Current": "30.0",
"Other Liabilities": "12.8",
"Assets, Current": "4.96",
"Assets": "3.82",
"Assets, Non-Current": "-1.98",
"Goodwill": "1.56",
"Property, Plant and Equipment, Net": "-0.648",
"Other Expenses": "10.1",
"Expenses": "9.99",
"Revenues": "25.6",
"Net Income": "35.7",
"Research and Development": "8.88",
"General and Administrative Expense": "-9.27",
"Other Revenues": "25.6",
"Comprehensive Net Income": "36.2",
"Other Net Income": "0.873",
"Economic Capital Ratio": "107"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000711377_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "122,502",
"Assets, Non-Current": "74,820",
"General and Administrative Expense": "45,132",
"Goodwill": "51,584",
"Liabilities, Current": "17,797",
"Liabilities, Non-Current": "0",
"Other Assets": "-51,584",
"Other Compr. Net Income": "1,282",
"Other Expenses": "97,291",
"Other Liabilities": "12,887",
"Other Net Income": "-596",
"Other Revenues": "172,683",
"Property, Plant and Equipment, Net": "22,340",
"Research and Development": "6,825"
},
"output_variables": {
"Liabilities": "30,684",
"Assets": "219,662",
"Expenses": "149,248",
"Revenues": "172,683",
"Stockholders Equity": "188,978",
"Net Income": "22,839",
"Comprehensive Net Income": "23,480",
"BaseVar": "287,078",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "253%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "143,941",
"Assets, Non-Current": "77,726",
"General and Administrative Expense": "143,671",
"Goodwill": "63,878",
"Liabilities, Current": "19,979",
"Liabilities, Non-Current": "0",
"Other Assets": "-63,878",
"Other Compr. Net Income": "-709",
"Other Expenses": "11,450",
"Other Liabilities": "12,567",
"Other Net Income": "100",
"Other Revenues": "184,046",
"Property, Plant and Equipment, Net": "29,933",
"Research and Development": "6,636"
},
"output_variables": {
"Liabilities": "32,546",
"Assets": "251,600",
"Expenses": "161,757",
"Revenues": "184,046",
"Stockholders Equity": "219,054",
"Net Income": "22,389",
"Comprehensive Net Income": "22,034",
"BaseVar": "315,379",
"ECR before LimitedLiability": "227%",
"Economic Capital Ratio": "254%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "168,447",
"Assets, Non-Current": "87,766",
"General and Administrative Expense": "159,041",
"Goodwill": "71,836",
"Liabilities, Current": "17,719",
"Liabilities, Non-Current": "0",
"Other Assets": "-71,836",
"Other Compr. Net Income": "4.0",
"Other Expenses": "14,100",
"Other Liabilities": "14,552",
"Other Net Income": "435",
"Other Revenues": "207,528",
"Property, Plant and Equipment, Net": "34,345",
"Research and Development": "7,781"
},
"output_variables": {
"Liabilities": "32,271",
"Assets": "290,558",
"Expenses": "180,922",
"Revenues": "207,528",
"Stockholders Equity": "258,287",
"Net Income": "27,041",
"Comprehensive Net Income": "27,043",
"BaseVar": "355,859",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "261%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "188,746",
"Assets, Non-Current": "114,606",
"General and Administrative Expense": "195,688",
"Goodwill": "93,420",
"Liabilities, Current": "24,967",
"Liabilities, Non-Current": "0",
"Other Assets": "-93,420",
"Other Compr. Net Income": "1,870",
"Other Expenses": "15,000",
"Other Liabilities": "14,034",
"Other Net Income": "-360",
"Other Revenues": "247,405",
"Property, Plant and Equipment, Net": "41,949",
"Research and Development": "8,326"
},
"output_variables": {
"Liabilities": "39,001",
"Assets": "345,301",
"Expenses": "219,014",
"Revenues": "247,405",
"Stockholders Equity": "306,300",
"Net Income": "28,031",
"Comprehensive Net Income": "28,966",
"BaseVar": "426,476",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "259%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "231,195",
"Assets, Non-Current": "116,513",
"General and Administrative Expense": "220,379",
"Goodwill": "107,493",
"Liabilities, Current": "25,456",
"Liabilities, Non-Current": "0",
"Other Assets": "-107,493",
"Other Compr. Net Income": "-2,863",
"Other Expenses": "18,500",
"Other Liabilities": "15,762",
"Other Net Income": "-1,042",
"Other Revenues": "283,074",
"Property, Plant and Equipment, Net": "44,473",
"Research and Development": "9,577"
},
"output_variables": {
"Liabilities": "41,218",
"Assets": "392,181",
"Expenses": "248,456",
"Revenues": "283,074",
"Stockholders Equity": "350,963",
"Net Income": "33,576",
"Comprehensive Net Income": "32,144",
"BaseVar": "484,417",
"ECR before LimitedLiability": "237%",
"Economic Capital Ratio": "261%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "248,226",
"Assets, Non-Current": "147,031",
"General and Administrative Expense": "254,999",
"Goodwill": "137,861",
"Liabilities, Current": "28,598",
"Liabilities, Non-Current": "2,423",
"Other Assets": "-137,861",
"Other Compr. Net Income": "-1,478",
"Other Expenses": "18,975",
"Other Liabilities": "14,758",
"Other Net Income": "-873",
"Other Revenues": "321,275",
"Property, Plant and Equipment, Net": "54,683",
"Research and Development": "9,890"
},
"output_variables": {
"Liabilities": "45,779",
"Assets": "449,940",
"Expenses": "283,864",
"Revenues": "321,275",
"Stockholders Equity": "404,161",
"Net Income": "36,538",
"Comprehensive Net Income": "35,799",
"BaseVar": "551,604",
"ECR before LimitedLiability": "238%",
"Economic Capital Ratio": "262%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "292,961",
"Assets, Non-Current": "173,700",
"General and Administrative Expense": "286,264",
"Goodwill": "159,377",
"Liabilities, Current": "36,002",
"Liabilities, Non-Current": "3,602",
"Other Assets": "-159,377",
"Other Compr. Net Income": "-3,437",
"Other Expenses": "22,700",
"Other Liabilities": "17,048",
"Other Net Income": "1,728",
"Other Revenues": "361,594",
"Property, Plant and Equipment, Net": "61,748",
"Research and Development": "10,385"
},
"output_variables": {
"Liabilities": "56,652",
"Assets": "528,409",
"Expenses": "319,349",
"Revenues": "361,594",
"Stockholders Equity": "471,757",
"Net Income": "43,973",
"Comprehensive Net Income": "42,254",
"BaseVar": "635,584",
"ECR before LimitedLiability": "235%",
"Economic Capital Ratio": "260%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "375,789",
"Assets, Non-Current": "169,151",
"General and Administrative Expense": "316,881",
"Goodwill": "0",
"Liabilities, Current": "38,688",
"Liabilities, Non-Current": "5,043",
"Other Assets": "0",
"Other Compr. Net Income": "-2,613",
"Other Expenses": "10,250",
"Other Liabilities": "14,103",
"Other Net Income": "3,271",
"Other Revenues": "397,930",
"Property, Plant and Equipment, Net": "73,069",
"Research and Development": "10,855"
},
"output_variables": {
"Liabilities": "57,834",
"Assets": "618,009",
"Expenses": "337,986",
"Revenues": "397,930",
"Stockholders Equity": "560,175",
"Net Income": "63,215",
"Comprehensive Net Income": "61,908",
"BaseVar": "708,822",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "268%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "449,529",
"Assets, Non-Current": "171,364",
"General and Administrative Expense": "333,287",
"Goodwill": "0",
"Liabilities, Current": "38,251",
"Liabilities, Non-Current": "3,972",
"Other Assets": "0",
"Other Compr. Net Income": "-1,894",
"Other Expenses": "12,783",
"Other Liabilities": "15,618",
"Other Net Income": "4,865",
"Other Revenues": "414,186",
"Property, Plant and Equipment, Net": "74,847",
"Research and Development": "12,805"
},
"output_variables": {
"Liabilities": "57,841",
"Assets": "695,740",
"Expenses": "358,875",
"Revenues": "414,186",
"Stockholders Equity": "637,899",
"Net Income": "60,176",
"Comprehensive Net Income": "59,229",
"BaseVar": "766,700",
"ECR before LimitedLiability": "248%",
"Economic Capital Ratio": "269%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "537,406",
"Assets, Non-Current": "4,184",
"General and Administrative Expense": "335,897",
"Goodwill": "161,704",
"Liabilities, Current": "66,614",
"Liabilities, Non-Current": "5,391",
"Other Assets": "15,217",
"Other Compr. Net Income": "-8,069",
"Other Expenses": "12,830",
"Other Liabilities": "0",
"Other Net Income": "4,782",
"Other Revenues": "418,170",
"Property, Plant and Equipment, Net": "78,671",
"Research and Development": "14,750"
},
"output_variables": {
"Liabilities": "72,005",
"Assets": "797,182",
"Expenses": "363,477",
"Revenues": "418,170",
"Stockholders Equity": "725,177",
"Net Income": "59,475",
"Comprehensive Net Income": "55,440",
"BaseVar": "831,842",
"ECR before LimitedLiability": "241%",
"Economic Capital Ratio": "265%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "591,451",
"Assets, Non-Current": "4,496",
"General and Administrative Expense": "378,043",
"Goodwill": "208,247",
"Liabilities, Current": "75,516",
"Liabilities, Non-Current": "4,299",
"Other Assets": "15,545",
"Other Compr. Net Income": "8,334",
"Other Expenses": "14,386",
"Other Liabilities": "0",
"Other Net Income": "1,099",
"Other Revenues": "468,459",
"Property, Plant and Equipment, Net": "100,453",
"Research and Development": "16,247"
},
"output_variables": {
"Liabilities": "79,815",
"Assets": "920,192",
"Expenses": "408,676",
"Revenues": "468,459",
"Stockholders Equity": "840,377",
"Net Income": "60,882",
"Comprehensive Net Income": "65,049",
"BaseVar": "943,288",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "266%"
}
}
},
"top_rated": true,
"trend": 2.0,
"value": 2.659889426870223,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000711377.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000711377.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000711377.svg"
},
{
"company_id": "0000885462",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000885462.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000885462.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000885462.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000885462_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000885462_main_keyfigs.svg",
"name": "GULF Resources INC",
"rank": 2,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000885462.svg",
"report_text": "The relative strengths and weaknesses of GULF Resources INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of GULF Resources INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 97% points.The greatest weakness of GULF Resources INC is the variable Other Expenses, reducing the Economic Capital Ratio by 12% points.
The company's Economic Capital Ratio, given in the ranking table, is 262%, being 103% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000885462_2022_GULF_Resources_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "58.2",
"Liabilities": "78.6",
"Assets": "1.19",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "196",
"Liabilities, Non-Current": "18.5",
"Other Liabilities": "15.1",
"Property, Plant and Equipment, Net": "2.06",
"Assets, Non-Current": "2.81",
"Other Assets": "-0.918",
"General and Administrative Expense": "5.94",
"Expenses": "32.9",
"Revenues": "28.8",
"Net Income": "52.7",
"Research and Development": "15.6",
"Other Expenses": "12.3",
"Other Revenues": "28.8",
"Comprehensive Net Income": "55.8",
"Other Net Income": "-7.64",
"Other Compr. Net Income": "3.57",
"Economic Capital Ratio": "134"
},
"2012": {
"Liabilities, Current": "33.6",
"Liabilities": "57.9",
"Stockholders Equity": "119",
"ECR before LimitedLiability": "152",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "19.3",
"Assets, Current": "0.692",
"Assets": "9.77",
"Other Assets": "-4.46",
"Assets, Non-Current": "14.7",
"Property, Plant and Equipment, Net": "11.6",
"Goodwill": "-0.899",
"Other Expenses": "19.7",
"Expenses": "36.6",
"Revenues": "2.24",
"Net Income": "38.3",
"Research and Development": "12.9",
"General and Administrative Expense": "5.14",
"Other Revenues": "2.24",
"Comprehensive Net Income": "38.6",
"Economic Capital Ratio": "119"
},
"2013": {
"Liabilities, Current": "43.0",
"Liabilities": "68.3",
"Assets": "4.81",
"Stockholders Equity": "122",
"ECR before LimitedLiability": "169",
"Other Liabilities": "15.4",
"Liabilities, Non-Current": "21.8",
"Assets, Non-Current": "5.03",
"Property, Plant and Equipment, Net": "4.00",
"Other Assets": "-2.12",
"General and Administrative Expense": "1.75",
"Expenses": "35.7",
"Revenues": "8.78",
"Net Income": "41.5",
"Research and Development": "11.6",
"Other Expenses": "23.2",
"Other Revenues": "8.78",
"Other Net Income": "-2.47",
"Comprehensive Net Income": "43.4",
"Other Compr. Net Income": "2.17",
"Economic Capital Ratio": "129"
},
"2014": {
"Liabilities, Non-Current": "23.9",
"Liabilities": "82.0",
"Stockholders Equity": "148",
"ECR before LimitedLiability": "200",
"Liabilities, Current": "59.8",
"Other Liabilities": "13.0",
"Assets, Current": "2.40",
"Assets": "5.67",
"Other Assets": "-1.62",
"Assets, Non-Current": "3.31",
"Property, Plant and Equipment, Net": "2.58",
"Other Expenses": "15.6",
"Expenses": "36.2",
"Revenues": "7.48",
"Net Income": "44.2",
"Research and Development": "13.0",
"General and Administrative Expense": "8.84",
"Other Revenues": "7.48",
"Other Net Income": "1.45",
"Comprehensive Net Income": "44.1",
"Economic Capital Ratio": "150"
},
"2015": {
"Other Liabilities": "22.3",
"Liabilities": "88.5",
"Stockholders Equity": "130",
"ECR before LimitedLiability": "188",
"Liabilities, Current": "57.0",
"Liabilities, Non-Current": "29.4",
"Assets, Current": "2.57",
"Assets": "6.69",
"Other Assets": "-3.71",
"Assets, Non-Current": "8.19",
"Property, Plant and Equipment, Net": "4.00",
"Research and Development": "11.0",
"Expenses": "31.3",
"Revenues": "21.4",
"Net Income": "51.9",
"General and Administrative Expense": "-3.26",
"Other Expenses": "24.0",
"Other Revenues": "21.4",
"Comprehensive Net Income": "48.2",
"Other Compr. Net Income": "-4.21",
"Economic Capital Ratio": "142"
},
"2016": {
"Liabilities, Non-Current": "28.1",
"Liabilities": "78.6",
"Assets": "4.77",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "155",
"Liabilities, Current": "53.9",
"Other Liabilities": "10.9",
"Other Assets": "-2.26",
"Assets, Non-Current": "4.53",
"Assets, Current": "2.39",
"Research and Development": "14.7",
"Expenses": "34.2",
"Revenues": "14.3",
"Net Income": "45.5",
"General and Administrative Expense": "-2.38",
"Other Expenses": "22.6",
"Other Revenues": "14.3",
"Comprehensive Net Income": "41.2",
"Other Net Income": "-1.90",
"Other Compr. Net Income": "-4.95",
"Economic Capital Ratio": "135"
},
"2017": {
"Other Liabilities": "16.1",
"Liabilities": "79.4",
"Assets": "4.55",
"Stockholders Equity": "132",
"ECR before LimitedLiability": "152",
"Liabilities, Current": "55.5",
"Liabilities, Non-Current": "22.5",
"Assets, Non-Current": "3.08",
"Other Assets": "-1.46",
"Assets, Current": "2.85",
"Research and Development": "13.2",
"Expenses": "28.4",
"Revenues": "2.51",
"Net Income": "26.9",
"Other Expenses": "7.51",
"General and Administrative Expense": "8.43",
"Other Revenues": "2.51",
"Comprehensive Net Income": "31.1",
"Other Net Income": "-4.14",
"Other Compr. Net Income": "4.48",
"Economic Capital Ratio": "130"
},
"2018": {
"Liabilities, Non-Current": "15.0",
"Liabilities": "53.4",
"Stockholders Equity": "147",
"ECR before LimitedLiability": "121",
"Other Liabilities": "10.5",
"Liabilities, Current": "34.6",
"Property, Plant and Equipment, Net": "9.60",
"Assets": "47.1",
"Other Assets": "-9.33",
"Assets, Current": "24.4",
"Assets, Non-Current": "19.8",
"Other Expenses": "-20.2",
"Expenses": "20.0",
"Revenues": "-31.6",
"Net Income": "-9.64",
"Research and Development": "9.00",
"General and Administrative Expense": "29.9",
"Other Revenues": "-31.6",
"Comprehensive Net Income": "-14.0",
"Other Compr. Net Income": "-4.21",
"Economic Capital Ratio": "100"
},
"2019": {
"Liabilities, Non-Current": "7.47",
"Liabilities": "42.8",
"Stockholders Equity": "131",
"ECR before LimitedLiability": "146",
"Other Liabilities": "12.1",
"Liabilities, Current": "27.7",
"Assets, Non-Current": "37.4",
"Assets": "38.6",
"Property, Plant and Equipment, Net": "22.0",
"Other Assets": "-11.5",
"Assets, Current": "6.17",
"Research and Development": "6.39",
"Expenses": "30.9",
"Revenues": "-24.1",
"Net Income": "11.6",
"Other Expenses": "-2.47",
"General and Administrative Expense": "27.2",
"Other Revenues": "-24.1",
"Other Net Income": "2.84",
"Comprehensive Net Income": "10.4",
"Economic Capital Ratio": "116"
},
"2020": {
"Liabilities, Current": "34.0",
"Liabilities": "52.5",
"Assets": "17.6",
"Stockholders Equity": "117",
"ECR before LimitedLiability": "159",
"Liabilities, Non-Current": "18.6",
"Other Liabilities": "6.42",
"Other Assets": "-7.18",
"Assets, Non-Current": "25.1",
"Property, Plant and Equipment, Net": "13.5",
"Other Expenses": "2.75",
"Expenses": "28.0",
"Revenues": "-17.5",
"Net Income": "15.8",
"Research and Development": "5.87",
"General and Administrative Expense": "19.9",
"Other Revenues": "-17.5",
"Comprehensive Net Income": "20.5",
"Other Net Income": "4.02",
"Other Compr. Net Income": "4.89",
"Economic Capital Ratio": "121"
},
"2021": {
"Liabilities, Non-Current": "17.0",
"Liabilities": "46.2",
"Stockholders Equity": "97.1",
"ECR before LimitedLiability": "107",
"Liabilities, Current": "25.8",
"Other Liabilities": "9.14",
"Assets": "15.7",
"Assets, Non-Current": "27.6",
"Other Assets": "-8.98",
"Goodwill": "-2.58",
"Property, Plant and Equipment, Net": "17.4",
"Other Expenses": "-12.2",
"Expenses": "24.9",
"Revenues": "-6.81",
"Net Income": "19.2",
"Research and Development": "8.03",
"General and Administrative Expense": "28.5",
"Other Revenues": "-6.81",
"Comprehensive Net Income": "20.8",
"Other Compr. Net Income": "1.65",
"Economic Capital Ratio": "103"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000885462_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "105,517",
"Assets, Non-Current": "152,811",
"General and Administrative Expense": "107,413",
"Goodwill": "0",
"Liabilities, Current": "12,178",
"Liabilities, Non-Current": "0",
"Other Assets": "-147,201",
"Other Compr. Net Income": "12,493",
"Other Expenses": "26,274",
"Other Liabilities": "3,037",
"Other Net Income": "57",
"Other Revenues": "164,980",
"Property, Plant and Equipment, Net": "147,201",
"Research and Development": "399"
},
"output_variables": {
"Liabilities": "15,215",
"Assets": "258,328",
"Expenses": "134,085",
"Revenues": "164,980",
"Stockholders Equity": "243,113",
"Net Income": "30,953",
"Comprehensive Net Income": "37,199",
"BaseVar": "292,579",
"ECR before LimitedLiability": "271%",
"Economic Capital Ratio": "287%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "107,259",
"Assets, Non-Current": "170,934",
"General and Administrative Expense": "80,231",
"Goodwill": "0",
"Liabilities, Current": "11,016",
"Liabilities, Non-Current": "0",
"Other Assets": "-165,943",
"Other Compr. Net Income": "733",
"Other Expenses": "6,622",
"Other Liabilities": "2,953",
"Other Net Income": "313",
"Other Revenues": "101,701",
"Property, Plant and Equipment, Net": "165,943",
"Research and Development": "165"
},
"output_variables": {
"Liabilities": "13,969",
"Assets": "278,193",
"Expenses": "87,018",
"Revenues": "101,701",
"Stockholders Equity": "264,224",
"Net Income": "14,996",
"Comprehensive Net Income": "15,362",
"BaseVar": "240,963",
"ECR before LimitedLiability": "258%",
"Economic Capital Ratio": "278%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "158,073",
"Assets, Non-Current": "151,172",
"General and Administrative Expense": "92,772",
"Goodwill": "0",
"Liabilities, Current": "11,306",
"Liabilities, Non-Current": "0",
"Other Assets": "-146,400",
"Other Compr. Net Income": "9,258",
"Other Expenses": "4,851",
"Other Liabilities": "2,944",
"Other Net Income": "340",
"Other Revenues": "118,392",
"Property, Plant and Equipment, Net": "146,400",
"Research and Development": "140"
},
"output_variables": {
"Liabilities": "14,250",
"Assets": "309,245",
"Expenses": "97,764",
"Revenues": "118,392",
"Stockholders Equity": "294,995",
"Net Income": "20,967",
"Comprehensive Net Income": "25,597",
"BaseVar": "274,624",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "283%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "194,128",
"Assets, Non-Current": "128,854",
"General and Administrative Expense": "88,899",
"Goodwill": "0",
"Liabilities, Current": "8,082",
"Liabilities, Non-Current": "0",
"Other Assets": "-124,351",
"Other Compr. Net Income": "-1,078",
"Other Expenses": "7,035",
"Other Liabilities": "2,826",
"Other Net Income": "280",
"Other Revenues": "113,660",
"Property, Plant and Equipment, Net": "124,351",
"Research and Development": "134"
},
"output_variables": {
"Liabilities": "10,909",
"Assets": "322,982",
"Expenses": "96,068",
"Revenues": "113,660",
"Stockholders Equity": "312,073",
"Net Income": "17,872",
"Comprehensive Net Income": "17,333",
"BaseVar": "272,488",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "284%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "190,821",
"Assets, Non-Current": "165,922",
"General and Administrative Expense": "115,705",
"Goodwill": "29,559",
"Liabilities, Current": "16,076",
"Liabilities, Non-Current": "0",
"Other Assets": "-157,430",
"Other Compr. Net Income": "-21,741",
"Other Expenses": "12,589",
"Other Liabilities": "2,556",
"Other Net Income": "275",
"Other Revenues": "162,317",
"Property, Plant and Equipment, Net": "127,871",
"Research and Development": "231"
},
"output_variables": {
"Liabilities": "18,632",
"Assets": "356,743",
"Expenses": "128,524",
"Revenues": "162,317",
"Stockholders Equity": "338,111",
"Net Income": "34,068",
"Comprehensive Net Income": "23,198",
"BaseVar": "344,116",
"ECR before LimitedLiability": "259%",
"Economic Capital Ratio": "278%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "221,767",
"Assets, Non-Current": "143,924",
"General and Administrative Expense": "100,564",
"Goodwill": "27,669",
"Liabilities, Current": "13,945",
"Liabilities, Non-Current": "0",
"Other Assets": "-136,400",
"Other Compr. Net Income": "-24,931",
"Other Expenses": "12,536",
"Other Liabilities": "2,285",
"Other Net Income": "313",
"Other Revenues": "149,275",
"Property, Plant and Equipment, Net": "108,731",
"Research and Development": "262"
},
"output_variables": {
"Liabilities": "16,230",
"Assets": "365,691",
"Expenses": "113,362",
"Revenues": "149,275",
"Stockholders Equity": "349,461",
"Net Income": "36,226",
"Comprehensive Net Income": "23,760",
"BaseVar": "334,901",
"ECR before LimitedLiability": "263%",
"Economic Capital Ratio": "281%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "241,513",
"Assets, Non-Current": "145,986",
"General and Administrative Expense": "71,972",
"Goodwill": "29,375",
"Liabilities, Current": "3,666",
"Liabilities, Non-Current": "7,273",
"Other Assets": "-124,489",
"Other Compr. Net Income": "24,157",
"Other Expenses": "33,195",
"Other Liabilities": "0",
"Other Net Income": "392",
"Other Revenues": "107,522",
"Property, Plant and Equipment, Net": "95,115",
"Research and Development": "195"
},
"output_variables": {
"Liabilities": "10,939",
"Assets": "387,499",
"Expenses": "105,363",
"Revenues": "107,522",
"Stockholders Equity": "376,560",
"Net Income": "2,551",
"Comprehensive Net Income": "14,630",
"BaseVar": "317,937",
"ECR before LimitedLiability": "266%",
"Economic Capital Ratio": "284%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "187,344",
"Assets, Non-Current": "111,203",
"General and Administrative Expense": "12,645",
"Goodwill": "0",
"Liabilities, Current": "2,624",
"Liabilities, Non-Current": "2,070",
"Other Assets": "-82,283",
"Other Compr. Net Income": "-18,641",
"Other Expenses": "60,414",
"Other Liabilities": "0",
"Other Net Income": "501",
"Other Revenues": "2,595",
"Property, Plant and Equipment, Net": "82,283",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,693",
"Assets": "298,547",
"Expenses": "73,060",
"Revenues": "2,595",
"Stockholders Equity": "293,853",
"Net Income": "-69,964",
"Comprehensive Net Income": "-79,284",
"BaseVar": "199,018",
"ECR before LimitedLiability": "213%",
"Economic Capital Ratio": "244%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "107,203",
"Assets, Non-Current": "172,048",
"General and Administrative Expense": "18,716",
"Goodwill": "0",
"Liabilities, Current": "6,306",
"Liabilities, Non-Current": "9,838",
"Other Assets": "-137,995",
"Other Compr. Net Income": "-5,014",
"Other Expenses": "18,128",
"Other Liabilities": "0",
"Other Net Income": "447",
"Other Revenues": "10,597",
"Property, Plant and Equipment, Net": "137,995",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,144",
"Assets": "279,251",
"Expenses": "36,843",
"Revenues": "10,597",
"Stockholders Equity": "263,107",
"Net Income": "-25,800",
"Comprehensive Net Income": "-28,307",
"BaseVar": "174,148",
"ECR before LimitedLiability": "225%",
"Economic Capital Ratio": "252%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "107,311",
"Assets, Non-Current": "186,727",
"General and Administrative Expense": "29,698",
"Goodwill": "0",
"Liabilities, Current": "7,102",
"Liabilities, Non-Current": "9,911",
"Other Assets": "-148,948",
"Other Compr. Net Income": "19,945",
"Other Expenses": "7,221",
"Other Liabilities": "0",
"Other Net Income": "291",
"Other Revenues": "28,207",
"Property, Plant and Equipment, Net": "148,948",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "17,014",
"Assets": "294,038",
"Expenses": "36,918",
"Revenues": "28,207",
"Stockholders Equity": "277,024",
"Net Income": "-8,420",
"Comprehensive Net Income": "1,552",
"BaseVar": "198,207",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "267%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "115,435",
"Assets, Non-Current": "194,422",
"General and Administrative Expense": "9,588",
"Goodwill": "0",
"Liabilities, Current": "13,890",
"Liabilities, Non-Current": "9,328",
"Other Assets": "-162,658",
"Other Compr. Net Income": "7,406",
"Other Expenses": "46,667",
"Other Liabilities": "0",
"Other Net Income": "300",
"Other Revenues": "55,031",
"Property, Plant and Equipment, Net": "162,658",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "23,218",
"Assets": "309,857",
"Expenses": "56,255",
"Revenues": "55,031",
"Stockholders Equity": "286,639",
"Net Income": "-925",
"Comprehensive Net Income": "2,778",
"BaseVar": "226,033",
"ECR before LimitedLiability": "237%",
"Economic Capital Ratio": "262%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.61639071368663,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000885462.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000885462.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000885462.svg"
},
{
"company_id": "0001141240",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001141240.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001141240.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001141240.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001141240_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001141240_main_keyfigs.svg",
"name": "Liquidmetal Technologies INC",
"rank": 3,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001141240.svg",
"report_text": "The relative strengths and weaknesses of Liquidmetal Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Liquidmetal Technologies INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 120% points.The greatest weakness of Liquidmetal Technologies INC is the variable Other Revenues, reducing the Economic Capital Ratio by 24% points.
The company's Economic Capital Ratio, given in the ranking table, is 260%, being 102% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001141240_2022_Liquidmetal_Technologies_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-40.4",
"Liabilities": "-11.9",
"Stockholders Equity": "-217",
"ECR before LimitedLiability": "76.3",
"Liabilities, Non-Current": "-1.08",
"Other Liabilities": "24.7",
"Property, Plant and Equipment, Net": "-17.8",
"Assets": "-57.7",
"Assets, Non-Current": "-8.47",
"Goodwill": "-3.55",
"Assets, Current": "-48.1",
"General and Administrative Expense": "21.1",
"Expenses": "36.6",
"Revenues": "-96.1",
"Net Income": "132",
"Research and Development": "4.07",
"Other Expenses": "9.81",
"Other Revenues": "-96.1",
"Comprehensive Net Income": "132",
"Other Net Income": "155",
"Economic Capital Ratio": "14.3"
},
"2012": {
"Liabilities, Current": "-5.03",
"Liabilities": "-5.65",
"Stockholders Equity": "-38.6",
"ECR before LimitedLiability": "-80.0",
"Liabilities, Non-Current": "0.726",
"Other Liabilities": "-1.25",
"Assets, Current": "-20.1",
"Assets": "-37.0",
"Assets, Non-Current": "-8.45",
"Property, Plant and Equipment, Net": "-17.1",
"Goodwill": "-13.3",
"Other Expenses": "-38.3",
"Expenses": "-23.8",
"Revenues": "-33.7",
"Net Income": "-22.7",
"Research and Development": "6.92",
"General and Administrative Expense": "18.0",
"Other Revenues": "-33.7",
"Other Net Income": "31.7",
"Comprehensive Net Income": "-22.6",
"Economic Capital Ratio": "-112"
},
"2013": {
"Liabilities, Current": "-0.728",
"Liabilities": "1.82",
"Stockholders Equity": "-43.7",
"ECR before LimitedLiability": "-107",
"Other Liabilities": "3.09",
"Goodwill": "-4.36",
"Assets": "-41.9",
"Assets, Non-Current": "-0.769",
"Property, Plant and Equipment, Net": "-6.88",
"Other Assets": "-2.06",
"Assets, Current": "-21.6",
"General and Administrative Expense": "-2.65",
"Expenses": "-17.3",
"Revenues": "-11.9",
"Net Income": "-50.1",
"Research and Development": "0.0995",
"Other Expenses": "-12.4",
"Other Revenues": "-11.9",
"Other Net Income": "-4.15",
"Comprehensive Net Income": "-50.1",
"Economic Capital Ratio": "-147"
},
"2014": {
"Liabilities, Non-Current": "0.616",
"Liabilities": "11.9",
"Stockholders Equity": "59.9",
"ECR before LimitedLiability": "57.7",
"Liabilities, Current": "33.2",
"Other Liabilities": "-24.2",
"Assets, Current": "65.1",
"Assets": "59.9",
"Goodwill": "-6.11",
"Assets, Non-Current": "-3.75",
"Property, Plant and Equipment, Net": "1.03",
"Other Expenses": "44.2",
"Expenses": "5.01",
"Revenues": "-33.1",
"Net Income": "-27.4",
"Research and Development": "-3.60",
"General and Administrative Expense": "-29.4",
"Other Revenues": "-33.1",
"Other Net Income": "1.48",
"Comprehensive Net Income": "-27.4",
"Economic Capital Ratio": "8.24"
},
"2015": {
"Other Liabilities": "1.58",
"Liabilities": "1.72",
"Stockholders Equity": "11.7",
"ECR before LimitedLiability": "-6.56",
"Liabilities, Current": "0.317",
"Liabilities, Non-Current": "-0.195",
"Assets, Current": "17.4",
"Assets": "10.8",
"Other Assets": "-0.931",
"Goodwill": "-0.854",
"Assets, Non-Current": "-0.520",
"Property, Plant and Equipment, Net": "2.23",
"Research and Development": "-1.99",
"Expenses": "-16.5",
"Revenues": "-26.8",
"Net Income": "-60.4",
"General and Administrative Expense": "-58.0",
"Other Expenses": "15.9",
"Other Revenues": "-26.8",
"Comprehensive Net Income": "-60.1",
"Economic Capital Ratio": "-52.4"
},
"2016": {
"Liabilities, Non-Current": "11.7",
"Liabilities": "32.8",
"Stockholders Equity": "123",
"ECR before LimitedLiability": "85.3",
"Liabilities, Current": "24.1",
"Other Liabilities": "-1.74",
"Property, Plant and Equipment, Net": "-4.41",
"Assets": "64.1",
"Assets, Non-Current": "-1.44",
"Assets, Current": "127",
"Goodwill": "-4.20",
"Research and Development": "4.75",
"Expenses": "17.7",
"Revenues": "-28.8",
"Net Income": "-15.9",
"General and Administrative Expense": "8.50",
"Other Expenses": "4.46",
"Other Revenues": "-28.8",
"Comprehensive Net Income": "-15.8",
"Other Net Income": "-5.41",
"Economic Capital Ratio": "65.3"
},
"2017": {
"Other Liabilities": "-11.1",
"Liabilities": "42.6",
"Stockholders Equity": "138",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "36.6",
"Liabilities, Non-Current": "17.4",
"Assets, Non-Current": "-0.937",
"Assets": "50.2",
"Assets, Current": "44.1",
"Goodwill": "-2.62",
"Property, Plant and Equipment, Net": "5.84",
"Research and Development": "4.02",
"Expenses": "23.8",
"Revenues": "-26.1",
"Net Income": "-3.48",
"Other Expenses": "12.9",
"General and Administrative Expense": "7.23",
"Other Revenues": "-26.1",
"Comprehensive Net Income": "-3.68",
"Other Net Income": "-2.78",
"Economic Capital Ratio": "89.4"
},
"2018": {
"Liabilities, Non-Current": "15.7",
"Liabilities": "41.9",
"Stockholders Equity": "136",
"ECR before LimitedLiability": "125",
"Other Liabilities": "-6.45",
"Liabilities, Current": "34.2",
"Property, Plant and Equipment, Net": "7.23",
"Assets": "45.7",
"Other Assets": "-0.0264",
"Assets, Current": "36.1",
"Goodwill": "-2.00",
"Assets, Non-Current": "-1.58",
"Other Expenses": "11.2",
"Expenses": "25.3",
"Revenues": "-27.3",
"Net Income": "-0.159",
"Research and Development": "1.35",
"General and Administrative Expense": "13.1",
"Other Revenues": "-27.3",
"Economic Capital Ratio": "104",
"Other Compr. Net Income": "0.155"
},
"2019": {
"Liabilities, Non-Current": "12.7",
"Liabilities": "48.2",
"Stockholders Equity": "135",
"ECR before LimitedLiability": "140",
"Other Liabilities": "12.4",
"Liabilities, Current": "28.9",
"Assets, Non-Current": "-2.37",
"Assets": "41.7",
"Goodwill": "-2.45",
"Property, Plant and Equipment, Net": "5.55",
"Other Assets": "8.87",
"Assets, Current": "20.6",
"Research and Development": "2.32",
"Expenses": "21.5",
"Revenues": "-24.7",
"Comprehensive Net Income": "1.08",
"Other Expenses": "1.24",
"General and Administrative Expense": "18.1",
"Other Revenues": "-24.7",
"Other Net Income": "2.75",
"Economic Capital Ratio": "111"
},
"2020": {
"Liabilities, Current": "33.3",
"Liabilities": "51.8",
"Stockholders Equity": "131",
"ECR before LimitedLiability": "157",
"Liabilities, Non-Current": "19.0",
"Other Liabilities": "5.79",
"Goodwill": "-1.41",
"Assets": "24.8",
"Other Assets": "11.0",
"Assets, Current": "5.19",
"Property, Plant and Equipment, Net": "3.56",
"Other Expenses": "5.76",
"Expenses": "24.9",
"Revenues": "-23.5",
"Net Income": "8.37",
"Research and Development": "4.91",
"General and Administrative Expense": "14.8",
"Other Revenues": "-23.5",
"Comprehensive Net Income": "8.64",
"Other Net Income": "5.30",
"Economic Capital Ratio": "119"
},
"2021": {
"Liabilities, Non-Current": "14.7",
"Liabilities": "47.2",
"Stockholders Equity": "120",
"ECR before LimitedLiability": "106",
"Liabilities, Current": "30.0",
"Other Liabilities": "7.91",
"Assets, Current": "9.16",
"Assets": "25.2",
"Other Assets": "8.32",
"Goodwill": "-2.30",
"Property, Plant and Equipment, Net": "4.75",
"Other Expenses": "7.57",
"Expenses": "23.7",
"Revenues": "-24.0",
"Net Income": "3.81",
"Research and Development": "6.62",
"General and Administrative Expense": "10.0",
"Other Revenues": "-24.0",
"Comprehensive Net Income": "3.45",
"Other Net Income": "2.55",
"Economic Capital Ratio": "102"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001141240_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "811",
"Assets, Non-Current": "52",
"General and Administrative Expense": "4,616",
"Goodwill": "968",
"Liabilities, Current": "3,610",
"Liabilities, Non-Current": "609",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,803",
"Other Liabilities": "0",
"Other Net Income": "12,722",
"Other Revenues": "972",
"Property, Plant and Equipment, Net": "162",
"Research and Development": "1,120"
},
"output_variables": {
"Liabilities": "4,219",
"Assets": "1,993",
"Expenses": "7,539",
"Revenues": "972",
"Stockholders Equity": "-2,226",
"Net Income": "6,155",
"Comprehensive Net Income": "6,155",
"BaseVar": "13,722",
"ECR before LimitedLiability": "100%",
"Economic Capital Ratio": "168%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,915",
"Assets, Non-Current": "28",
"General and Administrative Expense": "5,204",
"Goodwill": "869",
"Liabilities, Current": "6,923",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "20,063",
"Other Liabilities": "2,766",
"Other Net Income": "11,535",
"Other Revenues": "650",
"Property, Plant and Equipment, Net": "161",
"Research and Development": "943"
},
"output_variables": {
"Liabilities": "10,545",
"Assets": "8,973",
"Expenses": "26,210",
"Revenues": "650",
"Stockholders Equity": "-1,572",
"Net Income": "-14,025",
"Comprehensive Net Income": "-14,025",
"BaseVar": "28,956",
"ECR before LimitedLiability": "-166%",
"Economic Capital Ratio": "46%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,689",
"Assets, Non-Current": "401",
"General and Administrative Expense": "5,931",
"Goodwill": "764",
"Liabilities, Current": "1,071",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,749",
"Other Liabilities": "4,921",
"Other Net Income": "-1,438",
"Other Revenues": "1,026",
"Property, Plant and Equipment, Net": "249",
"Research and Development": "1,156"
},
"output_variables": {
"Liabilities": "6,848",
"Assets": "4,103",
"Expenses": "13,836",
"Revenues": "1,026",
"Stockholders Equity": "-2,745",
"Net Income": "-14,248",
"Comprehensive Net Income": "-14,248",
"BaseVar": "13,626",
"ECR before LimitedLiability": "-329%",
"Economic Capital Ratio": "7.6%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "10,466",
"Assets, Non-Current": "31",
"General and Administrative Expense": "7,946",
"Goodwill": "669",
"Liabilities, Current": "860",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,327",
"Other Liabilities": "2,005",
"Other Net Income": "30",
"Other Revenues": "627",
"Property, Plant and Equipment, Net": "1,118",
"Research and Development": "1,596"
},
"output_variables": {
"Liabilities": "3,721",
"Assets": "12,284",
"Expenses": "7,215",
"Revenues": "627",
"Stockholders Equity": "8,563",
"Net Income": "-6,558",
"Comprehensive Net Income": "-6,558",
"BaseVar": "11,938",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "5,302",
"Assets, Non-Current": "31",
"General and Administrative Expense": "7,359",
"Goodwill": "570",
"Liabilities, Current": "1,974",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-1,942",
"Other Liabilities": "59",
"Other Net Income": "0",
"Other Revenues": "147",
"Property, Plant and Equipment, Net": "1,370",
"Research and Development": "2,047"
},
"output_variables": {
"Liabilities": "2,889",
"Assets": "7,273",
"Expenses": "7,464",
"Revenues": "147",
"Stockholders Equity": "4,384",
"Net Income": "-7,317",
"Comprehensive Net Income": "-7,317",
"BaseVar": "8,886",
"ECR before LimitedLiability": "-26%",
"Economic Capital Ratio": "83%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "59,698",
"Assets, Non-Current": "36",
"General and Administrative Expense": "8,025",
"Goodwill": "494",
"Liabilities, Current": "3,638",
"Liabilities, Non-Current": "856",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,739",
"Other Liabilities": "2,047",
"Other Net Income": "-2,126",
"Other Revenues": "480",
"Property, Plant and Equipment, Net": "1,139",
"Research and Development": "2,342"
},
"output_variables": {
"Liabilities": "6,541",
"Assets": "61,367",
"Expenses": "17,106",
"Revenues": "480",
"Stockholders Equity": "54,826",
"Net Income": "-18,752",
"Comprehensive Net Income": "-18,752",
"BaseVar": "43,810",
"ECR before LimitedLiability": "166%",
"Economic Capital Ratio": "212%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "42,188",
"Assets, Non-Current": "14",
"General and Administrative Expense": "6,961",
"Goodwill": "408",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "143",
"Other Liabilities": "3,512",
"Other Net Income": "0",
"Other Revenues": "376",
"Property, Plant and Equipment, Net": "12,465",
"Research and Development": "1,962"
},
"output_variables": {
"Liabilities": "3,512",
"Assets": "55,075",
"Expenses": "9,066",
"Revenues": "376",
"Stockholders Equity": "51,563",
"Net Income": "-8,690",
"Comprehensive Net Income": "-8,690",
"BaseVar": "34,014",
"ECR before LimitedLiability": "211%",
"Economic Capital Ratio": "243%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "35,748",
"Assets, Non-Current": "14",
"General and Administrative Expense": "7,063",
"Goodwill": "322",
"Liabilities, Current": "0",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-1,267",
"Other Liabilities": "2,335",
"Other Net Income": "0",
"Other Revenues": "791",
"Property, Plant and Equipment, Net": "11,767",
"Research and Development": "2,429"
},
"output_variables": {
"Liabilities": "2,335",
"Assets": "47,851",
"Expenses": "8,225",
"Revenues": "791",
"Stockholders Equity": "45,516",
"Net Income": "-7,434",
"Comprehensive Net Income": "-7,434",
"BaseVar": "29,601",
"ECR before LimitedLiability": "219%",
"Economic Capital Ratio": "248%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "24,600",
"Assets, Non-Current": "14",
"General and Administrative Expense": "6,256",
"Goodwill": "239",
"Liabilities, Current": "907",
"Liabilities, Non-Current": "856",
"Other Assets": "7,659",
"Other Compr. Net Income": "3.0",
"Other Expenses": "1,665",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,832",
"Property, Plant and Equipment, Net": "8,819",
"Research and Development": "1,342"
},
"output_variables": {
"Liabilities": "1,763",
"Assets": "41,331",
"Expenses": "9,263",
"Revenues": "1,832",
"Stockholders Equity": "39,568",
"Net Income": "-7,431",
"Comprehensive Net Income": "-7,430",
"BaseVar": "27,096",
"ECR before LimitedLiability": "217%",
"Economic Capital Ratio": "247%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "17,018",
"Assets, Non-Current": "251",
"General and Administrative Expense": "4,419",
"Goodwill": "158",
"Liabilities, Current": "520",
"Liabilities, Non-Current": "899",
"Other Assets": "12,768",
"Other Compr. Net Income": "115",
"Other Expenses": "-35",
"Other Liabilities": "0",
"Other Net Income": "484",
"Other Revenues": "1,367",
"Property, Plant and Equipment, Net": "8,614",
"Research and Development": "110"
},
"output_variables": {
"Liabilities": "1,419",
"Assets": "38,809",
"Expenses": "4,494",
"Revenues": "1,367",
"Stockholders Equity": "37,390",
"Net Income": "-2,643",
"Comprehensive Net Income": "-2,586",
"BaseVar": "23,344",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "265%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "18,635",
"Assets, Non-Current": "306",
"General and Administrative Expense": "4,788",
"Goodwill": "102",
"Liabilities, Current": "414",
"Liabilities, Non-Current": "899",
"Other Assets": "8,267",
"Other Compr. Net Income": "-177",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "529",
"Other Revenues": "965",
"Property, Plant and Equipment, Net": "8,295",
"Research and Development": "84"
},
"output_variables": {
"Liabilities": "1,313",
"Assets": "35,605",
"Expenses": "4,872",
"Revenues": "965",
"Stockholders Equity": "34,292",
"Net Income": "-3,378",
"Comprehensive Net Income": "-3,466",
"BaseVar": "21,730",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "260%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.603469342915356,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001141240.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001141240.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001141240.svg"
},
{
"company_id": "0000744218",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000744218.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000744218.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000744218.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000744218_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000744218_main_keyfigs.svg",
"name": "Celldex Therapeutics Inc",
"rank": 4,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000744218.svg",
"report_text": "The relative strengths and weaknesses of Celldex Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Celldex Therapeutics Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 114% points.The greatest weakness of Celldex Therapeutics Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 25% points.
The company's Economic Capital Ratio, given in the ranking table, is 245%, being 86% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000744218_2022_Celldex_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "9.86",
"Liabilities": "-3.63",
"Stockholders Equity": "67.0",
"ECR before LimitedLiability": "60.1",
"Liabilities, Non-Current": "-3.93",
"Other Liabilities": "-9.89",
"Property, Plant and Equipment, Net": "0.343",
"Assets": "67.5",
"Assets, Non-Current": "-3.70",
"Goodwill": "40.9",
"Assets, Current": "26.4",
"General and Administrative Expense": "37.3",
"Expenses": "10.4",
"Revenues": "-30.9",
"Net Income": "-25.8",
"Research and Development": "-26.0",
"Other Expenses": "3.29",
"Other Revenues": "-30.9",
"Comprehensive Net Income": "-25.9",
"Other Net Income": "-4.47",
"Economic Capital Ratio": "-1.92"
},
"2012": {
"Liabilities, Current": "1.74",
"Liabilities": "4.57",
"Stockholders Equity": "78.6",
"ECR before LimitedLiability": "37.3",
"Liabilities, Non-Current": "-2.06",
"Other Liabilities": "4.88",
"Assets, Current": "49.6",
"Assets": "78.6",
"Assets, Non-Current": "-3.55",
"Property, Plant and Equipment, Net": "-3.08",
"Goodwill": "21.4",
"Other Expenses": "9.36",
"Expenses": "8.36",
"Revenues": "-32.0",
"Net Income": "-24.8",
"Research and Development": "-30.8",
"General and Administrative Expense": "33.5",
"Other Revenues": "-32.0",
"Other Net Income": "-0.401",
"Comprehensive Net Income": "-25.1",
"Economic Capital Ratio": "4.79"
},
"2013": {
"Liabilities, Current": "17.3",
"Liabilities": "31.9",
"Stockholders Equity": "133",
"ECR before LimitedLiability": "114",
"Other Liabilities": "10.4",
"Liabilities, Non-Current": "6.72",
"Goodwill": "1.26",
"Assets": "65.4",
"Assets, Non-Current": "-1.30",
"Property, Plant and Equipment, Net": "-1.50",
"Assets, Current": "79.0",
"General and Administrative Expense": "23.7",
"Expenses": "22.1",
"Revenues": "-30.5",
"Net Income": "-8.50",
"Research and Development": "-17.4",
"Other Expenses": "15.1",
"Other Revenues": "-30.5",
"Other Net Income": "-1.65",
"Comprehensive Net Income": "-8.59",
"Economic Capital Ratio": "73.7"
},
"2014": {
"Liabilities, Non-Current": "3.49",
"Liabilities": "35.9",
"Stockholders Equity": "99.6",
"ECR before LimitedLiability": "96.9",
"Liabilities, Current": "24.3",
"Other Liabilities": "9.38",
"Assets, Current": "96.6",
"Assets": "96.4",
"Goodwill": "3.01",
"Assets, Non-Current": "-1.97",
"Property, Plant and Equipment, Net": "-2.60",
"Other Expenses": "14.6",
"Expenses": "4.42",
"Revenues": "-33.2",
"Net Income": "-27.9",
"Research and Development": "-38.6",
"General and Administrative Expense": "30.8",
"Other Revenues": "-33.2",
"Comprehensive Net Income": "-26.9",
"Other Compr. Net Income": "1.06",
"Economic Capital Ratio": "47.5"
},
"2015": {
"Other Liabilities": "12.8",
"Liabilities": "36.3",
"Stockholders Equity": "111",
"ECR before LimitedLiability": "105",
"Liabilities, Current": "21.4",
"Liabilities, Non-Current": "3.92",
"Assets, Current": "110",
"Assets": "78.5",
"Other Assets": "-3.01",
"Assets, Non-Current": "-1.32",
"Property, Plant and Equipment, Net": "-2.77",
"Research and Development": "-27.3",
"Expenses": "8.22",
"Revenues": "-26.9",
"Net Income": "-18.0",
"General and Administrative Expense": "16.9",
"Other Expenses": "18.9",
"Other Revenues": "-26.9",
"Comprehensive Net Income": "-17.5",
"Other Net Income": "0.613",
"Economic Capital Ratio": "58.7"
},
"2016": {
"Liabilities, Non-Current": "-30.8",
"Liabilities": "-2.70",
"Stockholders Equity": "70.5",
"ECR before LimitedLiability": "36.2",
"Liabilities, Current": "19.0",
"Other Liabilities": "6.30",
"Property, Plant and Equipment, Net": "-6.84",
"Assets": "71.0",
"Assets, Non-Current": "-2.15",
"Assets, Current": "18.5",
"Goodwill": "54.6",
"Research and Development": "-18.5",
"Expenses": "16.3",
"Revenues": "-28.3",
"Net Income": "-14.8",
"General and Administrative Expense": "16.5",
"Other Expenses": "19.6",
"Other Revenues": "-28.3",
"Comprehensive Net Income": "-14.0",
"Other Net Income": "-1.35",
"Economic Capital Ratio": "16.2"
},
"2017": {
"Other Liabilities": "8.57",
"Liabilities": "9.71",
"Stockholders Equity": "84.0",
"ECR before LimitedLiability": "47.5",
"Liabilities, Current": "18.3",
"Liabilities, Non-Current": "-18.9",
"Assets, Non-Current": "-2.08",
"Assets": "64.0",
"Assets, Current": "16.1",
"Goodwill": "55.7",
"Property, Plant and Equipment, Net": "-7.96",
"Research and Development": "-22.9",
"Expenses": "13.1",
"Revenues": "-22.2",
"Net Income": "-12.6",
"Other Expenses": "19.0",
"General and Administrative Expense": "18.1",
"Other Revenues": "-22.2",
"Comprehensive Net Income": "-12.8",
"Other Net Income": "-3.01",
"Economic Capital Ratio": "26.0"
},
"2018": {
"Liabilities, Non-Current": "-6.30",
"Liabilities": "19.8",
"Stockholders Equity": "26.6",
"ECR before LimitedLiability": "-19.4",
"Other Liabilities": "12.7",
"Liabilities, Current": "19.5",
"Property, Plant and Equipment, Net": "-19.9",
"Assets": "20.8",
"Assets, Current": "20.7",
"Goodwill": "20.8",
"Assets, Non-Current": "-12.7",
"Other Expenses": "-54.4",
"Expenses": "-50.5",
"Revenues": "-42.9",
"Net Income": "-85.9",
"Research and Development": "-43.3",
"General and Administrative Expense": "21.8",
"Other Revenues": "-42.9",
"Comprehensive Net Income": "-85.6",
"Other Compr. Net Income": "0.343",
"Economic Capital Ratio": "-39.8"
},
"2019": {
"Liabilities, Non-Current": "-12.7",
"Liabilities": "12.8",
"Stockholders Equity": "80.2",
"ECR before LimitedLiability": "63.2",
"Other Liabilities": "11.0",
"Liabilities, Current": "13.9",
"Assets, Non-Current": "-5.39",
"Assets": "59.5",
"Goodwill": "41.0",
"Property, Plant and Equipment, Net": "-7.58",
"Assets, Current": "27.2",
"Research and Development": "-30.4",
"Expenses": "5.15",
"Revenues": "-25.4",
"Net Income": "-17.6",
"Other Expenses": "7.13",
"General and Administrative Expense": "31.4",
"Other Revenues": "-25.4",
"Other Net Income": "3.09",
"Comprehensive Net Income": "-17.5",
"Economic Capital Ratio": "33.7"
},
"2020": {
"Liabilities, Current": "24.1",
"Liabilities": "41.0",
"Stockholders Equity": "96.8",
"ECR before LimitedLiability": "93.4",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "5.51",
"Goodwill": "2.53",
"Assets": "36.7",
"Assets, Current": "66.0",
"Assets, Non-Current": "-4.34",
"Property, Plant and Equipment, Net": "-7.27",
"Expenses": "14.4",
"Net Income": "-8.83",
"Research and Development": "-15.2",
"General and Administrative Expense": "29.7",
"Other Revenues": "-27.5",
"Revenues": "-27.5",
"Other Compr. Net Income": "-15.0",
"Comprehensive Net Income": "-24.0",
"Other Net Income": "4.06",
"Economic Capital Ratio": "55.6"
},
"2021": {
"Liabilities, Non-Current": "15.3",
"Liabilities": "39.4",
"Stockholders Equity": "114",
"ECR before LimitedLiability": "90.5",
"Liabilities, Current": "20.9",
"Other Liabilities": "7.24",
"Assets, Current": "64.4",
"Assets": "34.8",
"Assets, Non-Current": "-2.18",
"Goodwill": "-1.33",
"Property, Plant and Equipment, Net": "-2.88",
"Other Expenses": "6.67",
"Expenses": "18.7",
"Revenues": "-25.2",
"Net Income": "-4.73",
"Research and Development": "-9.54",
"General and Administrative Expense": "21.2",
"Other Revenues": "-25.2",
"Comprehensive Net Income": "-4.84",
"Other Net Income": "0.414",
"Economic Capital Ratio": "86.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000744218_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "54,684",
"Assets, Non-Current": "329",
"General and Administrative Expense": "9,243",
"Goodwill": "33,888",
"Liabilities, Current": "14,298",
"Liabilities, Non-Current": "5,966",
"Other Assets": "0",
"Other Compr. Net Income": "-99",
"Other Expenses": "12,778",
"Other Liabilities": "9,008",
"Other Net Income": "396",
"Other Revenues": "9,265",
"Property, Plant and Equipment, Net": "9,093",
"Research and Development": "32,439"
},
"output_variables": {
"Liabilities": "29,272",
"Assets": "97,994",
"Expenses": "54,460",
"Revenues": "9,265",
"Stockholders Equity": "68,722",
"Net Income": "-44,799",
"Comprehensive Net Income": "-44,848",
"BaseVar": "95,743",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "152%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "85,114",
"Assets, Non-Current": "424",
"General and Administrative Expense": "10,016",
"Goodwill": "32,798",
"Liabilities, Current": "17,685",
"Liabilities, Non-Current": "6,336",
"Other Assets": "0",
"Other Compr. Net Income": "-953",
"Other Expenses": "11,865",
"Other Liabilities": "5,746",
"Other Net Income": "0",
"Other Revenues": "11,202",
"Property, Plant and Equipment, Net": "7,205",
"Research and Development": "47,398"
},
"output_variables": {
"Liabilities": "29,767",
"Assets": "125,541",
"Expenses": "69,279",
"Revenues": "11,202",
"Stockholders Equity": "95,774",
"Net Income": "-58,077",
"Comprehensive Net Income": "-58,554",
"BaseVar": "118,371",
"ECR before LimitedLiability": "94%",
"Economic Capital Ratio": "163%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "305,189",
"Assets, Non-Current": "148",
"General and Administrative Expense": "14,805",
"Goodwill": "31,785",
"Liabilities, Current": "20,350",
"Liabilities, Non-Current": "6,950",
"Other Assets": "0",
"Other Compr. Net Income": "-185",
"Other Expenses": "3,347",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,111",
"Property, Plant and Equipment, Net": "9,973",
"Research and Development": "67,401"
},
"output_variables": {
"Liabilities": "27,300",
"Assets": "347,095",
"Expenses": "85,553",
"Revenues": "4,111",
"Stockholders Equity": "319,795",
"Net Income": "-81,442",
"Comprehensive Net Income": "-81,534",
"BaseVar": "232,122",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "204,985",
"Assets, Non-Current": "1,722",
"General and Administrative Expense": "20,622",
"Goodwill": "30,772",
"Liabilities, Current": "24,491",
"Liabilities, Non-Current": "11,863",
"Other Assets": "0",
"Other Compr. Net Income": "4,272",
"Other Expenses": "1,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "3,586",
"Property, Plant and Equipment, Net": "10,535",
"Research and Development": "104,381"
},
"output_variables": {
"Liabilities": "36,354",
"Assets": "248,014",
"Expenses": "126,016",
"Revenues": "3,586",
"Stockholders Equity": "211,660",
"Net Income": "-122,430",
"Comprehensive Net Income": "-120,294",
"BaseVar": "209,121",
"ECR before LimitedLiability": "119%",
"Economic Capital Ratio": "181%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "294,936",
"Assets, Non-Current": "1,428",
"General and Administrative Expense": "33,837",
"Goodwill": "29,759",
"Liabilities, Current": "30,240",
"Liabilities, Non-Current": "17,239",
"Other Assets": "0",
"Other Compr. Net Income": "2,061",
"Other Expenses": "1,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "5,480",
"Property, Plant and Equipment, Net": "11,461",
"Research and Development": "100,171"
},
"output_variables": {
"Liabilities": "47,479",
"Assets": "337,584",
"Expenses": "135,021",
"Revenues": "5,480",
"Stockholders Equity": "290,105",
"Net Income": "-129,541",
"Comprehensive Net Income": "-128,510",
"BaseVar": "263,812",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "195%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "195,569",
"Assets, Non-Current": "2,134",
"General and Administrative Expense": "35,979",
"Goodwill": "172,463",
"Liabilities, Current": "35,223",
"Liabilities, Non-Current": "82,704",
"Other Assets": "0",
"Other Compr. Net Income": "4,620",
"Other Expenses": "997",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "6,786",
"Property, Plant and Equipment, Net": "13,192",
"Research and Development": "102,726"
},
"output_variables": {
"Liabilities": "117,927",
"Assets": "383,358",
"Expenses": "139,702",
"Revenues": "6,786",
"Stockholders Equity": "265,431",
"Net Income": "-132,916",
"Comprehensive Net Income": "-130,606",
"BaseVar": "326,196",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "163%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "144,756",
"Assets, Non-Current": "1,929",
"General and Administrative Expense": "25,003",
"Goodwill": "158,567",
"Liabilities, Current": "27,736",
"Liabilities, Non-Current": "51,519",
"Other Assets": "0",
"Other Compr. Net Income": "23",
"Other Expenses": "-11,186",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "16,957",
"Property, Plant and Equipment, Net": "10,372",
"Research and Development": "96,171"
},
"output_variables": {
"Liabilities": "79,255",
"Assets": "315,624",
"Expenses": "109,988",
"Revenues": "16,957",
"Stockholders Equity": "236,369",
"Net Income": "-93,031",
"Comprehensive Net Income": "-93,020",
"BaseVar": "260,924",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "179%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "99,079",
"Assets, Non-Current": "1,929",
"General and Administrative Expense": "19,269",
"Goodwill": "48,690",
"Liabilities, Current": "12,602",
"Liabilities, Non-Current": "19,147",
"Other Assets": "0",
"Other Compr. Net Income": "19",
"Other Expenses": "79,491",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "14,025",
"Property, Plant and Equipment, Net": "6,111",
"Research and Development": "66,449"
},
"output_variables": {
"Liabilities": "31,749",
"Assets": "155,809",
"Expenses": "165,209",
"Revenues": "14,025",
"Stockholders Equity": "124,060",
"Net Income": "-151,184",
"Comprehensive Net Income": "-151,174",
"BaseVar": "183,406",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "66,698",
"Assets, Non-Current": "3,514",
"General and Administrative Expense": "15,426",
"Goodwill": "48,690",
"Liabilities, Current": "11,643",
"Liabilities, Non-Current": "17,264",
"Other Assets": "0",
"Other Compr. Net Income": "36",
"Other Expenses": "506",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "7,726",
"Property, Plant and Equipment, Net": "4,031",
"Research and Development": "42,672"
},
"output_variables": {
"Liabilities": "28,907",
"Assets": "122,933",
"Expenses": "58,604",
"Revenues": "7,726",
"Stockholders Equity": "94,026",
"Net Income": "-50,878",
"Comprehensive Net Income": "-50,860",
"BaseVar": "109,103",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "197,843",
"Assets, Non-Current": "3,490",
"General and Administrative Expense": "14,456",
"Goodwill": "30,690",
"Liabilities, Current": "14,206",
"Liabilities, Non-Current": "12,275",
"Other Assets": "0",
"Other Compr. Net Income": "-59,810",
"Other Expenses": "12,615",
"Other Liabilities": "0",
"Other Net Income": "-30",
"Other Revenues": "9,825",
"Property, Plant and Equipment, Net": "3,815",
"Research and Development": "42,534"
},
"output_variables": {
"Liabilities": "26,481",
"Assets": "235,838",
"Expenses": "69,605",
"Revenues": "9,825",
"Stockholders Equity": "209,357",
"Net Income": "-59,810",
"Comprehensive Net Income": "-89,715",
"BaseVar": "200,794",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "202%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "410,839",
"Assets, Non-Current": "3,074",
"General and Administrative Expense": "20,488",
"Goodwill": "27,190",
"Liabilities, Current": "16,528",
"Liabilities, Non-Current": "8,650",
"Other Assets": "0",
"Other Compr. Net Income": "-695",
"Other Expenses": "1,868",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "5,156",
"Property, Plant and Equipment, Net": "3,551",
"Research and Development": "53,311"
},
"output_variables": {
"Liabilities": "25,178",
"Assets": "444,654",
"Expenses": "75,667",
"Revenues": "5,156",
"Stockholders Equity": "419,476",
"Net Income": "-70,511",
"Comprehensive Net Income": "-70,858",
"BaseVar": "275,675",
"ECR before LimitedLiability": "214%",
"Economic Capital Ratio": "245%"
}
}
},
"top_rated": true,
"trend": 11.0,
"value": 2.4492040016598002,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000744218.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000744218.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000744218.svg"
},
{
"company_id": "0001850902",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001850902.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001850902.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001850902.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001850902_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001850902_main_keyfigs.svg",
"name": "Alpha Teknova Inc",
"rank": 5,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001850902.svg",
"report_text": "The relative strengths and weaknesses of Alpha Teknova Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Alpha Teknova Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 72% points.The greatest weakness of Alpha Teknova Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 13% points.
The company's Economic Capital Ratio, given in the ranking table, is 232%, being 73% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001850902_2022_Alpha_Teknova_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "23.5",
"Liabilities": "30.7",
"Stockholders Equity": "72.3",
"ECR before LimitedLiability": "77.8",
"Liabilities, Current": "19.8",
"Other Liabilities": "-13.3",
"Assets, Current": "14.5",
"Assets": "20.6",
"Assets, Non-Current": "-3.67",
"Other Assets": "0.316",
"Goodwill": "4.32",
"Property, Plant and Equipment, Net": "3.29",
"Other Expenses": "9.77",
"Expenses": "16.3",
"Revenues": "-4.00",
"Net Income": "12.4",
"Research and Development": "4.80",
"General and Administrative Expense": "1.85",
"Other Revenues": "-4.00",
"Comprehensive Net Income": "12.4",
"Economic Capital Ratio": "73.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001850902_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "101,204",
"Assets, Non-Current": "180",
"General and Administrative Expense": "43,441",
"Goodwill": "35,317",
"Liabilities, Current": "10,896",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-7.0",
"Other Expenses": "-1,686",
"Other Liabilities": "12,412",
"Other Net Income": "-629",
"Other Revenues": "36,893",
"Property, Plant and Equipment, Net": "29,810",
"Research and Development": "4,312"
},
"output_variables": {
"Liabilities": "23,308",
"Assets": "166,511",
"Expenses": "46,067",
"Revenues": "36,893",
"Stockholders Equity": "143,203",
"Net Income": "-9,803",
"Comprehensive Net Income": "-9,806",
"BaseVar": "136,708",
"ECR before LimitedLiability": "196%",
"Economic Capital Ratio": "232%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.322978533478233,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001850902.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001850902.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001850902.svg"
},
{
"company_id": "0001656472",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001656472.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001656472.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001656472.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001656472_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001656472_main_keyfigs.svg",
"name": "Cronos Group Inc",
"rank": 6,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001656472.svg",
"report_text": "The relative strengths and weaknesses of Cronos Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cronos Group Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 97% points.The greatest weakness of Cronos Group Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 36% points.
The company's Economic Capital Ratio, given in the ranking table, is 232%, being 73% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001656472_2022_Cronos_Group_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "5.96",
"Liabilities": "31.6",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "135",
"Liabilities, Non-Current": "22.7",
"Other Liabilities": "4.90",
"Goodwill": "2.25",
"Assets": "32.9",
"Other Assets": "1.83",
"Assets, Current": "27.0",
"Assets, Non-Current": "-1.70",
"Other Expenses": "-0.629",
"Expenses": "25.1",
"Revenues": "-24.5",
"Net Income": "12.4",
"Research and Development": "3.77",
"General and Administrative Expense": "22.1",
"Other Revenues": "-24.5",
"Comprehensive Net Income": "13.0",
"Other Net Income": "10.2",
"Economic Capital Ratio": "97.4"
},
"2021": {
"Liabilities, Non-Current": "24.6",
"Liabilities": "55.2",
"Stockholders Equity": "96.8",
"ECR before LimitedLiability": "77.8",
"Liabilities, Current": "28.9",
"Other Liabilities": "8.74",
"Assets, Current": "32.7",
"Assets": "21.9",
"Assets, Non-Current": "-3.28",
"Other Assets": "8.79",
"Goodwill": "-5.32",
"Other Expenses": "-36.3",
"Expenses": "-4.16",
"Revenues": "-28.2",
"Net Income": "-15.7",
"Research and Development": "6.60",
"General and Administrative Expense": "23.2",
"Other Revenues": "-28.2",
"Comprehensive Net Income": "-15.3",
"Other Net Income": "15.6",
"Economic Capital Ratio": "73.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001656472_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "1,372,172",
"Assets, Non-Current": "29,011",
"General and Administrative Expense": "114,915",
"Goodwill": "249,242",
"Liabilities, Current": "206,834",
"Liabilities, Non-Current": "8,492",
"Other Assets": "87,658",
"Other Compr. Net Income": "17,294",
"Other Expenses": "92,132",
"Other Liabilities": "2,188",
"Other Net Income": "105,424",
"Other Revenues": "46,719",
"Property, Plant and Equipment, Net": "187,599",
"Research and Development": "20,366"
},
"output_variables": {
"Liabilities": "217,514",
"Assets": "1,925,682",
"Expenses": "227,413",
"Revenues": "46,719",
"Stockholders Equity": "1,708,168",
"Net Income": "-75,270",
"Comprehensive Net Income": "-66,623",
"BaseVar": "1,270,023",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "243%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,079,718",
"Assets, Non-Current": "25,746",
"General and Administrative Expense": "141,419",
"Goodwill": "19,177",
"Liabilities, Current": "54,454",
"Liabilities, Non-Current": "7,095",
"Other Assets": "199,027",
"Other Compr. Net Income": "7,963",
"Other Expenses": "469,848",
"Other Liabilities": "1,913",
"Other Net Income": "162,959",
"Other Revenues": "74,435",
"Property, Plant and Equipment, Net": "74,070",
"Research and Development": "23,331"
},
"output_variables": {
"Liabilities": "63,462",
"Assets": "1,397,738",
"Expenses": "634,598",
"Revenues": "74,435",
"Stockholders Equity": "1,334,276",
"Net Income": "-397,204",
"Comprehensive Net Income": "-393,222",
"BaseVar": "1,170,578",
"ECR before LimitedLiability": "196%",
"Economic Capital Ratio": "232%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.3229749303635714,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001656472.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001656472.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001656472.svg"
},
{
"company_id": "0001054905",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001054905.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001054905.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001054905.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001054905_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001054905_main_keyfigs.svg",
"name": "Innospec INC",
"rank": 7,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001054905.svg",
"report_text": "The relative strengths and weaknesses of Innospec INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Innospec INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 57% points.The greatest weakness of Innospec INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 38% points.
The company's Economic Capital Ratio, given in the ranking table, is 226%, being 68% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001054905_2022_Innospec_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "29.4",
"Liabilities": "60.0",
"Stockholders Equity": "21.0",
"ECR before LimitedLiability": "128",
"Liabilities, Non-Current": "18.6",
"Other Liabilities": "19.5",
"Property, Plant and Equipment, Net": "-4.79",
"Assets": "-7.47",
"Assets, Non-Current": "-3.61",
"Other Assets": "4.30",
"Goodwill": "6.41",
"Assets, Current": "-8.21",
"Other Revenues": "64.1",
"Revenues": "64.1",
"Net Income": "56.7",
"General and Administrative Expense": "55.2",
"Comprehensive Net Income": "57.8",
"Research and Development": "16.3",
"Other Net Income": "-8.06",
"Other Expenses": "-77.5",
"Economic Capital Ratio": "66.0"
},
"2012": {
"Liabilities, Current": "9.93",
"Liabilities": "53.3",
"Stockholders Equity": "17.3",
"ECR before LimitedLiability": "106",
"Liabilities, Non-Current": "19.1",
"Other Liabilities": "30.8",
"Assets, Current": "-7.25",
"Assets": "-5.35",
"Assets, Non-Current": "-2.98",
"Property, Plant and Equipment, Net": "-3.50",
"Goodwill": "9.79",
"Other Expenses": "-65.4",
"Expenses": "11.3",
"Revenues": "62.6",
"Net Income": "73.3",
"Research and Development": "16.9",
"General and Administrative Expense": "52.3",
"Other Revenues": "62.6",
"Other Net Income": "-1.02",
"Comprehensive Net Income": "73.4",
"Economic Capital Ratio": "74.0"
},
"2013": {
"Liabilities, Current": "23.2",
"Liabilities": "61.1",
"Stockholders Equity": "44.5",
"ECR before LimitedLiability": "121",
"Other Liabilities": "22.0",
"Liabilities, Non-Current": "25.4",
"General and Administrative Expense": "42.2",
"Expenses": "8.02",
"Net Income": "55.3",
"Research and Development": "12.9",
"Other Expenses": "-52.4",
"Other Revenues": "50.3",
"Revenues": "50.3",
"Goodwill": "12.2",
"Assets, Non-Current": "-2.38",
"Property, Plant and Equipment, Net": "-2.49",
"Other Assets": "-0.972",
"Assets, Current": "-3.40",
"Other Net Income": "-2.94",
"Comprehensive Net Income": "55.1",
"Economic Capital Ratio": "80.6"
},
"2014": {
"Liabilities, Non-Current": "26.9",
"Liabilities": "70.9",
"Stockholders Equity": "67.4",
"ECR before LimitedLiability": "145",
"Liabilities, Current": "36.5",
"Other Liabilities": "18.4",
"Assets, Current": "-5.99",
"Assets": "4.50",
"Goodwill": "17.1",
"Other Assets": "2.46",
"Assets, Non-Current": "-2.34",
"Other Expenses": "-54.6",
"Expenses": "13.8",
"Revenues": "43.9",
"Net Income": "59.8",
"Research and Development": "15.0",
"General and Administrative Expense": "48.3",
"Other Revenues": "43.9",
"Comprehensive Net Income": "62.2",
"Other Compr. Net Income": "2.31",
"Economic Capital Ratio": "95.2"
},
"2015": {
"Other Liabilities": "26.6",
"Liabilities": "80.9",
"Stockholders Equity": "66.2",
"ECR before LimitedLiability": "146",
"Liabilities, Current": "37.7",
"Liabilities, Non-Current": "31.7",
"Assets, Current": "-3.82",
"Assets": "1.29",
"Other Assets": "-0.904",
"Goodwill": "13.4",
"Assets, Non-Current": "-1.66",
"Property, Plant and Equipment, Net": "-2.57",
"Research and Development": "10.9",
"Expenses": "6.52",
"Revenues": "55.3",
"Net Income": "62.5",
"General and Administrative Expense": "31.1",
"Other Expenses": "-38.6",
"Other Revenues": "55.3",
"Comprehensive Net Income": "62.6",
"Economic Capital Ratio": "100"
},
"2016": {
"Liabilities, Non-Current": "28.7",
"Liabilities": "66.0",
"Stockholders Equity": "65.1",
"ECR before LimitedLiability": "116",
"Liabilities, Current": "34.4",
"Other Liabilities": "13.6",
"Assets": "4.90",
"Other Assets": "2.10",
"Assets, Non-Current": "-1.55",
"Assets, Current": "-5.48",
"Goodwill": "15.2",
"Research and Development": "14.4",
"Expenses": "12.0",
"Revenues": "35.9",
"Net Income": "44.9",
"General and Administrative Expense": "22.5",
"Other Expenses": "-26.7",
"Other Revenues": "35.9",
"Comprehensive Net Income": "44.4",
"Other Net Income": "-2.56",
"Economic Capital Ratio": "96.1"
},
"2017": {
"Other Liabilities": "19.5",
"Liabilities": "75.5",
"Stockholders Equity": "49.9",
"ECR before LimitedLiability": "104",
"Liabilities, Current": "34.6",
"Liabilities, Non-Current": "34.5",
"Other Revenues": "49.5",
"Revenues": "49.5",
"Net Income": "41.6",
"Assets, Non-Current": "-2.21",
"Other Assets": "3.96",
"Assets, Current": "-5.77",
"Goodwill": "9.43",
"Property, Plant and Equipment, Net": "-4.36",
"Comprehensive Net Income": "44.7",
"Other Compr. Net Income": "3.19",
"Other Expenses": "-55.2",
"Other Net Income": "-6.21",
"Research and Development": "16.2",
"General and Administrative Expense": "31.6",
"Economic Capital Ratio": "82.0"
},
"2018": {
"Liabilities, Non-Current": "29.7",
"Liabilities": "63.3",
"Stockholders Equity": "33.4",
"ECR before LimitedLiability": "104",
"Other Liabilities": "18.7",
"Liabilities, Current": "24.1",
"Property, Plant and Equipment, Net": "-3.47",
"Assets": "-3.87",
"Other Assets": "3.49",
"Assets, Current": "-6.44",
"Goodwill": "9.96",
"Assets, Non-Current": "-4.73",
"Other Expenses": "12.3",
"Expenses": "-1.27",
"Revenues": "51.6",
"Net Income": "50.2",
"Research and Development": "14.8",
"General and Administrative Expense": "-29.9",
"Other Revenues": "51.6",
"Comprehensive Net Income": "49.1",
"Economic Capital Ratio": "84.0"
},
"2019": {
"Liabilities, Non-Current": "33.9",
"Liabilities": "67.0",
"Stockholders Equity": "31.8",
"ECR before LimitedLiability": "123",
"Other Liabilities": "22.8",
"Liabilities, Current": "20.5",
"Assets, Non-Current": "-5.48",
"Assets": "-4.92",
"Goodwill": "7.67",
"Property, Plant and Equipment, Net": "-3.32",
"Other Assets": "4.65",
"Assets, Current": "-6.18",
"Other Revenues": "55.0",
"Revenues": "55.0",
"Net Income": "58.9",
"Research and Development": "10.8",
"Comprehensive Net Income": "59.1",
"General and Administrative Expense": "-24.0",
"Other Expenses": "10.5",
"Other Net Income": "5.56",
"Economic Capital Ratio": "94.0"
},
"2020": {
"Liabilities, Current": "24.0",
"Liabilities": "67.7",
"Stockholders Equity": "31.7",
"ECR before LimitedLiability": "123",
"Liabilities, Non-Current": "42.8",
"Other Liabilities": "9.90",
"Goodwill": "8.17",
"Assets": "-5.01",
"Other Assets": "4.37",
"Assets, Current": "-8.12",
"Assets, Non-Current": "-4.13",
"Other Expenses": "6.52",
"Expenses": "-15.6",
"Revenues": "44.3",
"Net Income": "36.5",
"Research and Development": "7.64",
"General and Administrative Expense": "-30.8",
"Other Revenues": "44.3",
"Comprehensive Net Income": "37.3",
"Other Net Income": "7.21",
"Economic Capital Ratio": "85.2"
},
"2021": {
"Liabilities, Non-Current": "37.7",
"Liabilities": "57.1",
"Stockholders Equity": "2.54",
"ECR before LimitedLiability": "71.9",
"Liabilities, Current": "12.1",
"Other Liabilities": "13.6",
"Assets, Current": "-8.59",
"Assets": "-10.4",
"Assets, Non-Current": "-5.79",
"Other Assets": "6.28",
"Goodwill": "1.67",
"Property, Plant and Equipment, Net": "-3.31",
"Other Expenses": "12.0",
"Expenses": "-13.2",
"Revenues": "51.6",
"Net Income": "39.7",
"Research and Development": "10.9",
"General and Administrative Expense": "-37.9",
"Other Revenues": "51.6",
"Comprehensive Net Income": "40.0",
"Economic Capital Ratio": "67.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001054905_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "320,300",
"Assets, Non-Current": "600",
"General and Administrative Expense": "155,900",
"Goodwill": "159,200",
"Liabilities, Current": "146,000",
"Liabilities, Non-Current": "0",
"Other Assets": "42,800",
"Other Compr. Net Income": "11,600",
"Other Expenses": "558,200",
"Other Liabilities": "0",
"Other Net Income": "6,900",
"Other Revenues": "774,400",
"Property, Plant and Equipment, Net": "45,900",
"Research and Development": "18,300"
},
"output_variables": {
"Liabilities": "146,000",
"Assets": "568,800",
"Expenses": "732,400",
"Revenues": "774,400",
"Stockholders Equity": "422,800",
"Net Income": "48,900",
"Comprehensive Net Income": "54,700",
"BaseVar": "1,120,050",
"ECR before LimitedLiability": "177%",
"Economic Capital Ratio": "219%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "296,600",
"Assets, Non-Current": "1,400",
"General and Administrative Expense": "117,100",
"Goodwill": "217,600",
"Liabilities, Current": "147,300",
"Liabilities, Non-Current": "0",
"Other Assets": "14,000",
"Other Compr. Net Income": "0",
"Other Expenses": "516,200",
"Other Liabilities": "0",
"Other Net Income": "-1,400",
"Other Revenues": "776,400",
"Property, Plant and Equipment, Net": "49,800",
"Research and Development": "19,600"
},
"output_variables": {
"Liabilities": "147,300",
"Assets": "579,400",
"Expenses": "652,900",
"Revenues": "776,400",
"Stockholders Equity": "432,100",
"Net Income": "122,100",
"Comprehensive Net Income": "122,100",
"BaseVar": "1,078,700",
"ECR before LimitedLiability": "197%",
"Economic Capital Ratio": "232%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "407,400",
"Assets, Non-Current": "1,800",
"General and Administrative Expense": "141,900",
"Goodwill": "314,700",
"Liabilities, Current": "155,600",
"Liabilities, Non-Current": "0",
"Other Assets": "10,400",
"Other Compr. Net Income": "-1,800",
"Other Expenses": "582,400",
"Other Liabilities": "0",
"Other Net Income": "4,500",
"Other Revenues": "818,800",
"Property, Plant and Equipment, Net": "60,400",
"Research and Development": "21,200"
},
"output_variables": {
"Liabilities": "155,600",
"Assets": "794,700",
"Expenses": "745,500",
"Revenues": "818,800",
"Stockholders Equity": "639,100",
"Net Income": "77,800",
"Comprehensive Net Income": "76,900",
"BaseVar": "1,260,450",
"ECR before LimitedLiability": "200%",
"Economic Capital Ratio": "235%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "414,200",
"Assets, Non-Current": "700",
"General and Administrative Expense": "169,200",
"Goodwill": "457,200",
"Liabilities, Current": "222,900",
"Liabilities, Non-Current": "0",
"Other Assets": "47,000",
"Other Compr. Net Income": "40,000",
"Other Expenses": "687,600",
"Other Liabilities": "0",
"Other Net Income": "2,200",
"Other Revenues": "960,900",
"Property, Plant and Equipment, Net": "80,800",
"Research and Development": "22,200"
},
"output_variables": {
"Liabilities": "222,900",
"Assets": "999,900",
"Expenses": "879,000",
"Revenues": "960,900",
"Stockholders Equity": "777,000",
"Net Income": "84,100",
"Comprehensive Net Income": "104,100",
"BaseVar": "1,552,450",
"ECR before LimitedLiability": "191%",
"Economic Capital Ratio": "229%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "458,700",
"Assets, Non-Current": "900",
"General and Administrative Expense": "206,700",
"Goodwill": "436,100",
"Liabilities, Current": "206,100",
"Liabilities, Non-Current": "0",
"Other Assets": "58,300",
"Other Compr. Net Income": "-4,600",
"Other Expenses": "656,800",
"Other Liabilities": "0",
"Other Net Income": "-4,000",
"Other Revenues": "1,012,300",
"Property, Plant and Equipment, Net": "76,000",
"Research and Development": "25,300"
},
"output_variables": {
"Liabilities": "206,100",
"Assets": "1,030,000",
"Expenses": "888,800",
"Revenues": "1,012,300",
"Stockholders Equity": "823,900",
"Net Income": "119,500",
"Comprehensive Net Income": "117,200",
"BaseVar": "1,572,900",
"ECR before LimitedLiability": "202%",
"Economic Capital Ratio": "236%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "441,100",
"Assets, Non-Current": "800",
"General and Administrative Expense": "209,500",
"Goodwill": "519,200",
"Liabilities, Current": "183,100",
"Liabilities, Non-Current": "0",
"Other Assets": "62,900",
"Other Compr. Net Income": "-15,300",
"Other Expenses": "564,900",
"Other Liabilities": "0",
"Other Net Income": "-2,300",
"Other Revenues": "883,400",
"Property, Plant and Equipment, Net": "157,400",
"Research and Development": "25,400"
},
"output_variables": {
"Liabilities": "183,100",
"Assets": "1,181,400",
"Expenses": "799,800",
"Revenues": "883,400",
"Stockholders Equity": "998,300",
"Net Income": "81,300",
"Comprehensive Net Income": "73,650",
"BaseVar": "1,532,650",
"ECR before LimitedLiability": "211%",
"Economic Capital Ratio": "243%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "561,500",
"Assets, Non-Current": "5,100",
"General and Administrative Expense": "239,500",
"Goodwill": "525,100",
"Liabilities, Current": "261,600",
"Liabilities, Non-Current": "0",
"Other Assets": "122,500",
"Other Compr. Net Income": "87,700",
"Other Expenses": "972,500",
"Other Liabilities": "0",
"Other Net Income": "-1,600",
"Other Revenues": "1,306,800",
"Property, Plant and Equipment, Net": "196,000",
"Research and Development": "31,400"
},
"output_variables": {
"Liabilities": "261,600",
"Assets": "1,410,200",
"Expenses": "1,243,400",
"Revenues": "1,306,800",
"Stockholders Equity": "1,148,600",
"Net Income": "61,800",
"Comprehensive Net Income": "105,650",
"BaseVar": "2,155,650",
"ECR before LimitedLiability": "201%",
"Economic Capital Ratio": "235%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "663,900",
"Assets, Non-Current": "7,200",
"General and Administrative Expense": "1,302,900",
"Goodwill": "501,200",
"Liabilities, Current": "296,600",
"Liabilities, Non-Current": "0",
"Other Assets": "104,700",
"Other Compr. Net Income": "-37,200",
"Other Expenses": "53,700",
"Other Liabilities": "0",
"Other Net Income": "-1,900",
"Other Revenues": "1,476,900",
"Property, Plant and Equipment, Net": "196,400",
"Research and Development": "33,400"
},
"output_variables": {
"Liabilities": "296,600",
"Assets": "1,473,400",
"Expenses": "1,390,000",
"Revenues": "1,476,900",
"Stockholders Equity": "1,176,800",
"Net Income": "85,000",
"Comprehensive Net Income": "66,400",
"BaseVar": "2,338,000",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "630,300",
"Assets, Non-Current": "38,300",
"General and Administrative Expense": "1,328,000",
"Goodwill": "476,500",
"Liabilities, Current": "303,500",
"Liabilities, Non-Current": "0",
"Other Assets": "125,000",
"Other Compr. Net Income": "1,300",
"Other Expenses": "38,200",
"Other Liabilities": "0",
"Other Net Income": "500",
"Other Revenues": "1,513,300",
"Property, Plant and Equipment, Net": "198,700",
"Research and Development": "35,400"
},
"output_variables": {
"Liabilities": "303,500",
"Assets": "1,468,800",
"Expenses": "1,401,600",
"Revenues": "1,513,300",
"Stockholders Equity": "1,165,300",
"Net Income": "112,200",
"Comprehensive Net Income": "112,850",
"BaseVar": "2,344,500",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "230%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "566,200",
"Assets, Non-Current": "48,300",
"General and Administrative Expense": "1,087,400",
"Goodwill": "446,500",
"Liabilities, Current": "252,400",
"Liabilities, Non-Current": "0",
"Other Assets": "125,600",
"Other Compr. Net Income": "17,100",
"Other Expenses": "52,100",
"Other Liabilities": "0",
"Other Net Income": "6,000",
"Other Revenues": "1,193,100",
"Property, Plant and Equipment, Net": "210,800",
"Research and Development": "30,900"
},
"output_variables": {
"Liabilities": "252,400",
"Assets": "1,397,400",
"Expenses": "1,170,400",
"Revenues": "1,193,100",
"Stockholders Equity": "1,145,000",
"Net Income": "28,700",
"Comprehensive Net Income": "37,250",
"BaseVar": "2,018,200",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "231%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "728,100",
"Assets, Non-Current": "40,400",
"General and Administrative Expense": "1,315,700",
"Goodwill": "421,800",
"Liabilities, Current": "336,600",
"Liabilities, Non-Current": "0",
"Other Assets": "166,200",
"Other Compr. Net Income": "10,400",
"Other Expenses": "39,500",
"Other Liabilities": "0",
"Other Net Income": "2,300",
"Other Revenues": "1,483,400",
"Property, Plant and Equipment, Net": "214,400",
"Research and Development": "37,400"
},
"output_variables": {
"Liabilities": "336,600",
"Assets": "1,570,900",
"Expenses": "1,392,600",
"Revenues": "1,483,400",
"Stockholders Equity": "1,234,300",
"Net Income": "93,100",
"Comprehensive Net Income": "98,300",
"BaseVar": "2,398,100",
"ECR before LimitedLiability": "188%",
"Economic Capital Ratio": "226%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.2631741513233723,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001054905.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001054905.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001054905.svg"
},
{
"company_id": "0001652130",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001652130.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001652130.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001652130.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001652130_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001652130_main_keyfigs.svg",
"name": "Intellia Therapeutics Inc",
"rank": 8,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001652130.svg",
"report_text": "The relative strengths and weaknesses of Intellia Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Intellia Therapeutics Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 98% points.The greatest weakness of Intellia Therapeutics Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 23% points.
The company's Economic Capital Ratio, given in the ranking table, is 226%, being 67% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001652130_2022_Intellia_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "15.8",
"Liabilities": "32.9",
"Assets": "46.6",
"Stockholders Equity": "119",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "12.8",
"Other Liabilities": "7.24",
"Property, Plant and Equipment, Net": "-2.08",
"Assets, Current": "72.6",
"Goodwill": "-2.98",
"Research and Development": "-4.35",
"Expenses": "28.5",
"Revenues": "-29.6",
"Net Income": "6.91",
"General and Administrative Expense": "16.2",
"Other Expenses": "16.9",
"Other Revenues": "-29.6",
"Comprehensive Net Income": "7.04",
"Other Net Income": "5.91",
"Other Compr. Net Income": "0.135",
"Economic Capital Ratio": "90.8"
},
"2017": {
"Other Liabilities": "10.2",
"Liabilities": "43.0",
"Stockholders Equity": "126",
"ECR before LimitedLiability": "102",
"Liabilities, Current": "19.2",
"Liabilities, Non-Current": "18.5",
"Assets, Non-Current": "-0.491",
"Assets": "46.1",
"Assets, Current": "90.3",
"Goodwill": "-3.80",
"Property, Plant and Equipment, Net": "-3.37",
"Research and Development": "-13.5",
"Expenses": "18.1",
"Revenues": "-29.8",
"Net Income": "-3.71",
"Other Expenses": "14.5",
"General and Administrative Expense": "16.6",
"Other Revenues": "-29.8",
"Comprehensive Net Income": "-3.92",
"Other Net Income": "6.43",
"Economic Capital Ratio": "80.5"
},
"2018": {
"Liabilities, Non-Current": "15.9",
"Liabilities": "31.8",
"Stockholders Equity": "107",
"ECR before LimitedLiability": "93.0",
"Other Liabilities": "9.78",
"Liabilities, Current": "8.48",
"Property, Plant and Equipment, Net": "-3.17",
"Assets": "47.8",
"Assets, Current": "96.7",
"Goodwill": "-4.49",
"Assets, Non-Current": "-2.36",
"Other Expenses": "8.59",
"Expenses": "13.2",
"Revenues": "-21.6",
"Net Income": "-6.00",
"Research and Development": "-21.9",
"General and Administrative Expense": "25.9",
"Other Revenues": "-21.6",
"Comprehensive Net Income": "-5.83",
"Other Net Income": "1.87",
"Economic Capital Ratio": "72.6"
},
"2019": {
"Liabilities, Non-Current": "19.4",
"Liabilities": "40.8",
"Stockholders Equity": "106",
"ECR before LimitedLiability": "106",
"Other Liabilities": "12.8",
"Liabilities, Current": "12.3",
"Assets": "40.7",
"Goodwill": "-5.56",
"Property, Plant and Equipment, Net": "-3.60",
"Other Assets": "0.300",
"Assets, Current": "75.0",
"Research and Development": "-32.1",
"Expenses": "6.45",
"Revenues": "-18.8",
"Net Income": "-6.53",
"Other Expenses": "7.65",
"General and Administrative Expense": "29.9",
"Other Revenues": "-18.8",
"Other Net Income": "5.57",
"Comprehensive Net Income": "-6.42",
"Economic Capital Ratio": "76.9"
},
"2020": {
"Liabilities, Current": "12.8",
"Liabilities": "39.7",
"Stockholders Equity": "105",
"ECR before LimitedLiability": "120",
"Liabilities, Non-Current": "24.9",
"Other Liabilities": "5.45",
"Goodwill": "-4.06",
"Assets": "35.9",
"Assets, Current": "68.5",
"Assets, Non-Current": "-0.107",
"Property, Plant and Equipment, Net": "-4.11",
"Other Expenses": "5.91",
"Expenses": "8.87",
"Revenues": "-18.9",
"Net Income": "-5.46",
"Research and Development": "-22.6",
"General and Administrative Expense": "24.5",
"Other Revenues": "-18.9",
"Comprehensive Net Income": "-5.42",
"Other Net Income": "4.11",
"Economic Capital Ratio": "82.2"
},
"2021": {
"Liabilities, Non-Current": "19.9",
"Liabilities": "30.4",
"Stockholders Equity": "98.3",
"ECR before LimitedLiability": "71.8",
"Liabilities, Current": "5.55",
"Other Liabilities": "6.89",
"Assets, Current": "21.3",
"Assets": "38.4",
"Assets, Non-Current": "21.3",
"Other Assets": "1.55",
"Goodwill": "-5.11",
"Property, Plant and Equipment, Net": "-3.84",
"Other Expenses": "7.28",
"Expenses": "13.4",
"Revenues": "-23.5",
"Net Income": "-8.93",
"Research and Development": "-15.5",
"General and Administrative Expense": "21.0",
"Other Revenues": "-23.5",
"Comprehensive Net Income": "-9.06",
"Economic Capital Ratio": "67.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001652130_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "281,306",
"Assets, Non-Current": "7,035",
"General and Administrative Expense": "16,798",
"Goodwill": "0",
"Liabilities, Current": "30,730",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "17,004",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "10,628",
"Research and Development": "31,840"
},
"output_variables": {
"Liabilities": "30,730",
"Assets": "298,969",
"Expenses": "48,638",
"Revenues": "0",
"Stockholders Equity": "268,239",
"Net Income": "-31,634",
"Comprehensive Net Income": "-31,634",
"BaseVar": "197,670",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "237%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "354,830",
"Assets, Non-Current": "6,133",
"General and Administrative Expense": "28,025",
"Goodwill": "0",
"Liabilities, Current": "31,359",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "28,129",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "15,272",
"Research and Development": "67,647"
},
"output_variables": {
"Liabilities": "31,359",
"Assets": "376,235",
"Expenses": "95,672",
"Revenues": "0",
"Stockholders Equity": "344,876",
"Net Income": "-67,543",
"Comprehensive Net Income": "-67,543",
"BaseVar": "265,698",
"ECR before LimitedLiability": "199%",
"Economic Capital Ratio": "234%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "324,977",
"Assets, Non-Current": "5,277",
"General and Administrative Expense": "32,189",
"Goodwill": "0",
"Liabilities, Current": "40,572",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-28",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "5,527",
"Other Revenues": "30,434",
"Property, Plant and Equipment, Net": "17,061",
"Research and Development": "89,115"
},
"output_variables": {
"Liabilities": "40,572",
"Assets": "347,315",
"Expenses": "121,304",
"Revenues": "30,434",
"Stockholders Equity": "306,743",
"Net Income": "-85,343",
"Comprehensive Net Income": "-85,357",
"BaseVar": "272,590",
"ECR before LimitedLiability": "173%",
"Economic Capital Ratio": "216%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "289,481",
"Assets, Non-Current": "26,803",
"General and Administrative Expense": "41,058",
"Goodwill": "0",
"Liabilities, Current": "35,633",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "289",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "6,835",
"Other Revenues": "43,103",
"Property, Plant and Equipment, Net": "17,996",
"Research and Development": "108,413"
},
"output_variables": {
"Liabilities": "35,633",
"Assets": "334,280",
"Expenses": "149,471",
"Revenues": "43,103",
"Stockholders Equity": "298,647",
"Net Income": "-99,533",
"Comprehensive Net Income": "-99,388",
"BaseVar": "284,806",
"ECR before LimitedLiability": "167%",
"Economic Capital Ratio": "213%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "616,517",
"Assets, Non-Current": "43,862",
"General and Administrative Expense": "44,169",
"Goodwill": "0",
"Liabilities, Current": "64,254",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-260",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "2,352",
"Other Revenues": "57,994",
"Property, Plant and Equipment, Net": "15,943",
"Research and Development": "150,408"
},
"output_variables": {
"Liabilities": "64,254",
"Assets": "676,322",
"Expenses": "194,577",
"Revenues": "57,994",
"Stockholders Equity": "612,068",
"Net Income": "-134,231",
"Comprehensive Net Income": "-134,361",
"BaseVar": "497,880",
"ECR before LimitedLiability": "190%",
"Economic Capital Ratio": "228%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "769,303",
"Assets, Non-Current": "474,635",
"General and Administrative Expense": "71,096",
"Goodwill": "0",
"Liabilities, Current": "125,833",
"Liabilities, Non-Current": "0",
"Other Assets": "29,558",
"Other Compr. Net Income": "-2,633",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "42",
"Other Revenues": "33,053",
"Property, Plant and Equipment, Net": "20,968",
"Research and Development": "229,807"
},
"output_variables": {
"Liabilities": "125,833",
"Assets": "1,294,464",
"Expenses": "300,903",
"Revenues": "33,053",
"Stockholders Equity": "1,168,631",
"Net Income": "-267,808",
"Comprehensive Net Income": "-269,124",
"BaseVar": "878,464",
"ECR before LimitedLiability": "188%",
"Economic Capital Ratio": "226%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.2628114860861155,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001652130.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001652130.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001652130.svg"
},
{
"company_id": "0000794172",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000794172.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000794172.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000794172.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000794172_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000794172_main_keyfigs.svg",
"name": "Meridian Bioscience INC",
"rank": 9,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000794172.svg",
"report_text": "The relative strengths and weaknesses of Meridian Bioscience INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Meridian Bioscience INC compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 43% points.The greatest weakness of Meridian Bioscience INC is the variable Other Assets, reducing the Economic Capital Ratio by 16% points.
The company's Economic Capital Ratio, given in the ranking table, is 223%, being 64% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000794172_2022_Meridian_Bioscience_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "1.55",
"Liabilities": "21.8",
"Stockholders Equity": "51.4",
"ECR before LimitedLiability": "62.8",
"Liabilities, Current": "18.5",
"Other Liabilities": "2.31",
"Property, Plant and Equipment, Net": "-0.449",
"Assets": "2.99",
"Other Assets": "-1.08",
"Assets, Current": "3.82",
"Assets, Non-Current": "0.609",
"Goodwill": "0.588",
"General and Administrative Expense": "29.9",
"Expenses": "20.1",
"Revenues": "-1.56",
"Net Income": "18.9",
"Other Expenses": "-6.87",
"Research and Development": "-3.78",
"Other Revenues": "-1.56",
"Comprehensive Net Income": "19.0",
"Economic Capital Ratio": "62.0"
},
"2010": {
"Other Liabilities": "6.11",
"Liabilities": "74.1",
"Stockholders Equity": "61.8",
"ECR before LimitedLiability": "99.5",
"Liabilities, Current": "29.2",
"Liabilities, Non-Current": "50.9",
"Goodwill": "0.732",
"Assets": "0.843",
"Assets, Current": "1.06",
"Assets, Non-Current": "1.69",
"Other Assets": "-1.80",
"Other Expenses": "-35.7",
"Expenses": "-1.55",
"Revenues": "29.3",
"Net Income": "31.7",
"General and Administrative Expense": "28.8",
"Research and Development": "2.56",
"Other Revenues": "29.3",
"Other Net Income": "4.05",
"Comprehensive Net Income": "31.8",
"Economic Capital Ratio": "101"
},
"2011": {
"Liabilities, Current": "58.6",
"Liabilities": "85.5",
"Stockholders Equity": "78.4",
"ECR before LimitedLiability": "185",
"Liabilities, Non-Current": "21.8",
"Other Liabilities": "22.8",
"Property, Plant and Equipment, Net": "0.429",
"Assets": "1.64",
"Assets, Non-Current": "2.86",
"Other Assets": "-2.25",
"Goodwill": "1.26",
"General and Administrative Expense": "39.3",
"Expenses": "17.5",
"Revenues": "58.2",
"Net Income": "65.8",
"Research and Development": "10.9",
"Other Expenses": "-36.3",
"Other Revenues": "58.2",
"Comprehensive Net Income": "65.8",
"Other Net Income": "-9.05",
"Economic Capital Ratio": "123"
},
"2012": {
"Liabilities, Current": "39.8",
"Liabilities": "79.5",
"Stockholders Equity": "64.2",
"ECR before LimitedLiability": "149",
"Liabilities, Non-Current": "22.2",
"Other Liabilities": "35.6",
"Assets": "0.880",
"Other Assets": "-2.35",
"Assets, Non-Current": "2.77",
"Property, Plant and Equipment, Net": "0.258",
"Goodwill": "0.840",
"Other Expenses": "-31.6",
"Expenses": "19.1",
"Revenues": "58.3",
"Net Income": "74.7",
"Research and Development": "12.8",
"General and Administrative Expense": "35.1",
"Other Revenues": "58.3",
"Other Net Income": "-0.427",
"Comprehensive Net Income": "74.8",
"Economic Capital Ratio": "116"
},
"2013": {
"Liabilities, Current": "46.1",
"Liabilities": "84.8",
"Stockholders Equity": "66.0",
"ECR before LimitedLiability": "159",
"Other Liabilities": "27.4",
"Liabilities, Non-Current": "31.5",
"Goodwill": "0.317",
"Assets": "0.688",
"Assets, Non-Current": "2.49",
"Other Assets": "-2.60",
"Assets, Current": "1.11",
"General and Administrative Expense": "30.8",
"Expenses": "15.5",
"Revenues": "64.2",
"Net Income": "74.3",
"Research and Development": "9.97",
"Other Expenses": "-27.5",
"Other Revenues": "64.2",
"Other Net Income": "-4.07",
"Comprehensive Net Income": "74.4",
"Economic Capital Ratio": "119"
},
"2014": {
"Liabilities, Non-Current": "34.4",
"Liabilities": "114",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "198",
"Liabilities, Current": "82.2",
"Other Liabilities": "26.3",
"Assets, Current": "0.686",
"Assets": "0.853",
"Other Assets": "0.236",
"Assets, Non-Current": "-0.327",
"Property, Plant and Equipment, Net": "0.187",
"Other Expenses": "-42.2",
"Expenses": "15.8",
"Revenues": "68.9",
"Net Income": "84.0",
"Research and Development": "12.0",
"General and Administrative Expense": "41.5",
"Other Revenues": "68.9",
"Other Net Income": "2.00",
"Comprehensive Net Income": "84.0",
"Economic Capital Ratio": "149"
},
"2015": {
"Other Liabilities": "35.8",
"Liabilities": "117",
"Assets": "0.339",
"Stockholders Equity": "94.1",
"ECR before LimitedLiability": "189",
"Liabilities, Current": "76.2",
"Liabilities, Non-Current": "39.1",
"Assets, Current": "1.40",
"Other Assets": "-0.503",
"Assets, Non-Current": "-0.368",
"Research and Development": "7.18",
"Expenses": "7.41",
"Revenues": "74.9",
"Net Income": "81.7",
"General and Administrative Expense": "25.7",
"Other Expenses": "-27.4",
"Other Revenues": "74.9",
"Comprehensive Net Income": "81.3",
"Other Net Income": "0.696",
"Other Compr. Net Income": "-0.515",
"Economic Capital Ratio": "143"
},
"2016": {
"Liabilities, Non-Current": "-31.2",
"Liabilities": "27.2",
"Stockholders Equity": "26.4",
"ECR before LimitedLiability": "77.0",
"Liabilities, Current": "40.9",
"Other Liabilities": "10.6",
"Property, Plant and Equipment, Net": "-3.23",
"Assets": "3.22",
"Assets, Non-Current": "-2.53",
"Assets, Current": "-3.95",
"Goodwill": "15.2",
"Research and Development": "9.54",
"Expenses": "18.2",
"Revenues": "30.4",
"Net Income": "47.4",
"General and Administrative Expense": "15.1",
"Other Expenses": "-6.51",
"Other Revenues": "30.4",
"Comprehensive Net Income": "47.0",
"Other Net Income": "-2.29",
"Economic Capital Ratio": "57.0"
},
"2017": {
"Other Liabilities": "14.5",
"Liabilities": "36.7",
"Stockholders Equity": "30.6",
"ECR before LimitedLiability": "72.6",
"Liabilities, Current": "40.6",
"Liabilities, Non-Current": "-22.0",
"Assets, Non-Current": "-2.98",
"Assets": "1.69",
"Assets, Current": "1.40",
"Goodwill": "10.4",
"Property, Plant and Equipment, Net": "-6.11",
"Research and Development": "8.96",
"Expenses": "9.22",
"Revenues": "35.4",
"Net Income": "39.7",
"Other Expenses": "-15.9",
"General and Administrative Expense": "16.1",
"Other Revenues": "35.4",
"Comprehensive Net Income": "39.9",
"Other Net Income": "-5.19",
"Economic Capital Ratio": "51.0"
},
"2018": {
"Liabilities, Non-Current": "-21.2",
"Liabilities": "32.3",
"Stockholders Equity": "23.3",
"ECR before LimitedLiability": "85.5",
"Other Liabilities": "14.8",
"Liabilities, Current": "35.4",
"Property, Plant and Equipment, Net": "-3.98",
"Assets": "0.240",
"Other Assets": "-14.5",
"Goodwill": "10.5",
"Assets, Non-Current": "15.5",
"Other Expenses": "5.70",
"Expenses": "10.5",
"Revenues": "36.6",
"Net Income": "47.3",
"Research and Development": "7.63",
"General and Administrative Expense": "-2.79",
"Other Revenues": "36.6",
"Comprehensive Net Income": "47.5",
"Other Net Income": "-0.526",
"Economic Capital Ratio": "65.0"
},
"2019": {
"Liabilities, Non-Current": "-51.5",
"Liabilities": "3.42",
"Stockholders Equity": "15.3",
"ECR before LimitedLiability": "77.7",
"Other Liabilities": "13.9",
"Liabilities, Current": "30.0",
"Assets, Non-Current": "32.5",
"Assets": "7.52",
"Goodwill": "30.2",
"Property, Plant and Equipment, Net": "-5.18",
"Other Assets": "-24.0",
"Research and Development": "4.00",
"Expenses": "21.3",
"Revenues": "18.2",
"Net Income": "45.0",
"Other Expenses": "5.31",
"General and Administrative Expense": "11.6",
"Other Revenues": "18.2",
"Other Net Income": "3.43",
"Comprehensive Net Income": "44.8",
"Economic Capital Ratio": "48.2"
},
"2020": {
"Liabilities, Current": "19.5",
"Liabilities": "10.2",
"Stockholders Equity": "9.38",
"ECR before LimitedLiability": "85.0",
"Liabilities, Non-Current": "-19.8",
"Other Liabilities": "8.15",
"Other Expenses": "4.69",
"Expenses": "10.8",
"Net Income": "37.7",
"Research and Development": "1.82",
"General and Administrative Expense": "4.20",
"Other Revenues": "21.5",
"Revenues": "21.5",
"Goodwill": "30.5",
"Other Assets": "-23.4",
"Assets, Current": "-7.98",
"Assets, Non-Current": "39.1",
"Property, Plant and Equipment, Net": "-6.57",
"Comprehensive Net Income": "38.2",
"Other Net Income": "4.40",
"Economic Capital Ratio": "47.2"
},
"2021": {
"Liabilities, Non-Current": "-5.89",
"Liabilities": "29.3",
"Stockholders Equity": "13.3",
"ECR before LimitedLiability": "68.7",
"Liabilities, Current": "24.4",
"Other Liabilities": "11.3",
"Assets, Current": "-5.58",
"Assets": "-2.03",
"Assets, Non-Current": "22.5",
"Other Assets": "-15.8",
"Goodwill": "14.7",
"Property, Plant and Equipment, Net": "-3.52",
"Other Expenses": "5.36",
"Expenses": "10.1",
"Revenues": "32.8",
"Net Income": "42.9",
"Research and Development": "5.12",
"General and Administrative Expense": "-0.390",
"Other Revenues": "32.8",
"Comprehensive Net Income": "43.1",
"Economic Capital Ratio": "64.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000794172_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "117,147",
"Assets, Non-Current": "18,376",
"General and Administrative Expense": "35,576",
"Goodwill": "17,183",
"Liabilities, Current": "16,752",
"Liabilities, Non-Current": "0",
"Other Assets": "-17,183",
"Other Compr. Net Income": "0",
"Other Expenses": "72,055",
"Other Liabilities": "0",
"Other Net Income": "544",
"Other Revenues": "148,274",
"Property, Plant and Equipment, Net": "20,474",
"Research and Development": "8,428"
},
"output_variables": {
"Liabilities": "16,752",
"Assets": "155,997",
"Expenses": "116,059",
"Revenues": "148,274",
"Stockholders Equity": "139,245",
"Net Income": "32,759",
"Comprehensive Net Income": "32,759",
"BaseVar": "218,813",
"ECR before LimitedLiability": "259%",
"Economic Capital Ratio": "278%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "94,020",
"Assets, Non-Current": "38,048",
"General and Administrative Expense": "37,527",
"Goodwill": "36,809",
"Liabilities, Current": "14,147",
"Liabilities, Non-Current": "0",
"Other Assets": "-36,809",
"Other Compr. Net Income": "0",
"Other Expenses": "70,518",
"Other Liabilities": "0",
"Other Net Income": "262",
"Other Revenues": "143,000",
"Property, Plant and Equipment, Net": "22,717",
"Research and Development": "8,570"
},
"output_variables": {
"Liabilities": "14,147",
"Assets": "154,785",
"Expenses": "116,615",
"Revenues": "143,000",
"Stockholders Equity": "140,638",
"Net Income": "26,647",
"Comprehensive Net Income": "26,647",
"BaseVar": "214,404",
"ECR before LimitedLiability": "260%",
"Economic Capital Ratio": "279%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "90,354",
"Assets, Non-Current": "38,600",
"General and Administrative Expense": "47,655",
"Goodwill": "34,071",
"Liabilities, Current": "15,264",
"Liabilities, Non-Current": "0",
"Other Assets": "-34,071",
"Other Compr. Net Income": "0",
"Other Expenses": "75,882",
"Other Liabilities": "0",
"Other Net Income": "467",
"Other Revenues": "159,723",
"Property, Plant and Equipment, Net": "26,539",
"Research and Development": "9,822"
},
"output_variables": {
"Liabilities": "15,264",
"Assets": "155,493",
"Expenses": "133,359",
"Revenues": "159,723",
"Stockholders Equity": "140,229",
"Net Income": "26,831",
"Comprehensive Net Income": "26,831",
"BaseVar": "232,153",
"ECR before LimitedLiability": "256%",
"Economic Capital Ratio": "276%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "96,590",
"Assets, Non-Current": "38,636",
"General and Administrative Expense": "49,294",
"Goodwill": "33,410",
"Liabilities, Current": "18,462",
"Liabilities, Non-Current": "0",
"Other Assets": "-33,410",
"Other Compr. Net Income": "0",
"Other Expenses": "81,022",
"Other Liabilities": "0",
"Other Net Income": "420",
"Other Revenues": "173,542",
"Property, Plant and Equipment, Net": "26,155",
"Research and Development": "10,275"
},
"output_variables": {
"Liabilities": "18,462",
"Assets": "161,381",
"Expenses": "140,591",
"Revenues": "173,542",
"Stockholders Equity": "142,919",
"Net Income": "33,371",
"Comprehensive Net Income": "33,371",
"BaseVar": "247,198",
"ECR before LimitedLiability": "255%",
"Economic Capital Ratio": "275%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "114,088",
"Assets, Non-Current": "36,569",
"General and Administrative Expense": "52,943",
"Goodwill": "31,172",
"Liabilities, Current": "21,703",
"Liabilities, Non-Current": "0",
"Other Assets": "-31,172",
"Other Compr. Net Income": "650",
"Other Expenses": "86,972",
"Other Liabilities": "0",
"Other Net Income": "48",
"Other Revenues": "188,686",
"Property, Plant and Equipment, Net": "26,091",
"Research and Development": "10,787"
},
"output_variables": {
"Liabilities": "21,703",
"Assets": "176,748",
"Expenses": "150,702",
"Revenues": "188,686",
"Stockholders Equity": "155,045",
"Net Income": "38,032",
"Comprehensive Net Income": "38,357",
"BaseVar": "269,268",
"ECR before LimitedLiability": "253%",
"Economic Capital Ratio": "273%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "112,748",
"Assets, Non-Current": "342",
"General and Administrative Expense": "52,299",
"Goodwill": "31,006",
"Liabilities, Current": "13,735",
"Liabilities, Non-Current": "2,165",
"Other Assets": "5,223",
"Other Compr. Net Income": "-436",
"Other Expenses": "88,954",
"Other Liabilities": "0",
"Other Net Income": "-284",
"Other Revenues": "188,832",
"Property, Plant and Equipment, Net": "27,610",
"Research and Development": "12,552"
},
"output_variables": {
"Liabilities": "15,900",
"Assets": "176,929",
"Expenses": "153,805",
"Revenues": "188,832",
"Stockholders Equity": "161,029",
"Net Income": "34,743",
"Comprehensive Net Income": "34,525",
"BaseVar": "268,093",
"ECR before LimitedLiability": "265%",
"Economic Capital Ratio": "282%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "122,853",
"Assets, Non-Current": "384",
"General and Administrative Expense": "53,217",
"Goodwill": "28,280",
"Liabilities, Current": "15,251",
"Liabilities, Non-Current": "2,158",
"Other Assets": "4,273",
"Other Compr. Net Income": "-2,639",
"Other Expenses": "92,471",
"Other Liabilities": "0",
"Other Net Income": "-997",
"Other Revenues": "194,830",
"Property, Plant and Equipment, Net": "27,492",
"Research and Development": "12,605"
},
"output_variables": {
"Liabilities": "17,409",
"Assets": "183,282",
"Expenses": "158,293",
"Revenues": "194,830",
"Stockholders Equity": "165,873",
"Net Income": "35,540",
"Comprehensive Net Income": "34,220",
"BaseVar": "278,725",
"ECR before LimitedLiability": "261%",
"Economic Capital Ratio": "279%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "126,791",
"Assets, Non-Current": "353",
"General and Administrative Expense": "60,436",
"Goodwill": "91,837",
"Liabilities, Current": "22,571",
"Liabilities, Non-Current": "62,780",
"Other Assets": "2,392",
"Other Compr. Net Income": "-3,186",
"Other Expenses": "88,868",
"Other Liabilities": "0",
"Other Net Income": "-734",
"Other Revenues": "196,082",
"Property, Plant and Equipment, Net": "30,450",
"Research and Development": "13,815"
},
"output_variables": {
"Liabilities": "85,351",
"Assets": "251,823",
"Expenses": "163,119",
"Revenues": "196,082",
"Stockholders Equity": "166,472",
"Net Income": "32,229",
"Comprehensive Net Income": "30,636",
"BaseVar": "350,148",
"ECR before LimitedLiability": "153%",
"Economic Capital Ratio": "204%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "133,875",
"Assets, Non-Current": "421",
"General and Administrative Expense": "64,381",
"Goodwill": "81,630",
"Liabilities, Current": "22,887",
"Liabilities, Non-Current": "57,305",
"Other Assets": "3,341",
"Other Compr. Net Income": "2,570",
"Other Expenses": "98,200",
"Other Liabilities": "0",
"Other Net Income": "-953",
"Other Revenues": "200,771",
"Property, Plant and Equipment, Net": "30,510",
"Research and Development": "15,680"
},
"output_variables": {
"Liabilities": "80,192",
"Assets": "249,777",
"Expenses": "178,261",
"Revenues": "200,771",
"Stockholders Equity": "169,585",
"Net Income": "21,557",
"Comprehensive Net Income": "22,842",
"BaseVar": "356,262",
"ECR before LimitedLiability": "155%",
"Economic Capital Ratio": "204%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "139,053",
"Assets, Non-Current": "82,329",
"General and Administrative Expense": "152,066",
"Goodwill": "77,750",
"Liabilities, Current": "24,173",
"Liabilities, Non-Current": "51,786",
"Other Assets": "-77,750",
"Other Compr. Net Income": "-431",
"Other Expenses": "19,582",
"Other Liabilities": "0",
"Other Net Income": "-1,204",
"Other Revenues": "213,571",
"Property, Plant and Equipment, Net": "29,995",
"Research and Development": "16,870"
},
"output_variables": {
"Liabilities": "75,959",
"Assets": "251,377",
"Expenses": "188,518",
"Revenues": "213,571",
"Stockholders Equity": "175,418",
"Net Income": "23,849",
"Comprehensive Net Income": "23,634",
"BaseVar": "365,530",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "144,761",
"Assets, Non-Current": "150,150",
"General and Administrative Expense": "144,137",
"Goodwill": "149,484",
"Liabilities, Current": "20,914",
"Liabilities, Non-Current": "113,597",
"Other Assets": "-149,484",
"Other Compr. Net Income": "-1,598",
"Other Expenses": "13,405",
"Other Liabilities": "0",
"Other Net Income": "-1,142",
"Other Revenues": "201,014",
"Property, Plant and Equipment, Net": "30,567",
"Research and Development": "17,948"
},
"output_variables": {
"Liabilities": "134,511",
"Assets": "325,478",
"Expenses": "175,490",
"Revenues": "201,014",
"Stockholders Equity": "190,967",
"Net Income": "24,382",
"Comprehensive Net Income": "23,583",
"BaseVar": "419,616",
"ECR before LimitedLiability": "124%",
"Economic Capital Ratio": "184%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "162,190",
"Assets, Non-Current": "211,951",
"General and Administrative Expense": "168,250",
"Goodwill": "197,383",
"Liabilities, Current": "56,328",
"Liabilities, Non-Current": "105,108",
"Other Assets": "-197,383",
"Other Compr. Net Income": "3,115",
"Other Expenses": "13,471",
"Other Liabilities": "-3,804",
"Other Net Income": "-2,031",
"Other Revenues": "253,667",
"Property, Plant and Equipment, Net": "31,120",
"Research and Development": "23,729"
},
"output_variables": {
"Liabilities": "157,632",
"Assets": "405,261",
"Expenses": "205,450",
"Revenues": "253,667",
"Stockholders Equity": "247,629",
"Net Income": "46,186",
"Comprehensive Net Income": "47,744",
"BaseVar": "513,578",
"ECR before LimitedLiability": "138%",
"Economic Capital Ratio": "193%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "192,807",
"Assets, Non-Current": "213,701",
"General and Administrative Expense": "193,069",
"Goodwill": "198,819",
"Liabilities, Current": "48,212",
"Liabilities, Non-Current": "74,263",
"Other Assets": "-198,819",
"Other Compr. Net Income": "2,058",
"Other Expenses": "26,926",
"Other Liabilities": "-1,055",
"Other Net Income": "-2,583",
"Other Revenues": "317,896",
"Property, Plant and Equipment, Net": "43,214",
"Research and Development": "23,911"
},
"output_variables": {
"Liabilities": "121,420",
"Assets": "449,722",
"Expenses": "243,906",
"Revenues": "317,896",
"Stockholders Equity": "328,302",
"Net Income": "71,407",
"Comprehensive Net Income": "72,436",
"BaseVar": "568,792",
"ECR before LimitedLiability": "183%",
"Economic Capital Ratio": "223%"
}
}
},
"top_rated": true,
"trend": 9.0,
"value": 2.231174101995517,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000794172.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000794172.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000794172.svg"
},
{
"company_id": "0001775194",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001775194.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001775194.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001775194_main_keyfigs.svg",
"name": "Upexi INC",
"rank": 10,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001775194.svg",
"report_text": "The relative strengths and weaknesses of Upexi INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Upexi INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Upexi INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 217%, being 58% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001775194_2022_Upexi_INC.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "34.2",
"Liabilities": "52.5",
"Stockholders Equity": "3.62",
"ECR before LimitedLiability": "62.6",
"Liabilities, Current": "10.5",
"Other Liabilities": "12.8",
"Assets, Current": "0.776",
"Assets": "-10.9",
"Assets, Non-Current": "-6.80",
"Other Assets": "3.66",
"Goodwill": "-3.81",
"Property, Plant and Equipment, Net": "-5.12",
"Other Expenses": "2.59",
"Expenses": "-13.6",
"Revenues": "45.8",
"Net Income": "31.8",
"Research and Development": "13.0",
"General and Administrative Expense": "-30.1",
"Other Revenues": "45.8",
"Comprehensive Net Income": "31.8",
"Economic Capital Ratio": "58.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001775194_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "18,293",
"Assets, Non-Current": "467",
"General and Administrative Expense": "21,027",
"Goodwill": "4,259",
"Liabilities, Current": "5,819",
"Liabilities, Non-Current": "217",
"Other Assets": "1,404",
"Other Compr. Net Income": "0",
"Other Expenses": "2,924",
"Other Liabilities": "0",
"Other Net Income": "-269",
"Other Revenues": "24,095",
"Property, Plant and Equipment, Net": "2,832",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,037",
"Assets": "27,255",
"Expenses": "23,951",
"Revenues": "24,095",
"Stockholders Equity": "21,218",
"Net Income": "-125",
"Comprehensive Net Income": "-125",
"BaseVar": "40,803",
"ECR before LimitedLiability": "174%",
"Economic Capital Ratio": "217%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.1710336752615795,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001775194.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001775194.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001775194.svg"
},
{
"company_id": "0000907654",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000907654.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000907654.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000907654.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000907654_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000907654_main_keyfigs.svg",
"name": "Oruka Therapeutics Inc",
"rank": 11,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000907654.svg",
"report_text": "The relative strengths and weaknesses of Oruka Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Oruka Therapeutics Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 131% points.The greatest weakness of Oruka Therapeutics Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 216%, being 57% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000907654_2022_Oruka_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "0",
"Liabilities": "0",
"ECR before LimitedLiability": "-91.5",
"Liabilities, Non-Current": "0",
"Other Liabilities": "0",
"Property, Plant and Equipment, Net": "0",
"Assets": "-77.5",
"Stockholders Equity": "0",
"Assets, Non-Current": "0",
"Goodwill": "0",
"Assets, Current": "-23.3",
"General and Administrative Expense": "0",
"Expenses": "-50.4",
"Net Income": "-38.9",
"Research and Development": "-0.0791",
"Other Expenses": "0",
"Other Revenues": "0",
"Revenues": "0",
"Comprehensive Net Income": "-39.1",
"Other Net Income": "0",
"Economic Capital Ratio": "-153"
},
"2013": {
"Liabilities, Current": "103",
"Liabilities": "173",
"Stockholders Equity": "105",
"ECR before LimitedLiability": "359",
"Other Liabilities": "51.5",
"Liabilities, Non-Current": "59.5",
"Goodwill": "23.8",
"Assets": "-14.2",
"Assets, Non-Current": "8.49",
"Property, Plant and Equipment, Net": "20.4",
"Assets, Current": "-131",
"General and Administrative Expense": "51.2",
"Expenses": "118",
"Revenues": "-98.7",
"Net Income": "265",
"Research and Development": "-7.38",
"Other Expenses": "75.8",
"Other Revenues": "-98.7",
"Other Net Income": "249",
"Comprehensive Net Income": "265",
"Economic Capital Ratio": "319"
},
"2014": {
"Liabilities, Non-Current": "14.8",
"Liabilities": "50.2",
"Stockholders Equity": "104",
"ECR before LimitedLiability": "97.3",
"Liabilities, Current": "28.4",
"Other Liabilities": "9.86",
"Assets, Current": "119",
"Assets": "97.2",
"Goodwill": "-8.03",
"Assets, Non-Current": "0.826",
"Property, Plant and Equipment, Net": "-6.21",
"Other Expenses": "15.9",
"Expenses": "-6.77",
"Revenues": "-36.8",
"Net Income": "-42.6",
"Research and Development": "-31.9",
"General and Administrative Expense": "10.2",
"Other Revenues": "-36.8",
"Other Net Income": "1.07",
"Comprehensive Net Income": "-42.5",
"Economic Capital Ratio": "47.9"
},
"2015": {
"Other Liabilities": "13.9",
"Liabilities": "55.9",
"Stockholders Equity": "149",
"ECR before LimitedLiability": "144",
"Liabilities, Current": "32.5",
"Liabilities, Non-Current": "16.8",
"Assets, Current": "145",
"Assets": "63.8",
"Other Assets": "-1.67",
"Goodwill": "-3.43",
"Property, Plant and Equipment, Net": "-2.84",
"Research and Development": "-17.1",
"Expenses": "14.4",
"Revenues": "-29.1",
"Net Income": "-12.9",
"General and Administrative Expense": "12.7",
"Other Expenses": "18.1",
"Other Revenues": "-29.1",
"Comprehensive Net Income": "-12.7",
"Other Net Income": "0.597",
"Economic Capital Ratio": "97.7"
},
"2016": {
"Liabilities, Non-Current": "17.4",
"Liabilities": "45.8",
"Stockholders Equity": "89.4",
"ECR before LimitedLiability": "43.3",
"Liabilities, Current": "23.2",
"Other Liabilities": "7.46",
"Property, Plant and Equipment, Net": "-10.7",
"Assets": "77.5",
"Other Assets": "11.4",
"Assets, Current": "88.5",
"Goodwill": "-9.40",
"Research and Development": "-49.0",
"Expenses": "-17.4",
"Revenues": "-36.0",
"Net Income": "-54.7",
"General and Administrative Expense": "10.1",
"Other Expenses": "24.3",
"Other Revenues": "-36.0",
"Comprehensive Net Income": "-54.6",
"Other Net Income": "-1.64",
"Economic Capital Ratio": "23.4"
},
"2017": {
"Other Liabilities": "2.58",
"Liabilities": "12.1",
"Stockholders Equity": "28.1",
"ECR before LimitedLiability": "-53.9",
"Liabilities, Current": "4.86",
"Liabilities, Non-Current": "5.01",
"Assets, Non-Current": "-2.57",
"Assets": "6.20",
"Assets, Current": "69.3",
"Goodwill": "-5.95",
"Property, Plant and Equipment, Net": "-6.57",
"Research and Development": "-96.2",
"Expenses": "-65.7",
"Revenues": "-16.6",
"Net Income": "-121",
"Other Expenses": "10.0",
"General and Administrative Expense": "0.760",
"Other Revenues": "-16.6",
"Comprehensive Net Income": "-121",
"Other Net Income": "-1.55",
"Economic Capital Ratio": "-75.5"
},
"2018": {
"Liabilities, Non-Current": "8.90",
"Liabilities": "12.2",
"Stockholders Equity": "26.7",
"ECR before LimitedLiability": "-30.1",
"Other Liabilities": "8.62",
"Liabilities, Current": "9.04",
"Property, Plant and Equipment, Net": "-28.7",
"Assets": "13.2",
"Assets, Current": "72.3",
"Goodwill": "-23.3",
"Assets, Non-Current": "-16.4",
"Other Expenses": "8.80",
"Expenses": "-73.7",
"Revenues": "-56.4",
"Net Income": "-118",
"Research and Development": "-74.3",
"General and Administrative Expense": "-17.8",
"Other Revenues": "-56.4",
"Comprehensive Net Income": "-118",
"Other Compr. Net Income": "0.397",
"Economic Capital Ratio": "-50.5"
},
"2019": {
"Liabilities, Non-Current": "18.9",
"Liabilities": "41.8",
"Stockholders Equity": "88.5",
"ECR before LimitedLiability": "64.4",
"Other Liabilities": "12.3",
"Liabilities, Current": "12.6",
"Assets, Non-Current": "-8.08",
"Assets": "68.5",
"Goodwill": "-9.48",
"Property, Plant and Equipment, Net": "-11.1",
"Assets, Current": "121",
"Research and Development": "-17.9",
"Expenses": "-16.5",
"Revenues": "-33.5",
"Net Income": "-46.4",
"Other Expenses": "11.0",
"General and Administrative Expense": "-9.18",
"Other Revenues": "-33.5",
"Other Net Income": "3.46",
"Comprehensive Net Income": "-46.4",
"Economic Capital Ratio": "35.0"
},
"2020": {
"Liabilities, Current": "15.1",
"Liabilities": "37.3",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "126",
"Liabilities, Non-Current": "20.6",
"Other Liabilities": "4.95",
"Goodwill": "-3.27",
"Assets": "44.6",
"Assets, Current": "107",
"Assets, Non-Current": "-2.27",
"Property, Plant and Equipment, Net": "-4.14",
"Other Expenses": "5.26",
"Expenses": "14.7",
"Revenues": "-26.8",
"Net Income": "-7.67",
"Research and Development": "-7.75",
"General and Administrative Expense": "17.0",
"Other Revenues": "-26.8",
"Comprehensive Net Income": "-7.62",
"Other Net Income": "3.28",
"Economic Capital Ratio": "88.0"
},
"2021": {
"Liabilities, Non-Current": "18.7",
"Liabilities": "38.0",
"Stockholders Equity": "107",
"ECR before LimitedLiability": "61.5",
"Liabilities, Current": "15.4",
"Other Liabilities": "7.04",
"Assets, Current": "131",
"Assets": "42.5",
"Assets, Non-Current": "-3.91",
"Goodwill": "-6.31",
"Property, Plant and Equipment, Net": "-5.63",
"Other Expenses": "7.70",
"Expenses": "0.856",
"Revenues": "-28.2",
"Net Income": "-26.8",
"Research and Development": "-24.8",
"General and Administrative Expense": "17.2",
"Other Revenues": "-28.2",
"Comprehensive Net Income": "-26.8",
"Other Net Income": "0.439",
"Economic Capital Ratio": "57.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000907654_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "6,212",
"Assets, Non-Current": "224",
"General and Administrative Expense": "39,356",
"Goodwill": "0",
"Liabilities, Current": "754",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "12,041",
"Other Liabilities": "16",
"Other Net Income": "27,282",
"Other Revenues": "2,026",
"Property, Plant and Equipment, Net": "66",
"Research and Development": "41,585"
},
"output_variables": {
"Liabilities": "770",
"Assets": "6,502",
"Expenses": "92,982",
"Revenues": "2,026",
"Stockholders Equity": "5,732",
"Net Income": "-63,674",
"Comprehensive Net Income": "-63,674",
"BaseVar": "64,781",
"ECR before LimitedLiability": "-1,535%",
"Economic Capital Ratio": "0.0000000000000000000015%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "16,925",
"Assets, Non-Current": "130",
"General and Administrative Expense": "4,012",
"Goodwill": "0",
"Liabilities, Current": "1,502",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,277",
"Other Liabilities": "1.0",
"Other Net Income": "27,282",
"Other Revenues": "5.0",
"Property, Plant and Equipment, Net": "29",
"Research and Development": "2,928"
},
"output_variables": {
"Liabilities": "1,503",
"Assets": "17,084",
"Expenses": "4,663",
"Revenues": "5.0",
"Stockholders Equity": "15,581",
"Net Income": "22,624",
"Comprehensive Net Income": "22,624",
"BaseVar": "25,268",
"ECR before LimitedLiability": "473%",
"Economic Capital Ratio": "474%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "15,488",
"Assets, Non-Current": "608",
"General and Administrative Expense": "4,068",
"Goodwill": "0",
"Liabilities, Current": "1,388",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3.0",
"Other Liabilities": "3.0",
"Other Net Income": "0",
"Other Revenues": "7.0",
"Property, Plant and Equipment, Net": "36",
"Research and Development": "5,625"
},
"output_variables": {
"Liabilities": "1,391",
"Assets": "16,132",
"Expenses": "9,696",
"Revenues": "7.0",
"Stockholders Equity": "14,741",
"Net Income": "-9,689",
"Comprehensive Net Income": "-9,689",
"BaseVar": "13,613",
"ECR before LimitedLiability": "120%",
"Economic Capital Ratio": "181%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "38,916",
"Assets, Non-Current": "630",
"General and Administrative Expense": "4,392",
"Goodwill": "0",
"Liabilities, Current": "1,504",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4.0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "14",
"Property, Plant and Equipment, Net": "28",
"Research and Development": "7,063"
},
"output_variables": {
"Liabilities": "1,504",
"Assets": "39,574",
"Expenses": "11,459",
"Revenues": "14",
"Stockholders Equity": "38,070",
"Net Income": "-11,445",
"Comprehensive Net Income": "-11,445",
"BaseVar": "26,276",
"ECR before LimitedLiability": "198%",
"Economic Capital Ratio": "234%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "21,445",
"Assets, Non-Current": "766",
"General and Administrative Expense": "4,265",
"Goodwill": "0",
"Liabilities, Current": "2,396",
"Liabilities, Non-Current": "0",
"Other Assets": "2,352",
"Other Compr. Net Income": "-19",
"Other Expenses": "0",
"Other Liabilities": "39",
"Other Net Income": "0",
"Other Revenues": "169",
"Property, Plant and Equipment, Net": "66",
"Research and Development": "12,348"
},
"output_variables": {
"Liabilities": "2,435",
"Assets": "24,629",
"Expenses": "16,613",
"Revenues": "169",
"Stockholders Equity": "22,194",
"Net Income": "-16,444",
"Comprehensive Net Income": "-16,454",
"BaseVar": "21,932",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "12,299",
"Assets, Non-Current": "24",
"General and Administrative Expense": "4,636",
"Goodwill": "0",
"Liabilities, Current": "2,070",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "17",
"Other Expenses": "-55",
"Other Liabilities": "20",
"Other Net Income": "0",
"Other Revenues": "167",
"Property, Plant and Equipment, Net": "42",
"Research and Development": "14,076"
},
"output_variables": {
"Liabilities": "2,090",
"Assets": "12,365",
"Expenses": "18,657",
"Revenues": "167",
"Stockholders Equity": "10,275",
"Net Income": "-18,490",
"Comprehensive Net Income": "-18,482",
"BaseVar": "16,648",
"ECR before LimitedLiability": "-61%",
"Economic Capital Ratio": "78%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,777",
"Assets, Non-Current": "24",
"General and Administrative Expense": "3,879",
"Goodwill": "0",
"Liabilities, Current": "793",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "2.0",
"Other Expenses": "-23",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "162",
"Property, Plant and Equipment, Net": "24",
"Research and Development": "4,239"
},
"output_variables": {
"Liabilities": "793",
"Assets": "6,825",
"Expenses": "8,095",
"Revenues": "162",
"Stockholders Equity": "6,032",
"Net Income": "-7,933",
"Comprehensive Net Income": "-7,932",
"BaseVar": "7,938",
"ECR before LimitedLiability": "8.7%",
"Economic Capital Ratio": "93%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "8,480",
"Assets, Non-Current": "46",
"General and Administrative Expense": "3,981",
"Goodwill": "0",
"Liabilities, Current": "926",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-160",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "172",
"Property, Plant and Equipment, Net": "10",
"Research and Development": "1,833"
},
"output_variables": {
"Liabilities": "926",
"Assets": "8,536",
"Expenses": "5,654",
"Revenues": "172",
"Stockholders Equity": "7,610",
"Net Income": "-5,482",
"Comprehensive Net Income": "-5,482",
"BaseVar": "7,644",
"ECR before LimitedLiability": "104%",
"Economic Capital Ratio": "171%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "49,968",
"Assets, Non-Current": "440",
"General and Administrative Expense": "4,774",
"Goodwill": "0",
"Liabilities, Current": "3,499",
"Liabilities, Non-Current": "409",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "28",
"Property, Plant and Equipment, Net": "21",
"Research and Development": "4,992"
},
"output_variables": {
"Liabilities": "3,908",
"Assets": "50,429",
"Expenses": "9,766",
"Revenues": "28",
"Stockholders Equity": "46,521",
"Net Income": "-9,738",
"Comprehensive Net Income": "-9,738",
"BaseVar": "32,066",
"ECR before LimitedLiability": "199%",
"Economic Capital Ratio": "234%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "54,421",
"Assets, Non-Current": "455",
"General and Administrative Expense": "5,503",
"Goodwill": "0",
"Liabilities, Current": "3,498",
"Liabilities, Non-Current": "383",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "13",
"Property, Plant and Equipment, Net": "48",
"Research and Development": "13,832"
},
"output_variables": {
"Liabilities": "3,881",
"Assets": "54,924",
"Expenses": "19,335",
"Revenues": "13",
"Stockholders Equity": "51,043",
"Net Income": "-19,322",
"Comprehensive Net Income": "-19,322",
"BaseVar": "39,076",
"ECR before LimitedLiability": "172%",
"Economic Capital Ratio": "216%"
}
}
},
"top_rated": true,
"trend": -5.0,
"value": 2.1593147379279407,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000907654.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000907654.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000907654.svg"
},
{
"company_id": "0000009326",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000009326.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000009326.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000009326.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000009326_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000009326_main_keyfigs.svg",
"name": "Balchem CORP",
"rank": 12,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000009326.svg",
"report_text": "The relative strengths and weaknesses of Balchem CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Balchem CORP compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Balchem CORP is the variable Other Liabilities, reducing the Economic Capital Ratio by 15% points.
The company's Economic Capital Ratio, given in the ranking table, is 214%, being 56% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000009326_2022_Balchem_CORP.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "39.3",
"Liabilities": "70.0",
"Stockholders Equity": "61.8",
"ECR before LimitedLiability": "134",
"Liabilities, Non-Current": "19.9",
"Other Liabilities": "24.1",
"Assets, Current": "3.11",
"Assets": "2.38",
"Assets, Non-Current": "-1.45",
"Property, Plant and Equipment, Net": "0.767",
"Goodwill": "0.209",
"Other Expenses": "27.0",
"Expenses": "15.7",
"Revenues": "48.0",
"Net Income": "61.6",
"Research and Development": "18.3",
"General and Administrative Expense": "-32.2",
"Other Revenues": "48.0",
"Other Net Income": "-0.697",
"Comprehensive Net Income": "61.7",
"Economic Capital Ratio": "102"
},
"2013": {
"Liabilities, Current": "44.6",
"Liabilities": "74.2",
"Stockholders Equity": "71.5",
"ECR before LimitedLiability": "146",
"Other Liabilities": "16.4",
"Liabilities, Non-Current": "27.4",
"Goodwill": "-0.644",
"Assets": "3.47",
"Assets, Non-Current": "-1.24",
"Other Assets": "-0.777",
"Assets, Current": "6.39",
"General and Administrative Expense": "-30.5",
"Expenses": "14.5",
"Revenues": "47.8",
"Net Income": "57.8",
"Research and Development": "14.8",
"Other Expenses": "27.9",
"Other Revenues": "47.8",
"Other Net Income": "-3.56",
"Comprehensive Net Income": "57.9",
"Economic Capital Ratio": "106"
},
"2014": {
"Liabilities, Non-Current": "16.9",
"Liabilities": "-5.56",
"Stockholders Equity": "21.9",
"ECR before LimitedLiability": "75.4",
"Liabilities, Current": "36.8",
"Other Liabilities": "-76.0",
"Assets, Current": "-20.0",
"Assets": "20.3",
"Goodwill": "70.7",
"Assets, Non-Current": "-3.54",
"Property, Plant and Equipment, Net": "3.19",
"Other Expenses": "16.5",
"Expenses": "32.0",
"Revenues": "13.1",
"Net Income": "48.9",
"Research and Development": "12.9",
"General and Administrative Expense": "1.39",
"Other Revenues": "13.1",
"Other Net Income": "1.31",
"Comprehensive Net Income": "48.7",
"Economic Capital Ratio": "26.0"
},
"2015": {
"Other Liabilities": "-61.5",
"Liabilities": "8.99",
"Stockholders Equity": "27.7",
"ECR before LimitedLiability": "82.6",
"Liabilities, Current": "37.0",
"Liabilities, Non-Current": "19.7",
"Assets, Current": "-16.3",
"Assets": "13.8",
"Other Assets": "-5.07",
"Goodwill": "55.2",
"Assets, Non-Current": "-2.35",
"Property, Plant and Equipment, Net": "4.85",
"Research and Development": "9.27",
"Expenses": "23.7",
"Revenues": "19.7",
"Net Income": "46.6",
"General and Administrative Expense": "-8.86",
"Other Expenses": "23.5",
"Other Revenues": "19.7",
"Comprehensive Net Income": "46.8",
"Economic Capital Ratio": "36.7"
},
"2016": {
"Liabilities, Non-Current": "-25.3",
"Liabilities": "-1.50",
"Stockholders Equity": "15.8",
"ECR before LimitedLiability": "49.3",
"Liabilities, Current": "30.5",
"Other Liabilities": "-10.7",
"Property, Plant and Equipment, Net": "0.860",
"Assets": "10.8",
"Assets, Non-Current": "-2.55",
"Assets, Current": "-20.0",
"Goodwill": "61.8",
"Research and Development": "12.7",
"Expenses": "23.7",
"Revenues": "14.2",
"Net Income": "37.2",
"General and Administrative Expense": "-10.9",
"Other Expenses": "22.2",
"Other Revenues": "14.2",
"Comprehensive Net Income": "37.4",
"Other Net Income": "-1.82",
"Economic Capital Ratio": "29.3"
},
"2017": {
"Other Liabilities": "1.29",
"Liabilities": "17.6",
"Stockholders Equity": "32.4",
"ECR before LimitedLiability": "65.0",
"Liabilities, Current": "29.3",
"Liabilities, Non-Current": "-15.5",
"Assets, Non-Current": "-2.58",
"Assets": "10.4",
"Assets, Current": "-13.1",
"Goodwill": "43.0",
"Property, Plant and Equipment, Net": "-0.510",
"Research and Development": "12.1",
"Expenses": "18.2",
"Revenues": "21.4",
"Net Income": "36.1",
"Other Expenses": "19.6",
"General and Administrative Expense": "-13.4",
"Other Revenues": "21.4",
"Comprehensive Net Income": "36.0",
"Other Net Income": "-4.22",
"Economic Capital Ratio": "43.4"
},
"2019": {
"Liabilities, Non-Current": "20.3",
"Liabilities": "8.95",
"Stockholders Equity": "27.9",
"ECR before LimitedLiability": "88.3",
"Other Liabilities": "-34.7",
"Liabilities, Current": "17.3",
"Assets, Non-Current": "-6.33",
"Assets": "11.8",
"Goodwill": "45.4",
"Property, Plant and Equipment, Net": "1.87",
"Assets, Current": "-12.1",
"Research and Development": "7.89",
"Expenses": "22.2",
"Revenues": "15.4",
"Net Income": "41.9",
"Other Expenses": "7.40",
"General and Administrative Expense": "6.57",
"Other Revenues": "15.4",
"Other Net Income": "3.09",
"Comprehensive Net Income": "41.9",
"Economic Capital Ratio": "58.8"
},
"2020": {
"Liabilities, Current": "22.6",
"Liabilities": "27.4",
"Stockholders Equity": "27.1",
"ECR before LimitedLiability": "102",
"Liabilities, Non-Current": "31.6",
"Other Liabilities": "-34.0",
"Goodwill": "35.8",
"Assets": "3.42",
"Assets, Current": "-13.4",
"Assets, Non-Current": "-5.34",
"Property, Plant and Equipment, Net": "0.977",
"Other Expenses": "6.17",
"Expenses": "6.90",
"Revenues": "22.1",
"Net Income": "33.8",
"Research and Development": "6.72",
"General and Administrative Expense": "-6.02",
"Other Revenues": "22.1",
"Comprehensive Net Income": "34.3",
"Other Net Income": "4.61",
"Economic Capital Ratio": "63.9"
},
"2021": {
"Liabilities, Non-Current": "28.6",
"Liabilities": "28.6",
"Stockholders Equity": "13.4",
"ECR before LimitedLiability": "60.0",
"Liabilities, Current": "13.2",
"Other Liabilities": "-14.7",
"Assets, Current": "-12.8",
"Assets": "-2.27",
"Assets, Non-Current": "-5.78",
"Other Assets": "0.677",
"Goodwill": "23.3",
"Property, Plant and Equipment, Net": "1.38",
"Other Expenses": "9.00",
"Expenses": "5.59",
"Revenues": "28.5",
"Net Income": "34.7",
"Research and Development": "9.41",
"General and Administrative Expense": "-13.0",
"Other Revenues": "28.5",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "55.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000009326_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "211,909",
"Assets, Non-Current": "538",
"General and Administrative Expense": "247,194",
"Goodwill": "47,373",
"Liabilities, Current": "30,234",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "179",
"Other Expenses": "19,849",
"Other Liabilities": "9,299",
"Other Net Income": "77",
"Other Revenues": "310,393",
"Property, Plant and Equipment, Net": "52,725",
"Research and Development": "3,422"
},
"output_variables": {
"Liabilities": "39,533",
"Assets": "312,545",
"Expenses": "270,465",
"Revenues": "310,393",
"Stockholders Equity": "273,012",
"Net Income": "40,005",
"Comprehensive Net Income": "40,094",
"BaseVar": "466,596",
"ECR before LimitedLiability": "235%",
"Economic Capital Ratio": "260%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "277,774",
"Assets, Non-Current": "541",
"General and Administrative Expense": "267,949",
"Goodwill": "43,641",
"Liabilities, Current": "35,753",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "957",
"Other Expenses": "20,968",
"Other Liabilities": "9,761",
"Other Net Income": "240",
"Other Revenues": "337,173",
"Property, Plant and Equipment, Net": "54,916",
"Research and Development": "3,622"
},
"output_variables": {
"Liabilities": "45,514",
"Assets": "376,872",
"Expenses": "292,539",
"Revenues": "337,173",
"Stockholders Equity": "331,358",
"Net Income": "44,874",
"Comprehensive Net Income": "45,352",
"BaseVar": "526,648",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "261%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "181,302",
"Assets, Non-Current": "4,341",
"General and Administrative Expense": "454,430",
"Goodwill": "544,040",
"Liabilities, Current": "95,522",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,849",
"Other Expenses": "29,371",
"Other Liabilities": "373,851",
"Other Net Income": "54",
"Other Revenues": "541,383",
"Property, Plant and Equipment, Net": "131,588",
"Research and Development": "4,810"
},
"output_variables": {
"Liabilities": "469,373",
"Assets": "861,271",
"Expenses": "488,611",
"Revenues": "541,383",
"Stockholders Equity": "391,898",
"Net Income": "52,826",
"Comprehensive Net Income": "51,402",
"BaseVar": "1,181,770",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "160%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "198,829",
"Assets, Non-Current": "5,062",
"General and Administrative Expense": "452,546",
"Goodwill": "518,817",
"Liabilities, Current": "81,120",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,463",
"Other Expenses": "33,934",
"Other Liabilities": "336,398",
"Other Net Income": "-300",
"Other Revenues": "552,492",
"Property, Plant and Equipment, Net": "158,515",
"Research and Development": "5,990"
},
"output_variables": {
"Liabilities": "417,518",
"Assets": "881,223",
"Expenses": "492,470",
"Revenues": "552,492",
"Stockholders Equity": "463,705",
"Net Income": "59,722",
"Comprehensive Net Income": "58,490",
"BaseVar": "1,173,233",
"ECR before LimitedLiability": "107%",
"Economic Capital Ratio": "173%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "188,442",
"Assets, Non-Current": "7,135",
"General and Administrative Expense": "455,041",
"Goodwill": "587,295",
"Liabilities, Current": "101,008",
"Liabilities, Non-Current": "226,490",
"Other Assets": "0",
"Other Compr. Net Income": "-1,735",
"Other Expenses": "34,227",
"Other Liabilities": "100,095",
"Other Net Income": "-639",
"Other Revenues": "553,204",
"Property, Plant and Equipment, Net": "165,754",
"Research and Development": "7,325"
},
"output_variables": {
"Liabilities": "427,593",
"Assets": "948,626",
"Expenses": "496,593",
"Revenues": "553,204",
"Stockholders Equity": "521,033",
"Net Income": "55,972",
"Comprehensive Net Income": "55,104",
"BaseVar": "1,214,195",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "176%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "199,336",
"Assets, Non-Current": "5,073",
"General and Administrative Expense": "488,230",
"Goodwill": "569,434",
"Liabilities, Current": "108,396",
"Liabilities, Non-Current": "183,964",
"Other Assets": "0",
"Other Compr. Net Income": "5,207",
"Other Expenses": "5,961",
"Other Liabilities": "54,395",
"Other Net Income": "-1,223",
"Other Revenues": "594,790",
"Property, Plant and Equipment, Net": "189,793",
"Research and Development": "9,305"
},
"output_variables": {
"Liabilities": "346,755",
"Assets": "963,636",
"Expenses": "503,496",
"Revenues": "594,790",
"Stockholders Equity": "616,881",
"Net Income": "90,071",
"Comprehensive Net Income": "92,674",
"BaseVar": "1,207,554",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "197%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "254,946",
"Assets, Non-Current": "15,955",
"General and Administrative Expense": "529,775",
"Goodwill": "667,922",
"Liabilities, Current": "148,689",
"Liabilities, Non-Current": "4,827",
"Other Assets": "0",
"Other Compr. Net Income": "-1,962",
"Other Expenses": "16,807",
"Other Liabilities": "258,499",
"Other Net Income": "-6,075",
"Other Revenues": "643,705",
"Property, Plant and Equipment, Net": "216,859",
"Research and Development": "11,377"
},
"output_variables": {
"Liabilities": "412,015",
"Assets": "1,155,682",
"Expenses": "557,959",
"Revenues": "643,705",
"Stockholders Equity": "743,667",
"Net Income": "79,671",
"Comprehensive Net Income": "78,690",
"BaseVar": "1,388,699",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "195%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "266,888",
"Assets, Non-Current": "11,326",
"General and Administrative Expense": "582,165",
"Goodwill": "651,123",
"Liabilities, Current": "145,787",
"Liabilities, Non-Current": "0",
"Other Assets": "8,410",
"Other Compr. Net Income": "9,737",
"Other Expenses": "21,794",
"Other Liabilities": "191,823",
"Other Net Income": "-4,730",
"Other Revenues": "703,644",
"Property, Plant and Equipment, Net": "228,096",
"Research and Development": "10,332"
},
"output_variables": {
"Liabilities": "337,610",
"Assets": "1,165,843",
"Expenses": "614,291",
"Revenues": "703,644",
"Stockholders Equity": "828,233",
"Net Income": "84,623",
"Comprehensive Net Income": "89,492",
"BaseVar": "1,417,928",
"ECR before LimitedLiability": "163%",
"Economic Capital Ratio": "210%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "322,232",
"Assets, Non-Current": "18,603",
"General and Administrative Expense": "657,997",
"Goodwill": "618,614",
"Liabilities, Current": "190,257",
"Liabilities, Non-Current": "4,811",
"Other Assets": "2,359",
"Other Compr. Net Income": "-9,166",
"Other Expenses": "29,129",
"Other Liabilities": "127,242",
"Other Net Income": "-2,269",
"Other Revenues": "799,023",
"Property, Plant and Equipment, Net": "237,517",
"Research and Development": "13,524"
},
"output_variables": {
"Liabilities": "322,310",
"Assets": "1,199,325",
"Expenses": "700,650",
"Revenues": "799,023",
"Stockholders Equity": "877,015",
"Net Income": "96,104",
"Comprehensive Net Income": "91,521",
"BaseVar": "1,516,372",
"ECR before LimitedLiability": "170%",
"Economic Capital Ratio": "214%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.14493637967229,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000009326.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000009326.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000009326.svg"
},
{
"company_id": "0000811641",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000811641.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000811641.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000811641.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000811641_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000811641_main_keyfigs.svg",
"name": "Immucell CORP DE",
"rank": 13,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000811641.svg",
"report_text": "The relative strengths and weaknesses of Immucell CORP DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Immucell CORP DE compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Immucell CORP DE is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 22% points.
The company's Economic Capital Ratio, given in the ranking table, is 207%, being 48% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000811641_2022_Immucell_CORP_DE.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "35.7",
"Liabilities": "30.0",
"Stockholders Equity": "78.7",
"ECR before LimitedLiability": "133",
"Liabilities, Non-Current": "11.4",
"Other Liabilities": "-21.1",
"Property, Plant and Equipment, Net": "7.45",
"Assets": "26.7",
"Assets, Non-Current": "-1.95",
"Other Assets": "6.85",
"Goodwill": "-4.32",
"Assets, Current": "15.6",
"General and Administrative Expense": "30.8",
"Expenses": "23.8",
"Revenues": "5.42",
"Net Income": "23.1",
"Research and Development": "-6.31",
"Other Revenues": "5.42",
"Comprehensive Net Income": "23.1",
"Other Net Income": "-6.15",
"Economic Capital Ratio": "70.7"
},
"2012": {
"Liabilities, Current": "26.9",
"Liabilities": "30.9",
"Stockholders Equity": "75.1",
"ECR before LimitedLiability": "107",
"Liabilities, Non-Current": "12.2",
"Other Liabilities": "-7.99",
"Assets, Current": "15.0",
"Assets": "21.8",
"Other Assets": "5.55",
"Assets, Non-Current": "-1.68",
"Property, Plant and Equipment, Net": "5.68",
"Goodwill": "-4.29",
"Other Expenses": "-3.33",
"Expenses": "25.9",
"Revenues": "6.62",
"Net Income": "31.9",
"Research and Development": "3.13",
"General and Administrative Expense": "26.1",
"Other Revenues": "6.62",
"Comprehensive Net Income": "31.9",
"Economic Capital Ratio": "74.4"
},
"2013": {
"Liabilities, Current": "36.6",
"Liabilities": "47.1",
"Stockholders Equity": "80.5",
"ECR before LimitedLiability": "126",
"Other Liabilities": "-6.91",
"Liabilities, Non-Current": "19.7",
"Goodwill": "-4.23",
"Assets": "16.4",
"Assets, Non-Current": "-1.64",
"Property, Plant and Equipment, Net": "6.13",
"Other Assets": "3.48",
"Assets, Current": "12.4",
"General and Administrative Expense": "25.6",
"Expenses": "20.4",
"Revenues": "17.0",
"Net Income": "34.3",
"Other Expenses": "-4.65",
"Other Revenues": "17.0",
"Other Net Income": "-2.68",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "85.4"
},
"2014": {
"Liabilities, Non-Current": "6.58",
"Liabilities": "67.0",
"Stockholders Equity": "92.2",
"ECR before LimitedLiability": "147",
"Liabilities, Current": "50.9",
"Other Liabilities": "16.2",
"Assets, Current": "1.73",
"Assets": "14.8",
"Goodwill": "-5.84",
"Other Assets": "8.55",
"Assets, Non-Current": "-1.91",
"Property, Plant and Equipment, Net": "13.8",
"Other Expenses": "-10.9",
"Expenses": "14.3",
"Revenues": "26.4",
"Net Income": "41.8",
"Research and Development": "-7.90",
"General and Administrative Expense": "32.2",
"Other Revenues": "26.4",
"Comprehensive Net Income": "41.9",
"Economic Capital Ratio": "97.7"
},
"2015": {
"Other Liabilities": "19.8",
"Liabilities": "46.8",
"Stockholders Equity": "60.7",
"ECR before LimitedLiability": "124",
"Liabilities, Current": "48.9",
"Liabilities, Non-Current": "-27.0",
"Assets, Current": "4.49",
"Assets": "11.1",
"Goodwill": "-6.99",
"Assets, Non-Current": "-1.71",
"Property, Plant and Equipment, Net": "18.9",
"Research and Development": "1.79",
"Expenses": "16.9",
"Revenues": "29.9",
"Net Income": "48.4",
"General and Administrative Expense": "21.6",
"Other Expenses": "-6.51",
"Other Revenues": "29.9",
"Comprehensive Net Income": "48.7",
"Other Net Income": "0.915",
"Economic Capital Ratio": "78.3"
},
"2016": {
"Liabilities, Non-Current": "-9.49",
"Liabilities": "31.1",
"Stockholders Equity": "72.8",
"ECR before LimitedLiability": "98.4",
"Liabilities, Current": "30.8",
"Other Liabilities": "9.12",
"Property, Plant and Equipment, Net": "17.4",
"Assets": "22.6",
"Assets, Non-Current": "-1.48",
"Assets, Current": "10.3",
"Goodwill": "-4.38",
"Research and Development": "6.30",
"Expenses": "24.2",
"Revenues": "6.02",
"Net Income": "28.5",
"General and Administrative Expense": "15.9",
"Other Expenses": "2.15",
"Other Revenues": "6.02",
"Comprehensive Net Income": "28.8",
"Other Net Income": "-1.61",
"Economic Capital Ratio": "78.4"
},
"2017": {
"Other Liabilities": "9.79",
"Liabilities": "7.22",
"Stockholders Equity": "55.6",
"ECR before LimitedLiability": "64.9",
"Liabilities, Current": "28.4",
"Liabilities, Non-Current": "-38.9",
"Assets, Non-Current": "-2.32",
"Assets": "31.4",
"Other Assets": "0.900",
"Assets, Current": "-7.63",
"Goodwill": "-6.60",
"Property, Plant and Equipment, Net": "82.2",
"Research and Development": "4.37",
"Expenses": "24.0",
"Revenues": "-0.236",
"Net Income": "20.4",
"Other Expenses": "0.864",
"General and Administrative Expense": "18.6",
"Other Revenues": "-0.236",
"Comprehensive Net Income": "20.2",
"Other Net Income": "-3.27",
"Economic Capital Ratio": "43.3"
},
"2018": {
"Liabilities, Non-Current": "-39.5",
"Liabilities": "-0.508",
"Stockholders Equity": "41.6",
"ECR before LimitedLiability": "62.0",
"Other Liabilities": "9.84",
"Liabilities, Current": "22.6",
"Property, Plant and Equipment, Net": "101",
"Assets": "28.3",
"Assets, Current": "-12.7",
"Goodwill": "-6.74",
"Assets, Non-Current": "-5.12",
"Other Expenses": "9.14",
"Expenses": "20.9",
"Revenues": "-1.56",
"Net Income": "19.2",
"Research and Development": "-0.554",
"General and Administrative Expense": "12.0",
"Other Revenues": "-1.56",
"Comprehensive Net Income": "19.5",
"Other Compr. Net Income": "0.238",
"Economic Capital Ratio": "41.5"
},
"2019": {
"Liabilities, Non-Current": "-23.5",
"Liabilities": "17.8",
"Stockholders Equity": "57.9",
"ECR before LimitedLiability": "101",
"Other Liabilities": "12.9",
"Liabilities, Current": "24.6",
"Assets, Non-Current": "-5.53",
"Assets": "24.3",
"Goodwill": "-5.90",
"Property, Plant and Equipment, Net": "56.3",
"Assets, Current": "-1.28",
"Research and Development": "-2.11",
"Expenses": "21.0",
"Revenues": "2.33",
"Net Income": "26.6",
"Other Expenses": "6.97",
"General and Administrative Expense": "16.1",
"Other Revenues": "2.33",
"Other Net Income": "3.23",
"Comprehensive Net Income": "26.6",
"Economic Capital Ratio": "71.1"
},
"2020": {
"Liabilities, Current": "28.8",
"Liabilities": "13.8",
"Stockholders Equity": "36.2",
"ECR before LimitedLiability": "89.2",
"Liabilities, Non-Current": "-25.0",
"Other Liabilities": "5.75",
"Goodwill": "-6.94",
"Assets": "14.3",
"Assets, Current": "-8.50",
"Assets, Non-Current": "-4.06",
"Property, Plant and Equipment, Net": "59.0",
"Other Expenses": "6.97",
"Expenses": "10.2",
"Revenues": "4.55",
"Net Income": "20.1",
"Research and Development": "-4.40",
"General and Administrative Expense": "7.58",
"Other Revenues": "4.55",
"Comprehensive Net Income": "20.2",
"Other Net Income": "5.19",
"Economic Capital Ratio": "51.4"
},
"2021": {
"Liabilities, Non-Current": "-22.3",
"Liabilities": "16.0",
"Stockholders Equity": "27.9",
"ECR before LimitedLiability": "52.2",
"Liabilities, Current": "26.1",
"Other Liabilities": "8.53",
"Assets, Current": "-5.74",
"Assets": "7.94",
"Assets, Non-Current": "-4.81",
"Other Assets": "0.530",
"Goodwill": "-8.60",
"Property, Plant and Equipment, Net": "44.3",
"Other Expenses": "9.68",
"Expenses": "11.6",
"Revenues": "10.6",
"Net Income": "22.0",
"Research and Development": "-0.824",
"General and Administrative Expense": "2.70",
"Other Revenues": "10.6",
"Comprehensive Net Income": "22.0",
"Economic Capital Ratio": "47.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000811641_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "7,151",
"Assets, Non-Current": "19",
"General and Administrative Expense": "1,726",
"Goodwill": "0",
"Liabilities, Current": "635",
"Liabilities, Non-Current": "0",
"Other Assets": "1,306",
"Other Compr. Net Income": "0",
"Other Expenses": "2,010",
"Other Liabilities": "1,336",
"Other Net Income": "-64",
"Other Revenues": "5,111",
"Property, Plant and Equipment, Net": "2,515",
"Research and Development": "1,720"
},
"output_variables": {
"Liabilities": "1,971",
"Assets": "10,991",
"Expenses": "5,457",
"Revenues": "5,111",
"Stockholders Equity": "9,020",
"Net Income": "-410",
"Comprehensive Net Income": "-410",
"BaseVar": "11,797",
"ECR before LimitedLiability": "184%",
"Economic Capital Ratio": "224%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,363",
"Assets, Non-Current": "64",
"General and Administrative Expense": "1,892",
"Goodwill": "0",
"Liabilities, Current": "666",
"Liabilities, Non-Current": "0",
"Other Assets": "1,246",
"Other Compr. Net Income": "0",
"Other Expenses": "2,491",
"Other Liabilities": "1,170",
"Other Net Income": "0",
"Other Revenues": "5,390",
"Property, Plant and Equipment, Net": "2,358",
"Research and Development": "918"
},
"output_variables": {
"Liabilities": "1,836",
"Assets": "11,030",
"Expenses": "5,300",
"Revenues": "5,390",
"Stockholders Equity": "9,195",
"Net Income": "90",
"Comprehensive Net Income": "90",
"BaseVar": "11,778",
"ECR before LimitedLiability": "197%",
"Economic Capital Ratio": "233%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "7,268",
"Assets, Non-Current": "14",
"General and Administrative Expense": "1,926",
"Goodwill": "0",
"Liabilities, Current": "636",
"Liabilities, Non-Current": "0",
"Other Assets": "1,155",
"Other Compr. Net Income": "0",
"Other Expenses": "2,810",
"Other Liabilities": "929",
"Other Net Income": "0",
"Other Revenues": "6,007",
"Property, Plant and Equipment, Net": "2,525",
"Research and Development": "1,154"
},
"output_variables": {
"Liabilities": "1,565",
"Assets": "10,961",
"Expenses": "5,890",
"Revenues": "6,007",
"Stockholders Equity": "9,396",
"Net Income": "117",
"Comprehensive Net Income": "117",
"BaseVar": "12,211",
"ECR before LimitedLiability": "207%",
"Economic Capital Ratio": "240%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "5,469",
"Assets, Non-Current": "19",
"General and Administrative Expense": "2,476",
"Goodwill": "0",
"Liabilities, Current": "1,009",
"Liabilities, Non-Current": "785",
"Other Assets": "1,726",
"Other Compr. Net Income": "-3.5",
"Other Expenses": "3,109",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "7,597",
"Property, Plant and Equipment, Net": "3,838",
"Research and Development": "2,179"
},
"output_variables": {
"Liabilities": "1,793",
"Assets": "11,052",
"Expenses": "7,764",
"Revenues": "7,597",
"Stockholders Equity": "9,258",
"Net Income": "-167",
"Comprehensive Net Income": "-169",
"BaseVar": "14,105",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "231%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "7,873",
"Assets, Non-Current": "50",
"General and Administrative Expense": "2,893",
"Goodwill": "0",
"Liabilities, Current": "818",
"Liabilities, Non-Current": "3,169",
"Other Assets": "959",
"Other Compr. Net Income": "-27",
"Other Expenses": "4,887",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,229",
"Property, Plant and Equipment, Net": "5,719",
"Research and Development": "1,235"
},
"output_variables": {
"Liabilities": "3,987",
"Assets": "14,601",
"Expenses": "9,015",
"Revenues": "10,229",
"Stockholders Equity": "10,614",
"Net Income": "1,213",
"Comprehensive Net Income": "1,200",
"BaseVar": "18,929",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "214%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "14,348",
"Assets, Non-Current": "34",
"General and Administrative Expense": "3,286",
"Goodwill": "267",
"Liabilities, Current": "2,059",
"Liabilities, Non-Current": "2,916",
"Other Assets": "201",
"Other Compr. Net Income": "26",
"Other Expenses": "4,505",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "9,544",
"Property, Plant and Equipment, Net": "9,846",
"Research and Development": "1,244"
},
"output_variables": {
"Liabilities": "4,975",
"Assets": "24,697",
"Expenses": "9,036",
"Revenues": "9,544",
"Stockholders Equity": "19,722",
"Net Income": "508",
"Comprehensive Net Income": "522",
"BaseVar": "24,139",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "225%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "7,507",
"Assets, Non-Current": "0.92",
"General and Administrative Expense": "3,418",
"Goodwill": "248",
"Liabilities, Current": "2,064",
"Liabilities, Non-Current": "8,640",
"Other Assets": "473",
"Other Compr. Net Income": "23",
"Other Expenses": "5,135",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,431",
"Property, Plant and Equipment, Net": "26,070",
"Research and Development": "2,047"
},
"output_variables": {
"Liabilities": "10,704",
"Assets": "34,299",
"Expenses": "10,599",
"Revenues": "10,431",
"Stockholders Equity": "23,595",
"Net Income": "-168",
"Comprehensive Net Income": "-157",
"BaseVar": "33,028",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "197%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,421",
"Assets, Non-Current": "13",
"General and Administrative Expense": "9,616",
"Goodwill": "229",
"Liabilities, Current": "2,565",
"Liabilities, Non-Current": "8,421",
"Other Assets": "40",
"Other Compr. Net Income": "31",
"Other Expenses": "175",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,986",
"Property, Plant and Equipment, Net": "26,028",
"Research and Development": "3,517"
},
"output_variables": {
"Liabilities": "10,986",
"Assets": "32,731",
"Expenses": "13,308",
"Revenues": "10,986",
"Stockholders Equity": "21,744",
"Net Income": "-2,322",
"Comprehensive Net Income": "-2,306",
"BaseVar": "34,021",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "185%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "13,189",
"Assets, Non-Current": "27",
"General and Administrative Expense": "10,989",
"Goodwill": "210",
"Liabilities, Current": "2,495",
"Liabilities, Non-Current": "7,205",
"Other Assets": "0",
"Other Compr. Net Income": "-74",
"Other Expenses": "342",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "13,723",
"Property, Plant and Equipment, Net": "25,266",
"Research and Development": "3,688"
},
"output_variables": {
"Liabilities": "9,701",
"Assets": "38,692",
"Expenses": "15,018",
"Revenues": "13,723",
"Stockholders Equity": "28,991",
"Net Income": "-1,296",
"Comprehensive Net Income": "-1,333",
"BaseVar": "38,604",
"ECR before LimitedLiability": "159%",
"Economic Capital Ratio": "207%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "12,157",
"Assets, Non-Current": "1,247",
"General and Administrative Expense": "12,368",
"Goodwill": "191",
"Liabilities, Current": "2,211",
"Liabilities, Non-Current": "9,872",
"Other Assets": "0",
"Other Compr. Net Income": "44",
"Other Expenses": "-10",
"Other Liabilities": "0",
"Other Net Income": "348",
"Other Revenues": "15,342",
"Property, Plant and Equipment, Net": "26,755",
"Research and Development": "4,355"
},
"output_variables": {
"Liabilities": "12,083",
"Assets": "40,350",
"Expenses": "16,712",
"Revenues": "15,342",
"Stockholders Equity": "28,266",
"Net Income": "-1,022",
"Comprehensive Net Income": "-1,000",
"BaseVar": "42,440",
"ECR before LimitedLiability": "144%",
"Economic Capital Ratio": "197%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "16,265",
"Assets, Non-Current": "1,135",
"General and Administrative Expense": "14,817",
"Goodwill": "172",
"Liabilities, Current": "2,534",
"Liabilities, Non-Current": "9,354",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "9.2",
"Other Liabilities": "0",
"Other Net Income": "-327",
"Other Revenues": "19,243",
"Property, Plant and Equipment, Net": "26,894",
"Research and Development": "4,169"
},
"output_variables": {
"Liabilities": "11,889",
"Assets": "44,466",
"Expenses": "18,995",
"Revenues": "19,243",
"Stockholders Equity": "32,577",
"Net Income": "-78",
"Comprehensive Net Income": "-78",
"BaseVar": "47,459",
"ECR before LimitedLiability": "158%",
"Economic Capital Ratio": "207%"
}
}
},
"top_rated": false,
"trend": 4.0,
"value": 2.066697906633383,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000811641.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000811641.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000811641.svg"
},
{
"company_id": "0000899923",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000899923.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000899923.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000899923.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000899923_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000899923_main_keyfigs.svg",
"name": "Myriad Genetics INC",
"rank": 14,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000899923.svg",
"report_text": "The relative strengths and weaknesses of Myriad Genetics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Myriad Genetics INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Myriad Genetics INC is the variable Assets, Current, reducing the Economic Capital Ratio by 10% points.
The company's Economic Capital Ratio, given in the ranking table, is 205%, being 46% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000899923_2022_Myriad_Genetics_INC.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "-1.22",
"Liabilities": "69.0",
"Stockholders Equity": "98.4",
"ECR before LimitedLiability": "125",
"Liabilities, Current": "33.4",
"Liabilities, Non-Current": "45.6",
"Goodwill": "1.45",
"Assets": "-6.03",
"Property, Plant and Equipment, Net": "1.03",
"Assets, Current": "-9.25",
"Assets, Non-Current": "-0.952",
"Other Expenses": "27.3",
"Expenses": "28.0",
"Revenues": "14.8",
"Net Income": "44.5",
"General and Administrative Expense": "-1.98",
"Research and Development": "2.70",
"Other Revenues": "14.8",
"Other Net Income": "3.09",
"Comprehensive Net Income": "44.6",
"Economic Capital Ratio": "127"
},
"2011": {
"Liabilities, Current": "53.8",
"Liabilities": "73.2",
"Stockholders Equity": "106",
"ECR before LimitedLiability": "194",
"Liabilities, Non-Current": "17.8",
"Other Liabilities": "13.0",
"Property, Plant and Equipment, Net": "-0.276",
"Assets": "2.26",
"Assets, Non-Current": "0.356",
"Other Assets": "0.209",
"Assets, Current": "1.57",
"General and Administrative Expense": "13.9",
"Expenses": "33.8",
"Revenues": "32.3",
"Net Income": "57.1",
"Research and Development": "8.82",
"Other Expenses": "12.1",
"Other Revenues": "32.3",
"Comprehensive Net Income": "57.0",
"Other Net Income": "-7.41",
"Economic Capital Ratio": "132"
},
"2012": {
"Liabilities, Current": "40.6",
"Liabilities": "71.1",
"Stockholders Equity": "92.7",
"ECR before LimitedLiability": "156",
"Liabilities, Non-Current": "18.7",
"Other Liabilities": "25.6",
"Assets, Current": "1.44",
"Assets": "2.80",
"Other Assets": "0.671",
"Assets, Non-Current": "0.981",
"Property, Plant and Equipment, Net": "-0.534",
"Other Expenses": "13.6",
"Expenses": "30.8",
"Revenues": "33.4",
"Net Income": "61.8",
"Research and Development": "8.65",
"General and Administrative Expense": "9.42",
"Other Revenues": "33.4",
"Other Net Income": "0.252",
"Comprehensive Net Income": "61.8",
"Economic Capital Ratio": "123"
},
"2013": {
"Liabilities, Current": "45.4",
"Liabilities": "76.5",
"Stockholders Equity": "89.4",
"ECR before LimitedLiability": "165",
"Other Liabilities": "19.5",
"Liabilities, Non-Current": "27.4",
"Goodwill": "-0.348",
"Assets": "2.83",
"Assets, Non-Current": "1.89",
"Property, Plant and Equipment, Net": "-0.650",
"Assets, Current": "1.55",
"General and Administrative Expense": "5.17",
"Expenses": "26.5",
"Revenues": "42.5",
"Net Income": "64.2",
"Research and Development": "5.90",
"Other Expenses": "16.0",
"Other Revenues": "42.5",
"Other Net Income": "-2.50",
"Comprehensive Net Income": "64.1",
"Economic Capital Ratio": "125"
},
"2014": {
"Liabilities, Non-Current": "32.7",
"Liabilities": "94.2",
"Stockholders Equity": "96.2",
"ECR before LimitedLiability": "187",
"Liabilities, Current": "67.1",
"Other Liabilities": "13.5",
"Assets, Current": "-1.70",
"Assets": "3.40",
"Goodwill": "6.64",
"Assets, Non-Current": "1.03",
"Property, Plant and Equipment, Net": "-1.19",
"Other Expenses": "9.45",
"Expenses": "23.0",
"Revenues": "55.3",
"Net Income": "77.9",
"Research and Development": "8.34",
"General and Administrative Expense": "5.68",
"Other Revenues": "55.3",
"Other Net Income": "2.50",
"Comprehensive Net Income": "77.9",
"Economic Capital Ratio": "138"
},
"2015": {
"Other Liabilities": "17.3",
"Liabilities": "95.5",
"Stockholders Equity": "83.7",
"ECR before LimitedLiability": "163",
"Liabilities, Current": "62.6",
"Liabilities, Non-Current": "34.8",
"Assets, Current": "-4.10",
"Assets": "2.29",
"Other Assets": "-2.17",
"Goodwill": "13.5",
"Property, Plant and Equipment, Net": "-1.32",
"Research and Development": "2.10",
"Expenses": "5.30",
"Revenues": "57.3",
"Net Income": "63.4",
"General and Administrative Expense": "-25.5",
"Other Expenses": "26.8",
"Other Revenues": "57.3",
"Comprehensive Net Income": "63.4",
"Other Net Income": "1.38",
"Economic Capital Ratio": "118"
},
"2016": {
"Liabilities, Non-Current": "31.9",
"Liabilities": "74.0",
"Stockholders Equity": "63.3",
"ECR before LimitedLiability": "127",
"Liabilities, Current": "55.4",
"Other Liabilities": "-5.54",
"Property, Plant and Equipment, Net": "-2.96",
"Assets": "2.23",
"Assets, Non-Current": "1.62",
"Assets, Current": "-5.24",
"Goodwill": "13.7",
"Research and Development": "8.61",
"Expenses": "12.5",
"Revenues": "46.8",
"Net Income": "56.2",
"General and Administrative Expense": "-22.6",
"Other Expenses": "24.9",
"Other Revenues": "46.8",
"Comprehensive Net Income": "56.3",
"Other Net Income": "-2.23",
"Economic Capital Ratio": "107"
},
"2017": {
"Other Liabilities": "-25.5",
"Liabilities": "20.3",
"Stockholders Equity": "29.6",
"ECR before LimitedLiability": "56.5",
"Liabilities, Current": "19.3",
"Liabilities, Non-Current": "23.0",
"Assets, Non-Current": "-0.654",
"Assets": "8.04",
"Assets, Current": "-13.3",
"Goodwill": "62.8",
"Property, Plant and Equipment, Net": "-10.7",
"Research and Development": "7.74",
"Expenses": "12.6",
"Revenues": "21.8",
"Net Income": "29.9",
"Other Expenses": "5.65",
"General and Administrative Expense": "-0.828",
"Other Revenues": "21.8",
"Comprehensive Net Income": "29.8",
"Other Net Income": "-4.93",
"Economic Capital Ratio": "34.9"
},
"2018": {
"Liabilities, Non-Current": "24.6",
"Liabilities": "46.4",
"Stockholders Equity": "61.9",
"ECR before LimitedLiability": "119",
"Other Liabilities": "-10.4",
"Liabilities, Current": "33.9",
"Property, Plant and Equipment, Net": "-4.09",
"Assets": "9.11",
"Assets, Current": "-5.48",
"Goodwill": "36.4",
"Assets, Non-Current": "-2.05",
"Other Expenses": "2.38",
"Expenses": "19.5",
"Revenues": "27.6",
"Net Income": "46.1",
"Research and Development": "6.41",
"General and Administrative Expense": "10.9",
"Other Revenues": "27.6",
"Comprehensive Net Income": "46.4",
"Other Compr. Net Income": "0.343",
"Economic Capital Ratio": "98.4"
},
"2019": {
"Liabilities, Non-Current": "21.9",
"Liabilities": "19.3",
"Stockholders Equity": "37.1",
"ECR before LimitedLiability": "92.8",
"Other Liabilities": "-24.1",
"Liabilities, Current": "18.0",
"Assets, Non-Current": "-5.00",
"Assets": "12.1",
"Goodwill": "71.6",
"Property, Plant and Equipment, Net": "-7.16",
"Assets, Current": "-11.7",
"Research and Development": "3.56",
"Expenses": "16.9",
"Revenues": "14.9",
"Net Income": "35.7",
"Other Expenses": "-3.69",
"General and Administrative Expense": "17.0",
"Other Revenues": "14.9",
"Other Net Income": "3.22",
"Comprehensive Net Income": "35.7",
"Economic Capital Ratio": "63.4"
},
"2021": {
"Liabilities, Non-Current": "16.3",
"Liabilities": "28.4",
"Stockholders Equity": "13.3",
"ECR before LimitedLiability": "50.2",
"Liabilities, Current": "8.06",
"Other Liabilities": "5.56",
"Assets, Current": "-10.2",
"Assets": "-2.79",
"Assets, Non-Current": "-1.13",
"Other Assets": "0.647",
"Goodwill": "23.6",
"Property, Plant and Equipment, Net": "-7.85",
"Other Revenues": "13.5",
"Revenues": "13.5",
"Net Income": "24.3",
"Other Expenses": "-6.68",
"Comprehensive Net Income": "24.2",
"Research and Development": "4.15",
"Other Net Income": "11.2",
"General and Administrative Expense": "2.06",
"Economic Capital Ratio": "45.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000899923_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "473,976",
"Assets, Non-Current": "85,154",
"General and Administrative Expense": "205,700",
"Goodwill": "2,052",
"Liabilities, Current": "27,466",
"Liabilities, Non-Current": "0",
"Other Assets": "9,404",
"Other Compr. Net Income": "0",
"Other Expenses": "-11,469",
"Other Liabilities": "8,800",
"Other Net Income": "0",
"Other Revenues": "368,407",
"Property, Plant and Equipment, Net": "23,261",
"Research and Development": "21,873"
},
"output_variables": {
"Liabilities": "36,266",
"Assets": "593,847",
"Expenses": "216,104",
"Revenues": "368,407",
"Stockholders Equity": "557,581",
"Net Income": "152,303",
"Comprehensive Net Income": "152,303",
"BaseVar": "607,312",
"ECR before LimitedLiability": "291%",
"Economic Capital Ratio": "304%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "418,261",
"Assets, Non-Current": "70,857",
"General and Administrative Expense": "215,478",
"Goodwill": "72,766",
"Liabilities, Current": "34,387",
"Liabilities, Non-Current": "0",
"Other Assets": "25,863",
"Other Compr. Net Income": "0",
"Other Expenses": "60,018",
"Other Liabilities": "9,648",
"Other Net Income": "0",
"Other Revenues": "403,957",
"Property, Plant and Equipment, Net": "23,080",
"Research and Development": "27,751"
},
"output_variables": {
"Liabilities": "44,035",
"Assets": "610,827",
"Expenses": "303,247",
"Revenues": "403,957",
"Stockholders Equity": "566,792",
"Net Income": "100,710",
"Comprehensive Net Income": "100,710",
"BaseVar": "681,033",
"ECR before LimitedLiability": "268%",
"Economic Capital Ratio": "285%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "422,492",
"Assets, Non-Current": "113,692",
"General and Administrative Expense": "259,835",
"Goodwill": "72,572",
"Liabilities, Current": "44,967",
"Liabilities, Non-Current": "0",
"Other Assets": "57,648",
"Other Compr. Net Income": "-313",
"Other Expenses": "85,596",
"Other Liabilities": "10,008",
"Other Net Income": "4,222",
"Other Revenues": "496,005",
"Property, Plant and Equipment, Net": "24,231",
"Research and Development": "42,645"
},
"output_variables": {
"Liabilities": "54,975",
"Assets": "690,635",
"Expenses": "388,076",
"Revenues": "496,005",
"Stockholders Equity": "635,660",
"Net Income": "112,151",
"Comprehensive Net Income": "111,994",
"BaseVar": "817,113",
"ECR before LimitedLiability": "264%",
"Economic Capital Ratio": "282%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "483,992",
"Assets, Non-Current": "171,748",
"General and Administrative Expense": "316,215",
"Goodwill": "70,180",
"Liabilities, Current": "64,509",
"Liabilities, Non-Current": "0",
"Other Assets": "50,299",
"Other Compr. Net Income": "-262",
"Other Expenses": "101,379",
"Other Liabilities": "10,718",
"Other Net Income": "5,274",
"Other Revenues": "613,165",
"Property, Plant and Equipment, Net": "27,602",
"Research and Development": "53,706"
},
"output_variables": {
"Liabilities": "75,227",
"Assets": "803,821",
"Expenses": "471,300",
"Revenues": "613,165",
"Stockholders Equity": "728,594",
"Net Income": "147,139",
"Comprehensive Net Income": "147,008",
"BaseVar": "984,524",
"ECR before LimitedLiability": "261%",
"Economic Capital Ratio": "279%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "322,400",
"Assets, Non-Current": "89,100",
"General and Administrative Expense": "423,200",
"Goodwill": "374,500",
"Liabilities, Current": "80,600",
"Liabilities, Non-Current": "0",
"Other Assets": "3,200",
"Other Compr. Net Income": "-1,100",
"Other Expenses": "114,700",
"Other Liabilities": "24,200",
"Other Net Income": "3,400",
"Other Revenues": "778,200",
"Property, Plant and Equipment, Net": "34,600",
"Research and Development": "67,500"
},
"output_variables": {
"Liabilities": "104,800",
"Assets": "823,800",
"Expenses": "605,400",
"Revenues": "778,200",
"Stockholders Equity": "719,000",
"Net Income": "176,200",
"Comprehensive Net Income": "175,650",
"BaseVar": "1,158,350",
"ECR before LimitedLiability": "250%",
"Economic Capital Ratio": "271%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "283,600",
"Assets, Non-Current": "45,600",
"General and Administrative Expense": "498,800",
"Goodwill": "369,800",
"Liabilities, Current": "68,700",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-5,500",
"Other Expenses": "69,300",
"Other Liabilities": "35,400",
"Other Net Income": "700",
"Other Revenues": "723,100",
"Property, Plant and Equipment, Net": "67,200",
"Research and Development": "75,500"
},
"output_variables": {
"Liabilities": "104,100",
"Assets": "766,200",
"Expenses": "643,600",
"Revenues": "723,100",
"Stockholders Equity": "662,100",
"Net Income": "80,200",
"Comprehensive Net Income": "77,450",
"BaseVar": "1,121,600",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "253%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "314,500",
"Assets, Non-Current": "84,900",
"General and Administrative Expense": "491,900",
"Goodwill": "422,800",
"Liabilities, Current": "72,300",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-2,500",
"Other Expenses": "68,100",
"Other Liabilities": "60,100",
"Other Net Income": "2,100",
"Other Revenues": "753,800",
"Property, Plant and Equipment, Net": "58,300",
"Research and Development": "70,600"
},
"output_variables": {
"Liabilities": "132,400",
"Assets": "880,500",
"Expenses": "630,600",
"Revenues": "753,800",
"Stockholders Equity": "748,100",
"Net Income": "125,300",
"Comprehensive Net Income": "124,050",
"BaseVar": "1,200,950",
"ECR before LimitedLiability": "227%",
"Economic Capital Ratio": "254%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "301,700",
"Assets, Non-Current": "48,500",
"General and Administrative Expense": "476,400",
"Goodwill": "807,600",
"Liabilities, Current": "217,500",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "4,200",
"Other Expenses": "191,000",
"Other Liabilities": "223,400",
"Other Net Income": "-7,800",
"Other Revenues": "769,900",
"Property, Plant and Equipment, Net": "51,100",
"Research and Development": "74,400"
},
"output_variables": {
"Liabilities": "440,900",
"Assets": "1,208,900",
"Expenses": "741,800",
"Revenues": "769,900",
"Stockholders Equity": "768,000",
"Net Income": "20,300",
"Comprehensive Net Income": "22,400",
"BaseVar": "1,586,750",
"ECR before LimitedLiability": "130%",
"Economic Capital Ratio": "188%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "327,600",
"Assets, Non-Current": "30,700",
"General and Administrative Expense": "435,000",
"Goodwill": "773,800",
"Liabilities, Current": "102,200",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "1,700",
"Other Expenses": "103,000",
"Other Liabilities": "107,000",
"Other Net Income": "-1,800",
"Other Revenues": "743,700",
"Property, Plant and Equipment, Net": "43,200",
"Research and Development": "70,800"
},
"output_variables": {
"Liabilities": "209,200",
"Assets": "1,175,300",
"Expenses": "608,800",
"Revenues": "743,700",
"Stockholders Equity": "966,100",
"Net Income": "133,100",
"Comprehensive Net Income": "133,950",
"BaseVar": "1,370,250",
"ECR before LimitedLiability": "211%",
"Economic Capital Ratio": "242%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "348,600",
"Assets, Non-Current": "54,900",
"General and Administrative Expense": "555,500",
"Goodwill": "1,101,900",
"Liabilities, Current": "200,400",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1,100",
"Other Expenses": "197,700",
"Other Liabilities": "273,400",
"Other Net Income": "-7,600",
"Other Revenues": "851,100",
"Property, Plant and Equipment, Net": "57,300",
"Research and Development": "85,900"
},
"output_variables": {
"Liabilities": "473,800",
"Assets": "1,562,700",
"Expenses": "839,100",
"Revenues": "851,100",
"Stockholders Equity": "1,088,900",
"Net Income": "4,400",
"Comprehensive Net Income": "3,850",
"BaseVar": "1,867,700",
"ECR before LimitedLiability": "147%",
"Economic Capital Ratio": "199%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "484,800",
"Assets, Non-Current": "149,100",
"General and Administrative Expense": "537,800",
"Goodwill": "643,300",
"Liabilities, Current": "240,100",
"Liabilities, Non-Current": "84,900",
"Other Assets": "0",
"Other Compr. Net Income": "-2,800",
"Other Expenses": "231,500",
"Other Liabilities": "27,900",
"Other Net Income": "133,400",
"Other Revenues": "690,600",
"Property, Plant and Equipment, Net": "43,500",
"Research and Development": "81,900"
},
"output_variables": {
"Liabilities": "352,900",
"Assets": "1,320,700",
"Expenses": "851,200",
"Revenues": "690,600",
"Stockholders Equity": "967,800",
"Net Income": "-27,200",
"Comprehensive Net Income": "-28,600",
"BaseVar": "1,675,800",
"ECR before LimitedLiability": "155%",
"Economic Capital Ratio": "205%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.0463872793724445,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000899923.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000899923.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000899923.svg"
},
{
"company_id": "0001731348",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001731348.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001731348.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001731348.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001731348_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001731348_main_keyfigs.svg",
"name": "Tilray Brands Inc",
"rank": 15,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001731348.svg",
"report_text": "The relative strengths and weaknesses of Tilray Brands Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Tilray Brands Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 85% points.The greatest weakness of Tilray Brands Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 16% points.
The company's Economic Capital Ratio, given in the ranking table, is 204%, being 45% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001731348_2022_Tilray_Brands_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "12.2",
"Liabilities": "-68.6",
"Stockholders Equity": "-7.05",
"ECR before LimitedLiability": "-4.71",
"Other Liabilities": "-124",
"Liabilities, Current": "22.2",
"Assets": "34.9",
"Other Assets": "3.20",
"Assets, Current": "39.7",
"Goodwill": "-10.2",
"Assets, Non-Current": "-7.84",
"Other Expenses": "6.64",
"Expenses": "34.3",
"Revenues": "-25.1",
"Net Income": "14.5",
"Research and Development": "9.20",
"General and Administrative Expense": "29.2",
"Other Revenues": "-25.1",
"Comprehensive Net Income": "14.7",
"Other Net Income": "-2.27",
"Economic Capital Ratio": "-25.2"
},
"2019": {
"Liabilities, Non-Current": "13.4",
"Liabilities": "-54.2",
"Stockholders Equity": "-11.7",
"ECR before LimitedLiability": "10.8",
"Other Liabilities": "-93.3",
"Liabilities, Current": "15.4",
"Assets, Non-Current": "-8.91",
"Assets": "32.6",
"Goodwill": "33.4",
"Property, Plant and Equipment, Net": "7.73",
"Other Assets": "5.38",
"Assets, Current": "-12.6",
"Research and Development": "8.02",
"Expenses": "32.7",
"Revenues": "-18.0",
"Net Income": "18.3",
"Other Expenses": "-4.72",
"General and Administrative Expense": "32.6",
"Other Revenues": "-18.0",
"Comprehensive Net Income": "18.7",
"Economic Capital Ratio": "-18.7"
},
"2020": {
"Liabilities, Current": "15.9",
"Liabilities": "10.0",
"Stockholders Equity": "52.5",
"ECR before LimitedLiability": "92.7",
"Liabilities, Non-Current": "-11.5",
"Other Liabilities": "4.58",
"Goodwill": "26.6",
"Assets": "26.3",
"Assets, Current": "-2.80",
"Assets, Non-Current": "12.2",
"Property, Plant and Equipment, Net": "-7.75",
"Other Expenses": "1.46",
"Expenses": "15.7",
"Revenues": "-5.52",
"Net Income": "13.6",
"Research and Development": "5.61",
"General and Administrative Expense": "8.58",
"Other Revenues": "-5.52",
"Comprehensive Net Income": "13.5",
"Other Net Income": "3.46",
"Economic Capital Ratio": "54.9"
},
"2021": {
"Liabilities, Non-Current": "-13.0",
"Liabilities": "-3.91",
"Assets": "34.6",
"Stockholders Equity": "54.1",
"ECR before LimitedLiability": "49.5",
"Liabilities, Current": "4.23",
"Other Liabilities": "4.12",
"Assets, Current": "-10.1",
"Assets, Non-Current": "-4.36",
"Goodwill": "84.7",
"Other Expenses": "5.02",
"Expenses": "29.0",
"Revenues": "-15.6",
"Net Income": "9.86",
"Research and Development": "6.31",
"General and Administrative Expense": "17.4",
"Other Revenues": "-15.6",
"Comprehensive Net Income": "10.9",
"Other Net Income": "-3.30",
"Other Compr. Net Income": "1.05",
"Economic Capital Ratio": "45.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001731348_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "554,302",
"Assets, Non-Current": "0",
"General and Administrative Expense": "75,528",
"Goodwill": "4,486",
"Liabilities, Current": "25,937",
"Liabilities, Non-Current": "0",
"Other Assets": "17,665",
"Other Compr. Net Income": "-103",
"Other Expenses": "16,537",
"Other Liabilities": "433,077",
"Other Net Income": "-14,524",
"Other Revenues": "43,130",
"Property, Plant and Equipment, Net": "80,214",
"Research and Development": "4,264"
},
"output_variables": {
"Liabilities": "459,014",
"Assets": "656,667",
"Expenses": "96,329",
"Revenues": "43,130",
"Stockholders Equity": "197,653",
"Net Income": "-67,723",
"Comprehensive Net Income": "-67,774",
"BaseVar": "634,884",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "119%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "259,027",
"Assets, Non-Current": "28,962",
"General and Administrative Expense": "143,052",
"Goodwill": "392,079",
"Liabilities, Current": "92,427",
"Liabilities, Non-Current": "15,341",
"Other Assets": "32,045",
"Other Compr. Net Income": "5,153",
"Other Expenses": "115,642",
"Other Liabilities": "503,291",
"Other Net Income": "-32,421",
"Other Revenues": "166,979",
"Property, Plant and Equipment, Net": "184,217",
"Research and Development": "6,558"
},
"output_variables": {
"Liabilities": "611,059",
"Assets": "896,330",
"Expenses": "265,252",
"Revenues": "166,979",
"Stockholders Equity": "285,271",
"Net Income": "-130,694",
"Comprehensive Net Income": "-128,118",
"BaseVar": "988,597",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "117%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "581,627",
"Assets, Non-Current": "426,062",
"General and Administrative Expense": "422,037",
"Goodwill": "710,648",
"Liabilities, Current": "168,341",
"Liabilities, Non-Current": "290,433",
"Other Assets": "19,595",
"Other Compr. Net Income": "-8,041",
"Other Expenses": "77,030",
"Other Liabilities": "4,227",
"Other Net Income": "-5,176",
"Other Revenues": "405,326",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "1,916"
},
"output_variables": {
"Liabilities": "463,001",
"Assets": "1,737,932",
"Expenses": "500,983",
"Revenues": "405,326",
"Stockholders Equity": "1,274,931",
"Net Income": "-100,833",
"Comprehensive Net Income": "-104,854",
"BaseVar": "1,560,230",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "201%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "883,609",
"Assets, Non-Current": "26,552",
"General and Administrative Expense": "528,054",
"Goodwill": "4,438,712",
"Liabilities, Current": "667,086",
"Liabilities, Non-Current": "839,017",
"Other Assets": "25,791",
"Other Compr. Net Income": "121,418",
"Other Expenses": "107,400",
"Other Liabilities": "53,946",
"Other Net Income": "-212,815",
"Other Revenues": "513,085",
"Property, Plant and Equipment, Net": "650,698",
"Research and Development": "830"
},
"output_variables": {
"Liabilities": "1,560,049",
"Assets": "6,025,362",
"Expenses": "636,284",
"Revenues": "513,085",
"Stockholders Equity": "4,465,313",
"Net Income": "-336,014",
"Comprehensive Net Income": "-275,305",
"BaseVar": "4,534,506",
"ECR before LimitedLiability": "154%",
"Economic Capital Ratio": "204%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 2.0398568892846938,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001731348.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001731348.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001731348.svg"
},
{
"company_id": "0001038133",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001038133.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001038133.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001038133.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001038133_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001038133_main_keyfigs.svg",
"name": "Heska CORP",
"rank": 16,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001038133.svg",
"report_text": "The relative strengths and weaknesses of Heska CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Heska CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 26% points.The greatest weakness of Heska CORP is the variable Other Liabilities, reducing the Economic Capital Ratio by 33% points.
The company's Economic Capital Ratio, given in the ranking table, is 203%, being 45% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001038133_2022_Heska_CORP.pdf",
"shrinked_graph_json": {
"2015": {
"Other Liabilities": "1.40",
"Liabilities": "63.3",
"Stockholders Equity": "50.0",
"ECR before LimitedLiability": "120",
"Liabilities, Current": "39.4",
"Liabilities, Non-Current": "27.6",
"Research and Development": "11.1",
"Expenses": "4.31",
"Net Income": "53.9",
"General and Administrative Expense": "-39.4",
"Other Expenses": "31.3",
"Other Revenues": "47.9",
"Revenues": "47.9",
"Assets, Current": "-9.24",
"Other Assets": "28.9",
"Goodwill": "-8.75",
"Assets, Non-Current": "-0.859",
"Property, Plant and Equipment, Net": "0.755",
"Comprehensive Net Income": "54.1",
"Other Net Income": "1.10",
"Economic Capital Ratio": "73.8"
},
"2016": {
"Liabilities, Non-Current": "26.3",
"Liabilities": "41.5",
"Stockholders Equity": "16.3",
"ECR before LimitedLiability": "74.3",
"Liabilities, Current": "22.3",
"Other Liabilities": "-5.68",
"Property, Plant and Equipment, Net": "-4.67",
"Assets": "-6.01",
"Other Assets": "11.2",
"Assets, Current": "-12.8",
"Goodwill": "2.96",
"Research and Development": "15.9",
"Expenses": "6.87",
"Revenues": "45.2",
"Net Income": "50.3",
"General and Administrative Expense": "-39.5",
"Other Expenses": "30.2",
"Other Revenues": "45.2",
"Comprehensive Net Income": "49.8",
"Other Net Income": "-2.34",
"Economic Capital Ratio": "54.3"
},
"2017": {
"Other Liabilities": "1.61",
"Liabilities": "57.7",
"Stockholders Equity": "34.8",
"ECR before LimitedLiability": "84.2",
"Liabilities, Current": "30.5",
"Liabilities, Non-Current": "30.7",
"Assets, Non-Current": "-0.989",
"Assets": "-2.92",
"Other Assets": "9.64",
"Assets, Current": "-4.71",
"Goodwill": "1.32",
"Property, Plant and Equipment, Net": "-6.18",
"Other Revenues": "48.7",
"Revenues": "48.7",
"Net Income": "42.2",
"Comprehensive Net Income": "42.0",
"Other Expenses": "19.9",
"Other Net Income": "-5.55",
"Research and Development": "15.8",
"General and Administrative Expense": "-38.3",
"Economic Capital Ratio": "62.6"
},
"2018": {
"Liabilities, Non-Current": "16.8",
"Liabilities": "48.7",
"Stockholders Equity": "40.3",
"ECR before LimitedLiability": "99.4",
"Other Liabilities": "5.70",
"Liabilities, Current": "30.7",
"Property, Plant and Equipment, Net": "-4.01",
"Assets": "1.98",
"Other Assets": "13.2",
"Assets, Current": "-6.13",
"Goodwill": "4.94",
"Assets, Non-Current": "-2.49",
"Other Expenses": "15.6",
"Expenses": "5.34",
"Revenues": "37.0",
"Net Income": "42.2",
"Research and Development": "12.7",
"General and Administrative Expense": "-24.0",
"Other Revenues": "37.0",
"Comprehensive Net Income": "42.5",
"Economic Capital Ratio": "78.9"
},
"2019": {
"Liabilities, Non-Current": "16.3",
"Liabilities": "5.89",
"Stockholders Equity": "27.4",
"ECR before LimitedLiability": "78.9",
"Other Liabilities": "-30.5",
"Liabilities, Current": "16.0",
"Assets, Non-Current": "-4.36",
"Assets": "14.0",
"Goodwill": "4.83",
"Property, Plant and Equipment, Net": "-6.38",
"Other Assets": "9.76",
"Assets, Current": "11.4",
"Research and Development": "5.50",
"Expenses": "19.3",
"Revenues": "10.4",
"Net Income": "34.1",
"Other Expenses": "8.22",
"General and Administrative Expense": "5.29",
"Other Revenues": "10.4",
"Comprehensive Net Income": "34.3",
"Economic Capital Ratio": "49.4"
},
"2020": {
"Liabilities, Current": "18.6",
"Liabilities": "25.4",
"Stockholders Equity": "31.4",
"ECR before LimitedLiability": "93.5",
"Liabilities, Non-Current": "27.8",
"Other Liabilities": "-24.8",
"Goodwill": "17.7",
"Assets": "6.36",
"Other Assets": "5.85",
"Assets, Non-Current": "-4.30",
"Property, Plant and Equipment, Net": "-4.95",
"Other Expenses": "6.32",
"Expenses": "4.46",
"Revenues": "12.4",
"Net Income": "21.6",
"Research and Development": "5.12",
"General and Administrative Expense": "-6.97",
"Other Revenues": "12.4",
"Comprehensive Net Income": "23.6",
"Other Net Income": "4.67",
"Economic Capital Ratio": "55.7"
},
"2021": {
"Liabilities, Non-Current": "21.7",
"Liabilities": "13.5",
"Stockholders Equity": "26.1",
"ECR before LimitedLiability": "48.9",
"Liabilities, Current": "18.7",
"Other Liabilities": "-33.2",
"Assets, Current": "3.94",
"Assets": "8.17",
"Assets, Non-Current": "-4.97",
"Other Assets": "7.37",
"Goodwill": "8.73",
"Property, Plant and Equipment, Net": "-5.28",
"Other Expenses": "9.82",
"Expenses": "12.3",
"Revenues": "9.15",
"Net Income": "21.8",
"Research and Development": "7.65",
"General and Administrative Expense": "-5.23",
"Other Revenues": "9.15",
"Comprehensive Net Income": "21.0",
"Economic Capital Ratio": "44.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001038133_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "41,262",
"Assets, Non-Current": "3,072",
"General and Administrative Expense": "94,382",
"Goodwill": "0",
"Liabilities, Current": "18,803",
"Liabilities, Non-Current": "69",
"Other Assets": "48,365",
"Other Compr. Net Income": "-376",
"Other Expenses": "3,038",
"Other Liabilities": "11,572",
"Other Net Income": "0",
"Other Revenues": "104,597",
"Property, Plant and Equipment, Net": "17,020",
"Research and Development": "1,658"
},
"output_variables": {
"Liabilities": "30,444",
"Assets": "109,719",
"Expenses": "99,078",
"Revenues": "104,597",
"Stockholders Equity": "79,275",
"Net Income": "5,519",
"Comprehensive Net Income": "5,331",
"BaseVar": "172,107",
"ECR before LimitedLiability": "163%",
"Economic Capital Ratio": "210%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "55,273",
"Assets, Non-Current": "8,875",
"General and Administrative Expense": "111,403",
"Goodwill": "28,993",
"Liabilities, Current": "32,414",
"Liabilities, Non-Current": "0",
"Other Assets": "21,122",
"Other Compr. Net Income": "-1,747",
"Other Expenses": "4,368",
"Other Liabilities": "11,455",
"Other Net Income": "0",
"Other Revenues": "130,083",
"Property, Plant and Equipment, Net": "16,581",
"Research and Development": "2,147"
},
"output_variables": {
"Liabilities": "43,869",
"Assets": "130,844",
"Expenses": "117,918",
"Revenues": "130,083",
"Stockholders Equity": "86,975",
"Net Income": "12,165",
"Comprehensive Net Income": "11,292",
"BaseVar": "212,230",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "201%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "62,912",
"Assets, Non-Current": "5,407",
"General and Administrative Expense": "109,118",
"Goodwill": "28,645",
"Liabilities, Current": "25,726",
"Liabilities, Non-Current": "0",
"Other Assets": "21,492",
"Other Compr. Net Income": "632",
"Other Expenses": "8,763",
"Other Liabilities": "9,621",
"Other Net Income": "0",
"Other Revenues": "129,341",
"Property, Plant and Equipment, Net": "17,331",
"Research and Development": "2,004"
},
"output_variables": {
"Liabilities": "35,347",
"Assets": "135,787",
"Expenses": "119,885",
"Revenues": "129,341",
"Stockholders Equity": "100,440",
"Net Income": "9,456",
"Comprehensive Net Income": "9,772",
"BaseVar": "210,496",
"ECR before LimitedLiability": "172%",
"Economic Capital Ratio": "216%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "62,407",
"Assets, Non-Current": "7,574",
"General and Administrative Expense": "120,318",
"Goodwill": "36,443",
"Liabilities, Current": "20,363",
"Liabilities, Non-Current": "6,598",
"Other Assets": "34,047",
"Other Compr. Net Income": "45",
"Other Expenses": "-2,133",
"Other Liabilities": "7,082",
"Other Net Income": "-72",
"Other Revenues": "127,446",
"Property, Plant and Equipment, Net": "15,981",
"Research and Development": "3,334"
},
"output_variables": {
"Liabilities": "34,043",
"Assets": "156,452",
"Expenses": "121,519",
"Revenues": "127,446",
"Stockholders Equity": "122,409",
"Net Income": "5,855",
"Comprehensive Net Income": "5,878",
"BaseVar": "219,788",
"ECR before LimitedLiability": "182%",
"Economic Capital Ratio": "223%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "139,867",
"Assets, Non-Current": "13,252",
"General and Administrative Expense": "114,094",
"Goodwill": "47,676",
"Liabilities, Current": "32,199",
"Liabilities, Non-Current": "5,686",
"Other Assets": "28,160",
"Other Compr. Net Income": "502",
"Other Expenses": "1,460",
"Other Liabilities": "52,005",
"Other Net Income": "-594",
"Other Revenues": "122,661",
"Property, Plant and Equipment, Net": "15,469",
"Research and Development": "8,240"
},
"output_variables": {
"Liabilities": "89,890",
"Assets": "244,424",
"Expenses": "123,794",
"Revenues": "122,661",
"Stockholders Equity": "154,534",
"Net Income": "-1,727",
"Comprehensive Net Income": "-1,476",
"BaseVar": "290,932",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "185%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "171,275",
"Assets, Non-Current": "13,896",
"General and Administrative Expense": "196,743",
"Goodwill": "144,268",
"Liabilities, Current": "53,971",
"Liabilities, Non-Current": "5,135",
"Other Assets": "34,858",
"Other Compr. Net Income": "14,009",
"Other Expenses": "5,840",
"Other Liabilities": "53,680",
"Other Net Income": "-720",
"Other Revenues": "197,323",
"Property, Plant and Equipment, Net": "35,542",
"Research and Development": "8,772"
},
"output_variables": {
"Liabilities": "112,786",
"Assets": "399,839",
"Expenses": "211,355",
"Revenues": "197,323",
"Stockholders Equity": "287,053",
"Net Income": "-14,752",
"Comprehensive Net Income": "-7,748",
"BaseVar": "468,016",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "202%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "319,555",
"Assets, Non-Current": "15,344",
"General and Administrative Expense": "247,750",
"Goodwill": "175,531",
"Liabilities, Current": "56,593",
"Liabilities, Non-Current": "7,837",
"Other Assets": "60,229",
"Other Compr. Net Income": "-9,132",
"Other Expenses": "-1,125",
"Other Liabilities": "103,788",
"Other Net Income": "-1,280",
"Other Revenues": "253,739",
"Property, Plant and Equipment, Net": "33,413",
"Research and Development": "6,982"
},
"output_variables": {
"Liabilities": "168,218",
"Assets": "604,072",
"Expenses": "253,607",
"Revenues": "253,739",
"Stockholders Equity": "435,854",
"Net Income": "-1,148",
"Comprehensive Net Income": "-5,714",
"BaseVar": "645,024",
"ECR before LimitedLiability": "153%",
"Economic Capital Ratio": "203%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 2.034062199134741,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001038133.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001038133.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001038133.svg"
},
{
"company_id": "0000787253",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000787253.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000787253.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000787253.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000787253_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000787253_main_keyfigs.svg",
"name": "Natural Alternatives International Inc",
"rank": 17,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000787253.svg",
"report_text": "The relative strengths and weaknesses of Natural Alternatives International Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Natural Alternatives International Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 92% points.The greatest weakness of Natural Alternatives International Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 56% points.
The company's Economic Capital Ratio, given in the ranking table, is 202%, being 43% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000787253_2022_Natural_Alternatives_International_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "62.5",
"Liabilities": "88.8",
"Stockholders Equity": "49.0",
"ECR before LimitedLiability": "164",
"Liabilities, Non-Current": "23.3",
"Other Liabilities": "19.7",
"Property, Plant and Equipment, Net": "3.33",
"Assets": "-2.70",
"Assets, Non-Current": "-1.64",
"Other Assets": "1.14",
"Goodwill": "-3.98",
"Assets, Current": "-0.823",
"Other Revenues": "75.4",
"Revenues": "75.4",
"Net Income": "65.3",
"General and Administrative Expense": "65.6",
"Comprehensive Net Income": "65.2",
"Research and Development": "22.0",
"Other Net Income": "-10.7",
"Other Expenses": "-107",
"Economic Capital Ratio": "102"
},
"2012": {
"Liabilities, Current": "45.7",
"Liabilities": "88.2",
"Stockholders Equity": "23.3",
"ECR before LimitedLiability": "120",
"Liabilities, Non-Current": "24.5",
"Other Liabilities": "36.6",
"Assets, Current": "-2.03",
"Assets": "-7.96",
"Other Assets": "1.11",
"Assets, Non-Current": "-2.53",
"Property, Plant and Equipment, Net": "1.14",
"Goodwill": "-6.11",
"Other Expenses": "-126",
"Expenses": "-9.87",
"Revenues": "81.9",
"Net Income": "71.6",
"Research and Development": "25.5",
"General and Administrative Expense": "67.7",
"Other Revenues": "81.9",
"Comprehensive Net Income": "72.3",
"Economic Capital Ratio": "87.9"
},
"2014": {
"Liabilities, Non-Current": "34.7",
"Liabilities": "105",
"Stockholders Equity": "60.1",
"ECR before LimitedLiability": "146",
"Liabilities, Current": "65.3",
"Other Liabilities": "23.0",
"Assets, Current": "3.27",
"Assets": "-6.77",
"Goodwill": "-8.57",
"Other Assets": "1.71",
"Assets, Non-Current": "-2.24",
"Other Expenses": "-119",
"Expenses": "-10.1",
"Revenues": "80.3",
"Net Income": "71.7",
"Research and Development": "23.0",
"General and Administrative Expense": "67.4",
"Other Revenues": "80.3",
"Other Net Income": "2.09",
"Comprehensive Net Income": "71.8",
"Economic Capital Ratio": "96.9"
},
"2015": {
"Other Liabilities": "31.2",
"Liabilities": "116",
"Stockholders Equity": "49.8",
"ECR before LimitedLiability": "144",
"Liabilities, Current": "66.5",
"Liabilities, Non-Current": "40.9",
"Assets, Current": "3.86",
"Assets": "-10.6",
"Other Assets": "-3.08",
"Goodwill": "-8.35",
"Property, Plant and Equipment, Net": "-1.84",
"Research and Development": "18.3",
"Expenses": "-22.4",
"Revenues": "96.6",
"Net Income": "74.8",
"General and Administrative Expense": "50.8",
"Other Expenses": "-107",
"Other Revenues": "96.6",
"Comprehensive Net Income": "75.1",
"Other Net Income": "1.93",
"Economic Capital Ratio": "97.9"
},
"2016": {
"Liabilities, Non-Current": "36.9",
"Liabilities": "83.2",
"ECR before LimitedLiability": "91.8",
"Liabilities, Current": "43.5",
"Other Liabilities": "14.1",
"Property, Plant and Equipment, Net": "-3.32",
"Assets": "-17.5",
"Other Assets": "1.50",
"Assets, Non-Current": "-2.83",
"Assets, Current": "-5.92",
"Goodwill": "-10.1",
"Research and Development": "24.1",
"Expenses": "-16.3",
"Net Income": "69.3",
"General and Administrative Expense": "44.6",
"Other Expenses": "-96.0",
"Other Revenues": "89.9",
"Revenues": "89.9",
"Comprehensive Net Income": "69.8",
"Other Net Income": "-1.41",
"Economic Capital Ratio": "71.8"
},
"2017": {
"Other Liabilities": "25.5",
"Liabilities": "123",
"Stockholders Equity": "21.5",
"ECR before LimitedLiability": "114",
"Liabilities, Current": "74.5",
"Liabilities, Non-Current": "50.7",
"Assets, Non-Current": "-2.45",
"Assets": "-12.8",
"Assets, Current": "-2.81",
"Goodwill": "-7.80",
"Property, Plant and Equipment, Net": "-3.67",
"Research and Development": "28.2",
"Expenses": "-43.6",
"Revenues": "118",
"Net Income": "66.4",
"Other Expenses": "38.2",
"General and Administrative Expense": "-129",
"Other Revenues": "118",
"Comprehensive Net Income": "65.6",
"Other Net Income": "-8.63",
"Economic Capital Ratio": "92.8"
},
"2018": {
"Liabilities, Non-Current": "39.2",
"Liabilities": "93.3",
"Stockholders Equity": "3.38",
"ECR before LimitedLiability": "107",
"Other Liabilities": "17.9",
"Liabilities, Current": "52.0",
"Property, Plant and Equipment, Net": "-2.52",
"Assets": "-15.7",
"Assets, Current": "-2.02",
"Goodwill": "-8.53",
"Assets, Non-Current": "-5.91",
"Other Expenses": "14.8",
"Expenses": "-29.8",
"Revenues": "96.4",
"Net Income": "66.3",
"Research and Development": "23.4",
"General and Administrative Expense": "-74.7",
"Other Revenues": "96.4",
"Comprehensive Net Income": "67.0",
"Other Net Income": "1.37",
"Economic Capital Ratio": "86.4"
},
"2019": {
"Liabilities, Non-Current": "-5.51",
"Liabilities": "92.0",
"Assets": "-7.74",
"Stockholders Equity": "32.1",
"ECR before LimitedLiability": "137",
"Other Liabilities": "62.1",
"Liabilities, Current": "46.4",
"Goodwill": "-6.43",
"Property, Plant and Equipment, Net": "-1.88",
"Assets, Current": "-0.792",
"Research and Development": "16.1",
"Expenses": "-15.5",
"Revenues": "72.0",
"Net Income": "65.9",
"Other Expenses": "14.6",
"General and Administrative Expense": "-50.0",
"Other Revenues": "72.0",
"Other Net Income": "8.75",
"Comprehensive Net Income": "66.4",
"Other Compr. Net Income": "0.577",
"Economic Capital Ratio": "107"
},
"2020": {
"Liabilities, Current": "17.5",
"Liabilities": "33.0",
"Stockholders Equity": "-17.1",
"ECR before LimitedLiability": "68.6",
"Liabilities, Non-Current": "11.9",
"Other Liabilities": "4.85",
"Goodwill": "-13.0",
"Assets": "-20.0",
"Assets, Current": "-4.67",
"Assets, Non-Current": "0.545",
"Property, Plant and Equipment, Net": "-5.26",
"Other Expenses": "-5.56",
"Expenses": "-15.9",
"Revenues": "47.0",
"Net Income": "35.5",
"Research and Development": "10.3",
"General and Administrative Expense": "-20.3",
"Other Revenues": "47.0",
"Comprehensive Net Income": "35.0",
"Other Net Income": "6.54",
"Economic Capital Ratio": "30.8"
},
"2021": {
"Liabilities, Non-Current": "19.4",
"Liabilities": "60.7",
"Stockholders Equity": "-55.9",
"ECR before LimitedLiability": "47.2",
"Liabilities, Current": "34.0",
"Other Liabilities": "12.8",
"Assets, Current": "-13.2",
"Assets": "-29.4",
"Assets, Non-Current": "-4.23",
"Other Assets": "1.18",
"Goodwill": "-15.9",
"Property, Plant and Equipment, Net": "-5.86",
"Other Expenses": "3.35",
"Expenses": "-31.8",
"Revenues": "92.2",
"Net Income": "52.7",
"Research and Development": "16.8",
"General and Administrative Expense": "-53.5",
"Other Revenues": "92.2",
"Comprehensive Net Income": "53.0",
"Economic Capital Ratio": "42.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000787253_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "27,828",
"Assets, Non-Current": "453",
"General and Administrative Expense": "8,304",
"Goodwill": "0",
"Liabilities, Current": "4,947",
"Liabilities, Non-Current": "0",
"Other Assets": "1,452",
"Other Compr. Net Income": "50",
"Other Expenses": "42,517",
"Other Liabilities": "719",
"Other Net Income": "25",
"Other Revenues": "55,882",
"Property, Plant and Equipment, Net": "11,411",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,666",
"Assets": "41,144",
"Expenses": "50,821",
"Revenues": "55,882",
"Stockholders Equity": "35,478",
"Net Income": "5,086",
"Comprehensive Net Income": "5,111",
"BaseVar": "76,794",
"ECR before LimitedLiability": "230%",
"Economic Capital Ratio": "256%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "34,519",
"Assets, Non-Current": "471",
"General and Administrative Expense": "9,251",
"Goodwill": "0",
"Liabilities, Current": "6,836",
"Liabilities, Non-Current": "0",
"Other Assets": "1,560",
"Other Compr. Net Income": "464",
"Other Expenses": "59,455",
"Other Liabilities": "493",
"Other Net Income": "42",
"Other Revenues": "72,822",
"Property, Plant and Equipment, Net": "10,647",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,329",
"Assets": "47,197",
"Expenses": "68,706",
"Revenues": "72,822",
"Stockholders Equity": "39,868",
"Net Income": "4,158",
"Comprehensive Net Income": "4,390",
"BaseVar": "98,280",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "246%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "40,903",
"Assets, Non-Current": "951",
"General and Administrative Expense": "9,961",
"Goodwill": "0",
"Liabilities, Current": "9,600",
"Liabilities, Non-Current": "0",
"Other Assets": "1,593",
"Other Compr. Net Income": "-39",
"Other Expenses": "61,878",
"Other Liabilities": "220",
"Other Net Income": "-109",
"Other Revenues": "73,942",
"Property, Plant and Equipment, Net": "8,811",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,820",
"Assets": "52,258",
"Expenses": "71,839",
"Revenues": "73,942",
"Stockholders Equity": "42,438",
"Net Income": "1,994",
"Comprehensive Net Income": "1,974",
"BaseVar": "104,004",
"ECR before LimitedLiability": "194%",
"Economic Capital Ratio": "230%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "43,600",
"Assets, Non-Current": "920",
"General and Administrative Expense": "10,180",
"Goodwill": "0",
"Liabilities, Current": "9,093",
"Liabilities, Non-Current": "21",
"Other Assets": "1,663",
"Other Compr. Net Income": "-297",
"Other Expenses": "66,130",
"Other Liabilities": "842",
"Other Net Income": "148",
"Other Revenues": "79,508",
"Property, Plant and Equipment, Net": "7,633",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,956",
"Assets": "53,816",
"Expenses": "76,310",
"Revenues": "79,508",
"Stockholders Equity": "43,860",
"Net Income": "3,346",
"Comprehensive Net Income": "3,198",
"BaseVar": "110,018",
"ECR before LimitedLiability": "198%",
"Economic Capital Ratio": "234%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "55,882",
"Assets, Non-Current": "899",
"General and Administrative Expense": "13,000",
"Goodwill": "0",
"Liabilities, Current": "19,205",
"Liabilities, Non-Current": "0",
"Other Assets": "2,227",
"Other Compr. Net Income": "86",
"Other Expenses": "92,969",
"Other Liabilities": "1,244",
"Other Net Income": "1,314",
"Other Revenues": "114,201",
"Property, Plant and Equipment, Net": "15,167",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "20,449",
"Assets": "74,175",
"Expenses": "105,969",
"Revenues": "114,201",
"Stockholders Equity": "53,726",
"Net Income": "9,546",
"Comprehensive Net Income": "9,589",
"BaseVar": "158,097",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "218%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "51,699",
"Assets, Non-Current": "774",
"General and Administrative Expense": "112,244",
"Goodwill": "0",
"Liabilities, Current": "10,270",
"Liabilities, Non-Current": "0",
"Other Assets": "2,002",
"Other Compr. Net Income": "-225",
"Other Expenses": "2,876",
"Other Liabilities": "1,193",
"Other Net Income": "409",
"Other Revenues": "121,946",
"Property, Plant and Equipment, Net": "18,136",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "11,463",
"Assets": "72,611",
"Expenses": "115,120",
"Revenues": "121,946",
"Stockholders Equity": "61,148",
"Net Income": "7,235",
"Comprehensive Net Income": "7,122",
"BaseVar": "160,887",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "246%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "65,183",
"Assets, Non-Current": "734",
"General and Administrative Expense": "122,904",
"Goodwill": "0",
"Liabilities, Current": "14,280",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "327",
"Other Expenses": "5,562",
"Other Liabilities": "2,679",
"Other Net Income": "1,080",
"Other Revenues": "132,437",
"Property, Plant and Equipment, Net": "19,290",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,959",
"Assets": "85,207",
"Expenses": "128,466",
"Revenues": "132,437",
"Stockholders Equity": "68,248",
"Net Income": "5,051",
"Comprehensive Net Income": "5,214",
"BaseVar": "182,238",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "230%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "71,386",
"Assets, Non-Current": "21,793",
"General and Administrative Expense": "132,329",
"Goodwill": "0",
"Liabilities, Current": "15,370",
"Liabilities, Non-Current": "20,897",
"Other Assets": "0",
"Other Compr. Net Income": "870",
"Other Expenses": "1,412",
"Other Liabilities": "-18,861",
"Other Net Income": "1,992",
"Other Revenues": "138,290",
"Property, Plant and Equipment, Net": "21,085",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "17,406",
"Assets": "114,264",
"Expenses": "133,741",
"Revenues": "138,290",
"Stockholders Equity": "96,858",
"Net Income": "6,541",
"Comprehensive Net Income": "6,976",
"BaseVar": "203,282",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "243%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "79,024",
"Assets, Non-Current": "19,460",
"General and Administrative Expense": "100,005",
"Goodwill": "0",
"Liabilities, Current": "27,806",
"Liabilities, Non-Current": "18,782",
"Other Assets": "196",
"Other Compr. Net Income": "-1,347",
"Other Expenses": "20,287",
"Other Liabilities": "2,240",
"Other Net Income": "-229",
"Other Revenues": "118,876",
"Property, Plant and Equipment, Net": "21,523",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "48,828",
"Assets": "120,203",
"Expenses": "120,292",
"Revenues": "118,876",
"Stockholders Equity": "71,375",
"Net Income": "-1,645",
"Comprehensive Net Income": "-2,318",
"BaseVar": "204,888",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "177%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "80,348",
"Assets, Non-Current": "17,448",
"General and Administrative Expense": "148,078",
"Goodwill": "0",
"Liabilities, Current": "22,072",
"Liabilities, Non-Current": "16,481",
"Other Assets": "214",
"Other Compr. Net Income": "622",
"Other Expenses": "18,127",
"Other Liabilities": "1,645",
"Other Net Income": "-1,547",
"Other Revenues": "178,520",
"Property, Plant and Equipment, Net": "22,271",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "40,198",
"Assets": "120,281",
"Expenses": "166,205",
"Revenues": "178,520",
"Stockholders Equity": "80,083",
"Net Income": "10,768",
"Comprehensive Net Income": "11,079",
"BaseVar": "253,686",
"ECR before LimitedLiability": "151%",
"Economic Capital Ratio": "202%"
}
}
},
"top_rated": false,
"trend": 4.0,
"value": 2.016850924342512,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000787253.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000787253.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000787253.svg"
},
{
"company_id": "0000037785",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000037785.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000037785.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000037785.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000037785_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000037785_main_keyfigs.svg",
"name": "FMC CORP",
"rank": 18,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000037785.svg",
"report_text": "The relative strengths and weaknesses of FMC CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of FMC CORP compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 29% points.The greatest weakness of FMC CORP is the variable Liabilities, Current, reducing the Economic Capital Ratio by 33% points.
The company's Economic Capital Ratio, given in the ranking table, is 200%, being 41% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000037785_2022_FMC_CORP.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "1.10",
"Liabilities": "-12.3",
"Stockholders Equity": "20.1",
"ECR before LimitedLiability": "9.42",
"Liabilities, Current": "-15.4",
"Other Liabilities": "1.64",
"Property, Plant and Equipment, Net": "6.68",
"Assets": "10.3",
"Other Assets": "4.39",
"Assets, Current": "-1.53",
"Goodwill": "0.287",
"General and Administrative Expense": "-28.3",
"Expenses": "12.9",
"Revenues": "-12.5",
"Comprehensive Net Income": "-0.188",
"Other Expenses": "39.8",
"Research and Development": "-0.0822",
"Other Revenues": "-12.5",
"Other Net Income": "-0.721",
"Other Compr. Net Income": "-0.157",
"Economic Capital Ratio": "8.70"
},
"2010": {
"Other Liabilities": "4.05",
"Liabilities": "23.4",
"Stockholders Equity": "10.1",
"ECR before LimitedLiability": "29.8",
"Liabilities, Current": "-21.9",
"Liabilities, Non-Current": "36.5",
"Other Expenses": "15.1",
"Expenses": "-3.63",
"Net Income": "14.6",
"General and Administrative Expense": "-24.5",
"Research and Development": "5.36",
"Other Revenues": "14.0",
"Revenues": "14.0",
"Goodwill": "-7.02",
"Property, Plant and Equipment, Net": "5.42",
"Assets, Current": "-4.49",
"Assets, Non-Current": "-2.70",
"Other Assets": "8.69",
"Other Net Income": "4.20",
"Comprehensive Net Income": "14.0",
"Economic Capital Ratio": "31.8"
},
"2011": {
"Liabilities, Current": "12.1",
"Liabilities": "38.3",
"Assets": "6.77",
"Stockholders Equity": "44.3",
"ECR before LimitedLiability": "130",
"Liabilities, Non-Current": "14.6",
"Other Liabilities": "15.3",
"Property, Plant and Equipment, Net": "7.10",
"Other Assets": "4.07",
"Assets, Current": "-3.03",
"General and Administrative Expense": "-12.1",
"Expenses": "20.0",
"Revenues": "34.4",
"Net Income": "46.8",
"Research and Development": "12.0",
"Other Expenses": "19.8",
"Other Revenues": "34.4",
"Comprehensive Net Income": "45.3",
"Other Net Income": "-8.00",
"Other Compr. Net Income": "-1.42",
"Economic Capital Ratio": "67.9"
},
"2012": {
"Liabilities, Current": "-7.79",
"Liabilities": "29.0",
"Stockholders Equity": "36.6",
"ECR before LimitedLiability": "92.7",
"Liabilities, Non-Current": "14.0",
"Other Liabilities": "23.0",
"Assets, Current": "-2.45",
"Assets": "6.71",
"Other Assets": "2.78",
"Property, Plant and Equipment, Net": "7.17",
"Goodwill": "-1.11",
"Other Expenses": "22.5",
"Expenses": "21.3",
"Revenues": "28.7",
"Net Income": "49.1",
"Research and Development": "12.8",
"General and Administrative Expense": "-14.3",
"Other Revenues": "28.7",
"Other Net Income": "-1.30",
"Comprehensive Net Income": "48.7",
"Economic Capital Ratio": "60.2"
},
"2013": {
"Liabilities, Current": "-25.8",
"Liabilities": "9.70",
"Assets": "8.11",
"Stockholders Equity": "21.7",
"ECR before LimitedLiability": "76.7",
"Other Liabilities": "14.8",
"Liabilities, Non-Current": "17.2",
"Goodwill": "-1.19",
"Property, Plant and Equipment, Net": "8.49",
"Assets, Current": "1.89",
"General and Administrative Expense": "-8.10",
"Expenses": "24.7",
"Revenues": "21.8",
"Net Income": "41.9",
"Research and Development": "9.95",
"Other Expenses": "22.8",
"Other Revenues": "21.8",
"Other Net Income": "-5.58",
"Comprehensive Net Income": "43.9",
"Other Compr. Net Income": "1.68",
"Economic Capital Ratio": "36.5"
},
"2014": {
"Liabilities, Non-Current": "20.0",
"Liabilities": "31.7",
"Stockholders Equity": "48.3",
"ECR before LimitedLiability": "108",
"Liabilities, Current": "-0.642",
"Other Liabilities": "13.5",
"Assets, Current": "2.63",
"Assets": "12.9",
"Goodwill": "-2.79",
"Other Assets": "2.87",
"Property, Plant and Equipment, Net": "9.21",
"Other Expenses": "17.0",
"Expenses": "24.0",
"Revenues": "24.5",
"Net Income": "50.4",
"Research and Development": "12.0",
"General and Administrative Expense": "-5.11",
"Other Revenues": "24.5",
"Comprehensive Net Income": "48.5",
"Other Compr. Net Income": "-1.64",
"Economic Capital Ratio": "58.5"
},
"2015": {
"Other Liabilities": "19.8",
"Liabilities": "50.9",
"Stockholders Equity": "72.7",
"ECR before LimitedLiability": "133",
"Liabilities, Current": "13.3",
"Liabilities, Non-Current": "23.8",
"Assets, Current": "2.04",
"Assets": "14.1",
"Goodwill": "6.74",
"Assets, Non-Current": "1.84",
"Property, Plant and Equipment, Net": "2.65",
"Research and Development": "7.85",
"Expenses": "19.6",
"Revenues": "14.5",
"Net Income": "46.5",
"General and Administrative Expense": "-9.50",
"Other Expenses": "21.0",
"Other Revenues": "14.5",
"Comprehensive Net Income": "46.0",
"Other Net Income": "12.5",
"Economic Capital Ratio": "87.6"
},
"2016": {
"Liabilities, Non-Current": "21.5",
"Liabilities": "33.8",
"Stockholders Equity": "57.3",
"ECR before LimitedLiability": "91.4",
"Liabilities, Current": "4.70",
"Other Liabilities": "9.94",
"Property, Plant and Equipment, Net": "0.974",
"Assets": "14.6",
"Other Assets": "2.15",
"Assets, Non-Current": "2.19",
"Goodwill": "7.93",
"Research and Development": "10.9",
"Expenses": "19.8",
"Revenues": "15.8",
"Net Income": "33.3",
"General and Administrative Expense": "-11.3",
"Other Expenses": "20.1",
"Other Revenues": "15.8",
"Comprehensive Net Income": "33.3",
"Other Net Income": "-2.37",
"Economic Capital Ratio": "71.5"
},
"2017": {
"Other Liabilities": "11.5",
"Liabilities": "25.4",
"Stockholders Equity": "66.5",
"ECR before LimitedLiability": "89.0",
"Liabilities, Current": "-6.92",
"Liabilities, Non-Current": "20.9",
"Assets, Non-Current": "0.578",
"Assets": "22.6",
"Other Assets": "1.42",
"Assets, Current": "2.27",
"Goodwill": "19.8",
"Property, Plant and Equipment, Net": "-2.44",
"Research and Development": "9.65",
"Expenses": "25.0",
"Net Income": "28.6",
"Other Net Income": "3.70",
"Other Expenses": "12.4",
"General and Administrative Expense": "3.10",
"Comprehensive Net Income": "29.7",
"Other Compr. Net Income": "1.12",
"Economic Capital Ratio": "67.4"
},
"2018": {
"Liabilities, Non-Current": "18.2",
"Liabilities": "11.1",
"Stockholders Equity": "42.4",
"ECR before LimitedLiability": "81.2",
"Other Liabilities": "11.2",
"Liabilities, Current": "-21.1",
"Property, Plant and Equipment, Net": "-2.50",
"Assets": "18.3",
"Other Assets": "1.61",
"Goodwill": "24.4",
"Assets, Non-Current": "-1.85",
"Other Expenses": "7.35",
"Expenses": "24.4",
"Revenues": "10.3",
"Net Income": "33.5",
"Research and Development": "7.98",
"General and Administrative Expense": "8.87",
"Other Revenues": "10.3",
"Comprehensive Net Income": "33.3",
"Other Net Income": "-1.47",
"Economic Capital Ratio": "60.7"
},
"2019": {
"Liabilities, Non-Current": "21.0",
"Liabilities": "18.4",
"Stockholders Equity": "47.4",
"ECR before LimitedLiability": "103",
"Other Liabilities": "13.9",
"Liabilities, Current": "-19.0",
"Assets, Non-Current": "-2.12",
"Assets": "17.1",
"Goodwill": "22.1",
"Property, Plant and Equipment, Net": "-3.70",
"Other Assets": "1.90",
"Research and Development": "5.34",
"Expenses": "23.4",
"Revenues": "10.9",
"Net Income": "37.5",
"Other Expenses": "3.72",
"General and Administrative Expense": "14.3",
"Other Revenues": "10.9",
"Other Net Income": "2.81",
"Comprehensive Net Income": "37.0",
"Economic Capital Ratio": "73.6"
},
"2020": {
"Liabilities, Current": "-17.1",
"Liabilities": "20.5",
"Stockholders Equity": "37.8",
"ECR before LimitedLiability": "103",
"Liabilities, Non-Current": "28.6",
"Other Liabilities": "6.25",
"Goodwill": "20.3",
"Assets": "10.9",
"Assets, Current": "-1.36",
"Assets, Non-Current": "-1.52",
"Property, Plant and Equipment, Net": "-4.38",
"Other Expenses": "2.60",
"Expenses": "13.0",
"Revenues": "11.7",
"Net Income": "29.0",
"Research and Development": "3.88",
"General and Administrative Expense": "6.53",
"Other Revenues": "11.7",
"Comprehensive Net Income": "29.7",
"Other Net Income": "4.20",
"Economic Capital Ratio": "64.9"
},
"2021": {
"Liabilities, Non-Current": "23.9",
"Liabilities": "4.87",
"Stockholders Equity": "14.7",
"ECR before LimitedLiability": "45.2",
"Liabilities, Current": "-33.3",
"Other Liabilities": "8.24",
"Assets, Current": "-1.27",
"Assets": "5.63",
"Assets, Non-Current": "-3.36",
"Other Assets": "1.90",
"Goodwill": "15.3",
"Property, Plant and Equipment, Net": "-4.43",
"Other Expenses": "6.33",
"Expenses": "15.8",
"Revenues": "13.1",
"Net Income": "29.2",
"Research and Development": "5.98",
"General and Administrative Expense": "3.40",
"Other Revenues": "13.1",
"Comprehensive Net Income": "29.1",
"Economic Capital Ratio": "40.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000037785_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "1,487,700",
"Assets, Non-Current": "211,400",
"General and Administrative Expense": "2,265,900",
"Goodwill": "209,500",
"Liabilities, Current": "709,200",
"Liabilities, Non-Current": "0",
"Other Assets": "263,100",
"Other Compr. Net Income": "-13,400",
"Other Expenses": "213,000",
"Other Liabilities": "0",
"Other Net Income": "-15,700",
"Other Revenues": "2,826,200",
"Property, Plant and Equipment, Net": "964,500",
"Research and Development": "92,800"
},
"output_variables": {
"Liabilities": "709,200",
"Assets": "3,136,200",
"Expenses": "2,571,700",
"Revenues": "2,826,200",
"Stockholders Equity": "2,427,000",
"Net Income": "238,800",
"Comprehensive Net Income": "232,100",
"BaseVar": "4,636,200",
"ECR before LimitedLiability": "185%",
"Economic Capital Ratio": "225%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,646,200",
"Assets, Non-Current": "223,700",
"General and Administrative Expense": "2,476,800",
"Goodwill": "194,400",
"Liabilities, Current": "963,400",
"Liabilities, Non-Current": "0",
"Other Assets": "337,100",
"Other Compr. Net Income": "-44,900",
"Other Expenses": "323,400",
"Other Liabilities": "0",
"Other Net Income": "36,500",
"Other Revenues": "3,116,300",
"Property, Plant and Equipment, Net": "918,500",
"Research and Development": "100,500"
},
"output_variables": {
"Liabilities": "963,400",
"Assets": "3,319,900",
"Expenses": "2,900,700",
"Revenues": "3,116,300",
"Stockholders Equity": "2,356,500",
"Net Income": "252,100",
"Comprehensive Net Income": "229,650",
"BaseVar": "5,190,850",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,869,400",
"Assets, Non-Current": "198,900",
"General and Administrative Expense": "2,653,000",
"Goodwill": "413,200",
"Liabilities, Current": "919,900",
"Liabilities, Non-Current": "0",
"Other Assets": "275,200",
"Other Compr. Net Income": "-94,600",
"Other Expenses": "208,400",
"Other Liabilities": "0",
"Other Net Income": "-29,100",
"Other Revenues": "3,377,900",
"Property, Plant and Equipment, Net": "986,800",
"Research and Development": "105,200"
},
"output_variables": {
"Liabilities": "919,900",
"Assets": "3,743,500",
"Expenses": "2,966,600",
"Revenues": "3,377,900",
"Stockholders Equity": "2,823,600",
"Net Income": "382,200",
"Comprehensive Net Income": "334,900",
"BaseVar": "5,565,800",
"ECR before LimitedLiability": "180%",
"Economic Capital Ratio": "221%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,181,800",
"Assets, Non-Current": "312,500",
"General and Administrative Expense": "2,934,200",
"Goodwill": "510,100",
"Liabilities, Current": "1,135,400",
"Liabilities, Non-Current": "0",
"Other Assets": "233,300",
"Other Compr. Net Income": "-38,400",
"Other Expenses": "230,200",
"Other Liabilities": "0",
"Other Net Income": "-30,400",
"Other Revenues": "3,748,300",
"Property, Plant and Equipment, Net": "1,136,200",
"Research and Development": "117,800"
},
"output_variables": {
"Liabilities": "1,135,400",
"Assets": "4,373,900",
"Expenses": "3,282,200",
"Revenues": "3,748,300",
"Stockholders Equity": "3,238,500",
"Net Income": "435,700",
"Comprehensive Net Income": "416,500",
"BaseVar": "6,304,300",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "219%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,945,000",
"Assets, Non-Current": "288,800",
"General and Administrative Expense": "3,050,200",
"Goodwill": "661,700",
"Liabilities, Current": "1,986,700",
"Liabilities, Non-Current": "0",
"Other Assets": "91,400",
"Other Compr. Net Income": "192,900",
"Other Expenses": "238,900",
"Other Liabilities": "0",
"Other Net Income": "-160,000",
"Other Revenues": "3,874,800",
"Property, Plant and Equipment, Net": "1,248,300",
"Research and Development": "117,700"
},
"output_variables": {
"Liabilities": "1,986,700",
"Assets": "5,235,200",
"Expenses": "3,406,800",
"Revenues": "3,874,800",
"Stockholders Equity": "3,248,500",
"Net Income": "308,000",
"Comprehensive Net Income": "404,450",
"BaseVar": "7,428,200",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "191%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "2,934,400",
"Assets, Non-Current": "298,100",
"General and Administrative Expense": "3,283,900",
"Goodwill": "599,400",
"Liabilities, Current": "1,910,400",
"Liabilities, Non-Current": "0",
"Other Assets": "200,100",
"Other Compr. Net Income": "-188,500",
"Other Expenses": "213,300",
"Other Liabilities": "0",
"Other Net Income": "-90,100",
"Other Revenues": "4,037,700",
"Property, Plant and Equipment, Net": "1,308,500",
"Research and Development": "128,300"
},
"output_variables": {
"Liabilities": "1,910,400",
"Assets": "5,340,500",
"Expenses": "3,625,500",
"Revenues": "4,037,700",
"Stockholders Equity": "3,430,100",
"Net Income": "322,100",
"Comprehensive Net Income": "227,850",
"BaseVar": "7,596,350",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "192%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "2,971,900",
"Assets, Non-Current": "437,600",
"General and Administrative Expense": "2,939,000",
"Goodwill": "1,613,100",
"Liabilities, Current": "1,453,300",
"Liabilities, Non-Current": "0",
"Other Assets": "286,900",
"Other Compr. Net Income": "-91,000",
"Other Expenses": "372,800",
"Other Liabilities": "0",
"Other Net Income": "677,500",
"Other Revenues": "3,276,500",
"Property, Plant and Equipment, Net": "1,016,400",
"Research and Development": "143,700"
},
"output_variables": {
"Liabilities": "1,453,300",
"Assets": "6,325,900",
"Expenses": "3,455,500",
"Revenues": "3,276,500",
"Stockholders Equity": "4,872,600",
"Net Income": "498,500",
"Comprehensive Net Income": "453,000",
"BaseVar": "7,639,850",
"ECR before LimitedLiability": "183%",
"Economic Capital Ratio": "223%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,849,200",
"Assets, Non-Current": "472,300",
"General and Administrative Expense": "2,612,100",
"Goodwill": "1,570,900",
"Liabilities, Current": "1,438,200",
"Liabilities, Non-Current": "0",
"Other Assets": "244,800",
"Other Compr. Net Income": "-23,700",
"Other Expenses": "284,500",
"Other Liabilities": "0",
"Other Net Income": "-32,600",
"Other Revenues": "3,282,400",
"Property, Plant and Equipment, Net": "1,002,100",
"Research and Development": "141,500"
},
"output_variables": {
"Liabilities": "1,438,200",
"Assets": "6,139,300",
"Expenses": "3,038,100",
"Revenues": "3,282,400",
"Stockholders Equity": "4,701,100",
"Net Income": "211,700",
"Comprehensive Net Income": "199,850",
"BaseVar": "6,977,150",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "218%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,652,700",
"Assets, Non-Current": "445,000",
"General and Administrative Expense": "2,395,900",
"Goodwill": "3,830,700",
"Liabilities, Current": "2,209,400",
"Liabilities, Non-Current": "0",
"Other Assets": "252,700",
"Other Compr. Net Income": "235,500",
"Other Expenses": "425,500",
"Other Liabilities": "0",
"Other Net Income": "622,700",
"Other Revenues": "2,878,600",
"Property, Plant and Equipment, Net": "1,025,200",
"Research and Development": "141,500"
},
"output_variables": {
"Liabilities": "2,209,400",
"Assets": "9,206,300",
"Expenses": "2,962,900",
"Revenues": "2,878,600",
"Stockholders Equity": "6,996,900",
"Net Income": "538,400",
"Comprehensive Net Income": "656,150",
"BaseVar": "9,057,700",
"ECR before LimitedLiability": "179%",
"Economic Capital Ratio": "221%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "4,030,200",
"Assets, Non-Current": "465,900",
"General and Administrative Expense": "3,492,100",
"Goodwill": "4,172,400",
"Liabilities, Current": "2,993,400",
"Liabilities, Non-Current": "0",
"Other Assets": "273,200",
"Other Compr. Net Income": "-78,000",
"Other Expenses": "290,800",
"Other Liabilities": "0",
"Other Net Income": "-141,900",
"Other Revenues": "4,727,800",
"Property, Plant and Equipment, Net": "1,032,600",
"Research and Development": "291,500"
},
"output_variables": {
"Liabilities": "2,993,400",
"Assets": "9,974,300",
"Expenses": "4,074,400",
"Revenues": "4,727,800",
"Stockholders Equity": "6,980,900",
"Net Income": "511,500",
"Comprehensive Net Income": "472,500",
"BaseVar": "10,994,900",
"ECR before LimitedLiability": "155%",
"Economic Capital Ratio": "204%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,074,800",
"Assets, Non-Current": "686,000",
"General and Administrative Expense": "3,319,100",
"Goodwill": "4,096,500",
"Liabilities, Current": "2,723,900",
"Liabilities, Non-Current": "0",
"Other Assets": "257,400",
"Other Compr. Net Income": "-91,800",
"Other Expenses": "451,000",
"Other Liabilities": "0",
"Other Net Income": "-61,400",
"Other Revenues": "4,609,800",
"Property, Plant and Equipment, Net": "758,000",
"Research and Development": "298,100"
},
"output_variables": {
"Liabilities": "2,723,900",
"Assets": "9,872,700",
"Expenses": "4,068,200",
"Revenues": "4,609,800",
"Stockholders Equity": "7,148,800",
"Net Income": "480,200",
"Comprehensive Net Income": "434,300",
"BaseVar": "10,713,900",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "209%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,375,600",
"Assets, Non-Current": "715,400",
"General and Administrative Expense": "3,319,800",
"Goodwill": "4,094,100",
"Liabilities, Current": "2,829,000",
"Liabilities, Non-Current": "0",
"Other Assets": "229,600",
"Other Compr. Net Income": "130,700",
"Other Expenses": "455,600",
"Other Liabilities": "0",
"Other Net Income": "-28,200",
"Other Revenues": "4,642,100",
"Property, Plant and Equipment, Net": "771,700",
"Research and Development": "287,900"
},
"output_variables": {
"Liabilities": "2,829,000",
"Assets": "10,186,400",
"Expenses": "4,063,300",
"Revenues": "4,642,100",
"Stockholders Equity": "7,357,400",
"Net Income": "550,600",
"Comprehensive Net Income": "615,950",
"BaseVar": "10,939,850",
"ECR before LimitedLiability": "164%",
"Economic Capital Ratio": "211%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "4,937,600",
"Assets, Non-Current": "623,000",
"General and Administrative Expense": "3,587,600",
"Goodwill": "3,985,200",
"Liabilities, Current": "3,520,300",
"Liabilities, Non-Current": "0",
"Other Assets": "218,500",
"Other Compr. Net Income": "-31,000",
"Other Expenses": "350,700",
"Other Liabilities": "0",
"Other Net Income": "-68,200",
"Other Revenues": "5,045,200",
"Property, Plant and Equipment, Net": "817,000",
"Research and Development": "304,700"
},
"output_variables": {
"Liabilities": "3,520,300",
"Assets": "10,581,300",
"Expenses": "4,243,000",
"Revenues": "5,045,200",
"Stockholders Equity": "7,061,000",
"Net Income": "734,000",
"Comprehensive Net Income": "718,500",
"BaseVar": "11,744,500",
"ECR before LimitedLiability": "147%",
"Economic Capital Ratio": "200%"
}
}
},
"top_rated": false,
"trend": -7.0,
"value": 1.9961181749748669,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000037785.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000037785.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000037785.svg"
},
{
"company_id": "0001742924",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001742924.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001742924.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001742924.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001742924_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001742924_main_keyfigs.svg",
"name": "Livent Corp",
"rank": 19,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001742924.svg",
"report_text": "The relative strengths and weaknesses of Livent Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Livent Corp compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 45% points.The greatest weakness of Livent Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 23% points.
The company's Economic Capital Ratio, given in the ranking table, is 192%, being 33% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001742924_2022_Livent_Corp.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "25.5",
"Liabilities": "47.1",
"Stockholders Equity": "61.3",
"ECR before LimitedLiability": "127",
"Other Liabilities": "16.0",
"Liabilities, Current": "11.7",
"Property, Plant and Equipment, Net": "10.7",
"Assets": "7.62",
"Other Assets": "0.103",
"Assets, Current": "0.438",
"Goodwill": "-3.47",
"Assets, Non-Current": "1.27",
"Other Expenses": "3.03",
"Expenses": "24.4",
"Revenues": "32.1",
"Net Income": "55.3",
"Research and Development": "13.0",
"General and Administrative Expense": "8.83",
"Other Revenues": "32.1",
"Comprehensive Net Income": "55.2",
"Economic Capital Ratio": "106"
},
"2019": {
"Assets, Non-Current": "1.31",
"Assets": "18.4",
"Stockholders Equity": "31.4",
"Liabilities, Non-Current": "-24.6",
"ECR before LimitedLiability": "85.3",
"Goodwill": "-7.50",
"Property, Plant and Equipment, Net": "39.5",
"Other Assets": "1.06",
"Assets, Current": "-5.38",
"Research and Development": "7.75",
"Expenses": "25.6",
"Revenues": "8.07",
"Net Income": "37.9",
"Other Expenses": "5.82",
"General and Administrative Expense": "11.6",
"Other Revenues": "8.07",
"Other Liabilities": "12.6",
"Liabilities, Current": "9.93",
"Other Net Income": "3.21",
"Comprehensive Net Income": "38.0",
"Economic Capital Ratio": "55.8"
},
"2020": {
"Liabilities, Current": "17.0",
"Liabilities": "-7.82",
"Stockholders Equity": "23.5",
"ECR before LimitedLiability": "70.6",
"Liabilities, Non-Current": "-33.7",
"Other Liabilities": "5.00",
"Goodwill": "-8.10",
"Assets": "19.6",
"Assets, Current": "-11.1",
"Assets, Non-Current": "3.53",
"Property, Plant and Equipment, Net": "52.8",
"Other Expenses": "5.76",
"Expenses": "16.9",
"Revenues": "-1.64",
"Net Income": "19.3",
"Research and Development": "5.71",
"General and Administrative Expense": "5.16",
"Other Revenues": "-1.64",
"Comprehensive Net Income": "19.6",
"Other Net Income": "3.95",
"Economic Capital Ratio": "32.8"
},
"2021": {
"Liabilities, Non-Current": "-23.0",
"Liabilities": "-2.29",
"Stockholders Equity": "20.4",
"ECR before LimitedLiability": "37.4",
"Liabilities, Current": "11.0",
"Other Liabilities": "7.40",
"Assets, Current": "-7.23",
"Assets": "12.5",
"Assets, Non-Current": "-0.142",
"Other Assets": "0.626",
"Goodwill": "-9.55",
"Property, Plant and Equipment, Net": "44.9",
"Other Expenses": "6.45",
"Expenses": "17.0",
"Revenues": "3.32",
"Net Income": "20.5",
"Research and Development": "7.89",
"General and Administrative Expense": "2.51",
"Other Revenues": "3.32",
"Comprehensive Net Income": "20.6",
"Economic Capital Ratio": "33.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001742924_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "301,300",
"Assets, Non-Current": "80,000",
"General and Administrative Expense": "257,900",
"Goodwill": "0",
"Liabilities, Current": "120,400",
"Liabilities, Non-Current": "0",
"Other Assets": "3,000",
"Other Compr. Net Income": "-3,600",
"Other Expenses": "54,700",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "442,500",
"Property, Plant and Equipment, Net": "275,700",
"Research and Development": "3,800"
},
"output_variables": {
"Liabilities": "120,400",
"Assets": "660,000",
"Expenses": "316,400",
"Revenues": "442,500",
"Stockholders Equity": "539,600",
"Net Income": "126,100",
"Comprehensive Net Income": "124,300",
"BaseVar": "771,450",
"ECR before LimitedLiability": "221%",
"Economic Capital Ratio": "250%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "272,000",
"Assets, Non-Current": "110,600",
"General and Administrative Expense": "314,000",
"Goodwill": "0",
"Liabilities, Current": "129,200",
"Liabilities, Non-Current": "186,400",
"Other Assets": "8,200",
"Other Compr. Net Income": "900",
"Other Expenses": "20,100",
"Other Liabilities": "0",
"Other Net Income": "-800",
"Other Revenues": "388,400",
"Property, Plant and Equipment, Net": "468,800",
"Research and Development": "3,300"
},
"output_variables": {
"Liabilities": "315,600",
"Assets": "859,600",
"Expenses": "337,400",
"Revenues": "388,400",
"Stockholders Equity": "544,000",
"Net Income": "50,200",
"Comprehensive Net Income": "50,650",
"BaseVar": "951,350",
"ECR before LimitedLiability": "135%",
"Economic Capital Ratio": "192%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "249,800",
"Assets, Non-Current": "128,300",
"General and Administrative Expense": "296,000",
"Goodwill": "0",
"Liabilities, Current": "96,200",
"Liabilities, Non-Current": "274,800",
"Other Assets": "13,400",
"Other Compr. Net Income": "3,900",
"Other Expenses": "6,800",
"Other Liabilities": "0",
"Other Net Income": "-600",
"Other Revenues": "288,200",
"Property, Plant and Equipment, Net": "545,300",
"Research and Development": "3,700"
},
"output_variables": {
"Liabilities": "371,000",
"Assets": "936,800",
"Expenses": "306,500",
"Revenues": "288,200",
"Stockholders Equity": "565,800",
"Net Income": "-18,900",
"Comprehensive Net Income": "-16,950",
"BaseVar": "953,500",
"ECR before LimitedLiability": "116%",
"Economic Capital Ratio": "179%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "399,300",
"Assets, Non-Current": "124,400",
"General and Administrative Expense": "381,900",
"Goodwill": "0",
"Liabilities, Current": "144,000",
"Liabilities, Non-Current": "263,100",
"Other Assets": "900",
"Other Compr. Net Income": "1,500",
"Other Expenses": "29,100",
"Other Liabilities": "0",
"Other Net Income": "-5,500",
"Other Revenues": "420,400",
"Property, Plant and Equipment, Net": "677,900",
"Research and Development": "3,000"
},
"output_variables": {
"Liabilities": "407,100",
"Assets": "1,202,500",
"Expenses": "414,000",
"Revenues": "420,400",
"Stockholders Equity": "795,400",
"Net Income": "900",
"Comprehensive Net Income": "1,650",
"BaseVar": "1,225,500",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "192%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 1.9184513783738697,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001742924.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001742924.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001742924.svg"
},
{
"company_id": "0001813814",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001813814.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001813814.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001813814.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001813814_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001813814_main_keyfigs.svg",
"name": "Definium Therapeutics Inc",
"rank": 20,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001813814.svg",
"report_text": "The relative strengths and weaknesses of Definium Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Definium Therapeutics Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 103% points.The greatest weakness of Definium Therapeutics Inc is the variable Net Income, reducing the Economic Capital Ratio by 50% points.
The company's Economic Capital Ratio, given in the ranking table, is 189%, being 30% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001813814_2022_Definium_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "21.7",
"Liabilities": "42.6",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "34.1",
"Liabilities, Current": "18.7",
"Other Liabilities": "4.55",
"Assets, Current": "87.4",
"Assets": "42.9",
"Assets, Non-Current": "-6.97",
"Other Assets": "4.53",
"Goodwill": "-0.454",
"Property, Plant and Equipment, Net": "-8.99",
"Other Expenses": "9.86",
"Expenses": "-18.4",
"Revenues": "-31.4",
"Net Income": "-50.1",
"Research and Development": "-17.9",
"General and Administrative Expense": "-10.2",
"Other Revenues": "-31.4",
"Comprehensive Net Income": "-49.8",
"Economic Capital Ratio": "29.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001813814_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "137,215",
"Assets, Non-Current": "0",
"General and Administrative Expense": "59,065",
"Goodwill": "19,918",
"Liabilities, Current": "10,408",
"Liabilities, Non-Current": "0",
"Other Assets": "6,869",
"Other Compr. Net Income": "762",
"Other Expenses": "-1,157",
"Other Liabilities": "1,930",
"Other Net Income": "-339",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "34,789"
},
"output_variables": {
"Liabilities": "12,338",
"Assets": "164,002",
"Expenses": "92,697",
"Revenues": "0",
"Stockholders Equity": "151,664",
"Net Income": "-93,036",
"Comprehensive Net Income": "-92,655",
"BaseVar": "135,069",
"ECR before LimitedLiability": "131%",
"Economic Capital Ratio": "189%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.8851119851061586,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001813814.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001813814.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001813814.svg"
},
{
"company_id": "0001754195",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001754195.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001754195.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001754195.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001754195_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001754195_main_keyfigs.svg",
"name": "Trulieve Cannabis Corp",
"rank": 21,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001754195.svg",
"report_text": "The relative strengths and weaknesses of Trulieve Cannabis Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Trulieve Cannabis Corp compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Trulieve Cannabis Corp is the variable Other Liabilities, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 186%, being 27% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001754195_2022_Trulieve_Cannabis_Corp.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "12.9",
"Liabilities": "-12.7",
"Stockholders Equity": "20.1",
"ECR before LimitedLiability": "31.4",
"Liabilities, Current": "8.03",
"Other Liabilities": "-38.5",
"Assets, Current": "-15.9",
"Assets": "18.1",
"Assets, Non-Current": "-3.90",
"Other Assets": "2.28",
"Goodwill": "44.0",
"Property, Plant and Equipment, Net": "7.58",
"Other Expenses": "2.47",
"Expenses": "22.3",
"Revenues": "-2.13",
"Net Income": "19.5",
"Research and Development": "7.55",
"General and Administrative Expense": "11.9",
"Other Revenues": "-2.13",
"Comprehensive Net Income": "19.5",
"Economic Capital Ratio": "27.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001754195_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "524,420",
"Assets, Non-Current": "144,285",
"General and Administrative Expense": "687,972",
"Goodwill": "1,883,340",
"Liabilities, Current": "420,247",
"Liabilities, Non-Current": "130,530",
"Other Assets": "78,911",
"Other Compr. Net Income": "0",
"Other Expenses": "199,528",
"Other Liabilities": "712,722",
"Other Net Income": "-33,440",
"Other Revenues": "938,385",
"Property, Plant and Equipment, Net": "779,916",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,263,499",
"Assets": "3,410,872",
"Expenses": "887,500",
"Revenues": "938,385",
"Stockholders Equity": "2,147,373",
"Net Income": "17,445",
"Comprehensive Net Income": "17,445",
"BaseVar": "3,266,848",
"ECR before LimitedLiability": "127%",
"Economic Capital Ratio": "186%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.8588332453267062,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001754195.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001754195.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001754195.svg"
},
{
"company_id": "0001134765",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001134765.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001134765.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001134765.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001134765_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001134765_main_keyfigs.svg",
"name": "Charlie s Holdings Inc",
"rank": 22,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001134765.svg",
"report_text": "The relative strengths and weaknesses of Charlie s Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Charlie s Holdings Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 98% points.The greatest weakness of Charlie s Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 170% points.
The company's Economic Capital Ratio, given in the ranking table, is 180%, being 22% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001134765_2022_Charlie_s_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "0.0772",
"Liabilities": "0.0755",
"Stockholders Equity": "-37.6",
"ECR before LimitedLiability": "-91.4",
"Liabilities, Non-Current": "-0.0549",
"Other Liabilities": "-0.0251",
"Property, Plant and Equipment, Net": "-1.14",
"Assets": "-55.6",
"Assets, Non-Current": "-0.226",
"Other Assets": "0",
"Goodwill": "-0.885",
"Assets, Current": "-23.9",
"General and Administrative Expense": "-1.71",
"Expenses": "-0.811",
"Revenues": "-0.117",
"Net Income": "-11.9",
"Research and Development": "0.0474",
"Other Revenues": "-0.117",
"Comprehensive Net Income": "-11.9",
"Other Net Income": "-0.996",
"Economic Capital Ratio": "-153"
},
"2012": {
"Liabilities, Current": "-6.69",
"Liabilities": "-5.98",
"Stockholders Equity": "58.2",
"ECR before LimitedLiability": "17.6",
"Liabilities, Non-Current": "9.03",
"Other Liabilities": "-8.56",
"Assets, Current": "-21.0",
"Assets": "59.1",
"Other Assets": "39.8",
"Assets, Non-Current": "-5.07",
"Property, Plant and Equipment, Net": "-10.5",
"Goodwill": "62.2",
"Other Expenses": "9.56",
"Expenses": "9.06",
"Revenues": "-29.7",
"Net Income": "-24.1",
"Research and Development": "13.2",
"General and Administrative Expense": "-12.9",
"Other Revenues": "-29.7",
"Comprehensive Net Income": "-24.0",
"Economic Capital Ratio": "-14.8"
},
"2013": {
"Liabilities, Current": "-30.3",
"Liabilities": "-1.06",
"ECR before LimitedLiability": "-30.9",
"Other Liabilities": "1.40",
"Liabilities, Non-Current": "1.67",
"Goodwill": "7.73",
"Assets": "2.45",
"Assets, Non-Current": "-0.749",
"Property, Plant and Equipment, Net": "-1.12",
"Other Assets": "3.23",
"Assets, Current": "-0.669",
"General and Administrative Expense": "-0.797",
"Expenses": "-0.983",
"Net Income": "-32.8",
"Research and Development": "1.99",
"Other Expenses": "-1.11",
"Other Revenues": "-10.3",
"Revenues": "-10.3",
"Other Net Income": "-0.658",
"Comprehensive Net Income": "-32.9",
"Economic Capital Ratio": "-71.0"
},
"2014": {
"Liabilities, Non-Current": "4.06",
"Liabilities": "-4.97",
"Stockholders Equity": "-14.6",
"ECR before LimitedLiability": "-17.2",
"Liabilities, Current": "-12.6",
"Other Liabilities": "2.73",
"Assets, Current": "-14.7",
"Assets": "-11.6",
"Goodwill": "14.4",
"Other Assets": "12.1",
"Assets, Non-Current": "-4.01",
"Property, Plant and Equipment, Net": "-8.76",
"Other Expenses": "-6.80",
"Expenses": "-8.05",
"Revenues": "-5.19",
"Net Income": "-10.4",
"Research and Development": "7.15",
"General and Administrative Expense": "-7.63",
"Other Revenues": "-5.19",
"Comprehensive Net Income": "-10.4",
"Economic Capital Ratio": "-66.6"
},
"2015": {
"Other Liabilities": "3.47",
"Liabilities": "-2.30",
"Stockholders Equity": "-25.1",
"ECR before LimitedLiability": "-36.3",
"Liabilities, Current": "-13.2",
"Liabilities, Non-Current": "4.15",
"Assets, Current": "-21.7",
"Assets": "-25.4",
"Goodwill": "10.1",
"Assets, Non-Current": "-4.45",
"Property, Plant and Equipment, Net": "-13.2",
"Research and Development": "6.34",
"Expenses": "-15.3",
"Revenues": "-2.13",
"Net Income": "-20.5",
"General and Administrative Expense": "-14.5",
"Other Expenses": "-7.08",
"Other Revenues": "-2.13",
"Comprehensive Net Income": "-20.4",
"Other Net Income": "-4.35",
"Economic Capital Ratio": "-82.2"
},
"2016": {
"Liabilities, Non-Current": "4.13",
"Liabilities": "-10.1",
"Stockholders Equity": "-47.2",
"ECR before LimitedLiability": "-71.9",
"Liabilities, Current": "-20.1",
"Property, Plant and Equipment, Net": "-17.0",
"Assets": "-28.9",
"Other Assets": "5.47",
"Assets, Non-Current": "-5.15",
"Assets, Current": "-29.1",
"Goodwill": "25.6",
"Research and Development": "8.74",
"Expenses": "-12.8",
"Revenues": "-12.2",
"Net Income": "-10.8",
"General and Administrative Expense": "-22.5",
"Other Expenses": "3.80",
"Other Revenues": "-12.2",
"Comprehensive Net Income": "-10.7",
"Other Net Income": "14.7",
"Economic Capital Ratio": "-91.9"
},
"2017": {
"Other Liabilities": "-0.193",
"Liabilities": "-0.684",
"Stockholders Equity": "-61.6",
"ECR before LimitedLiability": "-113",
"Liabilities, Current": "-0.917",
"Liabilities, Non-Current": "0.275",
"Assets, Non-Current": "-5.88",
"Assets": "-57.7",
"Assets, Current": "-44.3",
"Goodwill": "7.62",
"Property, Plant and Equipment, Net": "-26.7",
"Research and Development": "5.30",
"Expenses": "-27.1",
"Revenues": "-7.69",
"Net Income": "-32.0",
"Other Expenses": "-15.0",
"General and Administrative Expense": "-17.4",
"Other Revenues": "-7.69",
"Comprehensive Net Income": "-32.2",
"Other Net Income": "3.51",
"Economic Capital Ratio": "-135"
},
"2018": {
"Liabilities, Non-Current": "0.226",
"Liabilities": "-1.47",
"Stockholders Equity": "-132",
"ECR before LimitedLiability": "-105",
"Liabilities, Current": "-3.22",
"Property, Plant and Equipment, Net": "-23.9",
"Assets": "-66.0",
"Other Assets": "-0.186",
"Assets, Current": "-56.6",
"Goodwill": "-0.850",
"Assets, Non-Current": "-12.5",
"Other Expenses": "5.03",
"Expenses": "-13.4",
"Revenues": "-16.5",
"Net Income": "0.768",
"Research and Development": "5.30",
"General and Administrative Expense": "-31.1",
"Other Revenues": "-16.5",
"Comprehensive Net Income": "0.876",
"Other Net Income": "14.8",
"Economic Capital Ratio": "-126"
},
"2019": {
"Liabilities, Non-Current": "5.92",
"Liabilities": "10.3",
"Stockholders Equity": "-140",
"ECR before LimitedLiability": "-27.5",
"Other Liabilities": "5.96",
"Liabilities, Current": "-1.38",
"Assets, Non-Current": "-3.96",
"Assets": "-99.6",
"Goodwill": "-15.1",
"Property, Plant and Equipment, Net": "-18.3",
"Assets, Current": "-50.5",
"Research and Development": "4.55",
"Expenses": "-52.6",
"Revenues": "39.9",
"Net Income": "23.2",
"Other Expenses": "2.89",
"General and Administrative Expense": "-78.5",
"Other Revenues": "39.9",
"Other Net Income": "15.6",
"Comprehensive Net Income": "23.3",
"Economic Capital Ratio": "-57.0"
},
"2020": {
"Liabilities, Current": "-13.5",
"Liabilities": "-4.78",
"Stockholders Equity": "-125",
"ECR before LimitedLiability": "-60.8",
"Liabilities, Non-Current": "3.76",
"Goodwill": "-21.6",
"Assets": "-75.2",
"Other Assets": "-4.27",
"Assets, Current": "-35.1",
"Assets, Non-Current": "-6.77",
"Property, Plant and Equipment, Net": "-23.8",
"Other Expenses": "6.82",
"Expenses": "-29.0",
"Revenues": "23.1",
"Net Income": "-3.29",
"Research and Development": "-5.56",
"General and Administrative Expense": "-29.9",
"Other Revenues": "23.1",
"Comprehensive Net Income": "-3.22",
"Other Net Income": "2.80",
"Economic Capital Ratio": "-98.6"
},
"2021": {
"Liabilities, Non-Current": "45.7",
"Liabilities": "60.4",
"Stockholders Equity": "-170",
"ECR before LimitedLiability": "25.9",
"Liabilities, Current": "-2.08",
"Other Liabilities": "18.9",
"Assets, Current": "-28.1",
"Assets": "-53.9",
"Assets, Non-Current": "-11.9",
"Other Assets": "-1.17",
"Goodwill": "-24.6",
"Property, Plant and Equipment, Net": "-20.7",
"Other Expenses": "-70.5",
"Expenses": "-47.1",
"Revenues": "98.0",
"Net Income": "97.0",
"Research and Development": "22.7",
"Other Revenues": "98.0",
"Comprehensive Net Income": "97.0",
"Other Net Income": "44.9",
"Economic Capital Ratio": "21.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001134765_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "238",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,369",
"Goodwill": "19",
"Liabilities, Current": "1,869",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "718",
"Other Liabilities": "103",
"Other Net Income": "-1,126",
"Other Revenues": "1,267",
"Property, Plant and Equipment, Net": "9.7",
"Research and Development": "0.29"
},
"output_variables": {
"Liabilities": "1,972",
"Assets": "267",
"Expenses": "4,087",
"Revenues": "1,267",
"Stockholders Equity": "-1,705",
"Net Income": "-3,946",
"Comprehensive Net Income": "-3,946",
"BaseVar": "4,359",
"ECR before LimitedLiability": "-561%",
"Economic Capital Ratio": "0.077%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,237",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,273",
"Goodwill": "3,573",
"Liabilities, Current": "1,292",
"Liabilities, Non-Current": "0",
"Other Assets": "1,579",
"Other Compr. Net Income": "0",
"Other Expenses": "750",
"Other Liabilities": "772",
"Other Net Income": "-118",
"Other Revenues": "1,022",
"Property, Plant and Equipment, Net": "25",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,064",
"Assets": "6,415",
"Expenses": "4,023",
"Revenues": "1,022",
"Stockholders Equity": "4,351",
"Net Income": "-3,119",
"Comprehensive Net Income": "-3,119",
"BaseVar": "6,821",
"ECR before LimitedLiability": "67%",
"Economic Capital Ratio": "144%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "4,960",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,926",
"Goodwill": "3,523",
"Liabilities, Current": "5,438",
"Liabilities, Non-Current": "0",
"Other Assets": "1,486",
"Other Compr. Net Income": "0",
"Other Expenses": "4,448",
"Other Liabilities": "0",
"Other Net Income": "-391",
"Other Revenues": "2,649",
"Property, Plant and Equipment, Net": "8.4",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,438",
"Assets": "9,977",
"Expenses": "10,374",
"Revenues": "2,649",
"Stockholders Equity": "4,539",
"Net Income": "-8,115",
"Comprehensive Net Income": "-8,115",
"BaseVar": "14,415",
"ECR before LimitedLiability": "-25%",
"Economic Capital Ratio": "83%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "3,004",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,838",
"Goodwill": "3,475",
"Liabilities, Current": "7,755",
"Liabilities, Non-Current": "0",
"Other Assets": "1,352",
"Other Compr. Net Income": "0",
"Other Expenses": "4,402",
"Other Liabilities": "0",
"Other Net Income": "430",
"Other Revenues": "4,693",
"Property, Plant and Equipment, Net": "4.6",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,755",
"Assets": "7,835",
"Expenses": "13,240",
"Revenues": "4,693",
"Stockholders Equity": "80",
"Net Income": "-8,117",
"Comprehensive Net Income": "-8,117",
"BaseVar": "16,977",
"ECR before LimitedLiability": "-103%",
"Economic Capital Ratio": "67%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "3,855",
"Assets, Non-Current": "0",
"General and Administrative Expense": "10,549",
"Goodwill": "3,475",
"Liabilities, Current": "9,159",
"Liabilities, Non-Current": "0",
"Other Assets": "1,280",
"Other Compr. Net Income": "0",
"Other Expenses": "6,282",
"Other Liabilities": "0",
"Other Net Income": "-1,281",
"Other Revenues": "6,121",
"Property, Plant and Equipment, Net": "4.5",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,159",
"Assets": "8,614",
"Expenses": "16,831",
"Revenues": "6,121",
"Stockholders Equity": "-545",
"Net Income": "-11,991",
"Comprehensive Net Income": "-11,991",
"BaseVar": "21,003",
"ECR before LimitedLiability": "-143%",
"Economic Capital Ratio": "54%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "998",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,608",
"Goodwill": "3,475",
"Liabilities, Current": "7,161",
"Liabilities, Non-Current": "0",
"Other Assets": "460",
"Other Compr. Net Income": "0",
"Other Expenses": "2,254",
"Other Liabilities": "0",
"Other Net Income": "2,841",
"Other Revenues": "2,575",
"Property, Plant and Equipment, Net": "11",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,161",
"Assets": "4,943",
"Expenses": "10,862",
"Revenues": "2,575",
"Stockholders Equity": "-2,217",
"Net Income": "-5,446",
"Comprehensive Net Income": "-5,446",
"BaseVar": "14,191",
"ECR before LimitedLiability": "-140%",
"Economic Capital Ratio": "55%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,389",
"Assets, Non-Current": "0",
"General and Administrative Expense": "10,699",
"Goodwill": "3,475",
"Liabilities, Current": "8,206",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "7,567",
"Other Liabilities": "2,050",
"Other Net Income": "1,996",
"Other Revenues": "3,823",
"Property, Plant and Equipment, Net": "5.9",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "10,256",
"Assets": "4,869",
"Expenses": "18,266",
"Revenues": "3,823",
"Stockholders Equity": "-5,386",
"Net Income": "-12,447",
"Comprehensive Net Income": "-12,447",
"BaseVar": "19,605",
"ECR before LimitedLiability": "-262%",
"Economic Capital Ratio": "18%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "53",
"Assets, Non-Current": "0",
"General and Administrative Expense": "12,638",
"Goodwill": "1,577",
"Liabilities, Current": "9,789",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "6,811",
"Other Revenues": "1,947",
"Property, Plant and Equipment, Net": "1.1",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "9,789",
"Assets": "1,631",
"Expenses": "12,638",
"Revenues": "1,947",
"Stockholders Equity": "-8,158",
"Net Income": "-3,879",
"Comprehensive Net Income": "-3,879",
"BaseVar": "16,408",
"ECR before LimitedLiability": "-264%",
"Economic Capital Ratio": "18%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "5,611",
"Assets, Non-Current": "2,237",
"General and Administrative Expense": "27,402",
"Goodwill": "0",
"Liabilities, Current": "7,177",
"Liabilities, Non-Current": "1,218",
"Other Assets": "-543",
"Other Compr. Net Income": "0",
"Other Expenses": "1,650",
"Other Liabilities": "0",
"Other Net Income": "3,618",
"Other Revenues": "22,740",
"Property, Plant and Equipment, Net": "543",
"Research and Development": "1,102"
},
"output_variables": {
"Liabilities": "8,395",
"Assets": "7,848",
"Expenses": "30,154",
"Revenues": "22,740",
"Stockholders Equity": "-547",
"Net Income": "-3,796",
"Comprehensive Net Income": "-3,796",
"BaseVar": "36,378",
"ECR before LimitedLiability": "-56%",
"Economic Capital Ratio": "79%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,723",
"Assets, Non-Current": "1,802",
"General and Administrative Expense": "20,084",
"Goodwill": "0",
"Liabilities, Current": "10,743",
"Liabilities, Non-Current": "1,778",
"Other Assets": "-531",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-417",
"Other Revenues": "16,692",
"Property, Plant and Equipment, Net": "531",
"Research and Development": "3,378"
},
"output_variables": {
"Liabilities": "12,521",
"Assets": "6,525",
"Expenses": "23,462",
"Revenues": "16,692",
"Stockholders Equity": "-5,996",
"Net Income": "-7,187",
"Comprehensive Net Income": "-7,187",
"BaseVar": "29,808",
"ECR before LimitedLiability": "-162%",
"Economic Capital Ratio": "47%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "7,994",
"Assets, Non-Current": "1,254",
"General and Administrative Expense": "10,484",
"Goodwill": "0",
"Liabilities, Current": "5,534",
"Liabilities, Non-Current": "583",
"Other Assets": "-431",
"Other Compr. Net Income": "0",
"Other Expenses": "10,765",
"Other Liabilities": "0",
"Other Net Income": "4,585",
"Other Revenues": "21,496",
"Property, Plant and Equipment, Net": "431",
"Research and Development": "24"
},
"output_variables": {
"Liabilities": "6,117",
"Assets": "9,248",
"Expenses": "21,273",
"Revenues": "21,496",
"Stockholders Equity": "3,131",
"Net Income": "4,808",
"Comprehensive Net Income": "4,808",
"BaseVar": "31,360",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "180%"
}
}
},
"top_rated": false,
"trend": 22.0,
"value": 1.8038816629365706,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001134765.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001134765.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001134765.svg"
},
{
"company_id": "0000768408",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000768408.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000768408.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000768408.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000768408_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000768408_main_keyfigs.svg",
"name": "Cyanotech CORP",
"rank": 23,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000768408.svg",
"report_text": "The relative strengths and weaknesses of Cyanotech CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cyanotech CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 51% points.The greatest weakness of Cyanotech CORP is the variable Stockholders Equity, reducing the Economic Capital Ratio by 45% points.
The company's Economic Capital Ratio, given in the ranking table, is 174%, being 15% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000768408_2022_Cyanotech_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "44.2",
"Liabilities": "64.9",
"Stockholders Equity": "41.4",
"ECR before LimitedLiability": "146",
"Liabilities, Non-Current": "9.21",
"Other Liabilities": "19.9",
"General and Administrative Expense": "39.9",
"Expenses": "8.05",
"Net Income": "58.1",
"Research and Development": "16.6",
"Other Expenses": "-54.2",
"Other Revenues": "59.5",
"Revenues": "59.5",
"Property, Plant and Equipment, Net": "7.85",
"Assets, Non-Current": "-1.81",
"Other Assets": "1.74",
"Goodwill": "-5.37",
"Assets, Current": "-1.96",
"Comprehensive Net Income": "58.0",
"Other Net Income": "-9.70",
"Economic Capital Ratio": "84.2"
},
"2012": {
"Liabilities, Current": "27.7",
"Liabilities": "65.1",
"Stockholders Equity": "30.6",
"ECR before LimitedLiability": "119",
"Liabilities, Non-Current": "15.4",
"Other Liabilities": "32.9",
"Assets, Current": "-2.73",
"Assets": "-3.23",
"Other Assets": "2.44",
"Assets, Non-Current": "-1.64",
"Property, Plant and Equipment, Net": "5.43",
"Goodwill": "-5.30",
"Other Expenses": "-52.3",
"Expenses": "10.3",
"Revenues": "63.6",
"Net Income": "72.5",
"Research and Development": "19.4",
"General and Administrative Expense": "37.4",
"Other Revenues": "63.6",
"Comprehensive Net Income": "72.6",
"Economic Capital Ratio": "87.0"
},
"2013": {
"Liabilities, Current": "36.1",
"Liabilities": "35.1",
"Stockholders Equity": "29.5",
"ECR before LimitedLiability": "102",
"Other Liabilities": "18.2",
"Liabilities, Non-Current": "-22.9",
"Goodwill": "-7.31",
"Assets": "1.96",
"Property, Plant and Equipment, Net": "10.5",
"Other Assets": "12.4",
"Assets, Current": "-7.17",
"General and Administrative Expense": "25.2",
"Expenses": "16.7",
"Revenues": "41.5",
"Net Income": "55.5",
"Research and Development": "13.0",
"Other Expenses": "-22.2",
"Other Revenues": "41.5",
"Other Net Income": "-3.50",
"Comprehensive Net Income": "55.4",
"Economic Capital Ratio": "61.8"
},
"2014": {
"Liabilities, Non-Current": "-12.0",
"Liabilities": "51.7",
"Stockholders Equity": "50.3",
"ECR before LimitedLiability": "111",
"Liabilities, Current": "47.8",
"Other Liabilities": "15.6",
"Assets, Current": "-9.36",
"Assets": "4.25",
"Goodwill": "-10.3",
"Other Assets": "4.38",
"Assets, Non-Current": "-1.65",
"Property, Plant and Equipment, Net": "33.6",
"Other Expenses": "-33.6",
"Expenses": "8.85",
"Revenues": "37.9",
"Net Income": "49.3",
"Research and Development": "15.1",
"General and Administrative Expense": "27.8",
"Other Revenues": "37.9",
"Comprehensive Net Income": "49.4",
"Economic Capital Ratio": "61.7"
},
"2015": {
"Other Liabilities": "24.3",
"Liabilities": "68.2",
"Stockholders Equity": "39.3",
"ECR before LimitedLiability": "109",
"Liabilities, Current": "50.4",
"Liabilities, Non-Current": "-3.00",
"Assets, Current": "-13.1",
"Assets": "-6.51",
"Other Assets": "1.58",
"Goodwill": "-10.8",
"Assets, Non-Current": "-1.31",
"Property, Plant and Equipment, Net": "27.8",
"Research and Development": "12.2",
"Expenses": "-3.97",
"Revenues": "57.9",
"Net Income": "54.2",
"General and Administrative Expense": "11.1",
"Other Expenses": "-27.4",
"Other Revenues": "57.9",
"Comprehensive Net Income": "54.7",
"Economic Capital Ratio": "62.7"
},
"2016": {
"Liabilities, Non-Current": "26.8",
"Liabilities": "34.1",
"Stockholders Equity": "-4.68",
"ECR before LimitedLiability": "34.1",
"Liabilities, Current": "35.7",
"Other Liabilities": "-32.1",
"Property, Plant and Equipment, Net": "45.6",
"Assets": "-17.8",
"Assets, Non-Current": "-3.28",
"Assets, Current": "-24.3",
"Goodwill": "-15.4",
"Research and Development": "18.5",
"Expenses": "-7.23",
"Revenues": "45.1",
"Net Income": "32.2",
"General and Administrative Expense": "13.0",
"Other Expenses": "-35.8",
"Other Revenues": "45.1",
"Comprehensive Net Income": "32.5",
"Other Net Income": "-3.54",
"Economic Capital Ratio": "14.2"
},
"2017": {
"Other Liabilities": "-25.7",
"Liabilities": "39.4",
"Stockholders Equity": "-2.55",
"ECR before LimitedLiability": "38.2",
"Liabilities, Current": "32.6",
"Liabilities, Non-Current": "30.0",
"Assets, Non-Current": "-4.88",
"Assets": "-17.2",
"Assets, Current": "-16.6",
"Goodwill": "-15.5",
"Property, Plant and Equipment, Net": "29.5",
"Research and Development": "17.6",
"Expenses": "-8.16",
"Revenues": "55.9",
"Net Income": "36.4",
"Other Expenses": "31.0",
"General and Administrative Expense": "-52.5",
"Other Revenues": "55.9",
"Comprehensive Net Income": "35.9",
"Other Net Income": "-7.68",
"Economic Capital Ratio": "16.7"
},
"2018": {
"Liabilities, Non-Current": "26.5",
"Liabilities": "34.4",
"Stockholders Equity": "-7.31",
"ECR before LimitedLiability": "61.6",
"Other Liabilities": "-22.5",
"Liabilities, Current": "28.0",
"Property, Plant and Equipment, Net": "26.9",
"Assets": "-15.0",
"Assets, Current": "-14.2",
"Goodwill": "-11.6",
"Assets, Non-Current": "-7.83",
"Other Expenses": "16.9",
"Expenses": "-2.32",
"Revenues": "55.9",
"Net Income": "51.0",
"Research and Development": "15.7",
"General and Administrative Expense": "-33.9",
"Other Revenues": "55.9",
"Comprehensive Net Income": "51.4",
"Other Net Income": "-1.66",
"Economic Capital Ratio": "41.1"
},
"2019": {
"Liabilities, Non-Current": "-1.24",
"Liabilities": "19.6",
"Stockholders Equity": "-21.5",
"ECR before LimitedLiability": "43.9",
"Other Liabilities": "18.5",
"Liabilities, Current": "2.35",
"Assets, Non-Current": "-14.8",
"Assets": "-22.3",
"Goodwill": "-17.0",
"Property, Plant and Equipment, Net": "32.8",
"Assets, Current": "-14.8",
"Research and Development": "11.0",
"Expenses": "-6.43",
"Revenues": "45.5",
"Net Income": "44.4",
"Other Expenses": "12.1",
"General and Administrative Expense": "-27.4",
"Other Revenues": "45.5",
"Other Net Income": "5.70",
"Comprehensive Net Income": "44.5",
"Economic Capital Ratio": "14.4"
},
"2020": {
"Liabilities, Current": "22.9",
"Liabilities": "18.4",
"Stockholders Equity": "-30.5",
"ECR before LimitedLiability": "54.4",
"Liabilities, Non-Current": "-13.2",
"Other Liabilities": "7.88",
"Goodwill": "-14.7",
"Assets": "-23.8",
"Assets, Current": "-19.4",
"Assets, Non-Current": "-2.73",
"Property, Plant and Equipment, Net": "15.2",
"Other Expenses": "8.95",
"Expenses": "-12.7",
"Revenues": "46.8",
"Net Income": "39.2",
"Research and Development": "8.50",
"General and Administrative Expense": "-28.9",
"Other Revenues": "46.8",
"Comprehensive Net Income": "39.3",
"Other Net Income": "6.79",
"Economic Capital Ratio": "16.6"
},
"2021": {
"Liabilities, Non-Current": "-10.9",
"Liabilities": "22.6",
"Stockholders Equity": "-44.7",
"ECR before LimitedLiability": "19.2",
"Liabilities, Current": "21.3",
"Other Liabilities": "11.7",
"Assets, Current": "-19.1",
"Assets": "-27.7",
"Assets, Non-Current": "-5.11",
"Goodwill": "-17.8",
"Property, Plant and Equipment, Net": "13.0",
"Other Expenses": "13.5",
"Expenses": "-14.3",
"Revenues": "51.1",
"Net Income": "39.7",
"Research and Development": "12.0",
"General and Administrative Expense": "-38.4",
"Other Revenues": "51.1",
"Comprehensive Net Income": "39.7",
"Other Net Income": "5.15",
"Economic Capital Ratio": "14.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000768408_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "8,481",
"Assets, Non-Current": "287",
"General and Administrative Expense": "4,808",
"Goodwill": "0",
"Liabilities, Current": "2,196",
"Liabilities, Non-Current": "553",
"Other Assets": "535",
"Other Compr. Net Income": "0",
"Other Expenses": "9,941",
"Other Liabilities": "0",
"Other Net Income": "-66",
"Other Revenues": "16,827",
"Property, Plant and Equipment, Net": "4,557",
"Research and Development": "282"
},
"output_variables": {
"Liabilities": "2,749",
"Assets": "13,860",
"Expenses": "15,031",
"Revenues": "16,827",
"Stockholders Equity": "11,111",
"Net Income": "1,730",
"Comprehensive Net Income": "1,730",
"BaseVar": "24,266",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "238%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "11,419",
"Assets, Non-Current": "478",
"General and Administrative Expense": "6,494",
"Goodwill": "0",
"Liabilities, Current": "3,361",
"Liabilities, Non-Current": "400",
"Other Assets": "1,307",
"Other Compr. Net Income": "0",
"Other Expenses": "14,135",
"Other Liabilities": "12",
"Other Net Income": "-50",
"Other Revenues": "24,631",
"Property, Plant and Equipment, Net": "5,834",
"Research and Development": "320"
},
"output_variables": {
"Liabilities": "3,773",
"Assets": "19,038",
"Expenses": "20,949",
"Revenues": "24,631",
"Stockholders Equity": "15,265",
"Net Income": "3,632",
"Comprehensive Net Income": "3,632",
"BaseVar": "34,220",
"ECR before LimitedLiability": "215%",
"Economic Capital Ratio": "245%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "12,191",
"Assets, Non-Current": "772",
"General and Administrative Expense": "8,355",
"Goodwill": "0",
"Liabilities, Current": "2,885",
"Liabilities, Non-Current": "5,454",
"Other Assets": "6,789",
"Other Compr. Net Income": "0",
"Other Expenses": "14,648",
"Other Liabilities": "21",
"Other Net Income": "-111",
"Other Revenues": "27,581",
"Property, Plant and Equipment, Net": "8,835",
"Research and Development": "258"
},
"output_variables": {
"Liabilities": "8,360",
"Assets": "28,587",
"Expenses": "23,261",
"Revenues": "27,581",
"Stockholders Equity": "20,227",
"Net Income": "4,209",
"Comprehensive Net Income": "4,209",
"BaseVar": "43,950",
"ECR before LimitedLiability": "173%",
"Economic Capital Ratio": "216%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "12,584",
"Assets, Non-Current": "902",
"General and Administrative Expense": "10,884",
"Goodwill": "0",
"Liabilities, Current": "4,155",
"Liabilities, Non-Current": "5,263",
"Other Assets": "1,737",
"Other Compr. Net Income": "0",
"Other Expenses": "17,127",
"Other Liabilities": "8.0",
"Other Net Income": "-118",
"Other Revenues": "28,178",
"Property, Plant and Equipment, Net": "14,754",
"Research and Development": "469"
},
"output_variables": {
"Liabilities": "9,426",
"Assets": "29,977",
"Expenses": "28,480",
"Revenues": "28,178",
"Stockholders Equity": "20,551",
"Net Income": "-420",
"Comprehensive Net Income": "-420",
"BaseVar": "48,090",
"ECR before LimitedLiability": "141%",
"Economic Capital Ratio": "195%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "11,794",
"Assets, Non-Current": "846",
"General and Administrative Expense": "13,531",
"Goodwill": "0",
"Liabilities, Current": "4,315",
"Liabilities, Non-Current": "5,109",
"Other Assets": "3,521",
"Other Compr. Net Income": "0",
"Other Expenses": "19,692",
"Other Liabilities": "8.0",
"Other Net Income": "-93",
"Other Revenues": "33,809",
"Property, Plant and Equipment, Net": "14,754",
"Research and Development": "517"
},
"output_variables": {
"Liabilities": "9,432",
"Assets": "30,915",
"Expenses": "33,740",
"Revenues": "33,809",
"Stockholders Equity": "21,483",
"Net Income": "-24",
"Comprehensive Net Income": "-24",
"BaseVar": "53,994",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "199%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "12,655",
"Assets, Non-Current": "696",
"General and Administrative Expense": "12,018",
"Goodwill": "0",
"Liabilities, Current": "6,121",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "23,302",
"Other Liabilities": "7,198",
"Other Net Income": "-282",
"Other Revenues": "31,840",
"Property, Plant and Equipment, Net": "17,796",
"Research and Development": "633"
},
"output_variables": {
"Liabilities": "13,319",
"Assets": "31,147",
"Expenses": "35,953",
"Revenues": "31,840",
"Stockholders Equity": "17,828",
"Net Income": "-4,395",
"Comprehensive Net Income": "-4,395",
"BaseVar": "56,270",
"ECR before LimitedLiability": "90%",
"Economic Capital Ratio": "161%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "12,236",
"Assets, Non-Current": "213",
"General and Administrative Expense": "32,131",
"Goodwill": "0",
"Liabilities, Current": "6,032",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5.0",
"Other Liabilities": "6,522",
"Other Net Income": "-528",
"Other Revenues": "32,042",
"Property, Plant and Equipment, Net": "16,712",
"Research and Development": "593"
},
"output_variables": {
"Liabilities": "12,554",
"Assets": "29,161",
"Expenses": "32,729",
"Revenues": "32,042",
"Stockholders Equity": "16,607",
"Net Income": "-1,215",
"Comprehensive Net Income": "-1,215",
"BaseVar": "53,507",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,617",
"Assets, Non-Current": "291",
"General and Administrative Expense": "32,138",
"Goodwill": "0",
"Liabilities, Current": "5,707",
"Liabilities, Non-Current": "0",
"Other Assets": "65",
"Other Compr. Net Income": "0",
"Other Expenses": "-110",
"Other Liabilities": "5,893",
"Other Net Income": "-499",
"Other Revenues": "34,115",
"Property, Plant and Equipment, Net": "15,734",
"Research and Development": "563"
},
"output_variables": {
"Liabilities": "11,600",
"Assets": "29,707",
"Expenses": "32,591",
"Revenues": "34,115",
"Stockholders Equity": "18,107",
"Net Income": "1,025",
"Comprehensive Net Income": "1,025",
"BaseVar": "54,256",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "185%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "14,592",
"Assets, Non-Current": "282",
"General and Administrative Expense": "32,276",
"Goodwill": "0",
"Liabilities, Current": "9,488",
"Liabilities, Non-Current": "5,229",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "599",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "30,202",
"Property, Plant and Equipment, Net": "14,752",
"Research and Development": "923"
},
"output_variables": {
"Liabilities": "14,717",
"Assets": "29,626",
"Expenses": "33,798",
"Revenues": "30,202",
"Stockholders Equity": "14,909",
"Net Income": "-3,596",
"Comprehensive Net Income": "-3,596",
"BaseVar": "54,172",
"ECR before LimitedLiability": "76%",
"Economic Capital Ratio": "150%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "14,728",
"Assets, Non-Current": "4,017",
"General and Administrative Expense": "30,238",
"Goodwill": "0",
"Liabilities, Current": "6,359",
"Liabilities, Non-Current": "9,582",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "666",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "31,899",
"Property, Plant and Equipment, Net": "13,042",
"Research and Development": "608"
},
"output_variables": {
"Liabilities": "15,941",
"Assets": "31,787",
"Expenses": "31,512",
"Revenues": "31,899",
"Stockholders Equity": "15,846",
"Net Income": "387",
"Comprehensive Net Income": "387",
"BaseVar": "55,570",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "163%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "15,106",
"Assets, Non-Current": "3,637",
"General and Administrative Expense": "31,622",
"Goodwill": "0",
"Liabilities, Current": "5,808",
"Liabilities, Non-Current": "8,030",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "553",
"Other Liabilities": "0",
"Other Net Income": "1,389",
"Other Revenues": "32,345",
"Property, Plant and Equipment, Net": "12,136",
"Research and Development": "639"
},
"output_variables": {
"Liabilities": "13,838",
"Assets": "30,879",
"Expenses": "32,814",
"Revenues": "32,345",
"Stockholders Equity": "17,041",
"Net Income": "920",
"Comprehensive Net Income": "920",
"BaseVar": "55,632",
"ECR before LimitedLiability": "109%",
"Economic Capital Ratio": "174%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 1.7367028530040605,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000768408.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000768408.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000768408.svg"
},
{
"company_id": "0001307954",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001307954.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001307954.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001307954.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001307954_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001307954_main_keyfigs.svg",
"name": "Huntsman CORP",
"rank": 24,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001307954.svg",
"report_text": "The relative strengths and weaknesses of Huntsman CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Huntsman CORP compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 45% points.The greatest weakness of Huntsman CORP is the variable Stockholders Equity, reducing the Economic Capital Ratio by 42% points.
The company's Economic Capital Ratio, given in the ranking table, is 170%, being 12% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001307954_2022_Huntsman_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "-2.03",
"Liabilities": "-45.4",
"Stockholders Equity": "-67.7",
"ECR before LimitedLiability": "-63.6",
"Liabilities, Current": "2.22",
"Liabilities, Non-Current": "-45.6",
"Goodwill": "-21.9",
"Assets": "-28.8",
"Property, Plant and Equipment, Net": "24.7",
"Assets, Current": "-25.7",
"Assets, Non-Current": "-6.92",
"Other Assets": "7.77",
"Other Revenues": "5.95",
"Revenues": "5.95",
"Net Income": "8.75",
"Comprehensive Net Income": "8.76",
"Research and Development": "8.63",
"Other Net Income": "2.35",
"Other Expenses": "-53.9",
"General and Administrative Expense": "32.3",
"Economic Capital Ratio": "-61.6"
},
"2011": {
"Liabilities, Current": "30.9",
"Liabilities": "-25.6",
"Stockholders Equity": "-54.5",
"ECR before LimitedLiability": "24.0",
"Liabilities, Non-Current": "-77.2",
"Other Liabilities": "9.20",
"Property, Plant and Equipment, Net": "30.9",
"Assets": "-28.2",
"Other Assets": "3.25",
"Goodwill": "-16.8",
"Assets, Current": "-33.8",
"General and Administrative Expense": "36.1",
"Expenses": "18.4",
"Revenues": "31.4",
"Net Income": "32.1",
"Research and Development": "19.3",
"Other Expenses": "-66.2",
"Other Revenues": "31.4",
"Comprehensive Net Income": "31.9",
"Other Net Income": "-9.30",
"Economic Capital Ratio": "-38.0"
},
"2012": {
"Liabilities, Current": "13.8",
"Liabilities": "-31.2",
"Stockholders Equity": "-59.2",
"ECR before LimitedLiability": "-7.55",
"Liabilities, Non-Current": "-71.2",
"Other Liabilities": "19.2",
"Assets, Current": "-31.5",
"Assets": "-28.6",
"Other Assets": "2.75",
"Property, Plant and Equipment, Net": "31.2",
"Goodwill": "-18.5",
"Other Expenses": "-56.5",
"Expenses": "23.9",
"Revenues": "33.9",
"Net Income": "35.4",
"Research and Development": "20.7",
"General and Administrative Expense": "36.9",
"Other Revenues": "33.9",
"Other Net Income": "-4.05",
"Comprehensive Net Income": "35.2",
"Economic Capital Ratio": "-40.0"
},
"2013": {
"Liabilities, Current": "21.5",
"Liabilities": "-21.0",
"Stockholders Equity": "-52.4",
"ECR before LimitedLiability": "6.12",
"Other Liabilities": "12.2",
"Liabilities, Non-Current": "-60.4",
"Goodwill": "-18.7",
"Assets": "-28.2",
"Property, Plant and Equipment, Net": "33.3",
"Other Assets": "-2.40",
"Assets, Current": "-30.0",
"General and Administrative Expense": "37.9",
"Expenses": "16.6",
"Revenues": "36.1",
"Net Income": "36.8",
"Research and Development": "17.1",
"Other Expenses": "-54.6",
"Other Revenues": "36.1",
"Other Net Income": "-6.37",
"Comprehensive Net Income": "36.9",
"Economic Capital Ratio": "-34.0"
},
"2014": {
"Liabilities, Non-Current": "-71.6",
"Liabilities": "-13.1",
"Stockholders Equity": "-30.3",
"ECR before LimitedLiability": "26.7",
"Liabilities, Current": "26.5",
"Other Liabilities": "9.73",
"Assets, Current": "-25.2",
"Assets": "-16.6",
"Goodwill": "-20.4",
"Other Assets": "5.65",
"Property, Plant and Equipment, Net": "26.3",
"Other Expenses": "-52.5",
"Expenses": "26.2",
"Revenues": "26.4",
"Net Income": "29.2",
"Research and Development": "19.3",
"General and Administrative Expense": "30.4",
"Other Revenues": "26.4",
"Comprehensive Net Income": "28.9",
"Other Compr. Net Income": "-2.12",
"Economic Capital Ratio": "-22.7"
},
"2018": {
"Property, Plant and Equipment, Net": "13.3",
"Assets": "-28.2",
"Liabilities, Non-Current": "-43.5",
"Stockholders Equity": "-45.1",
"ECR before LimitedLiability": "17.4",
"Other Assets": "4.42",
"Assets, Current": "-29.2",
"Goodwill": "-12.5",
"Other Expenses": "16.1",
"Expenses": "10.1",
"Revenues": "53.8",
"Net Income": "56.2",
"Research and Development": "17.4",
"General and Administrative Expense": "-21.3",
"Other Revenues": "53.8",
"Other Liabilities": "15.2",
"Liabilities, Current": "21.9",
"Comprehensive Net Income": "56.1",
"Other Net Income": "-2.76",
"Other Compr. Net Income": "-2.64",
"Economic Capital Ratio": "-3.04"
},
"2019": {
"Liabilities, Non-Current": "-45.7",
"Liabilities": "-19.0",
"Stockholders Equity": "-30.6",
"ECR before LimitedLiability": "34.9",
"Other Liabilities": "15.1",
"Liabilities, Current": "8.16",
"Assets": "-12.2",
"Goodwill": "-11.0",
"Property, Plant and Equipment, Net": "7.38",
"Other Assets": "4.94",
"Assets, Current": "-12.3",
"Research and Development": "10.2",
"Expenses": "19.7",
"Revenues": "27.5",
"Net Income": "56.8",
"Other Expenses": "12.4",
"General and Administrative Expense": "-3.15",
"Other Revenues": "27.5",
"Other Net Income": "5.80",
"Comprehensive Net Income": "56.8",
"Economic Capital Ratio": "5.48"
},
"2020": {
"Liabilities, Current": "6.12",
"Liabilities": "-9.32",
"Stockholders Equity": "-25.8",
"ECR before LimitedLiability": "51.6",
"Liabilities, Non-Current": "-22.9",
"Other Liabilities": "6.44",
"Goodwill": "-4.59",
"Assets": "-12.1",
"Other Assets": "2.73",
"Assets, Current": "-16.1",
"Property, Plant and Equipment, Net": "6.04",
"Other Expenses": "11.2",
"Expenses": "7.95",
"Revenues": "20.3",
"Net Income": "43.9",
"Research and Development": "7.07",
"General and Administrative Expense": "-9.91",
"Other Revenues": "20.3",
"Comprehensive Net Income": "43.9",
"Other Net Income": "13.0",
"Economic Capital Ratio": "13.8"
},
"2021": {
"Liabilities, Non-Current": "-16.9",
"Liabilities": "3.08",
"Stockholders Equity": "-42.2",
"ECR before LimitedLiability": "16.0",
"Liabilities, Current": "8.61",
"Other Liabilities": "10.3",
"Assets, Current": "-19.5",
"Assets": "-22.4",
"Assets, Non-Current": "-0.410",
"Other Assets": "2.84",
"Goodwill": "-9.55",
"Property, Plant and Equipment, Net": "3.81",
"Other Revenues": "38.0",
"Revenues": "38.0",
"Net Income": "44.8",
"Other Expenses": "11.7",
"Comprehensive Net Income": "45.3",
"Research and Development": "10.9",
"Other Net Income": "5.86",
"General and Administrative Expense": "-21.7",
"Economic Capital Ratio": "11.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001307954_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "4,008,000",
"Assets, Non-Current": "729,000",
"General and Administrative Expense": "861,000",
"Goodwill": "199,000",
"Liabilities, Current": "2,053,000",
"Liabilities, Non-Current": "4,493,000",
"Other Assets": "173,000",
"Other Compr. Net Income": "-15,000",
"Other Expenses": "8,086,000",
"Other Liabilities": "318,000",
"Other Net Income": "-122,000",
"Other Revenues": "9,252,000",
"Property, Plant and Equipment, Net": "3,605,000",
"Research and Development": "151,000"
},
"output_variables": {
"Liabilities": "6,864,000",
"Assets": "8,714,000",
"Expenses": "9,098,000",
"Revenues": "9,252,000",
"Stockholders Equity": "1,850,000",
"Net Income": "32,000",
"Comprehensive Net Income": "24,500",
"BaseVar": "17,032,500",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "3,946,000",
"Assets, Non-Current": "684,000",
"General and Administrative Expense": "921,000",
"Goodwill": "205,000",
"Liabilities, Current": "1,826,000",
"Liabilities, Non-Current": "4,742,000",
"Other Assets": "200,000",
"Other Compr. Net Income": "-269,000",
"Other Expenses": "9,886,000",
"Other Liabilities": "313,000",
"Other Net Income": "4,000",
"Other Revenues": "11,223,000",
"Property, Plant and Equipment, Net": "3,622,000",
"Research and Development": "166,000"
},
"output_variables": {
"Liabilities": "6,881,000",
"Assets": "8,657,000",
"Expenses": "10,973,000",
"Revenues": "11,223,000",
"Stockholders Equity": "1,776,000",
"Net Income": "254,000",
"Comprehensive Net Income": "119,500",
"BaseVar": "19,003,500",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4,119,000",
"Assets, Non-Current": "604,000",
"General and Administrative Expense": "951,000",
"Goodwill": "185,000",
"Liabilities, Current": "2,181,000",
"Liabilities, Non-Current": "4,575,000",
"Other Assets": "231,000",
"Other Compr. Net Income": "-195,000",
"Other Expenses": "9,408,000",
"Other Liabilities": "232,000",
"Other Net Income": "-303,000",
"Other Revenues": "11,187,000",
"Property, Plant and Equipment, Net": "3,745,000",
"Research and Development": "152,000"
},
"output_variables": {
"Liabilities": "6,988,000",
"Assets": "8,884,000",
"Expenses": "10,511,000",
"Revenues": "11,187,000",
"Stockholders Equity": "1,896,000",
"Net Income": "373,000",
"Comprehensive Net Income": "275,500",
"BaseVar": "19,034,000",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "118%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "4,159,000",
"Assets, Non-Current": "743,000",
"General and Administrative Expense": "942,000",
"Goodwill": "218,000",
"Liabilities, Current": "2,159,000",
"Liabilities, Non-Current": "4,581,000",
"Other Assets": "244,000",
"Other Compr. Net Income": "146,000",
"Other Expenses": "9,612,000",
"Other Liabilities": "319,000",
"Other Net Income": "-236,000",
"Other Revenues": "11,079,000",
"Property, Plant and Equipment, Net": "3,824,000",
"Research and Development": "140,000"
},
"output_variables": {
"Liabilities": "7,059,000",
"Assets": "9,188,000",
"Expenses": "10,694,000",
"Revenues": "11,079,000",
"Stockholders Equity": "2,129,000",
"Net Income": "149,000",
"Comprehensive Net Income": "222,000",
"BaseVar": "19,201,000",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "121%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "5,039,000",
"Assets, Non-Current": "888,000",
"General and Administrative Expense": "974,000",
"Goodwill": "217,000",
"Liabilities, Current": "2,332,000",
"Liabilities, Non-Current": "6,380,000",
"Other Assets": "435,000",
"Other Compr. Net Income": "-498,000",
"Other Expenses": "9,864,000",
"Other Liabilities": "339,000",
"Other Net Income": "-237,000",
"Other Revenues": "11,578,000",
"Property, Plant and Equipment, Net": "4,423,000",
"Research and Development": "158,000"
},
"output_variables": {
"Liabilities": "9,051,000",
"Assets": "11,002,000",
"Expenses": "10,996,000",
"Revenues": "11,578,000",
"Stockholders Equity": "1,951,000",
"Net Income": "345,000",
"Comprehensive Net Income": "96,000",
"BaseVar": "21,681,000",
"ECR before LimitedLiability": "28%",
"Economic Capital Ratio": "111%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "2,958,000",
"Assets, Non-Current": "1,079,000",
"General and Administrative Expense": "8,184,000",
"Goodwill": "494,000",
"Liabilities, Current": "1,907,000",
"Liabilities, Non-Current": "3,297,000",
"Other Assets": "358,000",
"Other Compr. Net Income": "-506,000",
"Other Expenses": "164,000",
"Other Liabilities": "0",
"Other Net Income": "-229,000",
"Other Revenues": "9,379,000",
"Property, Plant and Equipment, Net": "3,064,000",
"Research and Development": "152,000"
},
"output_variables": {
"Liabilities": "5,204,000",
"Assets": "7,953,000",
"Expenses": "8,500,000",
"Revenues": "9,379,000",
"Stockholders Equity": "2,749,000",
"Net Income": "650,000",
"Comprehensive Net Income": "397,000",
"BaseVar": "15,885,500",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "141%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "3,755,000",
"Assets, Non-Current": "1,383,000",
"General and Administrative Expense": "6,201,000",
"Goodwill": "473,000",
"Liabilities, Current": "2,037,000",
"Liabilities, Non-Current": "3,459,000",
"Other Assets": "326,000",
"Other Compr. Net Income": "-67,000",
"Other Expenses": "-48,000",
"Other Liabilities": "0",
"Other Net Income": "91,000",
"Other Revenues": "6,797,000",
"Property, Plant and Equipment, Net": "2,383,000",
"Research and Development": "137,000"
},
"output_variables": {
"Liabilities": "5,496,000",
"Assets": "8,320,000",
"Expenses": "6,290,000",
"Revenues": "6,797,000",
"Stockholders Equity": "2,824,000",
"Net Income": "598,000",
"Comprehensive Net Income": "564,500",
"BaseVar": "13,530,500",
"ECR before LimitedLiability": "64%",
"Economic Capital Ratio": "141%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,568,000",
"Assets, Non-Current": "1,366,000",
"General and Administrative Expense": "5,693,000",
"Goodwill": "986,000",
"Liabilities, Current": "2,191,000",
"Liabilities, Non-Current": "2,849,000",
"Other Assets": "288,000",
"Other Compr. Net Income": "-16,000",
"Other Expenses": "-197,000",
"Other Liabilities": "0",
"Other Net Income": "679,000",
"Other Revenues": "6,018,000",
"Property, Plant and Equipment, Net": "2,505,000",
"Research and Development": "135,000"
},
"output_variables": {
"Liabilities": "5,040,000",
"Assets": "8,713,000",
"Expenses": "5,631,000",
"Revenues": "6,018,000",
"Stockholders Equity": "3,673,000",
"Net Income": "1,066,000",
"Comprehensive Net Income": "1,058,000",
"BaseVar": "13,048,500",
"ECR before LimitedLiability": "89%",
"Economic Capital Ratio": "160%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,928,000",
"Assets, Non-Current": "1,563,000",
"General and Administrative Expense": "7,529,000",
"Goodwill": "1,119,000",
"Liabilities, Current": "2,212,000",
"Liabilities, Non-Current": "2,621,000",
"Other Assets": "206,000",
"Other Compr. Net Income": "84,000",
"Other Expenses": "188,000",
"Other Liabilities": "0",
"Other Net Income": "518,000",
"Other Revenues": "8,453,000",
"Property, Plant and Equipment, Net": "2,576,000",
"Research and Development": "150,000"
},
"output_variables": {
"Liabilities": "4,833,000",
"Assets": "9,392,000",
"Expenses": "7,867,000",
"Revenues": "8,453,000",
"Stockholders Equity": "4,559,000",
"Net Income": "1,104,000",
"Comprehensive Net Income": "1,146,000",
"BaseVar": "15,573,500",
"ECR before LimitedLiability": "104%",
"Economic Capital Ratio": "170%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.704970871952808,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001307954.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001307954.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001307954.svg"
},
{
"company_id": "0001056358",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001056358.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001056358.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001056358.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001056358_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001056358_main_keyfigs.svg",
"name": "Mannatech INC",
"rank": 25,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001056358.svg",
"report_text": "The relative strengths and weaknesses of Mannatech INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Mannatech INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 97% points.The greatest weakness of Mannatech INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 164% points.
The company's Economic Capital Ratio, given in the ranking table, is 159%, being 0.68% points above the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001056358_2022_Mannatech_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Non-Current": "-3.85",
"Liabilities": "-9.05",
"Stockholders Equity": "-140",
"ECR before LimitedLiability": "-70.0",
"Other Liabilities": "-5.76",
"Property, Plant and Equipment, Net": "-17.3",
"Assets": "-58.1",
"Other Assets": "9.04",
"Assets, Current": "-42.8",
"Assets, Non-Current": "-13.3",
"Goodwill": "-14.0",
"General and Administrative Expense": "3.92",
"Expenses": "-62.6",
"Revenues": "34.1",
"Net Income": "-34.3",
"Other Expenses": "-72.3",
"Research and Development": "7.47",
"Other Revenues": "34.1",
"Comprehensive Net Income": "-34.2",
"Other Net Income": "1.13",
"Economic Capital Ratio": "-70.7"
},
"2010": {
"Liabilities": "65.1",
"Stockholders Equity": "-124",
"ECR before LimitedLiability": "-29.4",
"Liabilities, Current": "11.6",
"Liabilities, Non-Current": "59.2",
"Goodwill": "-32.3",
"Assets": "-66.0",
"Property, Plant and Equipment, Net": "-17.8",
"Assets, Current": "-42.4",
"Assets, Non-Current": "-19.2",
"Other Assets": "15.5",
"Other Expenses": "-110",
"Expenses": "-90.9",
"Revenues": "69.9",
"Net Income": "2.46",
"General and Administrative Expense": "0.961",
"Research and Development": "20.1",
"Other Revenues": "69.9",
"Other Net Income": "7.69",
"Comprehensive Net Income": "2.63",
"Economic Capital Ratio": "-27.4"
},
"2011": {
"Liabilities, Current": "21.5",
"Liabilities": "26.5",
"Stockholders Equity": "-120",
"ECR before LimitedLiability": "12.3",
"Liabilities, Non-Current": "15.7",
"Other Liabilities": "19.3",
"Property, Plant and Equipment, Net": "-28.7",
"Assets": "-95.4",
"Assets, Non-Current": "-15.7",
"Goodwill": "-40.1",
"Assets, Current": "-73.9",
"General and Administrative Expense": "19.8",
"Expenses": "-80.7",
"Revenues": "66.1",
"Net Income": "25.7",
"Research and Development": "21.0",
"Other Expenses": "-141",
"Other Revenues": "66.1",
"Comprehensive Net Income": "25.8",
"Other Net Income": "-23.1",
"Economic Capital Ratio": "-49.7"
},
"2012": {
"Liabilities, Current": "31.4",
"Liabilities": "63.0",
"Stockholders Equity": "-131",
"ECR before LimitedLiability": "19.9",
"Liabilities, Non-Current": "23.7",
"Other Liabilities": "47.8",
"Assets, Current": "-53.5",
"Assets": "-73.2",
"Other Assets": "8.93",
"Assets, Non-Current": "-10.5",
"Property, Plant and Equipment, Net": "-24.7",
"Goodwill": "-31.3",
"Other Expenses": "-119",
"Expenses": "-64.4",
"Revenues": "99.2",
"Net Income": "69.9",
"Research and Development": "49.9",
"General and Administrative Expense": "15.8",
"Other Revenues": "99.2",
"Comprehensive Net Income": "69.9",
"Economic Capital Ratio": "-12.6"
},
"2013": {
"Liabilities, Current": "28.6",
"Liabilities": "69.1",
"Stockholders Equity": "-101",
"ECR before LimitedLiability": "38.7",
"Other Liabilities": "33.1",
"Liabilities, Non-Current": "34.3",
"Goodwill": "-27.6",
"Assets": "-63.4",
"Assets, Non-Current": "-7.35",
"Property, Plant and Equipment, Net": "-20.9",
"Assets, Current": "-41.2",
"General and Administrative Expense": "12.7",
"Expenses": "-49.9",
"Revenues": "98.1",
"Net Income": "73.4",
"Research and Development": "35.2",
"Other Expenses": "-90.9",
"Other Revenues": "98.1",
"Other Net Income": "-10.2",
"Comprehensive Net Income": "73.4",
"Economic Capital Ratio": "-1.46"
},
"2014": {
"Liabilities, Non-Current": "37.3",
"Liabilities": "82.2",
"Stockholders Equity": "-34.5",
"ECR before LimitedLiability": "81.1",
"Liabilities, Current": "60.6",
"Other Liabilities": "26.3",
"Assets, Current": "-31.3",
"Assets": "-49.0",
"Goodwill": "-24.3",
"Other Assets": "22.4",
"Assets, Non-Current": "-5.37",
"Property, Plant and Equipment, Net": "-20.0",
"Other Expenses": "-92.9",
"Expenses": "-34.1",
"Revenues": "99.1",
"Net Income": "85.9",
"Research and Development": "36.0",
"General and Administrative Expense": "28.8",
"Other Revenues": "99.1",
"Comprehensive Net Income": "86.0",
"Economic Capital Ratio": "31.6"
},
"2015": {
"Other Liabilities": "35.8",
"Liabilities": "98.1",
"Stockholders Equity": "-29.5",
"ECR before LimitedLiability": "91.3",
"Liabilities, Current": "64.6",
"Liabilities, Non-Current": "43.2",
"Assets, Current": "-24.4",
"Assets": "-44.4",
"Other Assets": "3.61",
"Goodwill": "-20.6",
"Property, Plant and Equipment, Net": "-17.7",
"Research and Development": "25.2",
"Expenses": "-45.3",
"Revenues": "113",
"Net Income": "97.9",
"General and Administrative Expense": "3.64",
"Other Expenses": "-74.5",
"Other Revenues": "113",
"Comprehensive Net Income": "98.1",
"Other Net Income": "-3.27",
"Economic Capital Ratio": "45.4"
},
"2016": {
"Liabilities, Non-Current": "42.8",
"Liabilities": "85.7",
"Stockholders Equity": "-69.9",
"ECR before LimitedLiability": "43.2",
"Liabilities, Current": "51.0",
"Other Liabilities": "19.2",
"Property, Plant and Equipment, Net": "-25.7",
"Assets": "-52.3",
"Other Assets": "23.1",
"Assets, Current": "-34.8",
"Goodwill": "-22.5",
"Research and Development": "36.7",
"Expenses": "-51.3",
"Revenues": "99.8",
"Net Income": "85.2",
"General and Administrative Expense": "-10.3",
"Other Expenses": "-74.8",
"Other Revenues": "99.8",
"Comprehensive Net Income": "85.3",
"Other Net Income": "-6.72",
"Economic Capital Ratio": "23.2"
},
"2017": {
"Other Liabilities": "26.0",
"Liabilities": "82.7",
"Stockholders Equity": "-57.8",
"ECR before LimitedLiability": "35.1",
"Liabilities, Current": "35.7",
"Liabilities, Non-Current": "45.2",
"Assets, Non-Current": "-5.22",
"Assets": "-50.3",
"Other Assets": "21.4",
"Assets, Current": "-24.1",
"Goodwill": "-24.0",
"Property, Plant and Equipment, Net": "-30.2",
"Research and Development": "33.8",
"Expenses": "-53.8",
"Revenues": "94.1",
"Net Income": "70.2",
"Other Expenses": "-82.6",
"Other Revenues": "94.1",
"Comprehensive Net Income": "72.7",
"Other Net Income": "-9.87",
"Economic Capital Ratio": "13.5"
},
"2018": {
"Liabilities, Non-Current": "40.3",
"Liabilities": "55.4",
"Stockholders Equity": "-109",
"ECR before LimitedLiability": "15.3",
"Other Liabilities": "25.9",
"Liabilities, Current": "24.7",
"Property, Plant and Equipment, Net": "-36.3",
"Assets": "-71.9",
"Other Assets": "34.2",
"Assets, Current": "-46.7",
"Goodwill": "-29.7",
"Assets, Non-Current": "-17.7",
"Other Expenses": "-124",
"Expenses": "-63.7",
"Revenues": "82.2",
"Net Income": "57.7",
"Research and Development": "38.7",
"General and Administrative Expense": "36.9",
"Other Revenues": "82.2",
"Comprehensive Net Income": "57.6",
"Economic Capital Ratio": "-5.21"
},
"2019": {
"Liabilities, Non-Current": "32.4",
"Liabilities": "70.3",
"Stockholders Equity": "-90.3",
"ECR before LimitedLiability": "48.3",
"Other Liabilities": "29.6",
"Liabilities, Current": "22.1",
"Assets, Non-Current": "-13.5",
"Assets": "-58.8",
"Goodwill": "-25.2",
"Property, Plant and Equipment, Net": "-29.1",
"Other Assets": "23.4",
"Assets, Current": "-33.9",
"Research and Development": "24.4",
"Expenses": "-45.5",
"Revenues": "86.7",
"Net Income": "73.7",
"Other Expenses": "-106",
"General and Administrative Expense": "45.5",
"Other Revenues": "86.7",
"Comprehensive Net Income": "73.6",
"Economic Capital Ratio": "18.8"
},
"2020": {
"Liabilities, Current": "17.2",
"Liabilities": "69.7",
"Stockholders Equity": "-108",
"ECR before LimitedLiability": "46.2",
"Liabilities, Non-Current": "44.6",
"Other Liabilities": "12.7",
"Goodwill": "-24.4",
"Assets": "-61.0",
"Other Assets": "16.7",
"Assets, Current": "-38.8",
"Property, Plant and Equipment, Net": "-29.7",
"Other Expenses": "-90.7",
"Expenses": "-61.4",
"Revenues": "82.1",
"Net Income": "70.0",
"Research and Development": "18.2",
"General and Administrative Expense": "14.6",
"Other Revenues": "82.1",
"Comprehensive Net Income": "70.1",
"Other Net Income": "13.7",
"Economic Capital Ratio": "8.44"
},
"2021": {
"Liabilities, Non-Current": "45.4",
"Liabilities": "74.0",
"Stockholders Equity": "-164",
"ECR before LimitedLiability": "5.02",
"Liabilities, Current": "13.6",
"Other Liabilities": "19.7",
"Assets, Current": "-41.5",
"Assets": "-66.7",
"Assets, Non-Current": "-14.5",
"Other Assets": "14.9",
"Goodwill": "-31.6",
"Property, Plant and Equipment, Net": "-29.0",
"Other Expenses": "-98.5",
"Expenses": "-66.7",
"Revenues": "96.5",
"Net Income": "75.5",
"Research and Development": "26.3",
"General and Administrative Expense": "7.66",
"Other Revenues": "96.5",
"Comprehensive Net Income": "75.3",
"Other Compr. Net Income": "-2.14",
"Economic Capital Ratio": "0.682"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001056358_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "64,485",
"Assets, Non-Current": "2,503",
"General and Administrative Expense": "116,810",
"Goodwill": "0",
"Liabilities, Current": "42,679",
"Liabilities, Non-Current": "3,348",
"Other Assets": "8,170",
"Other Compr. Net Income": "0",
"Other Expenses": "191,782",
"Other Liabilities": "4,991",
"Other Net Income": "1,519",
"Other Revenues": "289,705",
"Property, Plant and Equipment, Net": "27,144",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "51,018",
"Assets": "102,302",
"Expenses": "308,592",
"Revenues": "289,705",
"Stockholders Equity": "51,284",
"Net Income": "-17,368",
"Comprehensive Net Income": "-17,368",
"BaseVar": "376,568",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "55,215",
"Assets, Non-Current": "3,054",
"General and Administrative Expense": "95,411",
"Goodwill": "0",
"Liabilities, Current": "32,240",
"Liabilities, Non-Current": "4,996",
"Other Assets": "4,705",
"Other Compr. Net Income": "0",
"Other Expenses": "143,734",
"Other Liabilities": "3,107",
"Other Net Income": "441",
"Other Revenues": "228,088",
"Property, Plant and Equipment, Net": "18,449",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "40,343",
"Assets": "81,423",
"Expenses": "239,145",
"Revenues": "228,088",
"Stockholders Equity": "41,080",
"Net Income": "-10,616",
"Comprehensive Net Income": "-10,616",
"BaseVar": "294,720",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "150%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "41,731",
"Assets, Non-Current": "2,815",
"General and Administrative Expense": "86,118",
"Goodwill": "0",
"Liabilities, Current": "29,876",
"Liabilities, Non-Current": "5,382",
"Other Assets": "4,158",
"Other Compr. Net Income": "881",
"Other Expenses": "134,241",
"Other Liabilities": "1,359",
"Other Net Income": "-989",
"Other Revenues": "200,689",
"Property, Plant and Equipment, Net": "9,566",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,617",
"Assets": "58,270",
"Expenses": "220,359",
"Revenues": "200,689",
"Stockholders Equity": "21,653",
"Net Income": "-20,659",
"Comprehensive Net Income": "-20,218",
"BaseVar": "258,902",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "35,302",
"Assets, Non-Current": "3,187",
"General and Administrative Expense": "71,817",
"Goodwill": "0",
"Liabilities, Current": "24,221",
"Liabilities, Non-Current": "2,178",
"Other Assets": "4,246",
"Other Compr. Net Income": "-250",
"Other Expenses": "103,698",
"Other Liabilities": "940",
"Other Net Income": "680",
"Other Revenues": "173,447",
"Property, Plant and Equipment, Net": "4,825",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "27,339",
"Assets": "47,560",
"Expenses": "175,515",
"Revenues": "173,447",
"Stockholders Equity": "20,221",
"Net Income": "-1,388",
"Comprehensive Net Income": "-1,513",
"BaseVar": "212,396",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "146%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "43,674",
"Assets, Non-Current": "3,591",
"General and Administrative Expense": "69,855",
"Goodwill": "0",
"Liabilities, Current": "30,058",
"Liabilities, Non-Current": "2,101",
"Other Assets": "5,557",
"Other Compr. Net Income": "-66",
"Other Expenses": "102,447",
"Other Liabilities": "450",
"Other Net Income": "-1,947",
"Other Revenues": "177,423",
"Property, Plant and Equipment, Net": "3,239",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "32,609",
"Assets": "56,061",
"Expenses": "172,302",
"Revenues": "177,423",
"Stockholders Equity": "23,452",
"Net Income": "3,174",
"Comprehensive Net Income": "3,141",
"BaseVar": "220,204",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "153%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "49,363",
"Assets, Non-Current": "3,567",
"General and Administrative Expense": "74,543",
"Goodwill": "0",
"Liabilities, Current": "33,008",
"Liabilities, Non-Current": "2,136",
"Other Assets": "14,468",
"Other Compr. Net Income": "634",
"Other Expenses": "106,121",
"Other Liabilities": "878",
"Other Net Income": "-2,921",
"Other Revenues": "190,081",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,022",
"Assets": "67,398",
"Expenses": "180,664",
"Revenues": "190,081",
"Stockholders Equity": "31,376",
"Net Income": "6,496",
"Comprehensive Net Income": "6,813",
"BaseVar": "238,860",
"ECR before LimitedLiability": "96%",
"Economic Capital Ratio": "165%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "49,885",
"Assets, Non-Current": "3,759",
"General and Administrative Expense": "68,560",
"Goodwill": "0",
"Liabilities, Current": "26,379",
"Liabilities, Non-Current": "1,994",
"Other Assets": "14,998",
"Other Compr. Net Income": "795",
"Other Expenses": "101,923",
"Other Liabilities": "1,705",
"Other Net Income": "-3,945",
"Other Revenues": "180,267",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "30,078",
"Assets": "68,642",
"Expenses": "170,483",
"Revenues": "180,267",
"Stockholders Equity": "38,564",
"Net Income": "5,839",
"Comprehensive Net Income": "6,236",
"BaseVar": "227,105",
"ECR before LimitedLiability": "120%",
"Economic Capital Ratio": "181%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "50,762",
"Assets, Non-Current": "4,013",
"General and Administrative Expense": "73,744",
"Goodwill": "0",
"Liabilities, Current": "29,981",
"Liabilities, Non-Current": "1,465",
"Other Assets": "16,413",
"Other Compr. Net Income": "1,148",
"Other Expenses": "105,493",
"Other Liabilities": "857",
"Other Net Income": "-1,653",
"Other Revenues": "180,304",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "32,303",
"Assets": "71,188",
"Expenses": "179,237",
"Revenues": "180,304",
"Stockholders Equity": "38,885",
"Net Income": "-586",
"Comprehensive Net Income": "-12",
"BaseVar": "232,916",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "170%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "56,248",
"Assets, Non-Current": "3,876",
"General and Administrative Expense": "71,137",
"Goodwill": "0",
"Liabilities, Current": "34,592",
"Liabilities, Non-Current": "1,300",
"Other Assets": "16,118",
"Other Compr. Net Income": "4,150",
"Other Expenses": "107,287",
"Other Liabilities": "109",
"Other Net Income": "-59",
"Other Revenues": "176,696",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,001",
"Assets": "76,242",
"Expenses": "178,424",
"Revenues": "176,696",
"Stockholders Equity": "40,241",
"Net Income": "-1,787",
"Comprehensive Net Income": "288",
"BaseVar": "235,786",
"ECR before LimitedLiability": "99%",
"Economic Capital Ratio": "167%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "42,387",
"Assets, Non-Current": "3,894",
"General and Administrative Expense": "68,632",
"Goodwill": "0",
"Liabilities, Current": "33,617",
"Liabilities, Non-Current": "2,302",
"Other Assets": "15,917",
"Other Compr. Net Income": "-1,647",
"Other Expenses": "109,391",
"Other Liabilities": "955",
"Other Net Income": "579",
"Other Revenues": "173,558",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "36,874",
"Assets": "62,198",
"Expenses": "178,023",
"Revenues": "173,558",
"Stockholders Equity": "25,324",
"Net Income": "-3,886",
"Comprehensive Net Income": "-4,710",
"BaseVar": "226,440",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "139%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "41,029",
"Assets, Non-Current": "9,600",
"General and Administrative Expense": "62,374",
"Goodwill": "0",
"Liabilities, Current": "28,895",
"Liabilities, Non-Current": "6,200",
"Other Assets": "12,294",
"Other Compr. Net Income": "-580",
"Other Expenses": "91,368",
"Other Liabilities": "553",
"Other Net Income": "-697",
"Other Revenues": "157,700",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "35,648",
"Assets": "62,923",
"Expenses": "153,742",
"Revenues": "157,700",
"Stockholders Equity": "27,275",
"Net Income": "3,261",
"Comprehensive Net Income": "2,971",
"BaseVar": "205,645",
"ECR before LimitedLiability": "82%",
"Economic Capital Ratio": "155%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "42,477",
"Assets, Non-Current": "11,977",
"General and Administrative Expense": "63,350",
"Goodwill": "0",
"Liabilities, Current": "31,990",
"Liabilities, Non-Current": "7,245",
"Other Assets": "10,882",
"Other Compr. Net Income": "1,393",
"Other Expenses": "83,030",
"Other Liabilities": "129",
"Other Net Income": "1,234",
"Other Revenues": "151,407",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "39,364",
"Assets": "65,336",
"Expenses": "146,380",
"Revenues": "151,407",
"Stockholders Equity": "25,972",
"Net Income": "6,261",
"Comprehensive Net Income": "6,958",
"BaseVar": "202,557",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "42,838",
"Assets, Non-Current": "9,220",
"General and Administrative Expense": "63,576",
"Goodwill": "0",
"Liabilities, Current": "30,101",
"Liabilities, Non-Current": "5,049",
"Other Assets": "7,567",
"Other Compr. Net Income": "-2,808",
"Other Expenses": "86,187",
"Other Liabilities": "63",
"Other Net Income": "-157",
"Other Revenues": "159,762",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "35,213",
"Assets": "59,625",
"Expenses": "149,763",
"Revenues": "159,762",
"Stockholders Equity": "24,412",
"Net Income": "9,842",
"Comprehensive Net Income": "8,438",
"BaseVar": "203,664",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "159%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.5948277800894353,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001056358.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001056358.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001056358.svg"
},
{
"company_id": "0001644440",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001644440.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001644440.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001644440.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001644440_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001644440_main_keyfigs.svg",
"name": "GCP Applied Technologies Inc",
"rank": 26,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001644440.svg",
"report_text": "The relative strengths and weaknesses of GCP Applied Technologies Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of GCP Applied Technologies Inc compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 31% points.The greatest weakness of GCP Applied Technologies Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 32% points.
The company's Economic Capital Ratio, given in the ranking table, is 156%, being 2.5% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001644440_2022_GCP_Applied_Technologies_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-83.4",
"Liabilities": "-36.2",
"Stockholders Equity": "-86.3",
"Liabilities, Current": "2.08",
"Other Liabilities": "0.533",
"Property, Plant and Equipment, Net": "-0.224",
"Assets": "-44.1",
"Other Assets": "0.868",
"Assets, Non-Current": "-0.189",
"Assets, Current": "-35.0",
"Goodwill": "-0.625",
"Research and Development": "1.73",
"Expenses": "1.33",
"Revenues": "5.25",
"Net Income": "8.42",
"General and Administrative Expense": "-25.5",
"Other Expenses": "3.49",
"Other Revenues": "5.25",
"ECR before LimitedLiability": "-42.2",
"Comprehensive Net Income": "8.29",
"Economic Capital Ratio": "-62.2"
},
"2017": {
"Other Liabilities": "4.22",
"Liabilities": "-13.2",
"Stockholders Equity": "-29.7",
"ECR before LimitedLiability": "26.2",
"Liabilities, Current": "12.5",
"Liabilities, Non-Current": "-31.9",
"Assets, Non-Current": "-3.95",
"Assets": "-12.9",
"Other Assets": "2.81",
"Goodwill": "-3.02",
"Property, Plant and Equipment, Net": "-11.2",
"Research and Development": "15.3",
"Expenses": "25.1",
"Revenues": "7.20",
"Net Income": "68.4",
"Other Expenses": "14.1",
"General and Administrative Expense": "-4.66",
"Other Revenues": "7.20",
"Comprehensive Net Income": "70.0",
"Other Net Income": "30.0",
"Economic Capital Ratio": "4.70"
},
"2018": {
"Liabilities, Non-Current": "-30.8",
"Liabilities": "-12.0",
"Stockholders Equity": "-31.1",
"ECR before LimitedLiability": "17.3",
"Liabilities, Current": "16.3",
"Property, Plant and Equipment, Net": "-5.13",
"Assets": "-15.8",
"Other Assets": "3.78",
"Assets, Current": "-11.0",
"Goodwill": "6.12",
"Assets, Non-Current": "-9.37",
"Other Expenses": "6.67",
"Expenses": "12.0",
"Revenues": "30.6",
"Net Income": "47.3",
"Research and Development": "15.3",
"General and Administrative Expense": "-9.41",
"Other Revenues": "30.6",
"Comprehensive Net Income": "46.1",
"Other Net Income": "2.32",
"Economic Capital Ratio": "-3.13"
},
"2019": {
"Liabilities, Non-Current": "-35.9",
"Liabilities": "-10.6",
"Stockholders Equity": "-19.0",
"ECR before LimitedLiability": "44.4",
"Other Liabilities": "4.70",
"Liabilities, Current": "17.8",
"Assets, Non-Current": "-8.78",
"Assets": "-7.83",
"Goodwill": "4.87",
"Property, Plant and Equipment, Net": "-1.70",
"Other Assets": "4.68",
"Assets, Current": "-5.98",
"Research and Development": "9.98",
"Expenses": "16.6",
"Revenues": "25.9",
"Net Income": "50.9",
"Other Expenses": "7.51",
"Other Revenues": "25.9",
"Other Net Income": "4.99",
"Comprehensive Net Income": "51.1",
"Economic Capital Ratio": "14.9"
},
"2020": {
"Liabilities, Current": "15.8",
"Liabilities": "-10.2",
"Stockholders Equity": "-15.2",
"ECR before LimitedLiability": "53.8",
"Liabilities, Non-Current": "-25.5",
"Other Liabilities": "-2.19",
"Goodwill": "4.04",
"Assets": "-5.15",
"Other Assets": "2.27",
"Assets, Non-Current": "-5.74",
"Property, Plant and Equipment, Net": "-3.48",
"Other Expenses": "10.2",
"Expenses": "9.96",
"Revenues": "19.2",
"Net Income": "36.1",
"Research and Development": "6.73",
"General and Administrative Expense": "-6.75",
"Other Revenues": "19.2",
"Comprehensive Net Income": "36.4",
"Other Net Income": "5.18",
"Economic Capital Ratio": "16.0"
},
"2021": {
"Liabilities, Non-Current": "-30.7",
"Liabilities": "-12.9",
"Stockholders Equity": "-32.0",
"ECR before LimitedLiability": "1.85",
"Liabilities, Current": "14.6",
"Other Liabilities": "1.31",
"Assets, Current": "-3.11",
"Assets": "-14.6",
"Assets, Non-Current": "-5.79",
"Other Assets": "1.07",
"Goodwill": "-3.93",
"Property, Plant and Equipment, Net": "-4.29",
"Other Expenses": "7.66",
"Expenses": "6.72",
"Revenues": "22.4",
"Net Income": "30.7",
"Research and Development": "11.3",
"General and Administrative Expense": "-11.6",
"Other Revenues": "22.4",
"Comprehensive Net Income": "29.9",
"Economic Capital Ratio": "-2.49"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001644440_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "553,800",
"Assets, Non-Current": "27,000",
"General and Administrative Expense": "1,139,900",
"Goodwill": "172,300",
"Liabilities, Current": "320,400",
"Liabilities, Non-Current": "898,700",
"Other Assets": "104,500",
"Other Compr. Net Income": "-20,900",
"Other Expenses": "119,100",
"Other Liabilities": "9,700",
"Other Net Income": "0",
"Other Revenues": "1,355,800",
"Property, Plant and Equipment, Net": "232,200",
"Research and Development": "23,000"
},
"output_variables": {
"Liabilities": "1,228,800",
"Assets": "1,089,800",
"Expenses": "1,282,000",
"Revenues": "1,355,800",
"Stockholders Equity": "-139,000",
"Net Income": "73,800",
"Comprehensive Net Income": "63,350",
"BaseVar": "2,488,650",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,113,200",
"Assets, Non-Current": "23,800",
"General and Administrative Expense": "963,800",
"Goodwill": "290,000",
"Liabilities, Current": "497,500",
"Liabilities, Non-Current": "612,500",
"Other Assets": "59,400",
"Other Compr. Net Income": "61,400",
"Other Expenses": "211,000",
"Other Liabilities": "101,000",
"Other Net Income": "664,300",
"Other Revenues": "1,084,400",
"Property, Plant and Equipment, Net": "216,600",
"Research and Development": "20,000"
},
"output_variables": {
"Liabilities": "1,211,000",
"Assets": "1,703,000",
"Expenses": "1,194,800",
"Revenues": "1,084,400",
"Stockholders Equity": "492,000",
"Net Income": "553,900",
"Comprehensive Net Income": "584,600",
"BaseVar": "2,959,450",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "158%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "683,200",
"Assets, Non-Current": "28,000",
"General and Administrative Expense": "1,004,600",
"Goodwill": "296,900",
"Liabilities, Current": "289,900",
"Liabilities, Non-Current": "409,700",
"Other Assets": "48,700",
"Other Compr. Net Income": "-34,600",
"Other Expenses": "116,400",
"Other Liabilities": "100,900",
"Other Net Income": "31,300",
"Other Revenues": "1,125,400",
"Property, Plant and Equipment, Net": "225,100",
"Research and Development": "20,200"
},
"output_variables": {
"Liabilities": "800,500",
"Assets": "1,281,900",
"Expenses": "1,141,200",
"Revenues": "1,125,400",
"Stockholders Equity": "481,400",
"Net Income": "15,500",
"Comprehensive Net Income": "-1,800",
"BaseVar": "2,207,450",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "141%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "648,300",
"Assets, Non-Current": "67,300",
"General and Administrative Expense": "903,400",
"Goodwill": "289,600",
"Liabilities, Current": "225,900",
"Liabilities, Non-Current": "451,500",
"Other Assets": "51,600",
"Other Compr. Net Income": "2,600",
"Other Expenses": "50,700",
"Other Liabilities": "83,600",
"Other Net Income": "5,700",
"Other Revenues": "1,013,500",
"Property, Plant and Equipment, Net": "245,300",
"Research and Development": "18,400"
},
"output_variables": {
"Liabilities": "761,000",
"Assets": "1,302,100",
"Expenses": "972,500",
"Revenues": "1,013,500",
"Stockholders Equity": "541,100",
"Net Income": "46,700",
"Comprehensive Net Income": "48,000",
"BaseVar": "2,028,700",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "151%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "791,700",
"Assets, Non-Current": "75,100",
"General and Administrative Expense": "809,800",
"Goodwill": "285,900",
"Liabilities, Current": "239,300",
"Liabilities, Non-Current": "454,800",
"Other Assets": "39,300",
"Other Compr. Net Income": "6,000",
"Other Expenses": "-25,500",
"Other Liabilities": "69,400",
"Other Net Income": "-300",
"Other Revenues": "903,200",
"Property, Plant and Equipment, Net": "225,600",
"Research and Development": "17,900"
},
"output_variables": {
"Liabilities": "763,500",
"Assets": "1,417,600",
"Expenses": "802,200",
"Revenues": "903,200",
"Stockholders Equity": "654,100",
"Net Income": "100,700",
"Comprehensive Net Income": "103,700",
"BaseVar": "1,946,400",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "162%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "861,600",
"Assets, Non-Current": "117,500",
"General and Administrative Expense": "880,800",
"Goodwill": "254,300",
"Liabilities, Current": "231,900",
"Liabilities, Non-Current": "477,600",
"Other Assets": "0",
"Other Compr. Net Income": "-19,200",
"Other Expenses": "67,500",
"Other Liabilities": "65,200",
"Other Net Income": "-300",
"Other Revenues": "970,100",
"Property, Plant and Equipment, Net": "213,200",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "774,700",
"Assets": "1,446,600",
"Expenses": "948,300",
"Revenues": "970,100",
"Stockholders Equity": "671,900",
"Net Income": "21,500",
"Comprehensive Net Income": "11,900",
"BaseVar": "2,079,600",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "156%"
}
}
},
"top_rated": false,
"trend": -3.0,
"value": 1.5631104902040842,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001644440.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001644440.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001644440.svg"
},
{
"company_id": "0000874716",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000874716.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000874716.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000874716.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000874716_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000874716_main_keyfigs.svg",
"name": "Idexx Laboratories INC DE",
"rank": 27,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000874716.svg",
"report_text": "The relative strengths and weaknesses of Idexx Laboratories INC DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Idexx Laboratories INC DE compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 69% points.The greatest weakness of Idexx Laboratories INC DE is the variable Stockholders Equity, reducing the Economic Capital Ratio by 80% points.
The company's Economic Capital Ratio, given in the ranking table, is 154%, being 4.8% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000874716_2022_Idexx_Laboratories_INC_DE.pdf",
"shrinked_graph_json": {
"2010": {
"Other Liabilities": "4.39",
"Liabilities": "21.9",
"Stockholders Equity": "-14.3",
"ECR before LimitedLiability": "23.6",
"Liabilities, Current": "-18.4",
"Liabilities, Non-Current": "32.6",
"Assets": "-11.3",
"Property, Plant and Equipment, Net": "0.217",
"Assets, Current": "-8.67",
"Assets, Non-Current": "28.2",
"Other Assets": "-18.8",
"Other Expenses": "21.1",
"Expenses": "-8.82",
"Revenues": "28.5",
"Net Income": "23.0",
"General and Administrative Expense": "-32.3",
"Research and Development": "1.98",
"Other Revenues": "28.5",
"Other Net Income": "3.49",
"Comprehensive Net Income": "23.1",
"Economic Capital Ratio": "25.6"
},
"2011": {
"Liabilities, Current": "-10.1",
"Liabilities": "9.33",
"Stockholders Equity": "-4.45",
"ECR before LimitedLiability": "88.9",
"Liabilities, Non-Current": "4.54",
"Other Liabilities": "14.3",
"Assets": "-5.93",
"Assets, Non-Current": "45.2",
"Other Assets": "-23.7",
"Goodwill": "5.99",
"Assets, Current": "-11.7",
"General and Administrative Expense": "-12.4",
"Expenses": "17.7",
"Revenues": "45.9",
"Net Income": "58.1",
"Research and Development": "9.32",
"Other Expenses": "21.3",
"Other Revenues": "45.9",
"Comprehensive Net Income": "58.1",
"Other Net Income": "-7.26",
"Economic Capital Ratio": "26.9"
},
"2012": {
"Liabilities, Current": "-16.6",
"Liabilities": "13.2",
"Stockholders Equity": "-4.10",
"ECR before LimitedLiability": "64.6",
"Liabilities, Non-Current": "4.25",
"Other Liabilities": "23.5",
"Assets, Current": "-9.87",
"Assets": "-6.33",
"Other Assets": "-21.8",
"Assets, Non-Current": "39.4",
"Property, Plant and Equipment, Net": "3.65",
"Goodwill": "2.84",
"Other Expenses": "24.4",
"Expenses": "17.1",
"Revenues": "43.6",
"Net Income": "63.1",
"Research and Development": "10.4",
"General and Administrative Expense": "-17.2",
"Other Revenues": "43.6",
"Comprehensive Net Income": "63.2",
"Economic Capital Ratio": "32.1"
},
"2013": {
"Liabilities, Current": "-9.09",
"Liabilities": "-3.70",
"Stockholders Equity": "-20.6",
"ECR before LimitedLiability": "47.9",
"Other Liabilities": "16.4",
"Liabilities, Non-Current": "-11.9",
"Assets": "-11.0",
"Assets, Non-Current": "48.7",
"Property, Plant and Equipment, Net": "6.04",
"Other Assets": "-28.2",
"Assets, Current": "-11.7",
"General and Administrative Expense": "-16.4",
"Expenses": "18.6",
"Revenues": "44.8",
"Net Income": "63.5",
"Research and Development": "8.33",
"Other Expenses": "28.2",
"Other Revenues": "44.8",
"Other Net Income": "-3.22",
"Comprehensive Net Income": "63.2",
"Economic Capital Ratio": "7.79"
},
"2014": {
"Liabilities, Non-Current": "-25.6",
"Liabilities": "-26.1",
"Stockholders Equity": "-39.5",
"ECR before LimitedLiability": "24.4",
"Liabilities, Current": "-14.6",
"Other Liabilities": "13.5",
"Assets, Current": "-16.9",
"Assets": "-16.4",
"Goodwill": "-4.01",
"Other Assets": "-35.5",
"Assets, Non-Current": "26.5",
"Property, Plant and Equipment, Net": "6.26",
"Other Expenses": "23.5",
"Expenses": "24.1",
"Revenues": "24.2",
"Net Income": "28.5",
"Research and Development": "12.8",
"General and Administrative Expense": "-3.18",
"Other Revenues": "24.2",
"Comprehensive Net Income": "28.4",
"Economic Capital Ratio": "-25.0"
},
"2015": {
"Other Liabilities": "4.32",
"Liabilities": "-34.1",
"Stockholders Equity": "-63.1",
"Liabilities, Current": "-12.6",
"Liabilities, Non-Current": "-42.3",
"Assets, Current": "-20.3",
"Assets": "-32.5",
"Other Assets": "-46.4",
"Goodwill": "-8.19",
"Assets, Non-Current": "10.1",
"Property, Plant and Equipment, Net": "3.92",
"Research and Development": "3.97",
"Expenses": "4.98",
"Revenues": "6.60",
"Net Income": "12.0",
"General and Administrative Expense": "-15.1",
"Other Expenses": "5.64",
"Other Revenues": "6.60",
"ECR before LimitedLiability": "-1.40",
"Comprehensive Net Income": "11.8",
"Economic Capital Ratio": "-47.3"
},
"2016": {
"Liabilities, Non-Current": "-39.4",
"Liabilities": "-47.8",
"Stockholders Equity": "-84.4",
"Liabilities, Current": "-18.5",
"Other Liabilities": "4.65",
"Property, Plant and Equipment, Net": "-4.73",
"Assets": "-43.0",
"Other Assets": "-38.0",
"Assets, Non-Current": "10.2",
"Assets, Current": "-33.4",
"Goodwill": "-9.97",
"Research and Development": "4.84",
"Expenses": "5.34",
"Revenues": "7.23",
"Net Income": "11.0",
"General and Administrative Expense": "-23.8",
"Other Expenses": "6.20",
"Other Revenues": "7.23",
"ECR before LimitedLiability": "-37.4",
"Comprehensive Net Income": "11.0",
"Economic Capital Ratio": "-57.3"
},
"2017": {
"Other Liabilities": "10.9",
"Liabilities": "-39.4",
"Stockholders Equity": "-76.4",
"Liabilities, Current": "-18.6",
"Liabilities, Non-Current": "-35.1",
"Assets, Non-Current": "14.5",
"Assets": "-40.0",
"Other Assets": "-35.4",
"Assets, Current": "-20.2",
"Goodwill": "-12.6",
"Property, Plant and Equipment, Net": "-13.8",
"Research and Development": "10.9",
"Expenses": "10.9",
"Revenues": "13.4",
"Net Income": "15.1",
"Other Expenses": "11.2",
"General and Administrative Expense": "-20.7",
"Other Revenues": "13.4",
"ECR before LimitedLiability": "-36.4",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "-57.9"
},
"2018": {
"Liabilities, Non-Current": "-45.8",
"Liabilities": "-37.4",
"Stockholders Equity": "-87.6",
"ECR before LimitedLiability": "-16.2",
"Other Liabilities": "17.4",
"Liabilities, Current": "-10.6",
"Property, Plant and Equipment, Net": "-2.65",
"Assets": "-46.7",
"Other Assets": "-38.6",
"Assets, Current": "-38.7",
"Goodwill": "-7.42",
"Assets, Non-Current": "25.5",
"Other Expenses": "13.0",
"Expenses": "15.9",
"Revenues": "25.7",
"Net Income": "28.7",
"Research and Development": "14.2",
"General and Administrative Expense": "-10.8",
"Other Revenues": "25.7",
"Comprehensive Net Income": "28.7",
"Economic Capital Ratio": "-36.7"
},
"2019": {
"Liabilities, Non-Current": "-46.6",
"Liabilities": "-26.9",
"Stockholders Equity": "-72.7",
"ECR before LimitedLiability": "13.8",
"Other Liabilities": "20.0",
"Liabilities, Current": "-3.05",
"Assets, Non-Current": "37.1",
"Assets": "-38.8",
"Goodwill": "-7.55",
"Property, Plant and Equipment, Net": "0.630",
"Other Assets": "-35.2",
"Assets, Current": "-33.2",
"Research and Development": "8.25",
"Expenses": "17.3",
"Revenues": "36.8",
"Net Income": "40.4",
"Other Expenses": "8.60",
"Other Revenues": "36.8",
"Other Net Income": "6.06",
"Comprehensive Net Income": "40.4",
"Economic Capital Ratio": "-15.6"
},
"2020": {
"Liabilities, Current": "16.4",
"Liabilities": "-8.44",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "40.1",
"Liabilities, Non-Current": "-36.0",
"Other Liabilities": "8.34",
"Goodwill": "-7.30",
"Assets": "-31.3",
"Other Assets": "-25.6",
"Assets, Current": "-24.2",
"Assets, Non-Current": "44.8",
"Property, Plant and Equipment, Net": "-3.39",
"Other Revenues": "56.6",
"Revenues": "56.6",
"Net Income": "63.6",
"Comprehensive Net Income": "63.6",
"General and Administrative Expense": "-10.4",
"Other Expenses": "6.71",
"Other Net Income": "6.90",
"Research and Development": "4.97",
"Economic Capital Ratio": "2.32"
},
"2021": {
"Liabilities, Non-Current": "-28.5",
"Liabilities": "-10.3",
"Stockholders Equity": "-79.7",
"Economic Capital Ratio": "-4.81",
"Liabilities, Current": "4.93",
"Other Liabilities": "11.7",
"Assets, Current": "-30.2",
"Assets": "-37.5",
"Assets, Non-Current": "47.9",
"Other Assets": "-26.3",
"Goodwill": "-9.36",
"Property, Plant and Equipment, Net": "-2.92",
"Other Expenses": "8.78",
"Expenses": "0.672",
"Revenues": "69.1",
"Net Income": "69.4",
"Research and Development": "8.46",
"General and Administrative Expense": "-15.8",
"Other Revenues": "69.1",
"Comprehensive Net Income": "69.4",
"Other Net Income": "0.867"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000874716_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "460,591",
"Assets, Non-Current": "436,553",
"General and Administrative Expense": "830,914",
"Goodwill": "204,864",
"Liabilities, Current": "285,112",
"Liabilities, Non-Current": "37,751",
"Other Assets": "-406,589",
"Other Compr. Net Income": "0",
"Other Expenses": "63,224",
"Other Liabilities": "0",
"Other Net Income": "663",
"Other Revenues": "1,103,392",
"Property, Plant and Equipment, Net": "201,725",
"Research and Development": "68,597"
},
"output_variables": {
"Liabilities": "322,863",
"Assets": "897,144",
"Expenses": "962,735",
"Revenues": "1,103,392",
"Stockholders Equity": "574,281",
"Net Income": "141,320",
"Comprehensive Net Income": "141,320",
"BaseVar": "1,643,398",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "203%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "524,227",
"Assets, Non-Current": "506,587",
"General and Administrative Expense": "906,422",
"Goodwill": "241,819",
"Liabilities, Current": "436,879",
"Liabilities, Non-Current": "54,342",
"Other Assets": "-458,596",
"Other Compr. Net Income": "0",
"Other Expenses": "76,215",
"Other Liabilities": "0",
"Other Net Income": "1,744",
"Other Revenues": "1,218,689",
"Property, Plant and Equipment, Net": "216,777",
"Research and Development": "76,042"
},
"output_variables": {
"Liabilities": "491,221",
"Assets": "1,030,814",
"Expenses": "1,058,679",
"Revenues": "1,218,689",
"Stockholders Equity": "539,593",
"Net Income": "161,754",
"Comprehensive Net Income": "161,754",
"BaseVar": "1,900,574",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "180%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "569,537",
"Assets, Non-Current": "534,065",
"General and Administrative Expense": "948,761",
"Goodwill": "237,827",
"Liabilities, Current": "406,333",
"Liabilities, Non-Current": "61,012",
"Other Assets": "-483,004",
"Other Compr. Net Income": "491",
"Other Expenses": "86,178",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,295,240",
"Property, Plant and Equipment, Net": "245,177",
"Research and Development": "82,014"
},
"output_variables": {
"Liabilities": "467,345",
"Assets": "1,103,602",
"Expenses": "1,116,953",
"Revenues": "1,295,240",
"Stockholders Equity": "636,257",
"Net Income": "178,287",
"Comprehensive Net Income": "178,532",
"BaseVar": "1,991,816",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "191%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "652,706",
"Assets, Non-Current": "577,810",
"General and Administrative Expense": "1,022,293",
"Goodwill": "239,365",
"Liabilities, Current": "478,353",
"Liabilities, Non-Current": "233,949",
"Other Assets": "-520,579",
"Other Compr. Net Income": "-2,326",
"Other Expenses": "80,853",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,378,943",
"Property, Plant and Equipment, Net": "281,214",
"Research and Development": "88,003"
},
"output_variables": {
"Liabilities": "712,302",
"Assets": "1,230,516",
"Expenses": "1,191,149",
"Revenues": "1,378,943",
"Stockholders Equity": "518,214",
"Net Income": "187,794",
"Comprehensive Net Income": "186,631",
"BaseVar": "2,257,618",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "162%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "759,398",
"Assets, Non-Current": "624,813",
"General and Administrative Expense": "1,127,289",
"Goodwill": "249,572",
"Liabilities, Current": "820,906",
"Liabilities, Non-Current": "445,716",
"Other Assets": "-553,159",
"Other Compr. Net Income": "-21,738",
"Other Expenses": "80,033",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,487,536",
"Property, Plant and Equipment, Net": "303,587",
"Research and Development": "98,263"
},
"output_variables": {
"Liabilities": "1,266,622",
"Assets": "1,384,211",
"Expenses": "1,305,585",
"Revenues": "1,487,536",
"Stockholders Equity": "117,589",
"Net Income": "181,951",
"Comprehensive Net Income": "171,082",
"BaseVar": "2,732,846",
"ECR before LimitedLiability": "25%",
"Economic Capital Ratio": "109%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "821,634",
"Assets, Non-Current": "653,359",
"General and Administrative Expense": "1,194,087",
"Goodwill": "234,843",
"Liabilities, Current": "856,761",
"Liabilities, Non-Current": "702,227",
"Other Assets": "-567,869",
"Other Compr. Net Income": "-34,251",
"Other Expenses": "118,457",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,604,360",
"Property, Plant and Equipment, Net": "333,026",
"Research and Development": "99,681"
},
"output_variables": {
"Liabilities": "1,558,988",
"Assets": "1,474,993",
"Expenses": "1,412,225",
"Revenues": "1,604,360",
"Stockholders Equity": "-83,995",
"Net Income": "192,135",
"Comprehensive Net Income": "175,010",
"BaseVar": "3,042,408",
"ECR before LimitedLiability": "4.0%",
"Economic Capital Ratio": "89%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "845,584",
"Assets, Non-Current": "685,120",
"General and Administrative Expense": "1,324,062",
"Goodwill": "224,383",
"Liabilities, Current": "934,568",
"Liabilities, Non-Current": "704,349",
"Other Assets": "-581,805",
"Other Compr. Net Income": "-797",
"Other Expenses": "131,841",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,779,079",
"Property, Plant and Equipment, Net": "357,422",
"Research and Development": "101,122"
},
"output_variables": {
"Liabilities": "1,638,917",
"Assets": "1,530,704",
"Expenses": "1,557,025",
"Revenues": "1,779,079",
"Stockholders Equity": "-108,213",
"Net Income": "222,054",
"Comprehensive Net Income": "221,656",
"BaseVar": "3,253,261",
"ECR before LimitedLiability": "4.6%",
"Economic Capital Ratio": "89%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "971,985",
"Assets, Non-Current": "741,431",
"General and Administrative Expense": "1,446,848",
"Goodwill": "243,719",
"Liabilities, Current": "1,004,567",
"Liabilities, Non-Current": "762,691",
"Other Assets": "-622,815",
"Other Compr. Net Income": "6,458",
"Other Expenses": "155,013",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,974,312",
"Property, Plant and Equipment, Net": "379,096",
"Research and Development": "109,182"
},
"output_variables": {
"Liabilities": "1,767,258",
"Assets": "1,713,416",
"Expenses": "1,711,043",
"Revenues": "1,974,312",
"Stockholders Equity": "-53,842",
"Net Income": "263,269",
"Comprehensive Net Income": "266,498",
"BaseVar": "3,586,244",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "95%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "654,172",
"Assets, Non-Current": "883,177",
"General and Administrative Expense": "1,604,044",
"Goodwill": "256,314",
"Liabilities, Current": "799,711",
"Liabilities, Non-Current": "776,138",
"Other Assets": "-693,584",
"Other Compr. Net Income": "-5,337",
"Other Expenses": "115,439",
"Other Liabilities": "-29,267",
"Other Net Income": "0",
"Other Revenues": "2,214,393",
"Property, Plant and Equipment, Net": "437,270",
"Research and Development": "117,863"
},
"output_variables": {
"Liabilities": "1,546,582",
"Assets": "1,537,349",
"Expenses": "1,837,346",
"Revenues": "2,214,393",
"Stockholders Equity": "-9,233",
"Net Income": "377,047",
"Comprehensive Net Income": "374,378",
"BaseVar": "3,570,504",
"ECR before LimitedLiability": "23%",
"Economic Capital Ratio": "107%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "679,639",
"Assets, Non-Current": "1,152,836",
"General and Administrative Expense": "1,720,869",
"Goodwill": "298,192",
"Liabilities, Current": "758,361",
"Liabilities, Non-Current": "929,313",
"Other Assets": "-832,037",
"Other Compr. Net Income": "-4,463",
"Other Expenses": "125,481",
"Other Liabilities": "-33,024",
"Other Net Income": "0",
"Other Revenues": "2,407,335",
"Property, Plant and Equipment, Net": "533,845",
"Research and Development": "133,193"
},
"output_variables": {
"Liabilities": "1,654,650",
"Assets": "1,832,475",
"Expenses": "1,979,543",
"Revenues": "2,407,335",
"Stockholders Equity": "177,825",
"Net Income": "427,792",
"Comprehensive Net Income": "425,560",
"BaseVar": "3,939,233",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "120%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,062,738",
"Assets, Non-Current": "1,231,823",
"General and Administrative Expense": "1,870,882",
"Goodwill": "295,890",
"Liabilities, Current": "594,468",
"Liabilities, Non-Current": "1,079,005",
"Other Assets": "-851,057",
"Other Compr. Net Income": "-7,788",
"Other Expenses": "112,979",
"Other Liabilities": "-11,707",
"Other Net Income": "0",
"Other Revenues": "2,707,241",
"Property, Plant and Equipment, Net": "555,167",
"Research and Development": "141,249"
},
"output_variables": {
"Liabilities": "1,661,766",
"Assets": "2,294,561",
"Expenses": "2,125,110",
"Revenues": "2,707,241",
"Stockholders Equity": "632,795",
"Net Income": "582,131",
"Comprehensive Net Income": "578,237",
"BaseVar": "4,398,233",
"ECR before LimitedLiability": "73%",
"Economic Capital Ratio": "148%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "955,655",
"Assets, Non-Current": "1,481,548",
"General and Administrative Expense": "2,122,323",
"Goodwill": "458,380",
"Liabilities, Current": "772,514",
"Liabilities, Non-Current": "983,632",
"Other Assets": "-1,046,047",
"Other Compr. Net Income": "132",
"Other Expenses": "187,618",
"Other Liabilities": "-8,935",
"Other Net Income": "0",
"Other Revenues": "3,215,794",
"Property, Plant and Equipment, Net": "587,667",
"Research and Development": "161,009"
},
"output_variables": {
"Liabilities": "1,747,211",
"Assets": "2,437,203",
"Expenses": "2,470,950",
"Revenues": "3,215,794",
"Stockholders Equity": "689,992",
"Net Income": "744,844",
"Comprehensive Net Income": "744,910",
"BaseVar": "4,935,645",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.5398884535808746,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000874716.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000874716.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000874716.svg"
},
{
"company_id": "0000073290",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000073290.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000073290.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000073290.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000073290_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000073290_main_keyfigs.svg",
"name": "Biomerica INC",
"rank": 28,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000073290.svg",
"report_text": "The relative strengths and weaknesses of Biomerica INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biomerica INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 55% points.The greatest weakness of Biomerica INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 61% points.
The company's Economic Capital Ratio, given in the ranking table, is 147%, being 11% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000073290_2022_Biomerica_INC.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "42.9",
"Liabilities": "81.9",
"Stockholders Equity": "59.8",
"ECR before LimitedLiability": "137",
"Liabilities, Non-Current": "22.0",
"Other Liabilities": "35.3",
"Other Expenses": "36.8",
"Expenses": "7.40",
"Net Income": "63.2",
"Research and Development": "13.7",
"General and Administrative Expense": "-48.4",
"Other Revenues": "55.0",
"Revenues": "55.0",
"Assets, Current": "5.42",
"Other Assets": "0.942",
"Assets, Non-Current": "-1.18",
"Property, Plant and Equipment, Net": "-1.04",
"Goodwill": "-2.57",
"Other Net Income": "1.82",
"Comprehensive Net Income": "63.3",
"Economic Capital Ratio": "104"
},
"2013": {
"Liabilities, Current": "54.1",
"Liabilities": "90.9",
"Stockholders Equity": "73.5",
"ECR before LimitedLiability": "153",
"Other Liabilities": "27.2",
"Liabilities, Non-Current": "31.3",
"Goodwill": "-2.31",
"Assets": "1.05",
"Assets, Non-Current": "-0.902",
"Property, Plant and Equipment, Net": "-0.566",
"Assets, Current": "6.44",
"General and Administrative Expense": "-48.7",
"Expenses": "4.65",
"Revenues": "59.0",
"Net Income": "59.7",
"Research and Development": "8.57",
"Other Expenses": "39.4",
"Other Revenues": "59.0",
"Other Net Income": "-3.92",
"Comprehensive Net Income": "59.5",
"Economic Capital Ratio": "113"
},
"2014": {
"Liabilities, Non-Current": "29.6",
"Liabilities": "94.7",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "168",
"Liabilities, Current": "63.5",
"Other Liabilities": "20.4",
"Assets, Current": "11.8",
"Assets": "8.34",
"Goodwill": "-2.72",
"Other Assets": "3.02",
"Assets, Non-Current": "-1.31",
"Other Expenses": "30.1",
"Expenses": "6.39",
"Revenues": "38.8",
"Net Income": "46.7",
"Research and Development": "6.29",
"General and Administrative Expense": "-32.7",
"Other Revenues": "38.8",
"Other Net Income": "2.25",
"Comprehensive Net Income": "46.8",
"Economic Capital Ratio": "119"
},
"2015": {
"Other Liabilities": "28.5",
"Liabilities": "101",
"Stockholders Equity": "101",
"ECR before LimitedLiability": "160",
"Liabilities, Current": "60.9",
"Liabilities, Non-Current": "33.9",
"Assets, Current": "9.81",
"Assets": "4.76",
"Other Assets": "2.92",
"Goodwill": "-3.21",
"Property, Plant and Equipment, Net": "-1.78",
"Research and Development": "-1.47",
"Expenses": "-4.61",
"Revenues": "46.4",
"Net Income": "43.8",
"General and Administrative Expense": "-52.1",
"Other Expenses": "43.0",
"Other Revenues": "46.4",
"Comprehensive Net Income": "44.2",
"Other Net Income": "1.76",
"Economic Capital Ratio": "114"
},
"2016": {
"Liabilities, Non-Current": "33.0",
"Liabilities": "94.8",
"Stockholders Equity": "64.8",
"ECR before LimitedLiability": "95.5",
"Liabilities, Current": "59.7",
"Other Liabilities": "15.6",
"Property, Plant and Equipment, Net": "-6.92",
"Assets": "-4.06",
"Assets, Non-Current": "-2.31",
"Assets, Current": "13.3",
"Goodwill": "-6.54",
"Research and Development": "4.44",
"Expenses": "-28.1",
"Revenues": "43.9",
"Net Income": "15.0",
"General and Administrative Expense": "-61.2",
"Other Expenses": "24.6",
"Other Revenues": "43.9",
"Comprehensive Net Income": "15.3",
"Other Net Income": "-2.19",
"Economic Capital Ratio": "75.5"
},
"2017": {
"Other Liabilities": "23.3",
"Liabilities": "109",
"Stockholders Equity": "51.9",
"ECR before LimitedLiability": "95.4",
"Liabilities, Current": "63.6",
"Liabilities, Non-Current": "41.1",
"Assets, Non-Current": "-2.47",
"Assets": "-10.1",
"Assets, Current": "11.8",
"Goodwill": "-8.27",
"Property, Plant and Equipment, Net": "-10.0",
"Research and Development": "-3.93",
"Expenses": "-41.9",
"Revenues": "70.8",
"Net Income": "24.6",
"Other Expenses": "35.6",
"General and Administrative Expense": "-80.3",
"Other Revenues": "70.8",
"Comprehensive Net Income": "24.0",
"Other Net Income": "-6.42",
"Economic Capital Ratio": "73.8"
},
"2018": {
"Liabilities, Non-Current": "31.3",
"Liabilities": "78.8",
"Stockholders Equity": "26.9",
"ECR before LimitedLiability": "75.2",
"Other Liabilities": "19.4",
"Liabilities, Current": "36.4",
"Property, Plant and Equipment, Net": "-10.8",
"Assets": "-14.1",
"Other Assets": "2.34",
"Assets, Current": "15.0",
"Goodwill": "-10.3",
"Assets, Non-Current": "-7.00",
"Other Expenses": "18.2",
"Expenses": "-33.8",
"Revenues": "54.3",
"Net Income": "19.1",
"Research and Development": "-10.2",
"General and Administrative Expense": "-42.0",
"Other Revenues": "54.3",
"Comprehensive Net Income": "19.4",
"Economic Capital Ratio": "54.7"
},
"2019": {
"Liabilities, Non-Current": "34.0",
"Liabilities": "71.0",
"Stockholders Equity": "13.5",
"ECR before LimitedLiability": "57.0",
"Other Liabilities": "22.3",
"Liabilities, Current": "19.6",
"Assets, Non-Current": "-14.1",
"Assets": "-23.6",
"Goodwill": "-16.1",
"Property, Plant and Equipment, Net": "-15.7",
"Assets, Current": "23.6",
"Research and Development": "-20.0",
"Expenses": "-40.0",
"Revenues": "47.5",
"Net Income": "8.40",
"Other Expenses": "15.9",
"General and Administrative Expense": "-35.1",
"Other Revenues": "47.5",
"Other Net Income": "7.58",
"Comprehensive Net Income": "8.39",
"Economic Capital Ratio": "27.5"
},
"2020": {
"Liabilities, Current": "26.3",
"Liabilities": "40.9",
"Stockholders Equity": "59.7",
"ECR before LimitedLiability": "106",
"Liabilities, Non-Current": "10.8",
"Other Liabilities": "6.70",
"Goodwill": "-5.95",
"Assets": "13.2",
"Assets, Current": "37.7",
"Assets, Non-Current": "0.818",
"Property, Plant and Equipment, Net": "-7.35",
"Other Expenses": "7.60",
"Expenses": "-1.71",
"Revenues": "6.01",
"Net Income": "9.52",
"Research and Development": "-5.25",
"General and Administrative Expense": "-4.13",
"Other Revenues": "6.01",
"Comprehensive Net Income": "9.59",
"Other Net Income": "5.22",
"Economic Capital Ratio": "67.8"
},
"2021": {
"Liabilities, Non-Current": "13.3",
"Liabilities": "54.6",
"Stockholders Equity": "0.850",
"ECR before LimitedLiability": "-7.01",
"Liabilities, Current": "32.0",
"Other Liabilities": "12.0",
"Assets, Current": "15.0",
"Assets": "-26.3",
"Other Assets": "3.44",
"Goodwill": "-21.7",
"Property, Plant and Equipment, Net": "-19.3",
"Other Expenses": "17.3",
"Expenses": "-53.1",
"Revenues": "17.0",
"Net Income": "-37.4",
"Research and Development": "-7.57",
"General and Administrative Expense": "-60.9",
"Other Revenues": "17.0",
"Comprehensive Net Income": "-37.4",
"Other Net Income": "1.66",
"Economic Capital Ratio": "-11.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000073290_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "4,487",
"Assets, Non-Current": "79",
"General and Administrative Expense": "5,229",
"Goodwill": "195",
"Liabilities, Current": "592",
"Liabilities, Non-Current": "0",
"Other Assets": "226",
"Other Compr. Net Income": "-1.6",
"Other Expenses": "65",
"Other Liabilities": "0",
"Other Net Income": "108",
"Other Revenues": "6,081",
"Property, Plant and Equipment, Net": "585",
"Research and Development": "347"
},
"output_variables": {
"Liabilities": "592",
"Assets": "5,571",
"Expenses": "5,641",
"Revenues": "6,081",
"Stockholders Equity": "4,979",
"Net Income": "548",
"Comprehensive Net Income": "548",
"BaseVar": "8,998",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "263%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "5,253",
"Assets, Non-Current": "71",
"General and Administrative Expense": "5,500",
"Goodwill": "165",
"Liabilities, Current": "560",
"Liabilities, Non-Current": "0",
"Other Assets": "250",
"Other Compr. Net Income": "-3.0",
"Other Expenses": "-12",
"Other Liabilities": "0",
"Other Net Income": "10",
"Other Revenues": "6,473",
"Property, Plant and Equipment, Net": "655",
"Research and Development": "459"
},
"output_variables": {
"Liabilities": "560",
"Assets": "6,395",
"Expenses": "5,946",
"Revenues": "6,473",
"Stockholders Equity": "5,835",
"Net Income": "537",
"Comprehensive Net Income": "535",
"BaseVar": "9,694",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "268%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "4,913",
"Assets, Non-Current": "36",
"General and Administrative Expense": "4,977",
"Goodwill": "382",
"Liabilities, Current": "556",
"Liabilities, Non-Current": "0",
"Other Assets": "524",
"Other Compr. Net Income": "-1.1",
"Other Expenses": "-211",
"Other Liabilities": "0",
"Other Net Income": "20",
"Other Revenues": "5,120",
"Property, Plant and Equipment, Net": "614",
"Research and Development": "590"
},
"output_variables": {
"Liabilities": "556",
"Assets": "6,470",
"Expenses": "5,356",
"Revenues": "5,120",
"Stockholders Equity": "5,914",
"Net Income": "-216",
"Comprehensive Net Income": "-216",
"BaseVar": "8,762",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "252%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "4,392",
"Assets, Non-Current": "57",
"General and Administrative Expense": "4,899",
"Goodwill": "321",
"Liabilities, Current": "524",
"Liabilities, Non-Current": "0",
"Other Assets": "909",
"Other Compr. Net Income": "-2.1",
"Other Expenses": "-315",
"Other Liabilities": "0",
"Other Net Income": "24",
"Other Revenues": "4,962",
"Property, Plant and Equipment, Net": "445",
"Research and Development": "734"
},
"output_variables": {
"Liabilities": "524",
"Assets": "6,124",
"Expenses": "5,318",
"Revenues": "4,962",
"Stockholders Equity": "5,601",
"Net Income": "-331",
"Comprehensive Net Income": "-332",
"BaseVar": "8,477",
"ECR before LimitedLiability": "221%",
"Economic Capital Ratio": "249%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "4,835",
"Assets, Non-Current": "56",
"General and Administrative Expense": "5,186",
"Goodwill": "249",
"Liabilities, Current": "506",
"Liabilities, Non-Current": "0",
"Other Assets": "206",
"Other Compr. Net Income": "-1.3",
"Other Expenses": "704",
"Other Liabilities": "0",
"Other Net Income": "31",
"Other Revenues": "5,140",
"Property, Plant and Equipment, Net": "381",
"Research and Development": "780"
},
"output_variables": {
"Liabilities": "506",
"Assets": "5,727",
"Expenses": "6,671",
"Revenues": "5,140",
"Stockholders Equity": "5,220",
"Net Income": "-1,500",
"Comprehensive Net Income": "-1,500",
"BaseVar": "9,038",
"ECR before LimitedLiability": "181%",
"Economic Capital Ratio": "222%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "4,210",
"Assets, Non-Current": "95",
"General and Administrative Expense": "5,616",
"Goodwill": "174",
"Liabilities, Current": "529",
"Liabilities, Non-Current": "0",
"Other Assets": "206",
"Other Compr. Net Income": "-2.2",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "46",
"Other Revenues": "5,792",
"Property, Plant and Equipment, Net": "332",
"Research and Development": "1,131"
},
"output_variables": {
"Liabilities": "529",
"Assets": "5,018",
"Expenses": "6,746",
"Revenues": "5,792",
"Stockholders Equity": "4,489",
"Net Income": "-909",
"Comprehensive Net Income": "-910",
"BaseVar": "9,067",
"ECR before LimitedLiability": "189%",
"Economic Capital Ratio": "227%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "4,484",
"Assets, Non-Current": "113",
"General and Administrative Expense": "5,648",
"Goodwill": "99",
"Liabilities, Current": "897",
"Liabilities, Non-Current": "0",
"Other Assets": "175",
"Other Compr. Net Income": "-10",
"Other Expenses": "32",
"Other Liabilities": "0",
"Other Net Income": "48",
"Other Revenues": "5,564",
"Property, Plant and Equipment, Net": "351",
"Research and Development": "1,398"
},
"output_variables": {
"Liabilities": "897",
"Assets": "5,223",
"Expenses": "7,078",
"Revenues": "5,564",
"Stockholders Equity": "4,326",
"Net Income": "-1,466",
"Comprehensive Net Income": "-1,471",
"BaseVar": "9,410",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "198%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,495",
"Assets, Non-Current": "127",
"General and Administrative Expense": "5,934",
"Goodwill": "107",
"Liabilities, Current": "1,264",
"Liabilities, Non-Current": "0",
"Other Assets": "165",
"Other Compr. Net Income": "-10",
"Other Expenses": "24",
"Other Liabilities": "0",
"Other Net Income": "44",
"Other Revenues": "5,201",
"Property, Plant and Equipment, Net": "351",
"Research and Development": "1,679"
},
"output_variables": {
"Liabilities": "1,264",
"Assets": "5,245",
"Expenses": "7,638",
"Revenues": "5,201",
"Stockholders Equity": "3,981",
"Net Income": "-2,393",
"Comprehensive Net Income": "-2,398",
"BaseVar": "9,701",
"ECR before LimitedLiability": "94%",
"Economic Capital Ratio": "163%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "14,767",
"Assets, Non-Current": "1,880",
"General and Administrative Expense": "7,185",
"Goodwill": "169",
"Liabilities, Current": "1,477",
"Liabilities, Non-Current": "1,570",
"Other Assets": "165",
"Other Compr. Net Income": "-3.3",
"Other Expenses": "7.4",
"Other Liabilities": "0",
"Other Net Income": "71",
"Other Revenues": "6,693",
"Property, Plant and Equipment, Net": "279",
"Research and Development": "1,910"
},
"output_variables": {
"Liabilities": "3,047",
"Assets": "17,260",
"Expenses": "9,103",
"Revenues": "6,693",
"Stockholders Equity": "14,213",
"Net Income": "-2,339",
"Comprehensive Net Income": "-2,341",
"BaseVar": "18,088",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "214%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "9,231",
"Assets, Non-Current": "1,817",
"General and Administrative Expense": "12,504",
"Goodwill": "295",
"Liabilities, Current": "1,300",
"Liabilities, Non-Current": "1,292",
"Other Assets": "165",
"Other Compr. Net Income": "-8.1",
"Other Expenses": "13",
"Other Liabilities": "0",
"Other Net Income": "66",
"Other Revenues": "7,199",
"Property, Plant and Equipment, Net": "311",
"Research and Development": "2,194"
},
"output_variables": {
"Liabilities": "2,592",
"Assets": "11,819",
"Expenses": "14,712",
"Revenues": "7,199",
"Stockholders Equity": "9,227",
"Net Income": "-7,446",
"Comprehensive Net Income": "-7,450",
"BaseVar": "18,198",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "147%"
}
}
},
"top_rated": false,
"trend": -19.0,
"value": 1.4745029654713973,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000073290.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000073290.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000073290.svg"
},
{
"company_id": "0000074303",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000074303.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000074303.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000074303.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000074303_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000074303_main_keyfigs.svg",
"name": "OLIN Corp",
"rank": 29,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000074303.svg",
"report_text": "The relative strengths and weaknesses of OLIN Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of OLIN Corp compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 54% points.The greatest weakness of OLIN Corp is the variable Stockholders Equity, reducing the Economic Capital Ratio by 68% points.
The company's Economic Capital Ratio, given in the ranking table, is 146%, being 13% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000074303_2022_OLIN_Corp.pdf",
"shrinked_graph_json": {
"2010": {
"Liabilities": "-32.8",
"Stockholders Equity": "-28.9",
"ECR before LimitedLiability": "-30.5",
"Liabilities, Current": "1.73",
"Liabilities, Non-Current": "-36.2",
"Goodwill": "-4.33",
"Assets": "-4.43",
"Property, Plant and Equipment, Net": "15.0",
"Assets, Current": "-12.7",
"Assets, Non-Current": "-7.23",
"Other Assets": "9.43",
"Other Expenses": "21.0",
"Expenses": "8.06",
"Revenues": "-3.03",
"Net Income": "9.56",
"General and Administrative Expense": "-19.2",
"Research and Development": "8.02",
"Other Revenues": "-3.03",
"Other Net Income": "4.53",
"Comprehensive Net Income": "9.63",
"Economic Capital Ratio": "-28.5"
},
"2011": {
"Liabilities, Current": "25.7",
"Liabilities": "-22.1",
"Stockholders Equity": "-11.3",
"ECR before LimitedLiability": "63.0",
"Liabilities, Non-Current": "-61.5",
"Other Liabilities": "5.23",
"Property, Plant and Equipment, Net": "22.8",
"Assets": "3.43",
"Assets, Non-Current": "-2.36",
"Other Assets": "2.89",
"Goodwill": "11.7",
"Assets, Current": "-21.4",
"General and Administrative Expense": "-4.85",
"Expenses": "28.8",
"Revenues": "16.3",
"Net Income": "47.9",
"Research and Development": "14.7",
"Other Expenses": "18.4",
"Other Revenues": "16.3",
"Comprehensive Net Income": "47.8",
"Economic Capital Ratio": "0.966"
},
"2012": {
"Liabilities, Current": "15.1",
"Liabilities": "-34.4",
"Stockholders Equity": "-22.1",
"ECR before LimitedLiability": "16.0",
"Liabilities, Non-Current": "-69.6",
"Other Liabilities": "12.2",
"Assets, Current": "-26.2",
"Assets": "2.32",
"Assets, Non-Current": "1.50",
"Property, Plant and Equipment, Net": "27.3",
"Goodwill": "12.7",
"Other Expenses": "25.4",
"Expenses": "33.0",
"Revenues": "14.0",
"Net Income": "48.4",
"Research and Development": "16.2",
"General and Administrative Expense": "-8.75",
"Other Revenues": "14.0",
"Comprehensive Net Income": "46.8",
"Other Compr. Net Income": "-1.24",
"Economic Capital Ratio": "-16.5"
},
"2013": {
"Liabilities, Current": "25.1",
"Liabilities": "-16.8",
"Stockholders Equity": "-18.2",
"ECR before LimitedLiability": "35.3",
"Other Liabilities": "8.23",
"Liabilities, Non-Current": "-57.4",
"Goodwill": "9.75",
"Assets": "-4.23",
"Property, Plant and Equipment, Net": "23.4",
"Other Assets": "-2.99",
"Assets, Current": "-24.2",
"General and Administrative Expense": "-18.6",
"Expenses": "22.4",
"Revenues": "28.7",
"Net Income": "50.6",
"Research and Development": "14.3",
"Other Expenses": "28.6",
"Other Revenues": "28.7",
"Other Net Income": "-2.96",
"Comprehensive Net Income": "50.6",
"Economic Capital Ratio": "-4.82"
},
"2014": {
"Liabilities, Non-Current": "-58.3",
"Liabilities": "-1.31",
"Stockholders Equity": "3.36",
"ECR before LimitedLiability": "56.9",
"Liabilities, Current": "41.5",
"Other Liabilities": "6.72",
"Assets, Current": "-23.7",
"Assets": "3.47",
"Goodwill": "10.7",
"Assets, Non-Current": "1.43",
"Property, Plant and Equipment, Net": "25.0",
"Other Expenses": "18.1",
"Expenses": "25.8",
"Revenues": "24.3",
"Net Income": "55.5",
"Research and Development": "16.9",
"General and Administrative Expense": "-9.17",
"Other Revenues": "24.3",
"Other Net Income": "1.76",
"Comprehensive Net Income": "53.8",
"Economic Capital Ratio": "7.51"
},
"2015": {
"Other Liabilities": "-5.10",
"Liabilities": "-44.7",
"Stockholders Equity": "-3.52",
"ECR before LimitedLiability": "31.4",
"Liabilities, Current": "23.6",
"Liabilities, Non-Current": "-68.3",
"Assets, Current": "-21.1",
"Assets": "35.6",
"Other Assets": "-5.63",
"Goodwill": "23.8",
"Assets, Non-Current": "2.30",
"Property, Plant and Equipment, Net": "37.0",
"Research and Development": "9.38",
"Expenses": "36.8",
"Revenues": "-6.46",
"Net Income": "35.9",
"General and Administrative Expense": "8.62",
"Other Expenses": "22.4",
"Other Revenues": "-6.46",
"Comprehensive Net Income": "35.9",
"Economic Capital Ratio": "-14.5"
},
"2016": {
"Liabilities, Non-Current": "-66.8",
"Liabilities": "-35.4",
"Stockholders Equity": "-31.1",
"ECR before LimitedLiability": "-5.23",
"Liabilities, Current": "34.1",
"Other Liabilities": "-9.56",
"Property, Plant and Equipment, Net": "32.8",
"Assets": "-3.37",
"Assets, Non-Current": "2.84",
"Assets, Current": "-37.5",
"Goodwill": "19.8",
"Research and Development": "16.9",
"Expenses": "27.1",
"Revenues": "12.2",
"Net Income": "36.8",
"General and Administrative Expense": "-16.2",
"Other Expenses": "27.8",
"Other Revenues": "12.2",
"Comprehensive Net Income": "36.8",
"Other Net Income": "-2.11",
"Economic Capital Ratio": "-25.2"
},
"2017": {
"Other Liabilities": "11.6",
"Liabilities": "-25.3",
"Stockholders Equity": "-23.1",
"ECR before LimitedLiability": "0.975",
"Liabilities, Current": "25.2",
"Liabilities, Non-Current": "-71.0",
"Assets, Non-Current": "8.31",
"Assets": "-3.08",
"Assets, Current": "-29.2",
"Goodwill": "12.8",
"Property, Plant and Equipment, Net": "16.8",
"Research and Development": "16.0",
"Expenses": "21.7",
"Revenues": "19.9",
"Net Income": "38.0",
"Other Expenses": "25.3",
"General and Administrative Expense": "-17.9",
"Other Revenues": "19.9",
"Comprehensive Net Income": "37.7",
"Other Net Income": "-4.78",
"Economic Capital Ratio": "-20.6"
},
"2018": {
"Liabilities, Non-Current": "-66.1",
"Liabilities": "-27.7",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "8.83",
"Other Liabilities": "12.2",
"Liabilities, Current": "19.3",
"Property, Plant and Equipment, Net": "21.7",
"Assets": "-10.3",
"Assets, Current": "-33.4",
"Goodwill": "15.5",
"Assets, Non-Current": "1.48",
"Other Expenses": "8.51",
"Expenses": "19.2",
"Revenues": "23.2",
"Net Income": "44.5",
"Research and Development": "15.8",
"General and Administrative Expense": "-5.21",
"Other Revenues": "23.2",
"Comprehensive Net Income": "44.4",
"Other Compr. Net Income": "-0.146",
"Economic Capital Ratio": "-11.6"
},
"2019": {
"Liabilities, Non-Current": "-74.5",
"Liabilities": "-35.7",
"Stockholders Equity": "-37.2",
"ECR before LimitedLiability": "15.6",
"Other Liabilities": "13.9",
"Liabilities, Current": "17.3",
"Assets, Non-Current": "1.82",
"Assets": "-8.76",
"Goodwill": "13.7",
"Property, Plant and Equipment, Net": "20.7",
"Assets, Current": "-32.8",
"Research and Development": "11.8",
"Expenses": "24.9",
"Revenues": "15.4",
"Net Income": "37.6",
"Other Expenses": "8.45",
"General and Administrative Expense": "3.85",
"Other Revenues": "15.4",
"Other Net Income": "4.91",
"Comprehensive Net Income": "37.6",
"Economic Capital Ratio": "-13.9"
},
"2020": {
"Liabilities, Current": "13.9",
"Liabilities": "-37.9",
"Stockholders Equity": "-65.7",
"ECR before LimitedLiability": "-9.61",
"Liabilities, Non-Current": "-67.4",
"Other Liabilities": "6.52",
"Goodwill": "4.16",
"Assets": "-32.1",
"Assets, Current": "-47.5",
"Assets, Non-Current": "4.92",
"Property, Plant and Equipment, Net": "13.9",
"Expenses": "0.482",
"Net Income": "14.1",
"Research and Development": "10.9",
"General and Administrative Expense": "-9.58",
"Other Revenues": "13.9",
"Revenues": "13.9",
"Other Compr. Net Income": "0.832",
"Comprehensive Net Income": "14.1",
"Other Net Income": "7.13",
"Economic Capital Ratio": "-47.4"
},
"2021": {
"Liabilities, Non-Current": "-36.8",
"Liabilities": "-16.3",
"Stockholders Equity": "-67.8",
"ECR before LimitedLiability": "-8.60",
"Liabilities, Current": "8.03",
"Other Liabilities": "10.3",
"Assets, Current": "-35.1",
"Assets": "-33.6",
"Assets, Non-Current": "-1.15",
"Other Assets": "2.51",
"Goodwill": "-6.53",
"Property, Plant and Equipment, Net": "9.17",
"Other Expenses": "8.45",
"Expenses": "2.48",
"Revenues": "48.4",
"Net Income": "52.6",
"Research and Development": "13.7",
"General and Administrative Expense": "-18.4",
"Other Revenues": "48.4",
"Comprehensive Net Income": "53.9",
"Economic Capital Ratio": "-12.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000074303_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "882,800",
"Assets, Non-Current": "72,300",
"General and Administrative Expense": "1,484,300",
"Goodwill": "300,300",
"Liabilities, Current": "391,000",
"Liabilities, Non-Current": "803,900",
"Other Assets": "118,300",
"Other Compr. Net Income": "0",
"Other Expenses": "71,700",
"Other Liabilities": "23,500",
"Other Net Income": "34,900",
"Other Revenues": "1,585,900",
"Property, Plant and Equipment, Net": "675,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,218,400",
"Assets": "2,048,700",
"Expenses": "1,556,000",
"Revenues": "1,585,900",
"Stockholders Equity": "830,300",
"Net Income": "64,800",
"Comprehensive Net Income": "64,800",
"BaseVar": "3,221,950",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "149%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "780,300",
"Assets, Non-Current": "85,600",
"General and Administrative Expense": "1,735,300",
"Goodwill": "627,400",
"Liabilities, Current": "399,100",
"Liabilities, Non-Current": "965,100",
"Other Assets": "70,900",
"Other Compr. Net Income": "0",
"Other Expenses": "178,800",
"Other Liabilities": "99,600",
"Other Net Income": "185,900",
"Other Revenues": "1,969,900",
"Property, Plant and Equipment, Net": "885,400",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,463,800",
"Assets": "2,449,600",
"Expenses": "1,914,100",
"Revenues": "1,969,900",
"Stockholders Equity": "985,800",
"Net Income": "241,700",
"Comprehensive Net Income": "241,700",
"BaseVar": "3,991,650",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "749,100",
"Assets, Non-Current": "224,100",
"General and Administrative Expense": "1,916,600",
"Goodwill": "747,100",
"Liabilities, Current": "434,000",
"Liabilities, Non-Current": "1,234,900",
"Other Assets": "23,100",
"Other Compr. Net Income": "-77,100",
"Other Expenses": "118,800",
"Other Liabilities": "110,400",
"Other Net Income": "-7,300",
"Other Revenues": "2,192,300",
"Property, Plant and Equipment, Net": "1,034,300",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,779,300",
"Assets": "2,777,700",
"Expenses": "2,035,400",
"Revenues": "2,192,300",
"Stockholders Equity": "998,400",
"Net Income": "149,600",
"Comprehensive Net Income": "111,050",
"BaseVar": "4,434,550",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "839,900",
"Assets, Non-Current": "213,100",
"General and Administrative Expense": "2,223,700",
"Goodwill": "747,100",
"Liabilities, Current": "407,500",
"Liabilities, Non-Current": "1,176,600",
"Other Assets": "14,900",
"Other Compr. Net Income": "6,200",
"Other Expenses": "115,500",
"Other Liabilities": "117,600",
"Other Net Income": "2,100",
"Other Revenues": "2,515,700",
"Property, Plant and Equipment, Net": "987,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,701,700",
"Assets": "2,802,800",
"Expenses": "2,339,200",
"Revenues": "2,515,700",
"Stockholders Equity": "1,101,100",
"Net Income": "178,600",
"Comprehensive Net Income": "181,700",
"BaseVar": "4,683,850",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "150%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "816,100",
"Assets, Non-Current": "191,400",
"General and Administrative Expense": "2,023,600",
"Goodwill": "747,100",
"Liabilities, Current": "377,700",
"Liabilities, Non-Current": "1,200,000",
"Other Assets": "12,500",
"Other Compr. Net Income": "-78,000",
"Other Expenses": "176,100",
"Other Liabilities": "107,100",
"Other Net Income": "3,800",
"Other Revenues": "2,242,700",
"Property, Plant and Equipment, Net": "931,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,684,800",
"Assets": "2,698,100",
"Expenses": "2,199,700",
"Revenues": "2,242,700",
"Stockholders Equity": "1,013,300",
"Net Income": "46,800",
"Comprehensive Net Income": "7,800",
"BaseVar": "4,453,550",
"ECR before LimitedLiability": "64%",
"Economic Capital Ratio": "141%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,933,400",
"Assets, Non-Current": "487,500",
"General and Administrative Expense": "2,673,300",
"Goodwill": "2,851,600",
"Liabilities, Current": "1,147,700",
"Liabilities, Non-Current": "4,660,100",
"Other Assets": "95,900",
"Other Compr. Net Income": "-49,400",
"Other Expenses": "305,800",
"Other Liabilities": "1,095,200",
"Other Net Income": "3,000",
"Other Revenues": "2,900,100",
"Property, Plant and Equipment, Net": "3,953,400",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,903,000",
"Assets": "9,321,800",
"Expenses": "2,979,100",
"Revenues": "2,900,100",
"Stockholders Equity": "2,418,800",
"Net Income": "-76,000",
"Comprehensive Net Income": "-100,700",
"BaseVar": "11,078,200",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "121%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "1,546,200",
"Assets, Non-Current": "644,400",
"General and Administrative Expense": "5,246,900",
"Goodwill": "2,747,600",
"Liabilities, Current": "922,600",
"Liabilities, Non-Current": "4,534,500",
"Other Assets": "119,500",
"Other Compr. Net Income": "-17,500",
"Other Expenses": "400,600",
"Other Liabilities": "1,032,500",
"Other Net Income": "5,100",
"Other Revenues": "5,561,200",
"Property, Plant and Equipment, Net": "3,704,900",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,489,600",
"Assets": "8,762,600",
"Expenses": "5,647,500",
"Revenues": "5,561,200",
"Stockholders Equity": "2,273,000",
"Net Income": "-81,200",
"Comprehensive Net Income": "-89,950",
"BaseVar": "13,241,750",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "121%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,699,200",
"Assets, Non-Current": "1,208,400",
"General and Administrative Expense": "5,890,300",
"Goodwill": "2,698,500",
"Liabilities, Current": "1,465,500",
"Liabilities, Non-Current": "4,999,100",
"Other Assets": "36,400",
"Other Compr. Net Income": "25,400",
"Other Expenses": "-14,900",
"Other Liabilities": "0",
"Other Net Income": "3,600",
"Other Revenues": "6,271,700",
"Property, Plant and Equipment, Net": "3,575,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,464,600",
"Assets": "9,218,300",
"Expenses": "5,875,400",
"Revenues": "6,271,700",
"Stockholders Equity": "2,753,700",
"Net Income": "399,900",
"Comprehensive Net Income": "412,600",
"BaseVar": "13,929,500",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "133%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,707,400",
"Assets, Non-Current": "1,150,400",
"General and Administrative Expense": "6,252,700",
"Goodwill": "2,631,200",
"Liabilities, Current": "1,637,200",
"Liabilities, Non-Current": "4,528,000",
"Other Assets": "26,300",
"Other Compr. Net Income": "-80,500",
"Other Expenses": "562,700",
"Other Liabilities": "0",
"Other Net Income": "3,600",
"Other Revenues": "6,952,500",
"Property, Plant and Equipment, Net": "3,482,100",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,165,200",
"Assets": "8,997,400",
"Expenses": "6,815,400",
"Revenues": "6,952,500",
"Stockholders Equity": "2,832,200",
"Net Income": "140,700",
"Comprehensive Net Income": "100,450",
"BaseVar": "14,507,300",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,714,000",
"Assets, Non-Current": "1,546,900",
"General and Administrative Expense": "5,856,100",
"Goodwill": "2,567,800",
"Liabilities, Current": "1,536,700",
"Liabilities, Non-Current": "5,233,600",
"Other Assets": "35,300",
"Other Compr. Net Income": "-152,400",
"Other Expenses": "294,100",
"Other Liabilities": "0",
"Other Net Income": "17,300",
"Other Revenues": "6,121,600",
"Property, Plant and Equipment, Net": "3,323,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,770,300",
"Assets": "9,187,800",
"Expenses": "6,150,200",
"Revenues": "6,121,600",
"Stockholders Equity": "2,417,500",
"Net Income": "-11,300",
"Comprehensive Net Income": "-87,500",
"BaseVar": "14,199,800",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "122%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,717,100",
"Assets, Non-Current": "1,552,000",
"General and Administrative Expense": "5,796,600",
"Goodwill": "1,819,600",
"Liabilities, Current": "1,642,100",
"Liabilities, Non-Current": "5,178,000",
"Other Assets": "11,200",
"Other Compr. Net Income": "113,500",
"Other Expenses": "932,500",
"Other Liabilities": "0",
"Other Net Income": "500",
"Other Revenues": "5,758,700",
"Property, Plant and Equipment, Net": "3,171,000",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,820,100",
"Assets": "8,270,900",
"Expenses": "6,729,100",
"Revenues": "5,758,700",
"Stockholders Equity": "1,450,800",
"Net Income": "-969,900",
"Comprehensive Net Income": "-913,150",
"BaseVar": "13,846,400",
"ECR before LimitedLiability": "14%",
"Economic Capital Ratio": "98%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "2,248,300",
"Assets, Non-Current": "1,504,200",
"General and Administrative Expense": "7,033,300",
"Goodwill": "1,752,300",
"Liabilities, Current": "2,241,000",
"Liabilities, Non-Current": "3,624,500",
"Other Assets": "99,300",
"Other Compr. Net Income": "201,900",
"Other Expenses": "582,200",
"Other Liabilities": "0",
"Other Net Income": "200",
"Other Revenues": "8,912,000",
"Property, Plant and Equipment, Net": "2,913,600",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,865,500",
"Assets": "8,517,700",
"Expenses": "7,615,500",
"Revenues": "8,912,000",
"Stockholders Equity": "2,652,200",
"Net Income": "1,296,700",
"Comprehensive Net Income": "1,397,650",
"BaseVar": "15,556,400",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "146%"
}
}
},
"top_rated": false,
"trend": 4.0,
"value": 1.4586592651619676,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000074303.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000074303.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000074303.svg"
},
{
"company_id": "0001737927",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001737927.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001737927.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001737927.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001737927_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001737927_main_keyfigs.svg",
"name": "Canopy Growth Corp",
"rank": 30,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001737927.svg",
"report_text": "The relative strengths and weaknesses of Canopy Growth Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Canopy Growth Corp compared to the market average is the variable Assets, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Canopy Growth Corp is the variable Liabilities, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 140%, being 19% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001737927_2022_Canopy_Growth_Corp.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "18.8",
"Liabilities": "9.26",
"Stockholders Equity": "64.1",
"ECR before LimitedLiability": "84.7",
"Liabilities, Non-Current": "3.07",
"Other Liabilities": "-14.1",
"Goodwill": "24.5",
"Assets": "38.3",
"Other Assets": "2.66",
"Assets, Non-Current": "-4.30",
"Property, Plant and Equipment, Net": "8.01",
"Other Expenses": "-7.00",
"Expenses": "12.9",
"Revenues": "-21.8",
"Net Income": "-3.02",
"Research and Development": "5.39",
"General and Administrative Expense": "14.5",
"Other Revenues": "-21.8",
"Other Net Income": "6.04",
"Economic Capital Ratio": "46.9",
"Other Compr. Net Income": "2.33"
},
"2021": {
"Liabilities, Non-Current": "-26.0",
"Liabilities": "-30.3",
"Stockholders Equity": "6.92",
"ECR before LimitedLiability": "-14.5",
"Liabilities, Current": "21.1",
"Other Liabilities": "-26.8",
"Assets": "29.1",
"Assets, Non-Current": "-10.2",
"Other Assets": "14.1",
"Goodwill": "23.6",
"Property, Plant and Equipment, Net": "2.99",
"Expenses": "25.4",
"Net Income": "-5.62",
"Research and Development": "8.42",
"General and Administrative Expense": "18.8",
"Other Revenues": "-22.2",
"Revenues": "-22.2",
"Other Compr. Net Income": "-2.57",
"Comprehensive Net Income": "-8.12",
"Other Net Income": "-6.29",
"Economic Capital Ratio": "-18.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001737927_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "2,564,373",
"Assets, Non-Current": "88,479",
"General and Administrative Expense": "1,124,193",
"Goodwill": "2,430,837",
"Liabilities, Current": "467,702",
"Liabilities, Non-Current": "639,682",
"Other Assets": "249,253",
"Other Compr. Net Income": "292,918",
"Other Expenses": "821,928",
"Other Liabilities": "572,491",
"Other Net Income": "159,909",
"Other Revenues": "398,772",
"Property, Plant and Equipment, Net": "1,524,803",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,679,875",
"Assets": "6,857,745",
"Expenses": "1,946,121",
"Revenues": "398,772",
"Stockholders Equity": "5,177,870",
"Net Income": "-1,387,440",
"Comprehensive Net Income": "-1,240,981",
"BaseVar": "5,667,670",
"ECR before LimitedLiability": "137%",
"Economic Capital Ratio": "193%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "2,838,194",
"Assets, Non-Current": "5,061",
"General and Administrative Expense": "1,055,078",
"Goodwill": "2,197,521",
"Liabilities, Current": "305,709",
"Liabilities, Non-Current": "1,680,376",
"Other Assets": "708,167",
"Other Compr. Net Income": "-329,239",
"Other Expenses": "721,886",
"Other Liabilities": "1,215,575",
"Other Net Income": "-440,505",
"Other Revenues": "546,649",
"Property, Plant and Equipment, Net": "1,074,537",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,201,660",
"Assets": "6,823,480",
"Expenses": "1,776,964",
"Revenues": "546,649",
"Stockholders Equity": "3,621,820",
"Net Income": "-1,670,820",
"Comprehensive Net Income": "-1,835,440",
"BaseVar": "6,559,248",
"ECR before LimitedLiability": "62%",
"Economic Capital Ratio": "140%"
}
}
},
"top_rated": false,
"trend": -11.0,
"value": 1.3999181624736494,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001737927.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001737927.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001737927.svg"
},
{
"company_id": "0001708035",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001708035.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001708035.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001708035.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001708035_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001708035_main_keyfigs.svg",
"name": "Ecovyst Inc",
"rank": 31,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001708035.svg",
"report_text": "The relative strengths and weaknesses of Ecovyst Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ecovyst Inc compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Ecovyst Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 64% points.
The company's Economic Capital Ratio, given in the ranking table, is 135%, being 23% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001708035_2022_Ecovyst_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "9.19",
"Liabilities": "-37.3",
"ECR before LimitedLiability": "9.85",
"Liabilities, Current": "21.9",
"Liabilities, Non-Current": "-79.3",
"Assets, Non-Current": "8.57",
"Assets": "26.7",
"Assets, Current": "-23.3",
"Goodwill": "47.0",
"Property, Plant and Equipment, Net": "9.83",
"Research and Development": "12.1",
"Expenses": "35.2",
"Net Income": "26.2",
"Other Expenses": "-8.19",
"General and Administrative Expense": "31.2",
"Other Revenues": "-3.05",
"Revenues": "-3.05",
"Comprehensive Net Income": "26.6",
"Other Compr. Net Income": "0.353",
"Other Net Income": "-4.72",
"Economic Capital Ratio": "-11.7"
},
"2018": {
"Liabilities, Non-Current": "-80.9",
"Liabilities": "-41.6",
"Stockholders Equity": "-5.97",
"ECR before LimitedLiability": "19.8",
"Other Liabilities": "9.26",
"Liabilities, Current": "19.2",
"Property, Plant and Equipment, Net": "13.6",
"Assets": "22.6",
"Assets, Current": "-25.1",
"Goodwill": "47.5",
"Assets, Non-Current": "5.14",
"Other Expenses": "6.75",
"Expenses": "34.4",
"Revenues": "-2.65",
"Net Income": "31.8",
"Research and Development": "11.4",
"General and Administrative Expense": "14.6",
"Other Revenues": "-2.65",
"Comprehensive Net Income": "31.4",
"Other Net Income": "0.385",
"Economic Capital Ratio": "-0.700"
},
"2019": {
"Liabilities, Non-Current": "-71.3",
"Liabilities": "-35.1",
"Stockholders Equity": "-1.31",
"ECR before LimitedLiability": "42.5",
"Other Liabilities": "3.07",
"Liabilities, Current": "23.8",
"Assets, Non-Current": "3.03",
"Assets": "21.3",
"Goodwill": "41.8",
"Property, Plant and Equipment, Net": "12.8",
"Assets, Current": "-22.2",
"Research and Development": "8.47",
"Expenses": "33.6",
"Revenues": "-2.25",
"Net Income": "36.1",
"Other Expenses": "4.19",
"General and Administrative Expense": "19.5",
"Other Revenues": "-2.25",
"Other Net Income": "4.42",
"Comprehensive Net Income": "36.4",
"Economic Capital Ratio": "13.0"
},
"2020": {
"Liabilities, Current": "18.1",
"Liabilities": "-32.0",
"Stockholders Equity": "-14.3",
"ECR before LimitedLiability": "27.7",
"Liabilities, Non-Current": "-60.4",
"Other Liabilities": "5.16",
"Goodwill": "35.4",
"Assets": "8.82",
"Assets, Current": "-30.4",
"Assets, Non-Current": "7.02",
"Property, Plant and Equipment, Net": "16.2",
"Other Expenses": "-2.54",
"Expenses": "18.8",
"Revenues": "-3.37",
"Net Income": "16.9",
"Research and Development": "7.44",
"General and Administrative Expense": "13.6",
"Other Revenues": "-3.37",
"Comprehensive Net Income": "16.8",
"Other Net Income": "1.70",
"Economic Capital Ratio": "-10.1"
},
"2021": {
"Liabilities, Non-Current": "-63.6",
"Liabilities": "-42.5",
"Stockholders Equity": "-26.1",
"ECR before LimitedLiability": "-19.0",
"Liabilities, Current": "9.78",
"Other Liabilities": "6.95",
"Assets, Current": "-29.7",
"Assets": "4.27",
"Assets, Non-Current": "16.3",
"Goodwill": "12.7",
"Property, Plant and Equipment, Net": "18.5",
"Other Expenses": "6.45",
"Expenses": "29.1",
"Revenues": "-4.42",
"Net Income": "16.5",
"Research and Development": "9.50",
"General and Administrative Expense": "11.9",
"Other Revenues": "-4.42",
"Comprehensive Net Income": "17.0",
"Other Net Income": "-6.77",
"Economic Capital Ratio": "-23.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001708035_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "548,968",
"Assets, Non-Current": "544,003",
"General and Administrative Expense": "145,107",
"Goodwill": "2,092,100",
"Liabilities, Current": "477,745",
"Liabilities, Non-Current": "2,305,791",
"Other Assets": "0",
"Other Compr. Net Income": "57,062",
"Other Expenses": "1,219,337",
"Other Liabilities": "0",
"Other Net Income": "-49,094",
"Other Revenues": "1,472,101",
"Property, Plant and Equipment, Net": "1,230,384",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,783,536",
"Assets": "4,415,455",
"Expenses": "1,364,444",
"Revenues": "1,472,101",
"Stockholders Equity": "1,631,919",
"Net Income": "58,563",
"Comprehensive Net Income": "87,094",
"BaseVar": "5,070,846",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "142%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "558,616",
"Assets, Non-Current": "576,465",
"General and Administrative Expense": "1,395,148",
"Goodwill": "1,983,365",
"Liabilities, Current": "451,735",
"Liabilities, Non-Current": "2,211,545",
"Other Assets": "0",
"Other Compr. Net Income": "-44,736",
"Other Expenses": "172,168",
"Other Liabilities": "0",
"Other Net Income": "18,783",
"Other Revenues": "1,608,154",
"Property, Plant and Equipment, Net": "1,208,979",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,663,280",
"Assets": "4,327,425",
"Expenses": "1,567,316",
"Revenues": "1,608,154",
"Stockholders Equity": "1,664,145",
"Net Income": "59,621",
"Comprehensive Net Income": "37,253",
"BaseVar": "5,114,847",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "143%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "568,591",
"Assets, Non-Current": "629,294",
"General and Administrative Expense": "1,343,430",
"Goodwill": "1,936,190",
"Liabilities, Current": "269,468",
"Liabilities, Non-Current": "2,048,022",
"Other Assets": "0",
"Other Compr. Net Income": "21,111",
"Other Expenses": "188,064",
"Other Liabilities": "218,037",
"Other Net Income": "44,732",
"Other Revenues": "1,567,072",
"Property, Plant and Equipment, Net": "1,186,770",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,535,527",
"Assets": "4,320,845",
"Expenses": "1,531,494",
"Revenues": "1,567,072",
"Stockholders Equity": "1,785,318",
"Net Income": "80,310",
"Comprehensive Net Income": "90,866",
"BaseVar": "5,010,390",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "149%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "428,140",
"Assets, Non-Current": "542,405",
"General and Administrative Expense": "959,301",
"Goodwill": "1,244,041",
"Liabilities, Current": "377,239",
"Liabilities, Non-Current": "1,543,403",
"Other Assets": "0",
"Other Compr. Net Income": "-11,559",
"Other Expenses": "329,843",
"Other Liabilities": "0",
"Other Net Income": "-99,923",
"Other Revenues": "1,107,363",
"Property, Plant and Equipment, Net": "983,235",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,920,642",
"Assets": "3,197,821",
"Expenses": "1,289,144",
"Revenues": "1,107,363",
"Stockholders Equity": "1,277,179",
"Net Income": "-281,704",
"Comprehensive Net Income": "-287,484",
"BaseVar": "3,813,226",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "136%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "291,669",
"Assets, Non-Current": "491,563",
"General and Administrative Expense": "532,321",
"Goodwill": "551,756",
"Liabilities, Current": "271,830",
"Liabilities, Non-Current": "918,652",
"Other Assets": "0",
"Other Compr. Net Income": "18,986",
"Other Expenses": "73,410",
"Other Liabilities": "0",
"Other Net Income": "-145,086",
"Other Revenues": "611,201",
"Property, Plant and Equipment, Net": "596,231",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "1,190,482",
"Assets": "1,931,219",
"Expenses": "605,731",
"Revenues": "611,201",
"Stockholders Equity": "740,737",
"Net Income": "-139,616",
"Comprehensive Net Income": "-130,123",
"BaseVar": "2,251,352",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "135%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 1.3547712756018568,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001708035.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001708035.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001708035.svg"
},
{
"company_id": "0001653477",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001653477.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001653477.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001653477.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001653477_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001653477_main_keyfigs.svg",
"name": "Ingevity Corp",
"rank": 32,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001653477.svg",
"report_text": "The relative strengths and weaknesses of Ingevity Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ingevity Corp compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Ingevity Corp is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 73% points.
The company's Economic Capital Ratio, given in the ranking table, is 129%, being 30% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001653477_2022_Ingevity_Corp.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-68.7",
"Liabilities": "-22.5",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "-14.4",
"Liabilities, Current": "27.8",
"Property, Plant and Equipment, Net": "27.7",
"Assets": "-33.1",
"Other Assets": "11.1",
"Assets, Non-Current": "-4.47",
"Assets, Current": "-40.4",
"Goodwill": "-19.7",
"Research and Development": "22.2",
"Expenses": "15.2",
"Revenues": "28.0",
"Net Income": "29.2",
"General and Administrative Expense": "28.1",
"Other Expenses": "-43.4",
"Other Revenues": "28.0",
"Comprehensive Net Income": "29.1",
"Other Net Income": "-2.29",
"Economic Capital Ratio": "-34.4"
},
"2017": {
"Other Liabilities": "13.9",
"Liabilities": "-6.60",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "10.8",
"Liabilities, Current": "27.6",
"Liabilities, Non-Current": "-54.9",
"Assets": "-19.5",
"Other Assets": "8.10",
"Assets, Current": "-20.4",
"Goodwill": "-16.5",
"Property, Plant and Equipment, Net": "19.1",
"Research and Development": "16.5",
"Expenses": "13.2",
"Revenues": "47.1",
"Net Income": "56.4",
"Other Expenses": "-38.4",
"General and Administrative Expense": "42.3",
"Other Revenues": "47.1",
"Comprehensive Net Income": "55.2",
"Other Net Income": "-5.38",
"Economic Capital Ratio": "-10.7"
},
"2018": {
"Liabilities, Non-Current": "-77.8",
"Liabilities": "-33.1",
"Stockholders Equity": "-40.7",
"ECR before LimitedLiability": "11.3",
"Other Liabilities": "12.2",
"Liabilities, Current": "22.4",
"Property, Plant and Equipment, Net": "20.8",
"Assets": "-13.2",
"Other Assets": "5.75",
"Assets, Current": "-25.2",
"Goodwill": "2.63",
"Assets, Non-Current": "-8.41",
"Other Expenses": "8.57",
"Expenses": "25.2",
"Revenues": "29.3",
"Net Income": "50.1",
"Research and Development": "14.1",
"General and Administrative Expense": "1.73",
"Other Revenues": "29.3",
"Comprehensive Net Income": "50.0",
"Economic Capital Ratio": "-9.18"
},
"2019": {
"Liabilities, Non-Current": "-83.7",
"Liabilities": "-43.7",
"Stockholders Equity": "-33.4",
"ECR before LimitedLiability": "22.7",
"Other Liabilities": "12.9",
"Liabilities, Current": "17.3",
"Research and Development": "9.63",
"Expenses": "33.2",
"Net Income": "44.6",
"Other Expenses": "4.69",
"General and Administrative Expense": "17.4",
"Other Revenues": "11.8",
"Revenues": "11.8",
"Assets, Non-Current": "-9.30",
"Goodwill": "29.9",
"Property, Plant and Equipment, Net": "13.9",
"Other Assets": "4.86",
"Assets, Current": "-26.2",
"Other Net Income": "4.77",
"Comprehensive Net Income": "44.6",
"Economic Capital Ratio": "-6.78"
},
"2020": {
"Liabilities, Current": "17.2",
"Liabilities": "-41.7",
"Stockholders Equity": "-35.7",
"ECR before LimitedLiability": "24.4",
"Liabilities, Non-Current": "-70.7",
"Other Liabilities": "5.43",
"Goodwill": "24.6",
"Assets": "-4.67",
"Other Assets": "3.60",
"Assets, Current": "-25.2",
"Assets, Non-Current": "-7.74",
"Property, Plant and Equipment, Net": "11.7",
"Expenses": "21.1",
"Revenues": "8.68",
"Net Income": "37.1",
"Research and Development": "7.01",
"General and Administrative Expense": "10.0",
"Other Revenues": "8.68",
"Comprehensive Net Income": "37.4",
"Other Net Income": "5.58",
"Economic Capital Ratio": "-13.4"
},
"2021": {
"Liabilities, Non-Current": "-72.8",
"Liabilities": "-45.7",
"Stockholders Equity": "-50.9",
"ECR before LimitedLiability": "-25.2",
"Liabilities, Current": "13.2",
"Other Liabilities": "7.88",
"Assets, Current": "-27.4",
"Assets": "-15.1",
"Assets, Non-Current": "-8.06",
"Other Assets": "5.03",
"Goodwill": "11.7",
"Property, Plant and Equipment, Net": "11.6",
"Other Expenses": "7.50",
"Expenses": "22.5",
"Revenues": "12.6",
"Net Income": "33.8",
"Research and Development": "10.0",
"General and Administrative Expense": "4.27",
"Other Revenues": "12.6",
"Comprehensive Net Income": "34.0",
"Economic Capital Ratio": "-29.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001653477_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "295,200",
"Assets, Non-Current": "22,000",
"General and Administrative Expense": "114,000",
"Goodwill": "19,700",
"Liabilities, Current": "136,900",
"Liabilities, Non-Current": "491,500",
"Other Assets": "73,100",
"Other Compr. Net Income": "-11,700",
"Other Expenses": "754,500",
"Other Liabilities": "69,800",
"Other Net Income": "4,600",
"Other Revenues": "908,300",
"Property, Plant and Equipment, Net": "422,800",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "698,200",
"Assets": "832,800",
"Expenses": "868,500",
"Revenues": "908,300",
"Stockholders Equity": "134,600",
"Net Income": "44,400",
"Comprehensive Net Income": "38,550",
"BaseVar": "1,662,050",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "112%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "368,700",
"Assets, Non-Current": "30,400",
"General and Administrative Expense": "106,400",
"Goodwill": "17,300",
"Liabilities, Current": "194,500",
"Liabilities, Non-Current": "457,200",
"Other Assets": "74,700",
"Other Compr. Net Income": "-11,100",
"Other Expenses": "702,800",
"Other Liabilities": "0",
"Other Net Income": "1,800",
"Other Revenues": "972,400",
"Property, Plant and Equipment, Net": "438,500",
"Research and Development": "19,800"
},
"output_variables": {
"Liabilities": "651,700",
"Assets": "929,600",
"Expenses": "829,000",
"Revenues": "972,400",
"Stockholders Equity": "277,900",
"Net Income": "145,200",
"Comprehensive Net Income": "139,650",
"BaseVar": "1,697,800",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "143%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "422,700",
"Assets, Non-Current": "38,300",
"General and Administrative Expense": "849,200",
"Goodwill": "256,300",
"Liabilities, Current": "220,200",
"Liabilities, Non-Current": "756,300",
"Other Assets": "74,100",
"Other Compr. Net Income": "-18,700",
"Other Expenses": "83,500",
"Other Liabilities": "0",
"Other Net Income": "2,400",
"Other Revenues": "1,133,600",
"Property, Plant and Equipment, Net": "523,800",
"Research and Development": "21,500"
},
"output_variables": {
"Liabilities": "976,500",
"Assets": "1,315,200",
"Expenses": "954,200",
"Revenues": "1,133,600",
"Stockholders Equity": "338,700",
"Net Income": "181,800",
"Comprehensive Net Income": "172,450",
"BaseVar": "2,200,300",
"ECR before LimitedLiability": "56%",
"Economic Capital Ratio": "135%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "463,200",
"Assets, Non-Current": "103,600",
"General and Administrative Expense": "974,000",
"Goodwill": "832,600",
"Liabilities, Current": "315,800",
"Liabilities, Non-Current": "1,295,100",
"Other Assets": "77,600",
"Other Compr. Net Income": "12,700",
"Other Expenses": "127,500",
"Other Liabilities": "0",
"Other Net Income": "12,000",
"Other Revenues": "1,292,900",
"Property, Plant and Equipment, Net": "664,700",
"Research and Development": "19,700"
},
"output_variables": {
"Liabilities": "1,610,900",
"Assets": "2,141,700",
"Expenses": "1,121,200",
"Revenues": "1,292,900",
"Stockholders Equity": "530,800",
"Net Income": "183,700",
"Comprehensive Net Income": "190,050",
"BaseVar": "3,095,700",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "628,700",
"Assets, Non-Current": "101,900",
"General and Administrative Expense": "900,000",
"Goodwill": "818,600",
"Liabilities, Current": "340,400",
"Liabilities, Non-Current": "1,352,000",
"Other Assets": "81,700",
"Other Compr. Net Income": "9,700",
"Other Expenses": "121,100",
"Other Liabilities": "0",
"Other Net Income": "9,000",
"Other Revenues": "1,216,100",
"Property, Plant and Equipment, Net": "703,600",
"Research and Development": "22,600"
},
"output_variables": {
"Liabilities": "1,692,400",
"Assets": "2,334,500",
"Expenses": "1,043,700",
"Revenues": "1,216,100",
"Stockholders Equity": "642,100",
"Net Income": "181,400",
"Comprehensive Net Income": "186,250",
"BaseVar": "3,152,700",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "724,900",
"Assets, Non-Current": "161,900",
"General and Administrative Expense": "1,058,000",
"Goodwill": "779,600",
"Liabilities, Current": "383,500",
"Liabilities, Non-Current": "1,411,700",
"Other Assets": "82,900",
"Other Compr. Net Income": "8,400",
"Other Expenses": "113,200",
"Other Liabilities": "0",
"Other Net Income": "-75,900",
"Other Revenues": "1,391,500",
"Property, Plant and Equipment, Net": "719,700",
"Research and Development": "26,300"
},
"output_variables": {
"Liabilities": "1,795,200",
"Assets": "2,469,000",
"Expenses": "1,197,500",
"Revenues": "1,391,500",
"Stockholders Equity": "673,800",
"Net Income": "118,100",
"Comprehensive Net Income": "122,300",
"BaseVar": "3,468,750",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
}
},
"top_rated": false,
"trend": -2.0,
"value": 1.2925758995012413,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001653477.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001653477.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001653477.svg"
},
{
"company_id": "0001386570",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001386570.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001386570.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001386570.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001386570_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001386570_main_keyfigs.svg",
"name": "Niagen Bioscience Inc",
"rank": 33,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001386570.svg",
"report_text": "The relative strengths and weaknesses of Niagen Bioscience Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Niagen Bioscience Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Niagen Bioscience Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 85% points.
The company's Economic Capital Ratio, given in the ranking table, is 121%, being 38% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001386570_2022_Niagen_Bioscience_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities": "7.56",
"Stockholders Equity": "-10.8",
"ECR before LimitedLiability": "-18.3",
"Liabilities, Non-Current": "3.72",
"Other Liabilities": "3.91",
"Property, Plant and Equipment, Net": "-3.30",
"Assets": "-28.5",
"Assets, Non-Current": "-4.22",
"Other Assets": "-0.678",
"Goodwill": "-8.77",
"Assets, Current": "-9.16",
"General and Administrative Expense": "-102",
"Expenses": "-30.9",
"Revenues": "9.52",
"Net Income": "-15.5",
"Research and Development": "9.81",
"Other Expenses": "17.7",
"Other Revenues": "9.52",
"Comprehensive Net Income": "-15.6",
"Other Net Income": "-3.94",
"Economic Capital Ratio": "-80.3"
},
"2012": {
"Liabilities, Current": "-3.43",
"Liabilities": "6.79",
"Stockholders Equity": "-12.2",
"ECR before LimitedLiability": "-53.5",
"Liabilities, Non-Current": "3.82",
"Other Liabilities": "6.34",
"Assets, Current": "-7.18",
"Assets": "-34.0",
"Other Assets": "-1.13",
"Assets, Non-Current": "-4.98",
"Property, Plant and Equipment, Net": "-7.24",
"Goodwill": "-10.0",
"Other Expenses": "20.9",
"Expenses": "-31.1",
"Revenues": "7.55",
"Net Income": "-12.2",
"Research and Development": "11.0",
"General and Administrative Expense": "-110",
"Other Revenues": "7.55",
"Comprehensive Net Income": "-12.2",
"Economic Capital Ratio": "-86.0"
},
"2013": {
"Liabilities, Current": "10.9",
"Liabilities": "55.5",
"Stockholders Equity": "4.29",
"ECR before LimitedLiability": "29.8",
"Other Liabilities": "21.9",
"Liabilities, Non-Current": "25.6",
"Goodwill": "-18.8",
"Assets": "-26.0",
"Assets, Non-Current": "23.1",
"Property, Plant and Equipment, Net": "-6.61",
"Other Assets": "-7.78",
"Assets, Current": "-13.1",
"General and Administrative Expense": "-93.8",
"Expenses": "-35.4",
"Revenues": "50.9",
"Net Income": "2.23",
"Research and Development": "22.2",
"Other Expenses": "51.8",
"Other Revenues": "50.9",
"Other Net Income": "-5.03",
"Economic Capital Ratio": "-10.4"
},
"2019": {
"Liabilities, Non-Current": "3.11",
"Liabilities": "5.04",
"Stockholders Equity": "-43.1",
"Other Liabilities": "0.438",
"Liabilities, Current": "0.496",
"Assets, Non-Current": "-17.8",
"Assets": "-61.2",
"Goodwill": "-22.7",
"Property, Plant and Equipment, Net": "-21.4",
"Other Assets": "0.138",
"Research and Development": "0.572",
"Expenses": "-56.7",
"Revenues": "7.32",
"Net Income": "-5.67",
"Other Expenses": "2.12",
"General and Administrative Expense": "-79.9",
"Other Revenues": "7.32",
"ECR before LimitedLiability": "-22.2",
"Other Net Income": "0.425",
"Comprehensive Net Income": "-5.51",
"Economic Capital Ratio": "-51.6"
},
"2020": {
"Liabilities, Current": "8.43",
"Liabilities": "11.5",
"Stockholders Equity": "-92.5",
"ECR before LimitedLiability": "-15.1",
"Liabilities, Non-Current": "11.1",
"Other Liabilities": "-8.49",
"Goodwill": "-34.5",
"Assets": "-83.2",
"Assets, Current": "-33.4",
"Assets, Non-Current": "-25.9",
"Property, Plant and Equipment, Net": "-37.6",
"Other Expenses": "8.72",
"Expenses": "-81.6",
"Revenues": "20.4",
"Net Income": "3.13",
"Research and Development": "7.70",
"General and Administrative Expense": "-101",
"Other Revenues": "20.4",
"Comprehensive Net Income": "3.35",
"Other Net Income": "8.45",
"Economic Capital Ratio": "-52.9"
},
"2021": {
"Liabilities, Non-Current": "29.4",
"Liabilities": "36.2",
"Stockholders Equity": "-72.4",
"ECR before LimitedLiability": "-33.7",
"Liabilities, Current": "11.4",
"Assets, Current": "-11.2",
"Assets": "-60.2",
"Assets, Non-Current": "-16.2",
"Other Assets": "2.46",
"Goodwill": "-33.0",
"Property, Plant and Equipment, Net": "-26.8",
"Other Expenses": "23.1",
"Expenses": "-58.3",
"Revenues": "37.9",
"Net Income": "-5.28",
"Research and Development": "12.7",
"General and Administrative Expense": "-84.8",
"Other Revenues": "37.9",
"Comprehensive Net Income": "-5.29",
"Other Net Income": "1.25",
"Economic Capital Ratio": "-38.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001386570_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "4,953",
"Assets, Non-Current": "144",
"General and Administrative Expense": "15,977",
"Goodwill": "100",
"Liabilities, Current": "3,343",
"Liabilities, Non-Current": "0",
"Other Assets": "-100",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-31",
"Other Revenues": "8,113",
"Property, Plant and Equipment, Net": "1,172",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "3,343",
"Assets": "6,270",
"Expenses": "15,977",
"Revenues": "8,113",
"Stockholders Equity": "2,927",
"Net Income": "-7,895",
"Comprehensive Net Income": "-7,895",
"BaseVar": "16,867",
"ECR before LimitedLiability": "-81%",
"Economic Capital Ratio": "73%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,927",
"Assets, Non-Current": "171",
"General and Administrative Expense": "23,247",
"Goodwill": "136",
"Liabilities, Current": "4,763",
"Liabilities, Non-Current": "0",
"Other Assets": "-136",
"Other Compr. Net Income": "0",
"Other Expenses": "-29",
"Other Liabilities": "0",
"Other Net Income": "-23",
"Other Revenues": "11,610",
"Property, Plant and Equipment, Net": "936",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "4,763",
"Assets": "9,035",
"Expenses": "23,218",
"Revenues": "11,610",
"Stockholders Equity": "4,272",
"Net Income": "-11,630",
"Comprehensive Net Income": "-11,630",
"BaseVar": "24,324",
"ECR before LimitedLiability": "-84%",
"Economic Capital Ratio": "72%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "5,791",
"Assets, Non-Current": "2,133",
"General and Administrative Expense": "14,502",
"Goodwill": "202",
"Liabilities, Current": "2,838",
"Liabilities, Non-Current": "0",
"Other Assets": "-202",
"Other Compr. Net Income": "0",
"Other Expenses": "45",
"Other Liabilities": "0",
"Other Net Income": "-33",
"Other Revenues": "10,161",
"Property, Plant and Equipment, Net": "1,063",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "2,838",
"Assets": "8,987",
"Expenses": "14,547",
"Revenues": "10,161",
"Stockholders Equity": "6,149",
"Net Income": "-4,420",
"Comprehensive Net Income": "-4,420",
"BaseVar": "18,283",
"ECR before LimitedLiability": "68%",
"Economic Capital Ratio": "144%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "33,518",
"Assets, Non-Current": "1,653",
"General and Administrative Expense": "73,046",
"Goodwill": "1,311",
"Liabilities, Current": "15,063",
"Liabilities, Non-Current": "848",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "125",
"Other Liabilities": "3,891",
"Other Net Income": "-847",
"Other Revenues": "46,291",
"Property, Plant and Equipment, Net": "3,765",
"Research and Development": "4,420"
},
"output_variables": {
"Liabilities": "19,802",
"Assets": "40,247",
"Expenses": "77,591",
"Revenues": "46,291",
"Stockholders Equity": "20,445",
"Net Income": "-32,147",
"Comprehensive Net Income": "-32,147",
"BaseVar": "92,389",
"ECR before LimitedLiability": "-14%",
"Economic Capital Ratio": "84%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "32,219",
"Assets, Non-Current": "1,851",
"General and Administrative Expense": "75,379",
"Goodwill": "1,082",
"Liabilities, Current": "16,476",
"Liabilities, Non-Current": "997",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "4,461",
"Other Net Income": "-71",
"Other Revenues": "59,257",
"Property, Plant and Equipment, Net": "3,206",
"Research and Development": "3,732"
},
"output_variables": {
"Liabilities": "21,934",
"Assets": "38,358",
"Expenses": "79,111",
"Revenues": "59,257",
"Stockholders Equity": "16,424",
"Net Income": "-19,925",
"Comprehensive Net Income": "-19,925",
"BaseVar": "99,366",
"ECR before LimitedLiability": "8.5%",
"Economic Capital Ratio": "93%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "48,905",
"Assets, Non-Current": "5,075",
"General and Administrative Expense": "90,690",
"Goodwill": "857",
"Liabilities, Current": "17,613",
"Liabilities, Non-Current": "4,154",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "55",
"Other Liabilities": "4,346",
"Other Net Income": "0",
"Other Revenues": "67,449",
"Property, Plant and Equipment, Net": "3,003",
"Research and Development": "3,832"
},
"output_variables": {
"Liabilities": "26,113",
"Assets": "57,840",
"Expenses": "94,577",
"Revenues": "67,449",
"Stockholders Equity": "31,727",
"Net Income": "-27,128",
"Comprehensive Net Income": "-27,128",
"BaseVar": "122,990",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "121%"
}
}
},
"top_rated": false,
"trend": 2.0,
"value": 1.2074863758698196,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001386570.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001386570.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001386570.svg"
},
{
"company_id": "0000926617",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000926617.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000926617.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000926617.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000926617_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000926617_main_keyfigs.svg",
"name": "Aspira Women s Health Inc",
"rank": 34,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000926617.svg",
"report_text": "The relative strengths and weaknesses of Aspira Women s Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Aspira Women s Health Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 49% points.The greatest weakness of Aspira Women s Health Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 63% points.
The company's Economic Capital Ratio, given in the ranking table, is 119%, being 40% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000926617_2022_Aspira_Women_s_Health_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-27.4",
"Liabilities": "-16.5",
"Stockholders Equity": "1.22",
"Liabilities, Non-Current": "0.717",
"Other Liabilities": "0.0331",
"Property, Plant and Equipment, Net": "-0.750",
"Assets": "10.6",
"Assets, Non-Current": "-0.512",
"Goodwill": "-0.750",
"Assets, Current": "38.8",
"General and Administrative Expense": "-0.698",
"Expenses": "-0.271",
"Revenues": "-30.5",
"Net Income": "-40.2",
"Research and Development": "-0.703",
"Other Expenses": "3.05",
"Other Revenues": "-30.5",
"ECR before LimitedLiability": "-7.59",
"Comprehensive Net Income": "-40.3",
"Other Net Income": "-0.448",
"Economic Capital Ratio": "-69.6"
},
"2012": {
"Assets, Current": "16.6",
"Assets": "-0.140",
"Other Liabilities": "0.301",
"Stockholders Equity": "-0.140",
"Assets, Non-Current": "-2.31",
"Property, Plant and Equipment, Net": "-14.0",
"Goodwill": "-17.1",
"Other Expenses": "4.58",
"Expenses": "-21.6",
"Revenues": "-44.6",
"Net Income": "-41.3",
"Research and Development": "-1.11",
"General and Administrative Expense": "-46.7",
"Other Revenues": "-44.6",
"ECR before LimitedLiability": "-41.5",
"Liabilities, Current": "-9.91",
"Liabilities, Non-Current": "0.785",
"Other Net Income": "3.96",
"Comprehensive Net Income": "-40.2",
"Other Compr. Net Income": "0.0563",
"Economic Capital Ratio": "-74.0"
},
"2013": {
"Liabilities, Current": "7.06",
"Liabilities": "26.4",
"Stockholders Equity": "113",
"ECR before LimitedLiability": "94.4",
"Other Liabilities": "8.35",
"Liabilities, Non-Current": "12.6",
"Goodwill": "-4.97",
"Assets": "62.6",
"Assets, Non-Current": "-1.95",
"Property, Plant and Equipment, Net": "-3.52",
"Assets, Current": "125",
"General and Administrative Expense": "-1.21",
"Expenses": "15.3",
"Revenues": "-24.5",
"Net Income": "-10.5",
"Research and Development": "-1.71",
"Other Expenses": "18.2",
"Other Revenues": "-24.5",
"Other Net Income": "-1.65",
"Comprehensive Net Income": "-10.5",
"Economic Capital Ratio": "54.3"
},
"2014": {
"Liabilities, Non-Current": "17.8",
"Liabilities": "43.3",
"Stockholders Equity": "55.7",
"ECR before LimitedLiability": "45.4",
"Liabilities, Current": "15.5",
"Other Liabilities": "11.9",
"Assets, Current": "82.0",
"Assets": "48.5",
"Goodwill": "-16.2",
"Assets, Non-Current": "-5.60",
"Property, Plant and Equipment, Net": "-10.3",
"Other Expenses": "16.2",
"Expenses": "-24.0",
"Revenues": "-36.7",
"Net Income": "-56.4",
"Research and Development": "-10.7",
"General and Administrative Expense": "-28.1",
"Other Revenues": "-36.7",
"Other Net Income": "1.56",
"Comprehensive Net Income": "-56.3",
"Economic Capital Ratio": "-4.05"
},
"2015": {
"Other Liabilities": "17.7",
"Liabilities": "38.3",
"Stockholders Equity": "51.8",
"ECR before LimitedLiability": "32.1",
"Liabilities, Current": "24.9",
"Liabilities, Non-Current": "22.2",
"Assets, Current": "69.1",
"Assets": "39.1",
"Other Assets": "-8.79",
"Goodwill": "-18.6",
"Assets, Non-Current": "-5.20",
"Property, Plant and Equipment, Net": "-5.31",
"Research and Development": "-12.7",
"Expenses": "-43.9",
"Revenues": "-35.3",
"Net Income": "-72.6",
"General and Administrative Expense": "-48.9",
"Other Expenses": "20.1",
"Other Revenues": "-35.3",
"Comprehensive Net Income": "-72.3",
"Economic Capital Ratio": "-13.8"
},
"2016": {
"Liabilities, Non-Current": "-1.04",
"Liabilities": "3.87",
"Stockholders Equity": "-12.9",
"ECR before LimitedLiability": "-78.7",
"Liabilities, Current": "3.11",
"Other Liabilities": "1.84",
"Property, Plant and Equipment, Net": "-1.99",
"Assets": "-27.2",
"Assets, Non-Current": "-6.15",
"Assets, Current": "-6.93",
"Goodwill": "-18.1",
"Research and Development": "-2.20",
"Expenses": "-34.8",
"Revenues": "-15.8",
"Net Income": "-55.4",
"General and Administrative Expense": "-52.6",
"Other Expenses": "17.5",
"Other Revenues": "-15.8",
"Comprehensive Net Income": "-55.0",
"Other Net Income": "-1.40",
"Economic Capital Ratio": "-98.6"
},
"2017": {
"Other Liabilities": "3.10",
"Liabilities": "4.38",
"Stockholders Equity": "-7.42",
"ECR before LimitedLiability": "-64.3",
"Liabilities, Current": "2.00",
"Liabilities, Non-Current": "-0.645",
"Assets, Non-Current": "-4.65",
"Assets": "-13.8",
"Assets, Current": "14.3",
"Goodwill": "-12.0",
"Property, Plant and Equipment, Net": "-8.98",
"Research and Development": "3.65",
"Expenses": "-17.0",
"Revenues": "-6.68",
"Net Income": "-44.0",
"Other Expenses": "13.1",
"General and Administrative Expense": "-60.2",
"Other Revenues": "-6.68",
"Comprehensive Net Income": "-44.5",
"Other Net Income": "-2.71",
"Economic Capital Ratio": "-85.8"
},
"2018": {
"Liabilities, Non-Current": "0.0605",
"Liabilities": "1.66",
"Stockholders Equity": "2.14",
"ECR before LimitedLiability": "-39.4",
"Other Liabilities": "1.21",
"Liabilities, Current": "0.256",
"Property, Plant and Equipment, Net": "-7.68",
"Assets": "0.0872",
"Assets, Current": "28.8",
"Goodwill": "-8.99",
"Assets, Non-Current": "-0.974",
"Other Expenses": "2.14",
"Expenses": "-37.2",
"Revenues": "-12.9",
"Net Income": "-63.8",
"Research and Development": "1.37",
"General and Administrative Expense": "-64.0",
"Other Revenues": "-12.9",
"Comprehensive Net Income": "-63.5",
"Other Net Income": "-0.0401",
"Economic Capital Ratio": "-59.9"
},
"2019": {
"Liabilities, Non-Current": "1.57",
"Liabilities": "4.10",
"Stockholders Equity": "1.77",
"ECR before LimitedLiability": "-24.0",
"Other Liabilities": "2.33",
"Assets, Non-Current": "-2.18",
"Assets": "-1.83",
"Goodwill": "-2.36",
"Property, Plant and Equipment, Net": "-3.98",
"Other Assets": "0.254",
"Assets, Current": "35.4",
"Research and Development": "0.897",
"Expenses": "-39.5",
"Revenues": "-2.14",
"Net Income": "-56.6",
"Other Expenses": "2.68",
"General and Administrative Expense": "-58.9",
"Other Revenues": "-2.14",
"Other Net Income": "1.04",
"Comprehensive Net Income": "-56.5",
"Economic Capital Ratio": "-53.5"
},
"2020": {
"Liabilities, Current": "-0.785",
"Liabilities": "0.0403",
"Stockholders Equity": "-1.65",
"ECR before LimitedLiability": "-25.3",
"Liabilities, Non-Current": "0.203",
"Other Liabilities": "0.751",
"Goodwill": "-1.80",
"Assets": "-1.68",
"Assets, Current": "21.0",
"Assets, Non-Current": "-1.60",
"Property, Plant and Equipment, Net": "-3.81",
"Other Expenses": "1.71",
"Expenses": "-28.5",
"Revenues": "-1.80",
"Net Income": "-47.0",
"Research and Development": "-0.270",
"General and Administrative Expense": "-37.3",
"Other Revenues": "-1.80",
"Comprehensive Net Income": "-46.9",
"Other Net Income": "1.07",
"Economic Capital Ratio": "-63.1"
},
"2021": {
"Liabilities, Non-Current": "12.6",
"Liabilities": "25.0",
"Stockholders Equity": "25.0",
"ECR before LimitedLiability": "-35.2",
"Liabilities, Current": "3.69",
"Other Liabilities": "9.29",
"Other Expenses": "14.9",
"Expenses": "-43.3",
"Net Income": "-62.9",
"Research and Development": "-4.37",
"General and Administrative Expense": "-51.4",
"Other Revenues": "-26.7",
"Revenues": "-26.7",
"Assets, Current": "48.8",
"Assets, Non-Current": "-16.6",
"Other Assets": "2.63",
"Goodwill": "-24.7",
"Property, Plant and Equipment, Net": "-21.1",
"Comprehensive Net Income": "-62.9",
"Other Net Income": "3.96",
"Economic Capital Ratio": "-39.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000926617_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "22,893",
"Assets, Non-Current": "2.0",
"General and Administrative Expense": "14,177",
"Goodwill": "0",
"Liabilities, Current": "11,476",
"Liabilities, Non-Current": "52",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "114",
"Other Liabilities": "1,224",
"Other Net Income": "-35",
"Other Revenues": "1,923",
"Property, Plant and Equipment, Net": "216",
"Research and Development": "5,387"
},
"output_variables": {
"Liabilities": "12,752",
"Assets": "23,111",
"Expenses": "19,678",
"Revenues": "1,923",
"Stockholders Equity": "10,359",
"Net Income": "-17,790",
"Comprehensive Net Income": "-17,790",
"BaseVar": "28,750",
"ECR before LimitedLiability": "-20%",
"Economic Capital Ratio": "84%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "8,492",
"Assets, Non-Current": "0",
"General and Administrative Expense": "9,292",
"Goodwill": "0",
"Liabilities, Current": "3,197",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "153",
"Other Expenses": "118",
"Other Liabilities": "770",
"Other Net Income": "2,386",
"Other Revenues": "2,094",
"Property, Plant and Equipment, Net": "142",
"Research and Development": "2,216"
},
"output_variables": {
"Liabilities": "3,967",
"Assets": "8,634",
"Expenses": "11,626",
"Revenues": "2,094",
"Stockholders Equity": "4,667",
"Net Income": "-7,146",
"Comprehensive Net Income": "-7,070",
"BaseVar": "14,430",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "30,249",
"Assets, Non-Current": "0",
"General and Administrative Expense": "8,834",
"Goodwill": "0",
"Liabilities, Current": "3,558",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "316",
"Other Net Income": "44",
"Other Revenues": "2,566",
"Property, Plant and Equipment, Net": "391",
"Research and Development": "2,595"
},
"output_variables": {
"Liabilities": "3,874",
"Assets": "30,640",
"Expenses": "11,429",
"Revenues": "2,566",
"Stockholders Equity": "26,766",
"Net Income": "-8,819",
"Comprehensive Net Income": "-8,819",
"BaseVar": "24,276",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "209%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "23,666",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,835",
"Goodwill": "0",
"Liabilities, Current": "4,919",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,230",
"Other Liabilities": "0",
"Other Net Income": "2.0",
"Other Revenues": "2,521",
"Property, Plant and Equipment, Net": "508",
"Research and Development": "4,667"
},
"output_variables": {
"Liabilities": "4,919",
"Assets": "24,174",
"Expenses": "21,732",
"Revenues": "2,521",
"Stockholders Equity": "19,255",
"Net Income": "-19,209",
"Comprehensive Net Income": "-19,209",
"BaseVar": "26,674",
"ECR before LimitedLiability": "49%",
"Economic Capital Ratio": "129%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "19,366",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,366",
"Goodwill": "0",
"Liabilities, Current": "3,351",
"Liabilities, Non-Current": "0",
"Other Assets": "90",
"Other Compr. Net Income": "0",
"Other Expenses": "2,309",
"Other Liabilities": "63",
"Other Net Income": "134",
"Other Revenues": "2,177",
"Property, Plant and Equipment, Net": "1,504",
"Research and Development": "3,751"
},
"output_variables": {
"Liabilities": "3,414",
"Assets": "20,960",
"Expenses": "21,426",
"Revenues": "2,177",
"Stockholders Equity": "17,546",
"Net Income": "-19,115",
"Comprehensive Net Income": "-19,115",
"BaseVar": "24,056",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "122%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "6,108",
"Assets, Non-Current": "0",
"General and Administrative Expense": "15,424",
"Goodwill": "0",
"Liabilities, Current": "2,561",
"Liabilities, Non-Current": "1,696",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-14",
"Other Revenues": "2,642",
"Property, Plant and Equipment, Net": "1,911",
"Research and Development": "2,172"
},
"output_variables": {
"Liabilities": "4,257",
"Assets": "8,019",
"Expenses": "17,596",
"Revenues": "2,642",
"Stockholders Equity": "3,762",
"Net Income": "-14,968",
"Comprehensive Net Income": "-14,968",
"BaseVar": "16,264",
"ECR before LimitedLiability": "-160%",
"Economic Capital Ratio": "48%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "6,305",
"Assets, Non-Current": "11",
"General and Administrative Expense": "12,725",
"Goodwill": "0",
"Liabilities, Current": "2,609",
"Liabilities, Non-Current": "1,481",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-56",
"Other Revenues": "3,121",
"Property, Plant and Equipment, Net": "1,181",
"Research and Development": "837"
},
"output_variables": {
"Liabilities": "4,090",
"Assets": "7,497",
"Expenses": "13,562",
"Revenues": "3,121",
"Stockholders Equity": "3,407",
"Net Income": "-10,497",
"Comprehensive Net Income": "-10,497",
"BaseVar": "14,163",
"ECR before LimitedLiability": "-101%",
"Economic Capital Ratio": "68%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "10,788",
"Assets, Non-Current": "12",
"General and Administrative Expense": "13,836",
"Goodwill": "0",
"Liabilities, Current": "2,964",
"Liabilities, Non-Current": "1,292",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-38",
"Other Revenues": "3,053",
"Property, Plant and Equipment, Net": "608",
"Research and Development": "550"
},
"output_variables": {
"Liabilities": "4,256",
"Assets": "11,408",
"Expenses": "14,386",
"Revenues": "3,053",
"Stockholders Equity": "7,152",
"Net Income": "-11,371",
"Comprehensive Net Income": "-11,371",
"BaseVar": "16,570",
"ECR before LimitedLiability": "-20%",
"Economic Capital Ratio": "84%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "13,410",
"Assets, Non-Current": "65",
"General and Administrative Expense": "18,798",
"Goodwill": "0",
"Liabilities, Current": "3,978",
"Liabilities, Non-Current": "1,112",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "41",
"Other Revenues": "4,538",
"Property, Plant and Equipment, Net": "353",
"Research and Development": "1,018"
},
"output_variables": {
"Liabilities": "5,090",
"Assets": "13,828",
"Expenses": "19,816",
"Revenues": "4,538",
"Stockholders Equity": "8,738",
"Net Income": "-15,237",
"Comprehensive Net Income": "-15,237",
"BaseVar": "21,656",
"ECR before LimitedLiability": "-35%",
"Economic Capital Ratio": "82%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "18,603",
"Assets, Non-Current": "419",
"General and Administrative Expense": "20,528",
"Goodwill": "0",
"Liabilities, Current": "6,400",
"Liabilities, Non-Current": "3,486",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "76",
"Other Revenues": "4,651",
"Property, Plant and Equipment, Net": "583",
"Research and Development": "2,104"
},
"output_variables": {
"Liabilities": "9,886",
"Assets": "19,605",
"Expenses": "22,632",
"Revenues": "4,651",
"Stockholders Equity": "9,719",
"Net Income": "-17,905",
"Comprehensive Net Income": "-17,905",
"BaseVar": "28,425",
"ECR before LimitedLiability": "-31%",
"Economic Capital Ratio": "83%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "40,005",
"Assets, Non-Current": "360",
"General and Administrative Expense": "34,093",
"Goodwill": "0",
"Liabilities, Current": "7,840",
"Liabilities, Non-Current": "3,067",
"Other Assets": "250",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "933",
"Other Revenues": "6,812",
"Property, Plant and Equipment, Net": "464",
"Research and Development": "5,314"
},
"output_variables": {
"Liabilities": "10,907",
"Assets": "41,079",
"Expenses": "39,407",
"Revenues": "6,812",
"Stockholders Equity": "30,172",
"Net Income": "-31,662",
"Comprehensive Net Income": "-31,662",
"BaseVar": "49,569",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "119%"
}
}
},
"top_rated": false,
"trend": 4.0,
"value": 1.1927966438566147,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000926617.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000926617.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000926617.svg"
},
{
"company_id": "0001504678",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001504678.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001504678.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001504678.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001504678_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001504678_main_keyfigs.svg",
"name": "Loop Industries Inc",
"rank": 35,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001504678.svg",
"report_text": "The relative strengths and weaknesses of Loop Industries Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Loop Industries Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 43% points.The greatest weakness of Loop Industries Inc is the variable Net Income, reducing the Economic Capital Ratio by 75% points.
The company's Economic Capital Ratio, given in the ranking table, is 115%, being 43% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001504678_2022_Loop_Industries_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Liabilities, Current": "0.417",
"Liabilities": "0.401",
"Stockholders Equity": "-29.8",
"ECR before LimitedLiability": "-114",
"Other Liabilities": "-0.156",
"Liabilities, Non-Current": "-0.185",
"Goodwill": "-2.10",
"Assets": "-35.3",
"Assets, Non-Current": "-0.489",
"Property, Plant and Equipment, Net": "-1.61",
"Other Assets": "-0.257",
"Assets, Current": "-8.40",
"General and Administrative Expense": "-0.521",
"Expenses": "-7.67",
"Revenues": "-2.38",
"Net Income": "-27.7",
"Research and Development": "0.170",
"Other Expenses": "-6.03",
"Other Revenues": "-2.38",
"Comprehensive Net Income": "-27.8",
"Economic Capital Ratio": "-154"
},
"2016": {
"Liabilities, Non-Current": "3.22",
"Liabilities": "0.449",
"Stockholders Equity": "5.79",
"ECR before LimitedLiability": "-46.6",
"Liabilities, Current": "-3.39",
"Other Liabilities": "1.39",
"Property, Plant and Equipment, Net": "37.5",
"Assets": "6.80",
"Assets, Non-Current": "-1.52",
"Assets, Current": "-4.60",
"Goodwill": "0.450",
"Research and Development": "-3.48",
"Expenses": "-6.44",
"Revenues": "-15.4",
"Net Income": "-62.6",
"General and Administrative Expense": "-4.60",
"Other Expenses": "4.41",
"Other Revenues": "-15.4",
"Comprehensive Net Income": "-62.3",
"Other Net Income": "-0.460",
"Economic Capital Ratio": "-66.6"
},
"2021": {
"Liabilities, Non-Current": "17.3",
"Liabilities": "19.4",
"Stockholders Equity": "31.3",
"ECR before LimitedLiability": "-39.2",
"Liabilities, Current": "-6.22",
"Other Liabilities": "8.23",
"Assets, Current": "43.2",
"Assets": "28.1",
"Assets, Non-Current": "-11.6",
"Other Assets": "1.48",
"Goodwill": "-20.8",
"Property, Plant and Equipment, Net": "-9.88",
"Other Expenses": "-6.89",
"Expenses": "-40.0",
"Revenues": "-41.6",
"Net Income": "-75.4",
"Research and Development": "-44.2",
"General and Administrative Expense": "12.5",
"Other Revenues": "-41.6",
"Comprehensive Net Income": "-74.9",
"Economic Capital Ratio": "-43.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001504678_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "2.1",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6.5",
"Goodwill": "0",
"Liabilities, Current": "7.7",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "9.9",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7.7",
"Assets": "2.1",
"Expenses": "16",
"Revenues": "0",
"Stockholders Equity": "-5.6",
"Net Income": "-16",
"Comprehensive Net Income": "-16",
"BaseVar": "13",
"ECR before LimitedLiability": "-489%",
"Economic Capital Ratio": "0.42%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "712",
"Assets, Non-Current": "0",
"General and Administrative Expense": "1,748",
"Goodwill": "372",
"Liabilities, Current": "1,065",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "5.9",
"Other Expenses": "287",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "1,399",
"Research and Development": "802"
},
"output_variables": {
"Liabilities": "1,065",
"Assets": "2,483",
"Expenses": "2,836",
"Revenues": "0",
"Stockholders Equity": "1,417",
"Net Income": "-2,836",
"Comprehensive Net Income": "-2,833",
"BaseVar": "3,195",
"ECR before LimitedLiability": "-50%",
"Economic Capital Ratio": "80%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "37,596",
"Assets, Non-Current": "1,500",
"General and Administrative Expense": "11,540",
"Goodwill": "795",
"Liabilities, Current": "9,063",
"Liabilities, Non-Current": "1,516",
"Other Assets": "0",
"Other Compr. Net Income": "382",
"Other Expenses": "6,118",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,513",
"Research and Development": "18,687"
},
"output_variables": {
"Liabilities": "10,579",
"Assets": "43,404",
"Expenses": "36,345",
"Revenues": "0",
"Stockholders Equity": "32,825",
"Net Income": "-36,345",
"Comprehensive Net Income": "-36,154",
"BaseVar": "45,355",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.1530685547048654,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001504678.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001504678.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001504678.svg"
},
{
"company_id": "0001627223",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001627223.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001627223.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001627223.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001627223_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001627223_main_keyfigs.svg",
"name": "Chemours Co",
"rank": 36,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001627223.svg",
"report_text": "The relative strengths and weaknesses of Chemours Co are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Chemours Co compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Chemours Co is the variable Stockholders Equity, reducing the Economic Capital Ratio by 82% points.
The company's Economic Capital Ratio, given in the ranking table, is 112%, being 46% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001627223_2022_Chemours_Co.pdf",
"shrinked_graph_json": {
"2015": {
"Other Liabilities": "0.356",
"Liabilities": "-30.9",
"Stockholders Equity": "-54.3",
"Liabilities, Current": "1.52",
"Liabilities, Non-Current": "-84.9",
"Assets, Current": "-35.4",
"Assets": "-26.5",
"Other Assets": "-12.3",
"Goodwill": "-21.8",
"Property, Plant and Equipment, Net": "5.56",
"Research and Development": "0.386",
"Expenses": "1.07",
"Revenues": "1.68",
"Net Income": "5.71",
"General and Administrative Expense": "4.89",
"Other Expenses": "-37.9",
"Other Revenues": "1.68",
"ECR before LimitedLiability": "-5.32",
"Comprehensive Net Income": "5.42",
"Other Compr. Net Income": "-0.949",
"Economic Capital Ratio": "-51.2"
},
"2016": {
"Liabilities, Non-Current": "-78.6",
"Liabilities": "-46.8",
"Stockholders Equity": "-73.5",
"Liabilities, Current": "2.62",
"Other Liabilities": "2.18",
"Property, Plant and Equipment, Net": "3.87",
"Assets": "-34.5",
"Other Assets": "2.14",
"Assets, Non-Current": "2.14",
"Assets, Current": "-39.5",
"Goodwill": "-24.4",
"Research and Development": "2.73",
"Expenses": "2.89",
"Revenues": "3.00",
"Net Income": "5.93",
"General and Administrative Expense": "4.73",
"Other Expenses": "-34.4",
"Other Revenues": "3.00",
"ECR before LimitedLiability": "-39.8",
"Comprehensive Net Income": "5.92",
"Economic Capital Ratio": "-59.8"
},
"2017": {
"Other Liabilities": "8.49",
"Liabilities": "-37.3",
"Stockholders Equity": "-51.5",
"ECR before LimitedLiability": "-19.6",
"Liabilities, Current": "21.5",
"Liabilities, Non-Current": "-74.2",
"Assets": "-20.1",
"Other Assets": "2.64",
"Assets, Current": "-16.0",
"Goodwill": "-21.1",
"Property, Plant and Equipment, Net": "16.0",
"Research and Development": "17.5",
"Expenses": "23.4",
"Revenues": "27.6",
"Net Income": "28.4",
"Other Expenses": "-33.2",
"General and Administrative Expense": "28.1",
"Other Revenues": "27.6",
"Comprehensive Net Income": "28.5",
"Other Net Income": "-4.15",
"Economic Capital Ratio": "-41.2"
},
"2018": {
"Liabilities, Non-Current": "-74.0",
"Liabilities": "-44.1",
"Stockholders Equity": "-58.1",
"ECR before LimitedLiability": "-6.77",
"Other Liabilities": "8.30",
"Liabilities, Current": "15.6",
"Property, Plant and Equipment, Net": "28.2",
"Assets": "-21.9",
"Other Assets": "2.59",
"Assets, Current": "-22.2",
"Goodwill": "-17.9",
"Assets, Non-Current": "-5.02",
"Other Expenses": "10.7",
"Expenses": "26.5",
"Revenues": "29.5",
"Net Income": "33.4",
"Research and Development": "16.1",
"Other Revenues": "29.5",
"Comprehensive Net Income": "33.3",
"Other Net Income": "2.10",
"Economic Capital Ratio": "-27.2"
},
"2019": {
"Liabilities, Non-Current": "-83.7",
"Liabilities": "-50.0",
"Stockholders Equity": "-63.1",
"ECR before LimitedLiability": "-7.65",
"Other Liabilities": "12.2",
"Liabilities, Current": "14.2",
"Assets, Non-Current": "-8.32",
"Assets": "-23.3",
"Goodwill": "-21.4",
"Property, Plant and Equipment, Net": "15.5",
"Other Assets": "4.43",
"Assets, Current": "-26.5",
"Research and Development": "12.2",
"Expenses": "14.6",
"Revenues": "14.2",
"Net Income": "16.7",
"Other Expenses": "10.1",
"General and Administrative Expense": "6.78",
"Other Revenues": "14.2",
"Comprehensive Net Income": "16.9",
"Economic Capital Ratio": "-37.1"
},
"2020": {
"Liabilities, Current": "15.0",
"Liabilities": "-48.6",
"Stockholders Equity": "-66.9",
"ECR before LimitedLiability": "-3.94",
"Liabilities, Non-Current": "-74.8",
"Other Liabilities": "6.15",
"Goodwill": "-18.0",
"Assets": "-27.3",
"Assets, Current": "-31.6",
"Assets, Non-Current": "-4.18",
"Property, Plant and Equipment, Net": "20.2",
"Other Expenses": "7.07",
"Expenses": "12.6",
"Revenues": "18.4",
"Net Income": "20.2",
"Research and Development": "8.70",
"General and Administrative Expense": "-3.22",
"Other Revenues": "18.4",
"Comprehensive Net Income": "20.3",
"Other Net Income": "6.88",
"Economic Capital Ratio": "-41.7"
},
"2021": {
"Liabilities, Non-Current": "-65.5",
"Liabilities": "-45.5",
"Stockholders Equity": "-81.6",
"ECR before LimitedLiability": "-42.0",
"Liabilities, Current": "7.30",
"Other Liabilities": "9.27",
"Assets, Current": "-30.5",
"Assets": "-38.8",
"Assets, Non-Current": "-7.81",
"Other Assets": "3.42",
"Goodwill": "-25.0",
"Property, Plant and Equipment, Net": "24.2",
"Other Expenses": "11.8",
"Expenses": "9.99",
"Revenues": "27.8",
"Net Income": "28.4",
"Research and Development": "12.5",
"General and Administrative Expense": "-13.5",
"Other Revenues": "27.8",
"Comprehensive Net Income": "28.3",
"Economic Capital Ratio": "-46.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001627223_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "2,301,000",
"Assets, Non-Current": "644,000",
"General and Administrative Expense": "632,000",
"Goodwill": "176,000",
"Liabilities, Current": "1,466,000",
"Liabilities, Non-Current": "4,468,000",
"Other Assets": "0",
"Other Compr. Net Income": "-244,000",
"Other Expenses": "5,154,000",
"Other Liabilities": "234,000",
"Other Net Income": "76,000",
"Other Revenues": "5,717,000",
"Property, Plant and Equipment, Net": "3,177,000",
"Research and Development": "97,000"
},
"output_variables": {
"Liabilities": "6,168,000",
"Assets": "6,298,000",
"Expenses": "5,883,000",
"Revenues": "5,717,000",
"Stockholders Equity": "130,000",
"Net Income": "-90,000",
"Comprehensive Net Income": "-212,000",
"BaseVar": "12,193,000",
"ECR before LimitedLiability": "-0.54%",
"Economic Capital Ratio": "85%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,553,000",
"Assets, Non-Current": "553,000",
"General and Administrative Expense": "934,000",
"Goodwill": "0",
"Liabilities, Current": "1,771,000",
"Liabilities, Non-Current": "4,053,000",
"Other Assets": "170,000",
"Other Compr. Net Income": "-41,000",
"Other Expenses": "4,655,000",
"Other Liabilities": "132,000",
"Other Net Income": "276,000",
"Other Revenues": "5,400,000",
"Property, Plant and Equipment, Net": "2,784,000",
"Research and Development": "80,000"
},
"output_variables": {
"Liabilities": "5,956,000",
"Assets": "6,060,000",
"Expenses": "5,669,000",
"Revenues": "5,400,000",
"Stockholders Equity": "104,000",
"Net Income": "7,000",
"Comprehensive Net Income": "-13,500",
"BaseVar": "11,701,000",
"ECR before LimitedLiability": "2.1%",
"Economic Capital Ratio": "87%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,493,000",
"Assets, Non-Current": "626,000",
"General and Administrative Expense": "602,000",
"Goodwill": "0",
"Liabilities, Current": "1,648,000",
"Liabilities, Non-Current": "4,572,000",
"Other Assets": "166,000",
"Other Compr. Net Income": "134,000",
"Other Expenses": "4,866,000",
"Other Liabilities": "208,000",
"Other Net Income": "112,000",
"Other Revenues": "6,183,000",
"Property, Plant and Equipment, Net": "3,008,000",
"Research and Development": "80,000"
},
"output_variables": {
"Liabilities": "6,428,000",
"Assets": "7,293,000",
"Expenses": "5,548,000",
"Revenues": "6,183,000",
"Stockholders Equity": "865,000",
"Net Income": "747,000",
"Comprehensive Net Income": "814,000",
"BaseVar": "12,849,000",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "112%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "3,293,000",
"Assets, Non-Current": "597,000",
"General and Administrative Expense": "5,324,000",
"Goodwill": "0",
"Liabilities, Current": "1,709,000",
"Liabilities, Non-Current": "4,416,000",
"Other Assets": "181,000",
"Other Compr. Net Income": "-123,000",
"Other Expenses": "403,000",
"Other Liabilities": "217,000",
"Other Net Income": "167,000",
"Other Revenues": "6,638,000",
"Property, Plant and Equipment, Net": "3,291,000",
"Research and Development": "82,000"
},
"output_variables": {
"Liabilities": "6,342,000",
"Assets": "7,362,000",
"Expenses": "5,809,000",
"Revenues": "6,638,000",
"Stockholders Equity": "1,020,000",
"Net Income": "996,000",
"Comprehensive Net Income": "934,500",
"BaseVar": "13,220,500",
"ECR before LimitedLiability": "34%",
"Economic Capital Ratio": "117%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,777,000",
"Assets, Non-Current": "748,000",
"General and Administrative Expense": "5,011,000",
"Goodwill": "0",
"Liabilities, Current": "1,541,000",
"Liabilities, Non-Current": "4,904,000",
"Other Assets": "174,000",
"Other Compr. Net Income": "215,000",
"Other Expenses": "223,000",
"Other Liabilities": "118,000",
"Other Net Income": "-264,000",
"Other Revenues": "5,526,000",
"Property, Plant and Equipment, Net": "3,559,000",
"Research and Development": "80,000"
},
"output_variables": {
"Liabilities": "6,563,000",
"Assets": "7,258,000",
"Expenses": "5,314,000",
"Revenues": "5,526,000",
"Stockholders Equity": "695,000",
"Net Income": "-52,000",
"Comprehensive Net Income": "55,500",
"BaseVar": "12,570,000",
"ECR before LimitedLiability": "15%",
"Economic Capital Ratio": "99%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "2,633,000",
"Assets, Non-Current": "808,000",
"General and Administrative Expense": "4,429,000",
"Goodwill": "153,000",
"Liabilities, Current": "1,478,000",
"Liabilities, Non-Current": "4,789,000",
"Other Assets": "14,000",
"Other Compr. Net Income": "39,000",
"Other Expenses": "250,000",
"Other Liabilities": "0",
"Other Net Income": "22,000",
"Other Revenues": "4,969,000",
"Property, Plant and Equipment, Net": "3,474,000",
"Research and Development": "93,000"
},
"output_variables": {
"Liabilities": "6,267,000",
"Assets": "7,082,000",
"Expenses": "4,772,000",
"Revenues": "4,969,000",
"Stockholders Equity": "815,000",
"Net Income": "219,000",
"Comprehensive Net Income": "238,500",
"BaseVar": "11,575,500",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,345,000",
"Assets, Non-Current": "843,000",
"General and Administrative Expense": "5,556,000",
"Goodwill": "102,000",
"Liabilities, Current": "1,907,000",
"Liabilities, Non-Current": "4,561,000",
"Other Assets": "106,000",
"Other Compr. Net Income": "-54,000",
"Other Expenses": "259,000",
"Other Liabilities": "0",
"Other Net Income": "185,000",
"Other Revenues": "6,345,000",
"Property, Plant and Equipment, Net": "3,154,000",
"Research and Development": "107,000"
},
"output_variables": {
"Liabilities": "6,468,000",
"Assets": "7,550,000",
"Expenses": "5,922,000",
"Revenues": "6,345,000",
"Stockholders Equity": "1,082,000",
"Net Income": "608,000",
"Comprehensive Net Income": "581,000",
"BaseVar": "13,262,000",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "112%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 1.124526709474761,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001627223.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001627223.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001627223.svg"
},
{
"company_id": "0001642380",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001642380.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001642380.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001642380.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001642380_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001642380_main_keyfigs.svg",
"name": "Insight Molecular Diagnostics Inc",
"rank": 37,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001642380.svg",
"report_text": "The relative strengths and weaknesses of Insight Molecular Diagnostics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Insight Molecular Diagnostics Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Insight Molecular Diagnostics Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 92% points.
The company's Economic Capital Ratio, given in the ranking table, is 104%, being 55% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001642380_2022_Insight_Molecular_Diagnostics_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "17.9",
"Liabilities": "9.68",
"Stockholders Equity": "25.8",
"ECR before LimitedLiability": "-19.9",
"Liabilities, Current": "-12.6",
"Other Liabilities": "3.72",
"Property, Plant and Equipment, Net": "-13.8",
"Assets": "25.7",
"Assets, Non-Current": "-5.78",
"Assets, Current": "40.2",
"Goodwill": "-7.54",
"Research and Development": "-35.5",
"Expenses": "-18.5",
"Revenues": "-44.9",
"Net Income": "-62.0",
"General and Administrative Expense": "-10.7",
"Other Expenses": "22.2",
"Other Revenues": "-44.9",
"Comprehensive Net Income": "-63.0",
"Other Net Income": "-2.40",
"Economic Capital Ratio": "-39.9"
},
"2017": {
"Liabilities": "1.32",
"Stockholders Equity": "-7.66",
"ECR before LimitedLiability": "-86.6",
"Liabilities, Current": "-1.41",
"Liabilities, Non-Current": "3.37",
"Assets, Non-Current": "-6.06",
"Assets": "-16.1",
"Other Assets": "1.08",
"Assets, Current": "20.5",
"Goodwill": "-12.1",
"Property, Plant and Equipment, Net": "-17.3",
"Research and Development": "-21.9",
"Expenses": "-33.2",
"Revenues": "-23.4",
"Net Income": "-64.5",
"Other Expenses": "11.8",
"General and Administrative Expense": "-26.1",
"Other Revenues": "-23.4",
"Comprehensive Net Income": "-66.3",
"Other Net Income": "-4.79",
"Economic Capital Ratio": "-108"
},
"2019": {
"Liabilities, Non-Current": "17.2",
"Liabilities": "15.2",
"Stockholders Equity": "70.3",
"ECR before LimitedLiability": "47.8",
"Other Liabilities": "-13.5",
"Liabilities, Current": "10.9",
"Assets, Non-Current": "27.1",
"Assets": "69.6",
"Goodwill": "-10.4",
"Property, Plant and Equipment, Net": "-12.2",
"Other Assets": "21.4",
"Assets, Current": "40.0",
"Research and Development": "-12.1",
"Expenses": "-3.78",
"Revenues": "-33.7",
"Net Income": "-34.7",
"Other Expenses": "8.23",
"Other Revenues": "-33.7",
"Other Net Income": "2.76",
"Comprehensive Net Income": "-34.6",
"Economic Capital Ratio": "18.3"
},
"2021": {
"Liabilities, Non-Current": "19.2",
"Liabilities": "-46.4",
"Stockholders Equity": "-18.4",
"ECR before LimitedLiability": "-50.7",
"Liabilities, Current": "15.5",
"Other Liabilities": "-91.6",
"Assets, Current": "-26.5",
"Assets": "19.2",
"Assets, Non-Current": "-14.4",
"Other Assets": "11.5",
"Goodwill": "37.9",
"Property, Plant and Equipment, Net": "-18.7",
"Other Expenses": "-4.82",
"Expenses": "8.82",
"Revenues": "-30.1",
"Net Income": "-21.3",
"General and Administrative Expense": "14.0",
"Other Revenues": "-30.1",
"Comprehensive Net Income": "-21.3",
"Other Net Income": "1.23",
"Economic Capital Ratio": "-55.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001642380_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "12,696",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,463",
"Goodwill": "988",
"Liabilities, Current": "4,275",
"Liabilities, Non-Current": "0",
"Other Assets": "75",
"Other Compr. Net Income": "-304",
"Other Expenses": "0",
"Other Liabilities": "310",
"Other Net Income": "-28",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "688",
"Research and Development": "5,677"
},
"output_variables": {
"Liabilities": "4,585",
"Assets": "14,447",
"Expenses": "11,140",
"Revenues": "0",
"Stockholders Equity": "9,862",
"Net Income": "-11,168",
"Comprehensive Net Income": "-11,320",
"BaseVar": "15,252",
"ECR before LimitedLiability": "23%",
"Economic Capital Ratio": "107%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "8,528",
"Assets, Non-Current": "0",
"General and Administrative Expense": "11,675",
"Goodwill": "746",
"Liabilities, Current": "4,454",
"Liabilities, Non-Current": "0",
"Other Assets": "120",
"Other Compr. Net Income": "-234",
"Other Expenses": "0",
"Other Liabilities": "1,359",
"Other Net Income": "-526",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "822",
"Research and Development": "7,174"
},
"output_variables": {
"Liabilities": "5,813",
"Assets": "10,216",
"Expenses": "18,849",
"Revenues": "0",
"Stockholders Equity": "4,403",
"Net Income": "-19,375",
"Comprehensive Net Income": "-19,492",
"BaseVar": "17,819",
"ECR before LimitedLiability": "-168%",
"Economic Capital Ratio": "45%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "22,956",
"Assets, Non-Current": "10,964",
"General and Administrative Expense": "15,445",
"Goodwill": "0",
"Liabilities, Current": "4,440",
"Liabilities, Non-Current": "0",
"Other Assets": "5,939",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "4,581",
"Other Net Income": "-187",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "6,794"
},
"output_variables": {
"Liabilities": "9,021",
"Assets": "39,859",
"Expenses": "22,239",
"Revenues": "0",
"Stockholders Equity": "30,838",
"Net Income": "-22,426",
"Comprehensive Net Income": "-22,426",
"BaseVar": "35,653",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "154%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "39,143",
"Assets, Non-Current": "264",
"General and Administrative Expense": "37,688",
"Goodwill": "109,929",
"Liabilities, Current": "14,120",
"Liabilities, Non-Current": "0",
"Other Assets": "10,227",
"Other Compr. Net Income": "37",
"Other Expenses": "21,359",
"Other Liabilities": "80,226",
"Other Net Income": "854",
"Other Revenues": "7,727",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "13,631"
},
"output_variables": {
"Liabilities": "94,346",
"Assets": "159,563",
"Expenses": "72,678",
"Revenues": "7,727",
"Stockholders Equity": "65,217",
"Net Income": "-64,097",
"Comprehensive Net Income": "-64,078",
"BaseVar": "167,602",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "104%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.0379048865300748,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001642380.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001642380.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001642380.svg"
},
{
"company_id": "0001321834",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001321834.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001321834.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001321834.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001321834_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001321834_main_keyfigs.svg",
"name": "Q C Technologies INC",
"rank": 38,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001321834.svg",
"report_text": "The relative strengths and weaknesses of Q C Technologies INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Q C Technologies INC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 42% points.The greatest weakness of Q C Technologies INC is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 136% points.
The company's Economic Capital Ratio, given in the ranking table, is 103%, being 56% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001321834_2022_Q_C_Technologies_INC.pdf",
"shrinked_graph_json": {
"2014": {
"Liabilities, Non-Current": "17.8",
"Liabilities": "53.0",
"Stockholders Equity": "126",
"ECR before LimitedLiability": "141",
"Liabilities, Current": "29.3",
"Other Liabilities": "12.1",
"Assets, Current": "40.4",
"Assets": "41.6",
"Other Assets": "-6.74",
"Assets, Non-Current": "11.7",
"Property, Plant and Equipment, Net": "-3.37",
"Other Expenses": "4.87",
"Expenses": "16.5",
"Revenues": "-7.84",
"Net Income": "10.5",
"Research and Development": "4.74",
"General and Administrative Expense": "7.01",
"Other Revenues": "-7.84",
"Other Net Income": "1.70",
"Comprehensive Net Income": "10.6",
"Economic Capital Ratio": "91.5"
},
"2018": {
"Liabilities, Non-Current": "3.04",
"Liabilities": "6.50",
"Stockholders Equity": "6.83",
"ECR before LimitedLiability": "-39.9",
"Other Liabilities": "1.70",
"Liabilities, Current": "0.849",
"Property, Plant and Equipment, Net": "-14.8",
"Assets": "-0.886",
"Other Assets": "-0.794",
"Assets, Current": "18.6",
"Goodwill": "-2.18",
"Assets, Non-Current": "1.03",
"Other Expenses": "-0.883",
"Expenses": "-62.3",
"Revenues": "-22.9",
"Net Income": "-86.1",
"General and Administrative Expense": "-55.0",
"Other Revenues": "-22.9",
"Comprehensive Net Income": "-85.7",
"Other Net Income": "2.01",
"Economic Capital Ratio": "-60.4"
},
"2019": {
"Liabilities, Non-Current": "18.9",
"Liabilities": "35.0",
"Stockholders Equity": "97.2",
"ECR before LimitedLiability": "89.8",
"Other Liabilities": "12.4",
"Liabilities, Current": "5.64",
"Assets, Non-Current": "-2.67",
"Assets": "43.4",
"Goodwill": "-5.94",
"Property, Plant and Equipment, Net": "-8.03",
"Assets, Current": "112",
"Research and Development": "4.93",
"Expenses": "2.62",
"Revenues": "-18.0",
"Net Income": "-12.7",
"Other Expenses": "5.92",
"General and Administrative Expense": "-8.20",
"Other Revenues": "-18.0",
"Other Net Income": "2.59",
"Comprehensive Net Income": "-12.5",
"Economic Capital Ratio": "60.4"
},
"2020": {
"Liabilities, Current": "21.4",
"Liabilities": "47.5",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "94.8",
"Liabilities, Non-Current": "24.4",
"Other Liabilities": "5.25",
"Goodwill": "-6.09",
"Assets": "51.2",
"Assets, Current": "125",
"Assets, Non-Current": "-4.95",
"Property, Plant and Equipment, Net": "-7.71",
"Other Expenses": "6.20",
"Expenses": "5.27",
"Revenues": "-30.9",
"Net Income": "-40.1",
"Research and Development": "-21.1",
"General and Administrative Expense": "20.1",
"Other Revenues": "-30.9",
"Comprehensive Net Income": "-40.1",
"Other Net Income": "-14.0",
"Economic Capital Ratio": "57.0"
},
"2021": {
"Liabilities, Non-Current": "18.8",
"Liabilities": "22.9",
"Stockholders Equity": "30.3",
"ECR before LimitedLiability": "-51.2",
"Liabilities, Current": "19.2",
"Other Liabilities": "10.6",
"Assets": "17.9",
"Assets, Non-Current": "42.3",
"Other Assets": "-58.5",
"Goodwill": "25.2",
"Property, Plant and Equipment, Net": "-28.5",
"Other Expenses": "-78.8",
"Expenses": "-86.6",
"Revenues": "-54.6",
"Net Income": "-136",
"Research and Development": "-30.0",
"General and Administrative Expense": "18.6",
"Other Revenues": "-54.6",
"Comprehensive Net Income": "-136",
"Other Net Income": "-6.62",
"Economic Capital Ratio": "-55.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001321834_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "13,060",
"Assets, Non-Current": "3,591",
"General and Administrative Expense": "5,086",
"Goodwill": "2,176",
"Liabilities, Current": "1,844",
"Liabilities, Non-Current": "0",
"Other Assets": "-2,378",
"Other Compr. Net Income": "0",
"Other Expenses": "1,613",
"Other Liabilities": "0",
"Other Net Income": "77",
"Other Revenues": "4,427",
"Property, Plant and Equipment, Net": "201",
"Research and Development": "916"
},
"output_variables": {
"Liabilities": "1,844",
"Assets": "16,651",
"Expenses": "7,616",
"Revenues": "4,427",
"Stockholders Equity": "14,807",
"Net Income": "-3,111",
"Comprehensive Net Income": "-3,111",
"BaseVar": "15,307",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "225%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,670",
"Assets, Non-Current": "1,137",
"General and Administrative Expense": "8,987",
"Goodwill": "243",
"Liabilities, Current": "1,974",
"Liabilities, Non-Current": "0",
"Other Assets": "-327",
"Other Compr. Net Income": "0",
"Other Expenses": "1,676",
"Other Liabilities": "0",
"Other Net Income": "789",
"Other Revenues": "1,666",
"Property, Plant and Equipment, Net": "83",
"Research and Development": "1,063"
},
"output_variables": {
"Liabilities": "1,974",
"Assets": "7,807",
"Expenses": "11,726",
"Revenues": "1,666",
"Stockholders Equity": "5,834",
"Net Income": "-9,272",
"Comprehensive Net Income": "-9,272",
"BaseVar": "11,980",
"ECR before LimitedLiability": "-26%",
"Economic Capital Ratio": "83%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "10,311",
"Assets, Non-Current": "574",
"General and Administrative Expense": "5,065",
"Goodwill": "170",
"Liabilities, Current": "1,530",
"Liabilities, Non-Current": "0",
"Other Assets": "-204",
"Other Compr. Net Income": "44",
"Other Expenses": "181",
"Other Liabilities": "0",
"Other Net Income": "-58",
"Other Revenues": "1,577",
"Property, Plant and Equipment, Net": "34",
"Research and Development": "277"
},
"output_variables": {
"Liabilities": "1,530",
"Assets": "10,885",
"Expenses": "5,523",
"Revenues": "1,577",
"Stockholders Equity": "9,355",
"Net Income": "-4,004",
"Comprehensive Net Income": "-3,982",
"BaseVar": "9,808",
"ECR before LimitedLiability": "142%",
"Economic Capital Ratio": "196%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "36,843",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,322",
"Goodwill": "0",
"Liabilities, Current": "2,263",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-5,295",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "7,964"
},
"output_variables": {
"Liabilities": "2,263",
"Assets": "36,843",
"Expenses": "12,286",
"Revenues": "0",
"Stockholders Equity": "34,579",
"Net Income": "-17,581",
"Comprehensive Net Income": "-17,581",
"BaseVar": "28,343",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "203%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "12,665",
"Assets, Non-Current": "12,148",
"General and Administrative Expense": "6,420",
"Goodwill": "10,499",
"Liabilities, Current": "1,040",
"Liabilities, Non-Current": "126",
"Other Assets": "-10,499",
"Other Compr. Net Income": "0",
"Other Expenses": "15,645",
"Other Liabilities": "0",
"Other Net Income": "-1,079",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "6,745"
},
"output_variables": {
"Liabilities": "1,166",
"Assets": "24,813",
"Expenses": "28,810",
"Revenues": "0",
"Stockholders Equity": "23,647",
"Net Income": "-29,889",
"Comprehensive Net Income": "-29,889",
"BaseVar": "27,934",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "103%"
}
}
},
"top_rated": false,
"trend": -25.0,
"value": 1.032353817426051,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001321834.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001321834.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001321834.svg"
},
{
"company_id": "0001756390",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001756390.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001756390.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001756390.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001756390_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001756390_main_keyfigs.svg",
"name": "Ascend Wellness Holdings Inc",
"rank": 39,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001756390.svg",
"report_text": "The relative strengths and weaknesses of Ascend Wellness Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ascend Wellness Holdings Inc compared to the market average is the variable Property, Plant and Equipment, Net, increasing the Economic Capital Ratio by 18% points.The greatest weakness of Ascend Wellness Holdings Inc is the variable Liabilities, Non-Current, reducing the Economic Capital Ratio by 75% points.
The company's Economic Capital Ratio, given in the ranking table, is 103%, being 56% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001756390_2022_Ascend_Wellness_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "-75.0",
"Liabilities": "-49.9",
"Stockholders Equity": "-59.7",
"ECR before LimitedLiability": "-51.7",
"Liabilities, Current": "12.4",
"Other Liabilities": "8.00",
"Assets, Current": "-29.4",
"Assets": "-20.4",
"Assets, Non-Current": "3.24",
"Goodwill": "-9.80",
"Property, Plant and Equipment, Net": "18.1",
"Other Expenses": "1.74",
"Expenses": "18.1",
"Revenues": "1.95",
"Net Income": "12.4",
"Research and Development": "12.4",
"General and Administrative Expense": "4.91",
"Other Revenues": "1.95",
"Comprehensive Net Income": "12.4",
"Other Net Income": "-8.43",
"Economic Capital Ratio": "-56.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001756390_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "258,012",
"Assets, Non-Current": "123,530",
"General and Administrative Expense": "313,074",
"Goodwill": "102,238",
"Liabilities, Current": "118,818",
"Liabilities, Non-Current": "428,141",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "78,231",
"Other Liabilities": "0",
"Other Net Income": "-63,733",
"Other Revenues": "332,381",
"Property, Plant and Equipment, Net": "239,656",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "546,959",
"Assets": "723,436",
"Expenses": "391,305",
"Revenues": "332,381",
"Stockholders Equity": "176,477",
"Net Income": "-122,657",
"Comprehensive Net Income": "-122,657",
"BaseVar": "1,028,907",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "103%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.0272233681051202,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001756390.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001756390.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001756390.svg"
},
{
"company_id": "0000949858",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000949858.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000949858.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000949858.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000949858_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000949858_main_keyfigs.svg",
"name": "Achieve LIFE Sciences INC",
"rank": 40,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000949858.svg",
"report_text": "The relative strengths and weaknesses of Achieve LIFE Sciences INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Achieve LIFE Sciences INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Achieve LIFE Sciences INC is the variable Other Liabilities, reducing the Economic Capital Ratio by 58% points.
The company's Economic Capital Ratio, given in the ranking table, is 100%, being 59% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000949858_2022_Achieve_LIFE_Sciences_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "-43.8",
"Liabilities": "-43.7",
"Stockholders Equity": "19.4",
"ECR before LimitedLiability": "40.7",
"Liabilities, Non-Current": "7.76",
"Other Liabilities": "-7.86",
"Property, Plant and Equipment, Net": "-10.3",
"Assets": "48.0",
"Assets, Non-Current": "-3.79",
"Goodwill": "-9.74",
"Assets, Current": "59.2",
"General and Administrative Expense": "39.1",
"Expenses": "34.1",
"Revenues": "-40.2",
"Net Income": "2.87",
"Research and Development": "-21.6",
"Other Expenses": "19.2",
"Other Revenues": "-40.2",
"Comprehensive Net Income": "2.83",
"Other Net Income": "15.9",
"Economic Capital Ratio": "-21.3"
},
"2012": {
"Liabilities, Current": "4.96",
"Liabilities": "19.5",
"Stockholders Equity": "77.5",
"ECR before LimitedLiability": "70.3",
"Liabilities, Non-Current": "9.90",
"Other Liabilities": "5.33",
"Assets, Current": "97.0",
"Assets": "40.6",
"Assets, Non-Current": "-2.01",
"Property, Plant and Equipment, Net": "-6.18",
"Goodwill": "-6.64",
"Other Expenses": "23.7",
"Expenses": "13.2",
"Revenues": "-47.0",
"Net Income": "0.352",
"Research and Development": "-42.8",
"General and Administrative Expense": "32.9",
"Other Revenues": "-47.0",
"Other Net Income": "34.2",
"Comprehensive Net Income": "0.405",
"Economic Capital Ratio": "37.8"
},
"2013": {
"Liabilities": "26.7",
"Stockholders Equity": "30.0",
"ECR before LimitedLiability": "17.0",
"Other Liabilities": "4.51",
"Liabilities, Non-Current": "19.7",
"Goodwill": "-18.4",
"Assets": "3.95",
"Assets, Non-Current": "-5.18",
"Property, Plant and Equipment, Net": "-15.3",
"Other Assets": "-3.95",
"Assets, Current": "49.4",
"General and Administrative Expense": "46.8",
"Expenses": "-21.6",
"Revenues": "-61.1",
"Net Income": "-21.3",
"Research and Development": "-89.9",
"Other Expenses": "40.9",
"Other Revenues": "-61.1",
"Other Net Income": "48.9",
"Comprehensive Net Income": "-21.4",
"Economic Capital Ratio": "-23.2"
},
"2014": {
"Liabilities, Non-Current": "20.4",
"Liabilities": "28.2",
"Stockholders Equity": "47.1",
"ECR before LimitedLiability": "47.6",
"Liabilities, Current": "-5.45",
"Other Liabilities": "13.5",
"Assets, Current": "53.1",
"Assets": "21.1",
"Goodwill": "-17.9",
"Assets, Non-Current": "-5.69",
"Property, Plant and Equipment, Net": "-14.0",
"Other Expenses": "27.9",
"Expenses": "-6.25",
"Revenues": "-54.8",
"Net Income": "-3.20",
"Research and Development": "-68.4",
"General and Administrative Expense": "47.1",
"Other Revenues": "-54.8",
"Other Net Income": "48.5",
"Comprehensive Net Income": "-3.13",
"Economic Capital Ratio": "-1.85"
},
"2015": {
"Other Liabilities": "15.3",
"Liabilities": "19.4",
"Stockholders Equity": "60.3",
"ECR before LimitedLiability": "68.8",
"Liabilities, Current": "-15.6",
"Liabilities, Non-Current": "18.9",
"Assets, Current": "78.2",
"Assets": "34.1",
"Other Assets": "-5.24",
"Goodwill": "-11.4",
"Property, Plant and Equipment, Net": "-8.72",
"Research and Development": "-34.3",
"Expenses": "7.53",
"Revenues": "-37.4",
"Net Income": "5.56",
"General and Administrative Expense": "18.1",
"Other Expenses": "27.8",
"Other Revenues": "-37.4",
"Comprehensive Net Income": "5.87",
"Other Net Income": "41.2",
"Economic Capital Ratio": "23.0"
},
"2016": {
"Liabilities, Non-Current": "21.0",
"Liabilities": "24.0",
"Stockholders Equity": "31.7",
"ECR before LimitedLiability": "-11.4",
"Liabilities, Current": "-6.18",
"Other Liabilities": "9.13",
"Property, Plant and Equipment, Net": "-20.8",
"Assets": "29.7",
"Assets, Non-Current": "-6.24",
"Assets, Current": "47.8",
"Goodwill": "-18.9",
"Research and Development": "-48.3",
"Expenses": "-26.7",
"Revenues": "-50.6",
"Net Income": "-51.3",
"General and Administrative Expense": "3.66",
"Other Expenses": "23.2",
"Other Revenues": "-50.6",
"Comprehensive Net Income": "-51.0",
"Other Net Income": "29.3",
"Economic Capital Ratio": "-31.3"
},
"2017": {
"Other Liabilities": "3.68",
"Liabilities": "6.08",
"Stockholders Equity": "18.8",
"ECR before LimitedLiability": "-43.7",
"Liabilities, Current": "3.59",
"Liabilities, Non-Current": "4.22",
"Assets, Non-Current": "-2.55",
"Assets": "9.76",
"Assets, Current": "7.53",
"Goodwill": "9.65",
"Property, Plant and Equipment, Net": "-32.4",
"Research and Development": "-29.6",
"Expenses": "6.94",
"Revenues": "-52.9",
"Net Income": "-107",
"Other Expenses": "14.4",
"General and Administrative Expense": "-3.75",
"Other Revenues": "-52.9",
"Comprehensive Net Income": "-108",
"Other Net Income": "-98.4",
"Economic Capital Ratio": "-65.2"
},
"2018": {
"Liabilities, Non-Current": "16.3",
"Liabilities": "26.7",
"Stockholders Equity": "71.1",
"ECR before LimitedLiability": "30.2",
"Other Liabilities": "9.76",
"Liabilities, Current": "1.15",
"Property, Plant and Equipment, Net": "-13.0",
"Assets": "69.0",
"Assets, Current": "72.9",
"Goodwill": "11.0",
"Assets, Non-Current": "-6.80",
"Other Expenses": "11.0",
"Expenses": "-15.6",
"Revenues": "-36.9",
"Net Income": "-50.6",
"Research and Development": "-26.0",
"General and Administrative Expense": "0.432",
"Other Revenues": "-36.9",
"Comprehensive Net Income": "-50.4",
"Other Net Income": "0.802",
"Economic Capital Ratio": "9.76"
},
"2019": {
"Liabilities, Non-Current": "18.4",
"Liabilities": "39.1",
"Stockholders Equity": "65.4",
"ECR before LimitedLiability": "38.8",
"Other Liabilities": "13.0",
"Liabilities, Current": "9.16",
"Assets, Non-Current": "-9.00",
"Assets": "60.9",
"Goodwill": "5.93",
"Property, Plant and Equipment, Net": "-15.0",
"Assets, Current": "70.4",
"Research and Development": "-47.3",
"Expenses": "-27.2",
"Revenues": "-39.9",
"Net Income": "-60.6",
"Other Expenses": "9.98",
"General and Administrative Expense": "13.5",
"Other Revenues": "-39.9",
"Other Net Income": "4.89",
"Comprehensive Net Income": "-60.5",
"Economic Capital Ratio": "9.32"
},
"2020": {
"Liabilities, Current": "16.9",
"Liabilities": "41.6",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "105",
"Liabilities, Non-Current": "22.9",
"Other Liabilities": "5.06",
"Goodwill": "-0.638",
"Assets": "49.7",
"Assets, Current": "103",
"Assets, Non-Current": "-3.56",
"Property, Plant and Equipment, Net": "-6.27",
"Other Expenses": "5.76",
"Expenses": "-1.70",
"Revenues": "-29.1",
"Net Income": "-27.0",
"Research and Development": "-15.8",
"General and Administrative Expense": "8.09",
"Other Revenues": "-29.1",
"Comprehensive Net Income": "-27.0",
"Other Net Income": "3.65",
"Economic Capital Ratio": "67.2"
},
"2021": {
"Liabilities, Non-Current": "15.3",
"Liabilities": "-14.1",
"Stockholders Equity": "11.1",
"ECR before LimitedLiability": "-54.6",
"Liabilities, Current": "15.3",
"Other Liabilities": "-57.9",
"Assets, Current": "37.1",
"Assets": "15.5",
"Assets, Non-Current": "-16.7",
"Other Assets": "2.18",
"Goodwill": "-16.4",
"Property, Plant and Equipment, Net": "-21.5",
"Other Expenses": "12.6",
"Expenses": "-21.0",
"Revenues": "-39.9",
"Net Income": "-57.1",
"Research and Development": "-50.0",
"General and Administrative Expense": "15.4",
"Other Revenues": "-39.9",
"Comprehensive Net Income": "-57.1",
"Economic Capital Ratio": "-58.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000949858_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "67,326",
"Assets, Non-Current": "509",
"General and Administrative Expense": "6,230",
"Goodwill": "0",
"Liabilities, Current": "30,786",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "6,339",
"Other Net Income": "13,110",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "180",
"Research and Development": "21,553"
},
"output_variables": {
"Liabilities": "37,125",
"Assets": "68,015",
"Expenses": "27,783",
"Revenues": "0",
"Stockholders Equity": "30,890",
"Net Income": "-14,673",
"Comprehensive Net Income": "-14,673",
"BaseVar": "73,016",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "132%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "80,179",
"Assets, Non-Current": "1,152",
"General and Administrative Expense": "7,791",
"Goodwill": "0",
"Liabilities, Current": "11,556",
"Liabilities, Non-Current": "0",
"Other Assets": "314",
"Other Compr. Net Income": "1.0",
"Other Expenses": "-1,657",
"Other Liabilities": "4,253",
"Other Net Income": "24,984",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "371",
"Research and Development": "39,948"
},
"output_variables": {
"Liabilities": "15,809",
"Assets": "82,016",
"Expenses": "46,082",
"Revenues": "0",
"Stockholders Equity": "66,207",
"Net Income": "-21,098",
"Comprehensive Net Income": "-21,098",
"BaseVar": "84,446",
"ECR before LimitedLiability": "142%",
"Economic Capital Ratio": "196%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "53,867",
"Assets, Non-Current": "1,111",
"General and Administrative Expense": "9,892",
"Goodwill": "0",
"Liabilities, Current": "14,934",
"Liabilities, Non-Current": "0",
"Other Assets": "314",
"Other Compr. Net Income": "6.0",
"Other Expenses": "0",
"Other Liabilities": "3,544",
"Other Net Income": "33,360",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "397",
"Research and Development": "55,317"
},
"output_variables": {
"Liabilities": "18,478",
"Assets": "55,689",
"Expenses": "65,209",
"Revenues": "0",
"Stockholders Equity": "37,211",
"Net Income": "-31,849",
"Comprehensive Net Income": "-31,846",
"BaseVar": "86,371",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "131%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "55,761",
"Assets, Non-Current": "273",
"General and Administrative Expense": "10,625",
"Goodwill": "0",
"Liabilities, Current": "22,218",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-21",
"Other Expenses": "-267",
"Other Liabilities": "14",
"Other Net Income": "30,342",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "257",
"Research and Development": "46,224"
},
"output_variables": {
"Liabilities": "22,232",
"Assets": "56,291",
"Expenses": "56,582",
"Revenues": "0",
"Stockholders Equity": "34,059",
"Net Income": "-26,240",
"Comprehensive Net Income": "-26,250",
"BaseVar": "82,734",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "132%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "57,298",
"Assets, Non-Current": "37",
"General and Administrative Expense": "11,805",
"Goodwill": "0",
"Liabilities, Current": "20,664",
"Liabilities, Non-Current": "0",
"Other Assets": "272",
"Other Compr. Net Income": "10",
"Other Expenses": "0",
"Other Liabilities": "105",
"Other Net Income": "20,112",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "602",
"Research and Development": "25,108"
},
"output_variables": {
"Liabilities": "20,769",
"Assets": "58,209",
"Expenses": "36,913",
"Revenues": "0",
"Stockholders Equity": "37,440",
"Net Income": "-16,801",
"Comprehensive Net Income": "-16,796",
"BaseVar": "68,006",
"ECR before LimitedLiability": "87%",
"Economic Capital Ratio": "159%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "26,927",
"Assets, Non-Current": "13",
"General and Administrative Expense": "8,933",
"Goodwill": "0",
"Liabilities, Current": "8,455",
"Liabilities, Non-Current": "0",
"Other Assets": "272",
"Other Compr. Net Income": "8.0",
"Other Expenses": "2,533",
"Other Liabilities": "49",
"Other Net Income": "6,125",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "258",
"Research and Development": "14,788"
},
"output_variables": {
"Liabilities": "8,504",
"Assets": "27,470",
"Expenses": "26,254",
"Revenues": "0",
"Stockholders Equity": "18,966",
"Net Income": "-20,129",
"Comprehensive Net Income": "-20,125",
"BaseVar": "34,180",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "115%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "5,908",
"Assets, Non-Current": "309",
"General and Administrative Expense": "3,531",
"Goodwill": "3,566",
"Liabilities, Current": "2,013",
"Liabilities, Non-Current": "0",
"Other Assets": "50",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,051",
"Other Liabilities": "0",
"Other Net Income": "-7,002",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "59",
"Research and Development": "3,101"
},
"output_variables": {
"Liabilities": "2,013",
"Assets": "9,892",
"Expenses": "3,581",
"Revenues": "0",
"Stockholders Equity": "7,879",
"Net Income": "-10,583",
"Comprehensive Net Income": "-10,583",
"BaseVar": "11,244",
"ECR before LimitedLiability": "3.5%",
"Economic Capital Ratio": "88%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "15,537",
"Assets, Non-Current": "118",
"General and Administrative Expense": "6,945",
"Goodwill": "3,344",
"Liabilities, Current": "3,270",
"Liabilities, Non-Current": "0",
"Other Assets": "50",
"Other Compr. Net Income": "-1.0",
"Other Expenses": "0",
"Other Liabilities": "12",
"Other Net Income": "126",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "35",
"Research and Development": "5,868"
},
"output_variables": {
"Liabilities": "3,282",
"Assets": "19,084",
"Expenses": "12,813",
"Revenues": "0",
"Stockholders Equity": "15,802",
"Net Income": "-12,687",
"Comprehensive Net Income": "-12,688",
"BaseVar": "17,653",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "154%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "17,334",
"Assets, Non-Current": "516",
"General and Administrative Expense": "6,854",
"Goodwill": "3,121",
"Liabilities, Current": "2,869",
"Liabilities, Non-Current": "159",
"Other Assets": "50",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "133",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "57",
"Research and Development": "9,674"
},
"output_variables": {
"Liabilities": "3,028",
"Assets": "21,078",
"Expenses": "16,528",
"Revenues": "0",
"Stockholders Equity": "18,050",
"Net Income": "-16,395",
"Comprehensive Net Income": "-16,395",
"BaseVar": "20,384",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "145%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "36,975",
"Assets, Non-Current": "333",
"General and Administrative Expense": "7,868",
"Goodwill": "2,898",
"Liabilities, Current": "2,935",
"Liabilities, Non-Current": "77",
"Other Assets": "50",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "20",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "42",
"Research and Development": "6,882"
},
"output_variables": {
"Liabilities": "3,012",
"Assets": "40,298",
"Expenses": "14,750",
"Revenues": "0",
"Stockholders Equity": "37,286",
"Net Income": "-14,730",
"Comprehensive Net Income": "-14,730",
"BaseVar": "29,040",
"ECR before LimitedLiability": "168%",
"Economic Capital Ratio": "213%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "44,594",
"Assets, Non-Current": "64",
"General and Administrative Expense": "9,128",
"Goodwill": "2,675",
"Liabilities, Current": "4,550",
"Liabilities, Non-Current": "4.0",
"Other Assets": "183",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "14,920",
"Other Net Income": "-58",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "23,966"
},
"output_variables": {
"Liabilities": "19,474",
"Assets": "47,516",
"Expenses": "33,094",
"Revenues": "0",
"Stockholders Equity": "28,042",
"Net Income": "-33,152",
"Comprehensive Net Income": "-33,152",
"BaseVar": "50,071",
"ECR before LimitedLiability": "16%",
"Economic Capital Ratio": "100%"
}
}
},
"top_rated": false,
"trend": -30.0,
"value": 0.9988532655827995,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000949858.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000949858.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000949858.svg"
},
{
"company_id": "0000093314",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000093314.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000093314.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000093314.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000093314_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000093314_main_keyfigs.svg",
"name": "Volitionrx LTD",
"rank": 41,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000093314.svg",
"report_text": "The relative strengths and weaknesses of Volitionrx LTD are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Volitionrx LTD compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 12% points.The greatest weakness of Volitionrx LTD is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 80% points.
The company's Economic Capital Ratio, given in the ranking table, is 84%, being 75% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000093314_2022_Volitionrx_LTD.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "-1.38",
"Liabilities": "-3.49",
"Stockholders Equity": "-12.6",
"ECR before LimitedLiability": "-79.6",
"Liabilities, Non-Current": "1.66",
"Other Liabilities": "-4.00",
"Assets, Current": "-25.6",
"Assets": "-7.11",
"Assets, Non-Current": "-6.42",
"Property, Plant and Equipment, Net": "-10.6",
"Goodwill": "40.5",
"Other Expenses": "-2.31",
"Expenses": "-27.4",
"Revenues": "-27.1",
"Net Income": "-45.5",
"Research and Development": "-36.7",
"General and Administrative Expense": "17.7",
"Other Revenues": "-27.1",
"Comprehensive Net Income": "-46.4",
"Other Compr. Net Income": "-0.333",
"Economic Capital Ratio": "-112"
},
"2013": {
"Goodwill": "24.7",
"Assets": "-24.4",
"Stockholders Equity": "-20.1",
"Other Liabilities": "-2.21",
"ECR before LimitedLiability": "-65.8",
"Assets, Non-Current": "-7.00",
"Property, Plant and Equipment, Net": "-12.6",
"Other Assets": "-4.27",
"Assets, Current": "-23.1",
"General and Administrative Expense": "20.8",
"Expenses": "-29.8",
"Revenues": "-28.1",
"Net Income": "-35.8",
"Research and Development": "-33.6",
"Other Expenses": "-14.7",
"Other Revenues": "-28.1",
"Liabilities, Current": "-1.64",
"Liabilities, Non-Current": "3.07",
"Other Net Income": "14.7",
"Comprehensive Net Income": "-35.8",
"Economic Capital Ratio": "-106"
},
"2014": {
"Liabilities, Non-Current": "0.713",
"Liabilities": "-0.453",
"Stockholders Equity": "-14.8",
"ECR before LimitedLiability": "-60.1",
"Liabilities, Current": "-1.44",
"Assets, Current": "-6.61",
"Assets": "-18.5",
"Other Assets": "0.401",
"Assets, Non-Current": "-5.21",
"Property, Plant and Equipment, Net": "-7.01",
"Other Expenses": "-4.16",
"Expenses": "-10.1",
"Revenues": "-25.0",
"Net Income": "-55.5",
"Research and Development": "-31.8",
"General and Administrative Expense": "15.2",
"Other Revenues": "-25.0",
"Other Net Income": "-20.4",
"Comprehensive Net Income": "-55.6",
"Other Compr. Net Income": "-0.142",
"Economic Capital Ratio": "-109"
},
"2015": {
"Liabilities": "13.4",
"Stockholders Equity": "30.8",
"ECR before LimitedLiability": "-25.2",
"Liabilities, Current": "8.27",
"Liabilities, Non-Current": "5.28",
"Assets, Current": "33.9",
"Assets": "2.13",
"Other Assets": "-6.99",
"Goodwill": "-6.83",
"Assets, Non-Current": "-3.96",
"Property, Plant and Equipment, Net": "-3.58",
"Research and Development": "-20.2",
"Expenses": "-51.8",
"Revenues": "-18.3",
"Net Income": "-105",
"General and Administrative Expense": "21.9",
"Other Expenses": "-19.7",
"Other Revenues": "-18.3",
"Comprehensive Net Income": "-105",
"Other Net Income": "3.80",
"Economic Capital Ratio": "-71.1"
},
"2016": {
"Liabilities, Non-Current": "11.9",
"Liabilities": "30.8",
"Stockholders Equity": "97.8",
"ECR before LimitedLiability": "55.2",
"Liabilities, Current": "22.6",
"Other Liabilities": "-3.05",
"Property, Plant and Equipment, Net": "-1.79",
"Assets": "72.0",
"Assets, Non-Current": "-2.38",
"Assets, Current": "98.0",
"Goodwill": "-5.53",
"Other Revenues": "-32.6",
"Revenues": "-32.6",
"Net Income": "-32.3",
"Research and Development": "-21.5",
"Comprehensive Net Income": "-32.4",
"Other Compr. Net Income": "-0.102",
"Other Net Income": "0.291",
"General and Administrative Expense": "24.9",
"Other Expenses": "-2.17",
"Economic Capital Ratio": "35.2"
},
"2017": {
"Other Liabilities": "-0.100",
"Liabilities": "1.58",
"Stockholders Equity": "9.40",
"Liabilities, Current": "1.41",
"Liabilities, Non-Current": "0.222",
"Assets, Non-Current": "-0.235",
"Assets": "6.25",
"Assets, Current": "14.9",
"Goodwill": "-9.48",
"Property, Plant and Equipment, Net": "0.599",
"Research and Development": "-55.1",
"Expenses": "-39.9",
"Revenues": "-42.2",
"Net Income": "-85.8",
"Other Expenses": "2.85",
"General and Administrative Expense": "-0.242",
"Other Revenues": "-42.2",
"ECR before LimitedLiability": "-47.4",
"Comprehensive Net Income": "-85.9",
"Other Net Income": "-0.117",
"Economic Capital Ratio": "-69.0"
},
"2018": {
"Liabilities, Non-Current": "-0.121",
"Liabilities": "0.888",
"Stockholders Equity": "7.63",
"Other Liabilities": "-0.0123",
"Liabilities, Current": "1.23",
"Property, Plant and Equipment, Net": "0.238",
"Assets": "6.29",
"Assets, Current": "21.0",
"Goodwill": "-8.40",
"Assets, Non-Current": "-6.70",
"Other Expenses": "1.07",
"Expenses": "-38.3",
"Revenues": "-46.0",
"Net Income": "-84.9",
"Research and Development": "-59.4",
"General and Administrative Expense": "0.612",
"Other Revenues": "-46.0",
"ECR before LimitedLiability": "-38.9",
"Comprehensive Net Income": "-83.6",
"Other Compr. Net Income": "0.0806",
"Economic Capital Ratio": "-59.3"
},
"2020": {
"Liabilities, Current": "-4.82",
"Liabilities": "2.23",
"Stockholders Equity": "11.2",
"Liabilities, Non-Current": "7.66",
"Other Liabilities": "-0.735",
"Goodwill": "-18.5",
"Assets": "11.1",
"ECR before LimitedLiability": "-13.0",
"Assets, Current": "18.1",
"Assets, Non-Current": "-14.8",
"Property, Plant and Equipment, Net": "6.57",
"Other Expenses": "10.3",
"Expenses": "-34.9",
"Revenues": "-44.7",
"Net Income": "-65.6",
"Research and Development": "-59.4",
"General and Administrative Expense": "10.7",
"Other Revenues": "-44.7",
"Comprehensive Net Income": "-65.5",
"Other Net Income": "10.5",
"Economic Capital Ratio": "-50.8"
},
"2021": {
"Liabilities, Non-Current": "0.623",
"Liabilities": "0.459",
"Stockholders Equity": "0.393",
"Assets, Current": "12.0",
"Liabilities, Current": "-0.230",
"Other Liabilities": "0.174",
"Other Expenses": "1.31",
"Expenses": "-43.5",
"Net Income": "-79.6",
"Research and Development": "-49.4",
"General and Administrative Expense": "-0.329",
"Other Revenues": "-38.2",
"Revenues": "-38.2",
"Comprehensive Net Income": "-79.6",
"ECR before LimitedLiability": "-70.2",
"Assets, Non-Current": "-7.85",
"Other Assets": "0.125",
"Goodwill": "-18.9",
"Property, Plant and Equipment, Net": "0.145",
"Other Net Income": "0.563",
"Economic Capital Ratio": "-74.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000093314_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "695",
"Assets, Non-Current": "0",
"General and Administrative Expense": "448",
"Goodwill": "1,430",
"Liabilities, Current": "748",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-39",
"Other Expenses": "847",
"Other Liabilities": "635",
"Other Net Income": "0",
"Other Revenues": "55",
"Property, Plant and Equipment, Net": "91",
"Research and Development": "2,843"
},
"output_variables": {
"Liabilities": "1,383",
"Assets": "2,217",
"Expenses": "4,138",
"Revenues": "55",
"Stockholders Equity": "834",
"Net Income": "-4,083",
"Comprehensive Net Income": "-4,103",
"BaseVar": "3,916",
"ECR before LimitedLiability": "-164%",
"Economic Capital Ratio": "46%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,005",
"Assets, Non-Current": "0",
"General and Administrative Expense": "434",
"Goodwill": "1,002",
"Liabilities, Current": "957",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-26",
"Other Expenses": "1,638",
"Other Liabilities": "433",
"Other Net Income": "866",
"Other Revenues": "55",
"Property, Plant and Equipment, Net": "63",
"Research and Development": "2,504"
},
"output_variables": {
"Liabilities": "1,390",
"Assets": "2,071",
"Expenses": "4,576",
"Revenues": "55",
"Stockholders Equity": "681",
"Net Income": "-3,655",
"Comprehensive Net Income": "-3,668",
"BaseVar": "4,491",
"ECR before LimitedLiability": "-158%",
"Economic Capital Ratio": "49%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "2,336",
"Assets, Non-Current": "0",
"General and Administrative Expense": "299",
"Goodwill": "809",
"Liabilities, Current": "2,713",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-44",
"Other Expenses": "1,609",
"Other Liabilities": "352",
"Other Net Income": "-2,276",
"Other Revenues": "15",
"Property, Plant and Equipment, Net": "289",
"Research and Development": "4,044"
},
"output_variables": {
"Liabilities": "3,065",
"Assets": "3,433",
"Expenses": "5,952",
"Revenues": "15",
"Stockholders Equity": "368",
"Net Income": "-8,214",
"Comprehensive Net Income": "-8,236",
"BaseVar": "7,393",
"ECR before LimitedLiability": "-238%",
"Economic Capital Ratio": "24%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "6,223",
"Assets, Non-Current": "0",
"General and Administrative Expense": "669",
"Goodwill": "705",
"Liabilities, Current": "1,120",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "20",
"Other Expenses": "7,144",
"Other Liabilities": "548",
"Other Net Income": "471",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "784",
"Research and Development": "6,102"
},
"output_variables": {
"Liabilities": "1,668",
"Assets": "7,712",
"Expenses": "13,914",
"Revenues": "0",
"Stockholders Equity": "6,044",
"Net Income": "-13,443",
"Comprehensive Net Income": "-13,434",
"BaseVar": "11,892",
"ECR before LimitedLiability": "-110%",
"Economic Capital Ratio": "65%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "22,012",
"Assets, Non-Current": "0",
"General and Administrative Expense": "742",
"Goodwill": "602",
"Liabilities, Current": "2,033",
"Liabilities, Non-Current": "432",
"Other Assets": "0",
"Other Compr. Net Income": "-109",
"Other Expenses": "4,687",
"Other Liabilities": "1,092",
"Other Net Income": "361",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "2,119",
"Research and Development": "6,838"
},
"output_variables": {
"Liabilities": "3,558",
"Assets": "24,733",
"Expenses": "12,267",
"Revenues": "0",
"Stockholders Equity": "21,175",
"Net Income": "-11,905",
"Comprehensive Net Income": "-11,960",
"BaseVar": "20,514",
"ECR before LimitedLiability": "121%",
"Economic Capital Ratio": "182%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "10,567",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6,140",
"Goodwill": "576",
"Liabilities, Current": "2,290",
"Liabilities, Non-Current": "1,313",
"Other Assets": "0",
"Other Compr. Net Income": "64",
"Other Expenses": "0",
"Other Liabilities": "1,063",
"Other Net Income": "277",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,481",
"Research and Development": "8,906"
},
"output_variables": {
"Liabilities": "4,667",
"Assets": "14,624",
"Expenses": "15,046",
"Revenues": "0",
"Stockholders Equity": "9,958",
"Net Income": "-14,769",
"Comprehensive Net Income": "-14,737",
"BaseVar": "17,339",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,902",
"Assets, Non-Current": "0",
"General and Administrative Expense": "6,991",
"Goodwill": "467",
"Liabilities, Current": "2,333",
"Liabilities, Non-Current": "1,984",
"Other Assets": "0",
"Other Compr. Net Income": "353",
"Other Expenses": "111",
"Other Liabilities": "1,031",
"Other Net Income": "0",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "3,120",
"Research and Development": "10,907"
},
"output_variables": {
"Liabilities": "5,349",
"Assets": "17,489",
"Expenses": "18,009",
"Revenues": "0",
"Stockholders Equity": "12,140",
"Net Income": "-18,009",
"Comprehensive Net Income": "-17,832",
"BaseVar": "20,600",
"ECR before LimitedLiability": "-11%",
"Economic Capital Ratio": "84%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "20,332",
"Assets, Non-Current": "326",
"General and Administrative Expense": "6,727",
"Goodwill": "322",
"Liabilities, Current": "6,237",
"Liabilities, Non-Current": "2,759",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "862",
"Other Net Income": "849",
"Other Revenues": "13",
"Property, Plant and Equipment, Net": "5,171",
"Research and Development": "14,534"
},
"output_variables": {
"Liabilities": "9,857",
"Assets": "26,151",
"Expenses": "21,261",
"Revenues": "13",
"Stockholders Equity": "16,294",
"Net Income": "-20,399",
"Comprehensive Net Income": "-20,399",
"BaseVar": "29,065",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "95%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "21,979",
"Assets, Non-Current": "384",
"General and Administrative Expense": "12,881",
"Goodwill": "217",
"Liabilities, Current": "6,516",
"Liabilities, Non-Current": "2,442",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "810",
"Other Net Income": "1,343",
"Other Revenues": "90",
"Property, Plant and Equipment, Net": "4,911",
"Research and Development": "15,542"
},
"output_variables": {
"Liabilities": "9,768",
"Assets": "27,490",
"Expenses": "28,423",
"Revenues": "90",
"Stockholders Equity": "17,722",
"Net Income": "-26,990",
"Comprehensive Net Income": "-26,990",
"BaseVar": "33,558",
"ECR before LimitedLiability": "-15%",
"Economic Capital Ratio": "84%"
}
}
},
"top_rated": false,
"trend": -7.0,
"value": 0.8423125668810743,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000093314.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000093314.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000093314.svg"
},
{
"company_id": "0001586554",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001586554.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001586554.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001586554.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001586554_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001586554_main_keyfigs.svg",
"name": "Target Group Inc",
"rank": 42,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001586554.svg",
"report_text": "The relative strengths and weaknesses of Target Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Target Group Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 50% points.The greatest weakness of Target Group Inc is the variable Liabilities, reducing the Economic Capital Ratio by 101% points.
The company's Economic Capital Ratio, given in the ranking table, is 84%, being 75% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001586554_2022_Target_Group_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Liabilities, Non-Current": "-0.514",
"Liabilities": "2.14",
"Stockholders Equity": "-68.5",
"ECR before LimitedLiability": "-124",
"Liabilities, Current": "2.32",
"Property, Plant and Equipment, Net": "-6.90",
"Assets": "-54.5",
"Other Assets": "-2.05",
"Assets, Non-Current": "0.513",
"Assets, Current": "-30.5",
"Goodwill": "-2.42",
"Research and Development": "0.575",
"Expenses": "-7.30",
"Revenues": "-5.81",
"Net Income": "-15.9",
"General and Administrative Expense": "1.65",
"Other Expenses": "-22.8",
"Other Revenues": "-5.81",
"Comprehensive Net Income": "-15.8",
"Other Net Income": "0.930",
"Economic Capital Ratio": "-144"
},
"2018": {
"Liabilities, Non-Current": "12.6",
"Liabilities": "-41.3",
"Stockholders Equity": "26.2",
"ECR before LimitedLiability": "8.36",
"Other Liabilities": "7.64",
"Liabilities, Current": "-66.6",
"Property, Plant and Equipment, Net": "-12.9",
"Assets": "48.1",
"Other Assets": "-42.9",
"Assets, Current": "-25.0",
"Goodwill": "49.9",
"Assets, Non-Current": "108",
"Other Expenses": "-9.27",
"Expenses": "40.1",
"Revenues": "-30.6",
"Comprehensive Net Income": "-6.29",
"Research and Development": "8.22",
"General and Administrative Expense": "41.8",
"Other Revenues": "-30.6",
"Other Net Income": "-9.70",
"Economic Capital Ratio": "-12.1"
},
"2019": {
"Liabilities": "-10.3",
"Stockholders Equity": "25.4",
"ECR before LimitedLiability": "2.93",
"Other Liabilities": "11.7",
"Liabilities, Current": "-25.0",
"Assets, Non-Current": "107",
"Assets": "27.2",
"Goodwill": "32.8",
"Property, Plant and Equipment, Net": "31.0",
"Other Assets": "-77.7",
"Assets, Current": "-41.7",
"Research and Development": "10.3",
"Expenses": "25.5",
"Revenues": "-40.4",
"Net Income": "-39.6",
"Other Expenses": "-21.6",
"General and Administrative Expense": "26.9",
"Other Revenues": "-40.4",
"Other Net Income": "-37.2",
"Comprehensive Net Income": "-41.2",
"Economic Capital Ratio": "-26.5"
},
"2020": {
"Liabilities, Current": "-2.25",
"Liabilities": "-29.3",
"Stockholders Equity": "-34.7",
"ECR before LimitedLiability": "-35.0",
"Liabilities, Non-Current": "-18.1",
"Other Liabilities": "0.835",
"Goodwill": "5.66",
"Assets": "-3.68",
"Other Assets": "-28.9",
"Assets, Current": "-11.3",
"Assets, Non-Current": "58.2",
"Property, Plant and Equipment, Net": "23.4",
"Expenses": "15.5",
"Revenues": "-8.37",
"Net Income": "-5.10",
"Research and Development": "2.09",
"General and Administrative Expense": "13.4",
"Other Revenues": "-8.37",
"Comprehensive Net Income": "-5.28",
"Other Net Income": "-7.15",
"Economic Capital Ratio": "-72.8"
},
"2021": {
"Liabilities, Non-Current": "-89.9",
"Liabilities": "-101",
"Stockholders Equity": "-68.4",
"Liabilities, Current": "-0.587",
"Other Liabilities": "0.402",
"Assets, Current": "-33.0",
"Assets": "0.110",
"ECR before LimitedLiability": "-70.5",
"Assets, Non-Current": "49.5",
"Other Assets": "-54.1",
"Goodwill": "1.31",
"Property, Plant and Equipment, Net": "9.79",
"Expenses": "6.93",
"Revenues": "-15.8",
"Net Income": "2.71",
"Research and Development": "0.766",
"General and Administrative Expense": "5.03",
"Other Revenues": "-15.8",
"Comprehensive Net Income": "2.74",
"Other Net Income": "1.10",
"Economic Capital Ratio": "-74.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001586554_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "156",
"Assets, Non-Current": "138",
"General and Administrative Expense": "15",
"Goodwill": "138",
"Liabilities, Current": "2,114",
"Liabilities, Non-Current": "0",
"Other Assets": "-138",
"Other Compr. Net Income": "0",
"Other Expenses": "2,593",
"Other Liabilities": "0",
"Other Net Income": "371",
"Other Revenues": "5.9",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "114"
},
"output_variables": {
"Liabilities": "2,114",
"Assets": "294",
"Expenses": "2,721",
"Revenues": "5.9",
"Stockholders Equity": "-1,820",
"Net Income": "-2,345",
"Comprehensive Net Income": "-2,345",
"BaseVar": "2,753",
"ECR before LimitedLiability": "-402%",
"Economic Capital Ratio": "2.3%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "559",
"Assets, Non-Current": "6,222",
"General and Administrative Expense": "34",
"Goodwill": "3,594",
"Liabilities, Current": "3,437",
"Liabilities, Non-Current": "0",
"Other Assets": "-3,594",
"Other Compr. Net Income": "-56",
"Other Expenses": "1,155",
"Other Liabilities": "0",
"Other Net Income": "-620",
"Other Revenues": "0.26",
"Property, Plant and Equipment, Net": "0",
"Research and Development": "92"
},
"output_variables": {
"Liabilities": "3,437",
"Assets": "6,781",
"Expenses": "1,281",
"Revenues": "0.26",
"Stockholders Equity": "3,344",
"Net Income": "-1,900",
"Comprehensive Net Income": "-1,928",
"BaseVar": "6,087",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "132%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "213",
"Assets, Non-Current": "16,252",
"General and Administrative Expense": "535",
"Goodwill": "8,148",
"Liabilities, Current": "5,135",
"Liabilities, Non-Current": "1,394",
"Other Assets": "-16,252",
"Other Compr. Net Income": "-503",
"Other Expenses": "4,155",
"Other Liabilities": "0",
"Other Net Income": "-5,678",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "8,104",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,529",
"Assets": "16,464",
"Expenses": "4,690",
"Revenues": "0",
"Stockholders Equity": "9,935",
"Net Income": "-10,368",
"Comprehensive Net Income": "-10,619",
"BaseVar": "16,932",
"ECR before LimitedLiability": "26%",
"Economic Capital Ratio": "109%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "755",
"Assets, Non-Current": "12,282",
"General and Administrative Expense": "161",
"Goodwill": "3,666",
"Liabilities, Current": "4,873",
"Liabilities, Non-Current": "11,684",
"Other Assets": "-11,460",
"Other Compr. Net Income": "-278",
"Other Expenses": "1,433",
"Other Liabilities": "0",
"Other Net Income": "-5,509",
"Other Revenues": "30",
"Property, Plant and Equipment, Net": "7,794",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "16,557",
"Assets": "13,037",
"Expenses": "1,594",
"Revenues": "30",
"Stockholders Equity": "-3,520",
"Net Income": "-7,074",
"Comprehensive Net Income": "-7,213",
"BaseVar": "18,503",
"ECR before LimitedLiability": "-81%",
"Economic Capital Ratio": "73%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "584",
"Assets, Non-Current": "12,479",
"General and Administrative Expense": "0",
"Goodwill": "3,682",
"Liabilities, Current": "4,043",
"Liabilities, Non-Current": "11,172",
"Other Assets": "-10,524",
"Other Compr. Net Income": "64",
"Other Expenses": "1,350",
"Other Liabilities": "0",
"Other Net Income": "1,623",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "6,842",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "15,215",
"Assets": "13,063",
"Expenses": "1,350",
"Revenues": "0",
"Stockholders Equity": "-2,152",
"Net Income": "273",
"Comprehensive Net Income": "305",
"BaseVar": "15,657",
"ECR before LimitedLiability": "-19%",
"Economic Capital Ratio": "84%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 0.8397364889311372,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001586554.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001586554.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001586554.svg"
},
{
"company_id": "0001697834",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001697834.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001697834.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001697834.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001697834_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001697834_main_keyfigs.svg",
"name": "Stem Holdings Inc",
"rank": 43,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001697834.svg",
"report_text": "The relative strengths and weaknesses of Stem Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Stem Holdings Inc compared to the market average is the variable Goodwill, increasing the Economic Capital Ratio by 8.5% points.The greatest weakness of Stem Holdings Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 71% points.
The company's Economic Capital Ratio, given in the ranking table, is 81%, being 78% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001697834_2022_Stem_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Liabilities": "11.5",
"Liabilities": "65.0",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "57.8",
"Liabilities, Current": "37.4",
"Liabilities, Non-Current": "21.1",
"Assets": "59.0",
"Other Assets": "11.6",
"Assets, Current": "-14.5",
"Goodwill": "-8.94",
"Property, Plant and Equipment, Net": "112",
"Research and Development": "12.6",
"Expenses": "-24.5",
"Revenues": "-27.3",
"Net Income": "-56.7",
"Other Expenses": "-47.2",
"General and Administrative Expense": "9.94",
"Other Revenues": "-27.3",
"Comprehensive Net Income": "-57.0",
"Other Net Income": "-3.80",
"Economic Capital Ratio": "36.2"
},
"2018": {
"Liabilities, Non-Current": "-7.97",
"Liabilities": "-12.8",
"Stockholders Equity": "39.5",
"Economic Capital Ratio": "-19.0",
"Other Liabilities": "9.59",
"Liabilities, Current": "-14.7",
"Property, Plant and Equipment, Net": "44.9",
"Assets": "40.5",
"Other Assets": "40.1",
"Assets, Current": "-29.3",
"Goodwill": "-13.2",
"Assets, Non-Current": "1.63",
"Other Expenses": "-32.1",
"Expenses": "3.77",
"Revenues": "-30.0",
"Net Income": "-28.9",
"Research and Development": "12.7",
"General and Administrative Expense": "27.6",
"Other Revenues": "-30.0",
"Comprehensive Net Income": "-28.7",
"Other Net Income": "-2.40"
},
"2019": {
"Liabilities, Non-Current": "16.8",
"Liabilities": "17.1",
"Stockholders Equity": "22.5",
"ECR before LimitedLiability": "-5.09",
"Other Liabilities": "14.9",
"Liabilities, Current": "-6.33",
"Assets, Non-Current": "-10.5",
"Assets": "18.1",
"Goodwill": "16.8",
"Property, Plant and Equipment, Net": "25.7",
"Other Assets": "16.7",
"Assets, Current": "-38.9",
"Research and Development": "13.6",
"Expenses": "-15.0",
"Revenues": "-42.4",
"Net Income": "-75.9",
"Other Expenses": "-22.7",
"Other Revenues": "-42.4",
"Other Net Income": "-26.5",
"Comprehensive Net Income": "-75.8",
"Economic Capital Ratio": "-34.6"
},
"2020": {
"Liabilities, Current": "-19.8",
"Liabilities": "-1.07",
"Stockholders Equity": "16.6",
"ECR before LimitedLiability": "45.3",
"Liabilities, Non-Current": "12.1",
"Other Liabilities": "5.54",
"Goodwill": "48.3",
"Assets": "13.4",
"Other Assets": "4.95",
"Assets, Current": "-28.1",
"Assets, Non-Current": "-8.19",
"Property, Plant and Equipment, Net": "24.5",
"Other Expenses": "-4.02",
"Expenses": "3.40",
"Revenues": "-5.53",
"Net Income": "-1.63",
"Research and Development": "7.48",
"Other Revenues": "-5.53",
"Comprehensive Net Income": "-1.55",
"Other Net Income": "0.581",
"Economic Capital Ratio": "7.48"
},
"2021": {
"Liabilities, Non-Current": "3.16",
"Liabilities": "6.57",
"Stockholders Equity": "-32.5",
"ECR before LimitedLiability": "-73.4",
"Liabilities, Current": "1.65",
"Other Liabilities": "1.43",
"Assets, Current": "-52.7",
"Assets": "-50.6",
"Assets, Non-Current": "-2.68",
"Other Assets": "0.796",
"Goodwill": "8.49",
"Property, Plant and Equipment, Net": "-1.44",
"Other Expenses": "-71.4",
"Expenses": "-68.0",
"Revenues": "0.499",
"Net Income": "-58.4",
"Research and Development": "4.34",
"General and Administrative Expense": "-2.30",
"Other Revenues": "0.499",
"Comprehensive Net Income": "-58.4",
"Other Net Income": "1.66",
"Economic Capital Ratio": "-77.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001697834_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "598",
"Assets, Non-Current": "0",
"General and Administrative Expense": "828",
"Goodwill": "0",
"Liabilities, Current": "166",
"Liabilities, Non-Current": "0",
"Other Assets": "494",
"Other Compr. Net Income": "0",
"Other Expenses": "2,249",
"Other Liabilities": "0",
"Other Net Income": "4.2",
"Other Revenues": "326",
"Property, Plant and Equipment, Net": "3,259",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "166",
"Assets": "4,350",
"Expenses": "3,077",
"Revenues": "326",
"Stockholders Equity": "4,185",
"Net Income": "-2,747",
"Comprehensive Net Income": "-2,747",
"BaseVar": "3,962",
"ECR before LimitedLiability": "132%",
"Economic Capital Ratio": "190%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,905",
"Assets, Non-Current": "1,301",
"General and Administrative Expense": "3,021",
"Goodwill": "0",
"Liabilities, Current": "4,177",
"Liabilities, Non-Current": "1,913",
"Other Assets": "3,684",
"Other Compr. Net Income": "0",
"Other Expenses": "5,834",
"Other Liabilities": "0",
"Other Net Income": "-301",
"Other Revenues": "1,296",
"Property, Plant and Equipment, Net": "8,325",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "6,090",
"Assets": "15,215",
"Expenses": "8,855",
"Revenues": "1,296",
"Stockholders Equity": "9,125",
"Net Income": "-7,860",
"Comprehensive Net Income": "-7,860",
"BaseVar": "15,878",
"ECR before LimitedLiability": "44%",
"Economic Capital Ratio": "125%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "4,868",
"Assets, Non-Current": "1,771",
"General and Administrative Expense": "16,855",
"Goodwill": "7,386",
"Liabilities, Current": "7,503",
"Liabilities, Non-Current": "0",
"Other Assets": "2,366",
"Other Compr. Net Income": "0",
"Other Expenses": "7,659",
"Other Liabilities": "0",
"Other Net Income": "-6,922",
"Other Revenues": "2,451",
"Property, Plant and Equipment, Net": "14,706",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,503",
"Assets": "31,097",
"Expenses": "24,514",
"Revenues": "2,451",
"Stockholders Equity": "23,594",
"Net Income": "-28,985",
"Comprehensive Net Income": "-28,985",
"BaseVar": "36,244",
"ECR before LimitedLiability": "17%",
"Economic Capital Ratio": "101%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "5,265",
"Assets, Non-Current": "767",
"General and Administrative Expense": "18,568",
"Goodwill": "20,490",
"Liabilities, Current": "14,500",
"Liabilities, Non-Current": "3,685",
"Other Assets": "2,141",
"Other Compr. Net Income": "0",
"Other Expenses": "5,072",
"Other Liabilities": "0",
"Other Net Income": "-1,827",
"Other Revenues": "13,974",
"Property, Plant and Equipment, Net": "16,354",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "18,185",
"Assets": "45,017",
"Expenses": "23,640",
"Revenues": "13,974",
"Stockholders Equity": "26,832",
"Net Income": "-11,493",
"Comprehensive Net Income": "-11,493",
"BaseVar": "51,322",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "153%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "12,843",
"Assets, Non-Current": "5,570",
"General and Administrative Expense": "44,628",
"Goodwill": "25,894",
"Liabilities, Current": "15,798",
"Liabilities, Non-Current": "6,063",
"Other Assets": "271",
"Other Compr. Net Income": "0",
"Other Expenses": "59,005",
"Other Liabilities": "1,093",
"Other Net Income": "3,258",
"Other Revenues": "35,769",
"Property, Plant and Equipment, Net": "12,610",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "22,954",
"Assets": "57,188",
"Expenses": "103,633",
"Revenues": "35,769",
"Stockholders Equity": "34,234",
"Net Income": "-64,606",
"Comprehensive Net Income": "-64,606",
"BaseVar": "111,401",
"ECR before LimitedLiability": "-44%",
"Economic Capital Ratio": "81%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 0.8103533970626452,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001697834.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001697834.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001697834.svg"
},
{
"company_id": "0001596946",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001596946.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001596946.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001596946.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001596946_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001596946_main_keyfigs.svg",
"name": "Quotient Ltd",
"rank": 44,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001596946.svg",
"report_text": "The relative strengths and weaknesses of Quotient Ltd are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Quotient Ltd compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 4.6% points.The greatest weakness of Quotient Ltd is the variable Stockholders Equity, reducing the Economic Capital Ratio by 54% points.
The company's Economic Capital Ratio, given in the ranking table, is 76%, being 82% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001596946_2022_Quotient_Ltd.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "2.62",
"Liabilities": "-36.2",
"Stockholders Equity": "-36.8",
"ECR before LimitedLiability": "-27.7",
"Liabilities, Non-Current": "-49.3",
"Other Liabilities": "-1.09",
"Goodwill": "-3.05",
"Assets": "-1.71",
"Other Assets": "1.17",
"Assets, Current": "2.54",
"Property, Plant and Equipment, Net": "-0.676",
"Other Expenses": "1.60",
"Expenses": "3.39",
"Revenues": "-3.59",
"Net Income": "-2.34",
"Research and Development": "-2.22",
"General and Administrative Expense": "4.89",
"Other Revenues": "-3.59",
"Comprehensive Net Income": "-2.34",
"Other Net Income": "-0.634",
"Economic Capital Ratio": "-65.5"
},
"2021": {
"Liabilities, Non-Current": "-22.1",
"Liabilities": "-31.8",
"Stockholders Equity": "-54.3",
"ECR before LimitedLiability": "-78.0",
"Other Liabilities": "-0.946",
"Assets, Current": "-0.683",
"Assets": "-6.49",
"Assets, Non-Current": "-1.25",
"Other Assets": "2.15",
"Goodwill": "-5.99",
"Property, Plant and Equipment, Net": "-1.13",
"Other Expenses": "2.92",
"Expenses": "4.56",
"Revenues": "-4.95",
"Net Income": "-3.75",
"Research and Development": "-2.40",
"General and Administrative Expense": "4.37",
"Other Revenues": "-4.95",
"Comprehensive Net Income": "-3.82",
"Other Net Income": "-2.30",
"Economic Capital Ratio": "-82.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001596946_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "150,472",
"Assets, Non-Current": "25,947",
"General and Administrative Expense": "59,603",
"Goodwill": "625",
"Liabilities, Current": "31,157",
"Liabilities, Non-Current": "179,291",
"Other Assets": "9,254",
"Other Compr. Net Income": "-271",
"Other Expenses": "661",
"Other Liabilities": "21,542",
"Other Net Income": "-21,421",
"Other Revenues": "32,656",
"Property, Plant and Equipment, Net": "40,165",
"Research and Development": "53,744"
},
"output_variables": {
"Liabilities": "231,990",
"Assets": "226,463",
"Expenses": "114,008",
"Revenues": "32,656",
"Stockholders Equity": "-5,527",
"Net Income": "-102,773",
"Comprehensive Net Income": "-102,908",
"BaseVar": "313,404",
"ECR before LimitedLiability": "-48%",
"Economic Capital Ratio": "80%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "143,876",
"Assets, Non-Current": "26,967",
"General and Administrative Expense": "72,349",
"Goodwill": "619",
"Liabilities, Current": "60,611",
"Liabilities, Non-Current": "172,862",
"Other Assets": "9,279",
"Other Compr. Net Income": "-1,926",
"Other Expenses": "1,254",
"Other Liabilities": "21,920",
"Other Net Income": "-27,081",
"Other Revenues": "43,379",
"Property, Plant and Equipment, Net": "39,071",
"Research and Development": "53,727"
},
"output_variables": {
"Liabilities": "255,393",
"Assets": "219,812",
"Expenses": "127,330",
"Revenues": "43,379",
"Stockholders Equity": "-35,581",
"Net Income": "-111,032",
"Comprehensive Net Income": "-111,995",
"BaseVar": "337,460",
"ECR before LimitedLiability": "-68%",
"Economic Capital Ratio": "76%"
}
}
},
"top_rated": false,
"trend": -5.0,
"value": 0.7644459333677058,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001596946.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001596946.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001596946.svg"
},
{
"company_id": "0001421819",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001421819.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001421819.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001421819_main_keyfigs.svg",
"name": "Hanjiao Group Inc",
"rank": 45,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001421819.svg",
"report_text": "The relative strengths and weaknesses of Hanjiao Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Hanjiao Group Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 55% points.The greatest weakness of Hanjiao Group Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 101% points.
The company's Economic Capital Ratio, given in the ranking table, is 72%, being 87% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001421819_2022_Hanjiao_Group_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Liabilities, Current": "-67.5",
"Liabilities": "-25.2",
"Stockholders Equity": "-32.3",
"ECR before LimitedLiability": "-34.2",
"Liabilities, Non-Current": "4.05",
"Goodwill": "-5.38",
"Assets": "-3.61",
"Other Assets": "30.8",
"Assets, Current": "-5.39",
"Assets, Non-Current": "-4.11",
"Property, Plant and Equipment, Net": "-4.66",
"Other Expenses": "2.41",
"Expenses": "6.60",
"Revenues": "-7.84",
"Net Income": "-5.61",
"Research and Development": "2.10",
"General and Administrative Expense": "1.72",
"Other Revenues": "-7.84",
"Comprehensive Net Income": "-5.65",
"Other Net Income": "-2.42",
"Economic Capital Ratio": "-72.0"
},
"2021": {
"Liabilities, Non-Current": "3.42",
"Liabilities": "-57.2",
"Stockholders Equity": "-65.3",
"ECR before LimitedLiability": "-82.4",
"Liabilities, Current": "-101",
"Other Liabilities": "1.14",
"Assets, Current": "-12.1",
"Assets": "-8.12",
"Assets, Non-Current": "-5.13",
"Other Assets": "54.8",
"Goodwill": "-7.17",
"Property, Plant and Equipment, Net": "-4.30",
"Other Expenses": "2.97",
"Expenses": "11.4",
"Revenues": "-6.80",
"Comprehensive Net Income": "-0.141",
"Research and Development": "2.76",
"General and Administrative Expense": "4.92",
"Other Revenues": "-6.80",
"Other Net Income": "-2.28",
"Economic Capital Ratio": "-86.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001421819_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "11,436",
"Assets, Non-Current": "341",
"General and Administrative Expense": "11,540",
"Goodwill": "0",
"Liabilities, Current": "31,307",
"Liabilities, Non-Current": "99",
"Other Assets": "12,384",
"Other Compr. Net Income": "-167",
"Other Expenses": "-190",
"Other Liabilities": "0",
"Other Net Income": "-4,346",
"Other Revenues": "675",
"Property, Plant and Equipment, Net": "1,920",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "31,406",
"Assets": "26,081",
"Expenses": "11,351",
"Revenues": "675",
"Stockholders Equity": "-5,325",
"Net Income": "-15,021",
"Comprehensive Net Income": "-15,104",
"BaseVar": "37,013",
"ECR before LimitedLiability": "-78%",
"Economic Capital Ratio": "74%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,320",
"Assets, Non-Current": "85",
"General and Administrative Expense": "6,739",
"Goodwill": "0",
"Liabilities, Current": "34,453",
"Liabilities, Non-Current": "0",
"Other Assets": "18,752",
"Other Compr. Net Income": "-212",
"Other Expenses": "39",
"Other Liabilities": "0",
"Other Net Income": "-2,621",
"Other Revenues": "2,521",
"Property, Plant and Equipment, Net": "1,881",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "34,453",
"Assets": "22,038",
"Expenses": "6,778",
"Revenues": "2,521",
"Stockholders Equity": "-12,415",
"Net Income": "-6,877",
"Comprehensive Net Income": "-6,983",
"BaseVar": "34,312",
"ECR before LimitedLiability": "-85%",
"Economic Capital Ratio": "72%"
}
}
},
"top_rated": false,
"trend": -5.0,
"value": 0.720914503775627,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001421819.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001421819.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001421819.svg"
},
{
"company_id": "0001138608",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001138608.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001138608.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001138608.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001138608_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001138608_main_keyfigs.svg",
"name": "Bloomios INC",
"rank": 46,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001138608.svg",
"report_text": "The relative strengths and weaknesses of Bloomios INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Bloomios INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 27% points.The greatest weakness of Bloomios INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 142% points.
The company's Economic Capital Ratio, given in the ranking table, is 72%, being 87% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001138608_2022_Bloomios_INC.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities, Non-Current": "8.20",
"Liabilities": "-4.85",
"Stockholders Equity": "-142",
"ECR before LimitedLiability": "-82.9",
"Liabilities, Current": "-12.9",
"Other Liabilities": "1.53",
"Assets, Current": "-45.9",
"Assets": "-80.2",
"Assets, Non-Current": "-10.4",
"Other Assets": "5.23",
"Goodwill": "-11.8",
"Other Expenses": "-13.0",
"Expenses": "-12.6",
"Revenues": "27.5",
"Net Income": "5.52",
"Research and Development": "7.32",
"General and Administrative Expense": "-3.75",
"Other Revenues": "27.5",
"Comprehensive Net Income": "5.52",
"Other Net Income": "1.79",
"Economic Capital Ratio": "-87.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001138608_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "1,514",
"Assets, Non-Current": "0",
"General and Administrative Expense": "5,606",
"Goodwill": "300",
"Liabilities, Current": "5,327",
"Liabilities, Non-Current": "0",
"Other Assets": "331",
"Other Compr. Net Income": "0",
"Other Expenses": "5,213",
"Other Liabilities": "250",
"Other Net Income": "230",
"Other Revenues": "8,576",
"Property, Plant and Equipment, Net": "1,862",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,577",
"Assets": "4,007",
"Expenses": "10,818",
"Revenues": "8,576",
"Stockholders Equity": "-1,570",
"Net Income": "-2,011",
"Comprehensive Net Income": "-2,011",
"BaseVar": "14,605",
"ECR before LimitedLiability": "-87%",
"Economic Capital Ratio": "72%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.7157072816365049,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001138608.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001138608.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001138608.svg"
},
{
"company_id": "0001078799",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001078799.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001078799.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001078799.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001078799_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001078799_main_keyfigs.svg",
"name": "Marijuana Co of America Inc",
"rank": 47,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001078799.svg",
"report_text": "The relative strengths and weaknesses of Marijuana Co of America Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Marijuana Co of America Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 25% points.The greatest weakness of Marijuana Co of America Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 25% points.
The company's Economic Capital Ratio, given in the ranking table, is 59%, being 99% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001078799_2022_Marijuana_Co_of_America_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Liabilities, Non-Current": "-0.411",
"Liabilities": "0.868",
"Stockholders Equity": "-38.4",
"ECR before LimitedLiability": "-122",
"Liabilities, Current": "1.08",
"Property, Plant and Equipment, Net": "-5.88",
"Assets": "-45.8",
"Other Assets": "0.660",
"Assets, Current": "-13.6",
"Goodwill": "-3.92",
"Assets, Non-Current": "-2.32",
"Other Expenses": "0.434",
"Expenses": "0.622",
"Revenues": "-3.74",
"Net Income": "-37.0",
"Research and Development": "0.457",
"General and Administrative Expense": "-0.258",
"Other Revenues": "-3.74",
"Comprehensive Net Income": "-36.8",
"Other Net Income": "-24.3",
"Economic Capital Ratio": "-143"
},
"2019": {
"Liabilities, Non-Current": "-0.131",
"Liabilities": "0.134",
"Stockholders Equity": "-41.2",
"ECR before LimitedLiability": "-106",
"Other Liabilities": "-0.0783",
"Liabilities, Current": "0.135",
"Assets, Non-Current": "-0.931",
"Assets": "-45.7",
"Goodwill": "-1.16",
"Property, Plant and Equipment, Net": "-1.66",
"Other Assets": "0.101",
"Assets, Current": "-13.7",
"Research and Development": "0.0523",
"Expenses": "0.0919",
"Revenues": "-0.630",
"Net Income": "-11.1",
"Other Expenses": "0.0519",
"Other Revenues": "-0.630",
"Other Net Income": "-6.96",
"Comprehensive Net Income": "-11.0",
"Economic Capital Ratio": "-136"
},
"2020": {
"Liabilities, Current": "2.12",
"Liabilities": "1.74",
"Stockholders Equity": "-60.5",
"ECR before LimitedLiability": "-106",
"Liabilities, Non-Current": "-0.775",
"Goodwill": "-5.69",
"Assets": "-55.6",
"Other Assets": "2.04",
"Assets, Current": "-32.5",
"Assets, Non-Current": "-4.20",
"Property, Plant and Equipment, Net": "-8.19",
"Other Expenses": "-3.40",
"Expenses": "0.257",
"Revenues": "-4.52",
"Net Income": "-31.6",
"Research and Development": "0.500",
"General and Administrative Expense": "1.32",
"Other Revenues": "-4.52",
"Comprehensive Net Income": "-31.5",
"Other Net Income": "-15.7",
"Economic Capital Ratio": "-144"
},
"2021": {
"Liabilities, Non-Current": "4.52",
"Liabilities": "-11.9",
"Stockholders Equity": "-25.0",
"ECR before LimitedLiability": "-95.0",
"Liabilities, Current": "-20.6",
"Assets, Current": "-19.6",
"Assets": "-20.2",
"Assets, Non-Current": "-10.6",
"Other Assets": "24.6",
"Goodwill": "5.33",
"Property, Plant and Equipment, Net": "-12.6",
"Other Expenses": "-3.22",
"Expenses": "5.64",
"Revenues": "-12.9",
"Net Income": "-23.3",
"Research and Development": "4.83",
"General and Administrative Expense": "4.09",
"Other Revenues": "-12.9",
"Comprehensive Net Income": "-23.3",
"Other Net Income": "-19.3",
"Economic Capital Ratio": "-99.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001078799_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "1,497",
"Assets, Non-Current": "0",
"General and Administrative Expense": "4,062",
"Goodwill": "0",
"Liabilities, Current": "5,054",
"Liabilities, Non-Current": "0",
"Other Assets": "411",
"Other Compr. Net Income": "0",
"Other Expenses": "5.3",
"Other Liabilities": "0",
"Other Net Income": "-7,281",
"Other Revenues": "252",
"Property, Plant and Equipment, Net": "12",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "5,054",
"Assets": "1,920",
"Expenses": "4,067",
"Revenues": "252",
"Stockholders Equity": "-3,134",
"Net Income": "-11,096",
"Comprehensive Net Income": "-11,096",
"BaseVar": "9,287",
"ECR before LimitedLiability": "-441%",
"Economic Capital Ratio": "1.1%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "418",
"Assets, Non-Current": "0",
"General and Administrative Expense": "7,159",
"Goodwill": "0",
"Liabilities, Current": "11,745",
"Liabilities, Non-Current": "0",
"Other Assets": "719",
"Other Compr. Net Income": "0",
"Other Expenses": "7.3",
"Other Liabilities": "0",
"Other Net Income": "-13,710",
"Other Revenues": "695",
"Property, Plant and Equipment, Net": "7.5",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "11,745",
"Assets": "1,144",
"Expenses": "7,166",
"Revenues": "695",
"Stockholders Equity": "-10,601",
"Net Income": "-20,180",
"Comprehensive Net Income": "-20,180",
"BaseVar": "17,230",
"ECR before LimitedLiability": "-539%",
"Economic Capital Ratio": "0.13%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "538",
"Assets, Non-Current": "0",
"General and Administrative Expense": "1,703",
"Goodwill": "0",
"Liabilities, Current": "7,568",
"Liabilities, Non-Current": "0",
"Other Assets": "1,562",
"Other Compr. Net Income": "0",
"Other Expenses": "3,433",
"Other Liabilities": "0",
"Other Net Income": "-7,290",
"Other Revenues": "281",
"Property, Plant and Equipment, Net": "6.5",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,568",
"Assets": "2,106",
"Expenses": "5,136",
"Revenues": "281",
"Stockholders Equity": "-5,461",
"Net Income": "-12,145",
"Comprehensive Net Income": "-12,145",
"BaseVar": "11,191",
"ECR before LimitedLiability": "-406%",
"Economic Capital Ratio": "2.2%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "2,763",
"Assets, Non-Current": "0",
"General and Administrative Expense": "3,750",
"Goodwill": "2,744",
"Liabilities, Current": "7,729",
"Liabilities, Non-Current": "0",
"Other Assets": "2,332",
"Other Compr. Net Income": "-7.4",
"Other Expenses": "1,991",
"Other Liabilities": "0",
"Other Net Income": "-5,480",
"Other Revenues": "1,030",
"Property, Plant and Equipment, Net": "122",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "7,729",
"Assets": "7,960",
"Expenses": "5,741",
"Revenues": "1,030",
"Stockholders Equity": "231",
"Net Income": "-10,191",
"Comprehensive Net Income": "-10,195",
"BaseVar": "13,974",
"ECR before LimitedLiability": "-126%",
"Economic Capital Ratio": "59%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 0.5949182509142991,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001078799.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001078799.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001078799.svg"
},
{
"company_id": "0000810509",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0000810509.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0000810509.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0000810509.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0000810509_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000810509_main_keyfigs.svg",
"name": "Navidea Biopharmaceuticals Inc",
"rank": 48,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0000810509.svg",
"report_text": "The relative strengths and weaknesses of Navidea Biopharmaceuticals Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Navidea Biopharmaceuticals Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 5.9% points.The greatest weakness of Navidea Biopharmaceuticals Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 44%, being 115% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0000810509_2022_Navidea_Biopharmaceuticals_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities, Current": "29.9",
"Liabilities": "10.3",
"Stockholders Equity": "39.4",
"ECR before LimitedLiability": "121",
"Liabilities, Non-Current": "9.91",
"Other Liabilities": "-38.6",
"Property, Plant and Equipment, Net": "-5.14",
"Assets": "15.4",
"Assets, Non-Current": "-1.57",
"Goodwill": "-5.25",
"Assets, Current": "39.7",
"General and Administrative Expense": "21.2",
"Expenses": "31.2",
"Revenues": "-53.2",
"Net Income": "47.8",
"Research and Development": "-37.8",
"Other Expenses": "46.8",
"Other Revenues": "-53.2",
"Comprehensive Net Income": "47.7",
"Other Net Income": "69.0",
"Economic Capital Ratio": "59.4"
},
"2012": {
"Liabilities, Current": "-0.559",
"Liabilities": "-2.16",
"Stockholders Equity": "-35.8",
"ECR before LimitedLiability": "-104",
"Liabilities, Non-Current": "0.244",
"Other Liabilities": "-1.72",
"Assets, Current": "1.12",
"Assets": "-24.6",
"Assets, Non-Current": "-4.04",
"Property, Plant and Equipment, Net": "-8.32",
"Goodwill": "-13.2",
"Other Expenses": "8.35",
"Expenses": "-23.5",
"Revenues": "-26.1",
"Net Income": "-53.7",
"Research and Development": "-34.5",
"General and Administrative Expense": "-1.92",
"Other Revenues": "-26.1",
"Other Net Income": "-2.51",
"Comprehensive Net Income": "-53.7",
"Economic Capital Ratio": "-136"
},
"2013": {
"Liabilities": "-17.0",
"Stockholders Equity": "-19.2",
"ECR before LimitedLiability": "-50.9",
"Other Liabilities": "-18.8",
"Liabilities, Non-Current": "1.46",
"Goodwill": "-8.26",
"Assets": "-0.428",
"Assets, Non-Current": "-2.50",
"Property, Plant and Equipment, Net": "-4.77",
"Other Assets": "-2.12",
"Assets, Current": "23.4",
"General and Administrative Expense": "5.62",
"Expenses": "1.24",
"Revenues": "-14.5",
"Net Income": "-16.4",
"Research and Development": "-12.1",
"Other Expenses": "9.77",
"Other Revenues": "-14.5",
"Other Net Income": "-4.08",
"Comprehensive Net Income": "-16.4",
"Economic Capital Ratio": "-91.1"
},
"2014": {
"Liabilities": "-3.68",
"Stockholders Equity": "-59.8",
"ECR before LimitedLiability": "-64.2",
"Liabilities, Current": "0.195",
"Other Liabilities": "-4.67",
"Assets, Current": "-19.8",
"Assets": "-36.1",
"Goodwill": "-11.7",
"Other Assets": "0.816",
"Assets, Non-Current": "-2.79",
"Property, Plant and Equipment, Net": "-3.40",
"Other Expenses": "4.21",
"Expenses": "-3.14",
"Revenues": "-10.1",
"Net Income": "-13.5",
"Research and Development": "-11.7",
"General and Administrative Expense": "2.42",
"Other Revenues": "-10.1",
"Other Net Income": "0.399",
"Comprehensive Net Income": "-13.5",
"Economic Capital Ratio": "-114"
},
"2015": {
"Other Liabilities": "-19.1",
"Liabilities": "-8.64",
"Stockholders Equity": "-61.3",
"ECR before LimitedLiability": "-66.9",
"Liabilities, Current": "0.848",
"Assets, Current": "-19.0",
"Assets": "-41.6",
"Other Assets": "-5.55",
"Goodwill": "-11.7",
"Assets, Non-Current": "-2.50",
"Property, Plant and Equipment, Net": "-6.77",
"Research and Development": "3.07",
"Expenses": "5.52",
"Revenues": "-5.47",
"Net Income": "-4.69",
"General and Administrative Expense": "10.6",
"Other Expenses": "-11.2",
"Other Revenues": "-5.47",
"Comprehensive Net Income": "-4.59",
"Other Net Income": "-5.68",
"Economic Capital Ratio": "-113"
},
"2016": {
"Liabilities, Non-Current": "0.664",
"Liabilities": "-18.4",
"Stockholders Equity": "-99.3",
"ECR before LimitedLiability": "-101",
"Liabilities, Current": "-17.4",
"Other Liabilities": "-0.915",
"Property, Plant and Equipment, Net": "-12.4",
"Assets": "-47.2",
"Assets, Non-Current": "-3.31",
"Assets, Current": "-28.8",
"Goodwill": "-11.8",
"Research and Development": "4.46",
"Expenses": "10.3",
"Revenues": "-2.17",
"Net Income": "2.27",
"General and Administrative Expense": "10.5",
"Other Expenses": "-5.21",
"Other Revenues": "-2.17",
"Comprehensive Net Income": "2.33",
"Other Net Income": "-8.16",
"Economic Capital Ratio": "-121"
},
"2017": {
"Other Liabilities": "72.6",
"Liabilities": "284",
"Stockholders Equity": "-78.4",
"ECR before LimitedLiability": "488",
"Liabilities, Current": "145",
"Liabilities, Non-Current": "150",
"Assets": "150",
"Other Assets": "-67.0",
"Assets, Current": "81.5",
"Goodwill": "68.0",
"Property, Plant and Equipment, Net": "88.7",
"Research and Development": "15.7",
"Expenses": "165",
"Revenues": "-125",
"Net Income": "516",
"Other Expenses": "98.5",
"General and Administrative Expense": "51.4",
"Other Revenues": "-125",
"Comprehensive Net Income": "515",
"Other Net Income": "482",
"Economic Capital Ratio": "466"
},
"2018": {
"Liabilities, Non-Current": "1.35",
"Liabilities": "0.268",
"Stockholders Equity": "-23.2",
"ECR before LimitedLiability": "-94.5",
"Other Liabilities": "-0.592",
"Liabilities, Current": "-0.696",
"Property, Plant and Equipment, Net": "-21.5",
"Assets": "-35.4",
"Assets, Current": "-1.27",
"Goodwill": "-13.1",
"Assets, Non-Current": "-2.77",
"Other Expenses": "6.33",
"Expenses": "-17.2",
"Revenues": "-21.5",
"Net Income": "-55.7",
"Research and Development": "-14.7",
"General and Administrative Expense": "-9.48",
"Other Revenues": "-21.5",
"Comprehensive Net Income": "-55.7",
"Other Net Income": "-29.5",
"Economic Capital Ratio": "-115"
},
"2019": {
"Liabilities, Non-Current": "0.0969",
"Liabilities": "-0.363",
"Stockholders Equity": "-43.1",
"ECR before LimitedLiability": "-88.6",
"Liabilities, Current": "-0.498",
"Assets, Non-Current": "-3.06",
"Assets": "-43.5",
"Goodwill": "-10.6",
"Property, Plant and Equipment, Net": "-18.9",
"Other Assets": "0.721",
"Assets, Current": "-13.2",
"Research and Development": "-28.0",
"Expenses": "-33.8",
"Revenues": "-16.6",
"Net Income": "-52.0",
"Other Expenses": "3.43",
"General and Administrative Expense": "-8.23",
"Other Revenues": "-16.6",
"Other Net Income": "1.53",
"Comprehensive Net Income": "-51.9",
"Economic Capital Ratio": "-118"
},
"2020": {
"Liabilities, Current": "-9.30",
"Liabilities": "-4.69",
"Stockholders Equity": "-18.4",
"ECR before LimitedLiability": "-45.8",
"Liabilities, Non-Current": "4.88",
"Other Liabilities": "-1.38",
"Goodwill": "-7.24",
"Assets": "-15.9",
"Assets, Current": "10.9",
"Assets, Non-Current": "-6.09",
"Property, Plant and Equipment, Net": "-13.2",
"Other Expenses": "4.16",
"Expenses": "-19.5",
"Revenues": "-13.8",
"Net Income": "-23.4",
"Research and Development": "-16.6",
"General and Administrative Expense": "-8.96",
"Other Revenues": "-13.8",
"Comprehensive Net Income": "-23.3",
"Other Net Income": "2.52",
"Economic Capital Ratio": "-83.6"
},
"2021": {
"Liabilities, Non-Current": "3.47",
"Liabilities": "-5.83",
"Stockholders Equity": "-37.3",
"ECR before LimitedLiability": "-111",
"Liabilities, Current": "-11.0",
"Assets, Current": "-4.12",
"Assets": "-33.8",
"Assets, Non-Current": "-11.1",
"Other Assets": "1.27",
"Goodwill": "-13.4",
"Property, Plant and Equipment, Net": "-17.6",
"Other Expenses": "5.86",
"Expenses": "-30.3",
"Revenues": "-18.8",
"Net Income": "-39.3",
"Research and Development": "-21.6",
"General and Administrative Expense": "-16.3",
"Other Revenues": "-18.8",
"Comprehensive Net Income": "-39.3",
"Other Net Income": "2.16",
"Economic Capital Ratio": "-115"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0000810509_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "30,047",
"Assets, Non-Current": "599",
"General and Administrative Expense": "9,548",
"Goodwill": "85",
"Liabilities, Current": "3,348",
"Liabilities, Non-Current": "257",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-7,880",
"Other Liabilities": "6,456",
"Other Net Income": "22,435",
"Other Revenues": "0",
"Property, Plant and Equipment, Net": "463",
"Research and Development": "15,154"
},
"output_variables": {
"Liabilities": "10,062",
"Assets": "31,194",
"Expenses": "16,822",
"Revenues": "0",
"Stockholders Equity": "21,132",
"Net Income": "5,613",
"Comprehensive Net Income": "5,613",
"BaseVar": "40,257",
"ECR before LimitedLiability": "168%",
"Economic Capital Ratio": "213%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "10,617",
"Assets, Non-Current": "328",
"General and Administrative Expense": "11,178",
"Goodwill": "92",
"Liabilities, Current": "6,191",
"Liabilities, Non-Current": "257",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "6,930",
"Other Net Income": "-1,168",
"Other Revenues": "79",
"Property, Plant and Equipment, Net": "935",
"Research and Development": "16,890"
},
"output_variables": {
"Liabilities": "13,378",
"Assets": "11,972",
"Expenses": "28,068",
"Revenues": "79",
"Stockholders Equity": "-1,405",
"Net Income": "-29,157",
"Comprehensive Net Income": "-29,157",
"BaseVar": "27,332",
"ECR before LimitedLiability": "-245%",
"Economic Capital Ratio": "22%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "37,331",
"Assets, Non-Current": "723",
"General and Administrative Expense": "15,526",
"Goodwill": "137",
"Liabilities, Current": "11,291",
"Liabilities, Non-Current": "1,770",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "333",
"Other Liabilities": "31,265",
"Other Net Income": "-4,261",
"Other Revenues": "1,131",
"Property, Plant and Equipment, Net": "2,125",
"Research and Development": "23,710"
},
"output_variables": {
"Liabilities": "44,326",
"Assets": "40,317",
"Expenses": "39,569",
"Revenues": "1,131",
"Stockholders Equity": "-4,010",
"Net Income": "-42,699",
"Comprehensive Net Income": "-42,699",
"BaseVar": "64,802",
"ECR before LimitedLiability": "-114%",
"Economic Capital Ratio": "63%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "8,599",
"Assets, Non-Current": "389",
"General and Administrative Expense": "15,542",
"Goodwill": "181",
"Liabilities, Current": "9,095",
"Liabilities, Non-Current": "3,089",
"Other Assets": "242",
"Other Compr. Net Income": "0",
"Other Expenses": "1,586",
"Other Liabilities": "29,539",
"Other Net Income": "0",
"Other Revenues": "6,275",
"Property, Plant and Equipment, Net": "2,510",
"Research and Development": "16,780"
},
"output_variables": {
"Liabilities": "41,724",
"Assets": "11,920",
"Expenses": "33,908",
"Revenues": "6,275",
"Stockholders Equity": "-29,803",
"Net Income": "-27,633",
"Comprehensive Net Income": "-27,633",
"BaseVar": "46,913",
"ECR before LimitedLiability": "-255%",
"Economic Capital Ratio": "20%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "12,577",
"Assets, Non-Current": "274",
"General and Administrative Expense": "0",
"Goodwill": "186",
"Liabilities, Current": "6,184",
"Liabilities, Non-Current": "1,678",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "31,364",
"Other Liabilities": "60,939",
"Other Net Income": "-9,449",
"Other Revenues": "13,249",
"Property, Plant and Equipment, Net": "1,928",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "68,800",
"Assets": "14,965",
"Expenses": "31,364",
"Revenues": "13,249",
"Stockholders Equity": "-53,836",
"Net Income": "-27,564",
"Comprehensive Net Income": "-27,564",
"BaseVar": "68,913",
"ECR before LimitedLiability": "-242%",
"Economic Capital Ratio": "23%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "10,826",
"Assets, Non-Current": "203",
"General and Administrative Expense": "0",
"Goodwill": "181",
"Liabilities, Current": "69,862",
"Liabilities, Non-Current": "599",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "24,193",
"Other Liabilities": "9,667",
"Other Net Income": "-12,086",
"Other Revenues": "21,970",
"Property, Plant and Equipment, Net": "1,252",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "80,128",
"Assets": "12,462",
"Expenses": "24,193",
"Revenues": "21,970",
"Stockholders Equity": "-67,666",
"Net Income": "-14,309",
"Comprehensive Net Income": "-14,309",
"BaseVar": "75,419",
"ECR before LimitedLiability": "-231%",
"Economic Capital Ratio": "26%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "13,832",
"Assets, Non-Current": "1,445",
"General and Administrative Expense": "11,170",
"Goodwill": "458",
"Liabilities, Current": "8,068",
"Liabilities, Non-Current": "77",
"Other Assets": "4,809",
"Other Compr. Net Income": "-2.4",
"Other Expenses": "-4,059",
"Other Liabilities": "588",
"Other Net Income": "84,760",
"Other Revenues": "1,810",
"Property, Plant and Equipment, Net": "237",
"Research and Development": "4,514"
},
"output_variables": {
"Liabilities": "8,733",
"Assets": "20,781",
"Expenses": "11,625",
"Revenues": "1,810",
"Stockholders Equity": "12,048",
"Net Income": "74,946",
"Comprehensive Net Income": "74,945",
"BaseVar": "63,856",
"ECR before LimitedLiability": "620%",
"Economic Capital Ratio": "620%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "5,596",
"Assets, Non-Current": "835",
"General and Administrative Expense": "7,795",
"Goodwill": "428",
"Liabilities, Current": "3,379",
"Liabilities, Non-Current": "64",
"Other Assets": "0",
"Other Compr. Net Income": "1.7",
"Other Expenses": "-9.8",
"Other Liabilities": "1,168",
"Other Net Income": "-5,277",
"Other Revenues": "1,169",
"Property, Plant and Equipment, Net": "162",
"Research and Development": "4,222"
},
"output_variables": {
"Liabilities": "4,611",
"Assets": "7,022",
"Expenses": "12,007",
"Revenues": "1,169",
"Stockholders Equity": "2,410",
"Net Income": "-16,114",
"Comprehensive Net Income": "-16,113",
"BaseVar": "15,044",
"ECR before LimitedLiability": "-220%",
"Economic Capital Ratio": "29%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,916",
"Assets, Non-Current": "820",
"General and Administrative Expense": "6,282",
"Goodwill": "385",
"Liabilities, Current": "3,820",
"Liabilities, Non-Current": "512",
"Other Assets": "0",
"Other Compr. Net Income": "0.73",
"Other Expenses": "0.71",
"Other Liabilities": "700",
"Other Net Income": "15",
"Other Revenues": "658",
"Property, Plant and Equipment, Net": "30",
"Research and Development": "5,338"
},
"output_variables": {
"Liabilities": "5,032",
"Assets": "4,151",
"Expenses": "11,621",
"Revenues": "658",
"Stockholders Equity": "-881",
"Net Income": "-10,948",
"Comprehensive Net Income": "-10,948",
"BaseVar": "10,739",
"ECR before LimitedLiability": "-265%",
"Economic Capital Ratio": "18%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "6,528",
"Assets, Non-Current": "477",
"General and Administrative Expense": "6,696",
"Goodwill": "620",
"Liabilities, Current": "4,715",
"Liabilities, Non-Current": "296",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "700",
"Other Net Income": "-11",
"Other Revenues": "915",
"Property, Plant and Equipment, Net": "132",
"Research and Development": "4,930"
},
"output_variables": {
"Liabilities": "5,711",
"Assets": "7,758",
"Expenses": "11,626",
"Revenues": "915",
"Stockholders Equity": "2,047",
"Net Income": "-10,722",
"Comprehensive Net Income": "-10,722",
"BaseVar": "13,010",
"ECR before LimitedLiability": "-118%",
"Economic Capital Ratio": "62%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "5,383",
"Assets, Non-Current": "355",
"General and Administrative Expense": "7,450",
"Goodwill": "786",
"Liabilities, Current": "5,300",
"Liabilities, Non-Current": "20",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "16",
"Other Liabilities": "700",
"Other Net Income": "346",
"Other Revenues": "532",
"Property, Plant and Equipment, Net": "120",
"Research and Development": "5,142"
},
"output_variables": {
"Liabilities": "6,020",
"Assets": "6,645",
"Expenses": "12,608",
"Revenues": "532",
"Stockholders Equity": "625",
"Net Income": "-11,731",
"Comprehensive Net Income": "-11,731",
"BaseVar": "13,075",
"ECR before LimitedLiability": "-172%",
"Economic Capital Ratio": "44%"
}
}
},
"top_rated": false,
"trend": -6.0,
"value": 0.43942181663133184,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0000810509.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0000810509.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0000810509.svg"
},
{
"company_id": "0001590695",
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution_0001590695.svg",
"graph_url": "https://www.realrate-archive.com/us_medicinal_products/2021/graphs/IME_0001590695.svg",
"logo_url": "https://www.realrate-archive.com/us_medicinal_products/logos/0001590695.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_medicinal_products/logos/0001590695_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001590695_main_keyfigs.svg",
"name": "Twinlab Consolidated Holdings Inc",
"rank": 49,
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_0001590695.svg",
"report_text": "The relative strengths and weaknesses of Twinlab Consolidated Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Twinlab Consolidated Holdings Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 7.2% points.The greatest weakness of Twinlab Consolidated Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 148% points.
The company's Economic Capital Ratio, given in the ranking table, is 32%, being 127% points below the market average of 159%.",
"report_url": "https://www.realrate-archive.com/us_medicinal_products/2021/report/0001590695_2022_Twinlab_Consolidated_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2014": {
"Liabilities, Non-Current": "-3.39",
"Liabilities": "-0.909",
"Stockholders Equity": "-34.8",
"ECR before LimitedLiability": "-7.23",
"Liabilities, Current": "-0.530",
"Other Liabilities": "3.17",
"Assets, Current": "-6.92",
"Assets": "-24.7",
"Goodwill": "-3.67",
"Other Assets": "0.285",
"Assets, Non-Current": "-2.40",
"Property, Plant and Equipment, Net": "-4.88",
"Other Revenues": "13.8",
"Revenues": "13.8",
"Net Income": "8.05",
"Other Expenses": "-15.4",
"Comprehensive Net Income": "8.08",
"General and Administrative Expense": "12.6",
"Other Net Income": "-3.66",
"Research and Development": "7.23",
"Economic Capital Ratio": "-56.6"
},
"2015": {
"Other Liabilities": "2.98",
"Liabilities": "-2.28",
"Stockholders Equity": "-30.7",
"ECR before LimitedLiability": "-8.66",
"Liabilities, Current": "-4.86",
"Assets, Current": "-21.8",
"Assets": "-10.3",
"Other Assets": "-2.09",
"Goodwill": "21.9",
"Assets, Non-Current": "-0.933",
"Property, Plant and Equipment, Net": "-2.58",
"Research and Development": "3.06",
"Expenses": "3.54",
"Revenues": "5.06",
"Net Income": "3.85",
"General and Administrative Expense": "8.05",
"Other Expenses": "-3.25",
"Other Revenues": "5.06",
"Comprehensive Net Income": "3.97",
"Other Net Income": "-2.73",
"Economic Capital Ratio": "-54.5"
},
"2016": {
"Liabilities, Non-Current": "-61.3",
"Liabilities": "-39.5",
"Stockholders Equity": "-77.7",
"Liabilities, Current": "1.95",
"Other Liabilities": "2.02",
"Property, Plant and Equipment, Net": "-26.1",
"Assets": "-41.9",
"Assets, Non-Current": "-6.49",
"Assets, Current": "-48.4",
"Goodwill": "8.20",
"Research and Development": "2.69",
"Expenses": "2.26",
"Revenues": "2.72",
"Net Income": "6.11",
"General and Administrative Expense": "2.68",
"Other Expenses": "-27.3",
"Other Revenues": "2.72",
"ECR before LimitedLiability": "-40.1",
"Comprehensive Net Income": "6.17",
"Other Net Income": "2.03",
"Economic Capital Ratio": "-60.1"
},
"2017": {
"Other Liabilities": "2.68",
"Liabilities": "-8.67",
"Stockholders Equity": "-64.6",
"ECR before LimitedLiability": "-57.7",
"Liabilities, Current": "-24.5",
"Liabilities, Non-Current": "3.63",
"Assets, Non-Current": "-2.50",
"Assets": "-17.1",
"Assets, Current": "-10.2",
"Goodwill": "12.2",
"Property, Plant and Equipment, Net": "-8.88",
"Other Revenues": "8.56",
"Revenues": "8.56",
"Net Income": "3.20",
"Comprehensive Net Income": "3.05",
"Other Compr. Net Income": "-0.132",
"Other Expenses": "-9.37",
"Other Net Income": "-4.15",
"Research and Development": "6.44",
"General and Administrative Expense": "8.52",
"Economic Capital Ratio": "-79.2"
},
"2018": {
"Liabilities, Non-Current": "-0.563",
"Liabilities": "-12.9",
"Stockholders Equity": "-76.3",
"ECR before LimitedLiability": "-51.6",
"Other Liabilities": "2.35",
"Liabilities, Current": "-26.8",
"Property, Plant and Equipment, Net": "-8.74",
"Assets": "-12.7",
"Assets, Current": "-11.7",
"Goodwill": "14.5",
"Assets, Non-Current": "-4.98",
"Other Expenses": "5.11",
"Expenses": "5.17",
"Revenues": "4.22",
"Net Income": "7.58",
"Research and Development": "5.45",
"General and Administrative Expense": "-4.67",
"Other Revenues": "4.22",
"Comprehensive Net Income": "7.69",
"Other Net Income": "-1.85",
"Economic Capital Ratio": "-72.1"
},
"2019": {
"Liabilities, Non-Current": "1.38",
"Liabilities": "-11.1",
"Stockholders Equity": "-105",
"ECR before LimitedLiability": "-78.1",
"Other Liabilities": "0.923",
"Liabilities, Current": "-23.7",
"Assets, Non-Current": "-14.9",
"Assets": "-53.8",
"Goodwill": "-5.28",
"Property, Plant and Equipment, Net": "-20.7",
"Other Assets": "0.870",
"Assets, Current": "-37.7",
"Research and Development": "4.60",
"Expenses": "-4.83",
"Revenues": "5.93",
"Net Income": "1.51",
"Other Expenses": "-4.58",
"General and Administrative Expense": "-5.30",
"Other Revenues": "5.93",
"Comprehensive Net Income": "1.54",
"Economic Capital Ratio": "-108"
},
"2020": {
"Liabilities, Current": "-39.7",
"Liabilities": "-28.0",
"Stockholders Equity": "-120",
"ECR before LimitedLiability": "-66.7",
"Liabilities, Non-Current": "2.58",
"Other Liabilities": "0.742",
"Goodwill": "-5.15",
"Assets": "-42.1",
"Assets, Current": "-32.8",
"Assets, Non-Current": "-7.62",
"Property, Plant and Equipment, Net": "-18.4",
"Other Expenses": "3.90",
"Expenses": "2.35",
"Revenues": "5.78",
"Net Income": "7.12",
"Research and Development": "3.70",
"General and Administrative Expense": "-5.43",
"Other Revenues": "5.78",
"Comprehensive Net Income": "7.16",
"Other Net Income": "-0.959",
"Economic Capital Ratio": "-105"
},
"2021": {
"Liabilities, Non-Current": "1.35",
"Liabilities": "-24.3",
"Stockholders Equity": "-148",
"ECR before LimitedLiability": "-123",
"Liabilities, Current": "-38.7",
"Assets, Current": "-38.6",
"Assets": "-52.3",
"Assets, Non-Current": "-8.65",
"Other Assets": "1.15",
"Goodwill": "-20.2",
"Property, Plant and Equipment, Net": "-18.5",
"Other Expenses": "1.10",
"Expenses": "0.855",
"Revenues": "7.16",
"Net Income": "5.91",
"Research and Development": "4.48",
"General and Administrative Expense": "-5.08",
"Other Revenues": "7.16",
"Comprehensive Net Income": "5.91",
"Other Net Income": "-2.32",
"Economic Capital Ratio": "-127"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/plot_over_time/0001590695_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "28,279",
"Assets, Non-Current": "986",
"General and Administrative Expense": "25,924",
"Goodwill": "7,564",
"Liabilities, Current": "29,322",
"Liabilities, Non-Current": "14,824",
"Other Assets": "0",
"Other Compr. Net Income": "-31",
"Other Expenses": "47,715",
"Other Liabilities": "0",
"Other Net Income": "-8,917",
"Other Revenues": "61,426",
"Property, Plant and Equipment, Net": "2,680",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "44,146",
"Assets": "39,509",
"Expenses": "73,639",
"Revenues": "61,426",
"Stockholders Equity": "-4,637",
"Net Income": "-21,130",
"Comprehensive Net Income": "-21,146",
"BaseVar": "113,834",
"ECR before LimitedLiability": "-66%",
"Economic Capital Ratio": "77%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "24,504",
"Assets, Non-Current": "1,475",
"General and Administrative Expense": "25,521",
"Goodwill": "56,509",
"Liabilities, Current": "71,720",
"Liabilities, Non-Current": "14,751",
"Other Assets": "0",
"Other Compr. Net Income": "83",
"Other Expenses": "70,097",
"Other Liabilities": "0",
"Other Net Income": "-22,464",
"Other Revenues": "81,672",
"Property, Plant and Equipment, Net": "3,712",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "86,471",
"Assets": "86,200",
"Expenses": "95,618",
"Revenues": "81,672",
"Stockholders Equity": "-271",
"Net Income": "-36,410",
"Comprehensive Net Income": "-36,368",
"BaseVar": "186,254",
"ECR before LimitedLiability": "-43%",
"Economic Capital Ratio": "81%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "33,336",
"Assets, Non-Current": "1,667",
"General and Administrative Expense": "33,452",
"Goodwill": "54,295",
"Liabilities, Current": "37,386",
"Liabilities, Non-Current": "53,674",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "66,189",
"Other Liabilities": "0",
"Other Net Income": "12,634",
"Other Revenues": "86,323",
"Property, Plant and Equipment, Net": "3,528",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "91,060",
"Assets": "92,826",
"Expenses": "99,641",
"Revenues": "86,323",
"Stockholders Equity": "1,766",
"Net Income": "-684",
"Comprehensive Net Income": "-684",
"BaseVar": "191,242",
"ECR before LimitedLiability": "1.9%",
"Economic Capital Ratio": "87%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "27,302",
"Assets, Non-Current": "1,762",
"General and Administrative Expense": "29,032",
"Goodwill": "40,860",
"Liabilities, Current": "95,366",
"Liabilities, Non-Current": "4,948",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "76,651",
"Other Liabilities": "0",
"Other Net Income": "-9,309",
"Other Revenues": "85,501",
"Property, Plant and Equipment, Net": "3,169",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "100,314",
"Assets": "73,093",
"Expenses": "105,683",
"Revenues": "85,501",
"Stockholders Equity": "-27,221",
"Net Income": "-29,491",
"Comprehensive Net Income": "-29,491",
"BaseVar": "186,950",
"ECR before LimitedLiability": "-77%",
"Economic Capital Ratio": "74%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "29,298",
"Assets, Non-Current": "1,720",
"General and Administrative Expense": "87,281",
"Goodwill": "39,105",
"Liabilities, Current": "98,803",
"Liabilities, Non-Current": "16,324",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "29",
"Other Liabilities": "0",
"Other Net Income": "-6,390",
"Other Revenues": "73,291",
"Property, Plant and Equipment, Net": "1,117",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "115,127",
"Assets": "71,240",
"Expenses": "87,310",
"Revenues": "73,291",
"Stockholders Equity": "-43,887",
"Net Income": "-20,409",
"Comprehensive Net Income": "-20,409",
"BaseVar": "176,679",
"ECR before LimitedLiability": "-86%",
"Economic Capital Ratio": "72%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "16,300",
"Assets, Non-Current": "834",
"General and Administrative Expense": "87,820",
"Goodwill": "13,181",
"Liabilities, Current": "118,147",
"Liabilities, Non-Current": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "24,486",
"Other Liabilities": "0",
"Other Net Income": "-5,655",
"Other Revenues": "73,460",
"Property, Plant and Equipment, Net": "72",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "118,147",
"Assets": "30,387",
"Expenses": "112,306",
"Revenues": "73,460",
"Stockholders Equity": "-87,760",
"Net Income": "-44,501",
"Comprehensive Net Income": "-44,501",
"BaseVar": "169,978",
"ECR before LimitedLiability": "-222%",
"Economic Capital Ratio": "28%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "17,345",
"Assets, Non-Current": "5,470",
"General and Administrative Expense": "71,757",
"Goodwill": "12,071",
"Liabilities, Current": "132,032",
"Liabilities, Non-Current": "5,068",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "38",
"Other Liabilities": "0",
"Other Net Income": "-8,943",
"Other Revenues": "66,349",
"Property, Plant and Equipment, Net": "65",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "137,100",
"Assets": "34,951",
"Expenses": "71,795",
"Revenues": "66,349",
"Stockholders Equity": "-102,149",
"Net Income": "-14,389",
"Comprehensive Net Income": "-14,389",
"BaseVar": "159,569",
"ECR before LimitedLiability": "-179%",
"Economic Capital Ratio": "41%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "17,371",
"Assets, Non-Current": "6,781",
"General and Administrative Expense": "68,663",
"Goodwill": "576",
"Liabilities, Current": "136,760",
"Liabilities, Non-Current": "5,197",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "11,131",
"Other Liabilities": "0",
"Other Net Income": "-7,235",
"Other Revenues": "72,089",
"Property, Plant and Equipment, Net": "140",
"Research and Development": "0"
},
"output_variables": {
"Liabilities": "141,957",
"Assets": "24,868",
"Expenses": "79,794",
"Revenues": "72,089",
"Stockholders Equity": "-117,089",
"Net Income": "-14,940",
"Comprehensive Net Income": "-14,940",
"BaseVar": "162,972",
"ECR before LimitedLiability": "-210%",
"Economic Capital Ratio": "32%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 0.3169603542989461,
"company_index": "https://www.realrate-archive.com/us_medicinal_products/2021/industry_indexes/0001590695.svg",
"analysing_equity": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/equity/0001590695.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_medicinal_products/2021/analytics/profit_loss/0001590695.svg"
}
],
"feature_distribution_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_distribution/feature_distribution.svg",
"final_var_label": "Economic Capital Ratio",
"industry_box": [
[
"Revenues",
"42.6 B"
],
[
"Assets",
"73.5 B"
],
[
"Expenses",
"41.2 B"
],
[
"Stockholders Equity",
"37.9 B"
]
],
"industry_id": "us_medicinal_products",
"industry_label": "Medicinal Products",
"num_companies": 49,
"num_top_companies": 12,
"ecr_records": {
"2009": {
"0000794172": {
"rank": 1,
"ecr": "278"
},
"0000037785": {
"rank": 2,
"ecr": "225"
},
"0001056358": {
"rank": 3,
"ecr": "145"
}
},
"2010": {
"0000899923": {
"rank": 1,
"ecr": "304"
},
"0000794172": {
"rank": 2,
"ecr": "279"
},
"0000037785": {
"rank": 3,
"ecr": "209"
},
"0000874716": {
"rank": 4,
"ecr": "203"
},
"0001056358": {
"rank": 5,
"ecr": "150"
},
"0000074303": {
"rank": 6,
"ecr": "149"
},
"0001315695": {
"rank": 7,
"ecr": "132"
},
"0001145460": {
"rank": 8,
"ecr": "130"
},
"0001307954": {
"rank": 9,
"ecr": "115"
},
"0000722104": {
"rank": 10,
"ecr": "102"
}
},
"2011": {
"0000885462": {
"rank": 1,
"ecr": "287"
},
"0000899923": {
"rank": 2,
"ecr": "285"
},
"0000794172": {
"rank": 3,
"ecr": "276"
},
"0000736822": {
"rank": 4,
"ecr": "270"
},
"0000787253": {
"rank": 5,
"ecr": "256"
},
"0000711377": {
"rank": 6,
"ecr": "253"
},
"0000353569": {
"rank": 7,
"ecr": "250"
},
"0000768408": {
"rank": 8,
"ecr": "238"
},
"0000896264": {
"rank": 9,
"ecr": "235"
},
"0000811641": {
"rank": 10,
"ecr": "224"
},
"0000037785": {
"rank": 11,
"ecr": "221"
},
"0001054905": {
"rank": 12,
"ecr": "219"
},
"0001086303": {
"rank": 13,
"ecr": "216"
},
"0000810509": {
"rank": 14,
"ecr": "213"
},
"0001050007": {
"rank": 15,
"ecr": "208"
},
"0001374328": {
"rank": 16,
"ecr": "199"
},
"0000722830": {
"rank": 17,
"ecr": "183"
},
"0000874716": {
"rank": 18,
"ecr": "180"
},
"0000722104": {
"rank": 19,
"ecr": "176"
},
"0001063665": {
"rank": 20,
"ecr": "175"
},
"0001141240": {
"rank": 21,
"ecr": "168"
},
"0000074303": {
"rank": 22,
"ecr": "154"
},
"0000744218": {
"rank": 23,
"ecr": "152"
},
"0001315695": {
"rank": 24,
"ecr": "148"
},
"0001407038": {
"rank": 25,
"ecr": "146"
},
"0000949858": {
"rank": 26,
"ecr": "132"
},
"0001145460": {
"rank": 27,
"ecr": "127"
},
"0001307954": {
"rank": 28,
"ecr": "115"
},
"0001056358": {
"rank": 29,
"ecr": "104"
},
"0001402785": {
"rank": 30,
"ecr": "85"
},
"0000926617": {
"rank": 31,
"ecr": "84"
},
"0001124608": {
"rank": 32,
"ecr": "80"
},
"0001346526": {
"rank": 33,
"ecr": "80"
},
"0001386570": {
"rank": 34,
"ecr": "73"
},
"0000776008": {
"rank": 35,
"ecr": "34"
},
"0001037649": {
"rank": 36,
"ecr": "24"
},
"0001310630": {
"rank": 37,
"ecr": "20"
},
"0001119643": {
"rank": 38,
"ecr": "0.99"
},
"0001134765": {
"rank": 39,
"ecr": "0.077"
},
"0000880242": {
"rank": 40,
"ecr": "0.028"
},
"0000907654": {
"rank": 41,
"ecr": "0.0000000000000000000015"
}
},
"2012": {
"0000899923": {
"rank": 1,
"ecr": "282"
},
"0000885462": {
"rank": 2,
"ecr": "278"
},
"0000794172": {
"rank": 3,
"ecr": "275"
},
"0000073290": {
"rank": 4,
"ecr": "263"
},
"0000009326": {
"rank": 5,
"ecr": "260"
},
"0000353569": {
"rank": 6,
"ecr": "256"
},
"0000711377": {
"rank": 7,
"ecr": "254"
},
"0000787253": {
"rank": 8,
"ecr": "246"
},
"0000768408": {
"rank": 9,
"ecr": "245"
},
"0000722830": {
"rank": 10,
"ecr": "240"
},
"0001374328": {
"rank": 11,
"ecr": "239"
},
"0000896264": {
"rank": 12,
"ecr": "234"
},
"0000811641": {
"rank": 13,
"ecr": "233"
},
"0001054905": {
"rank": 14,
"ecr": "232"
},
"0000037785": {
"rank": 15,
"ecr": "219"
},
"0001086303": {
"rank": 16,
"ecr": "211"
},
"0001050007": {
"rank": 17,
"ecr": "209"
},
"0001510518": {
"rank": 18,
"ecr": "204"
},
"0001063665": {
"rank": 19,
"ecr": "199"
},
"0000949858": {
"rank": 20,
"ecr": "196"
},
"0001028215": {
"rank": 21,
"ecr": "194"
},
"0000874716": {
"rank": 22,
"ecr": "191"
},
"0000744218": {
"rank": 23,
"ecr": "163"
},
"0001056358": {
"rank": 24,
"ecr": "146"
},
"0001124608": {
"rank": 25,
"ecr": "146"
},
"0001134765": {
"rank": 26,
"ecr": "144"
},
"0000074303": {
"rank": 27,
"ecr": "142"
},
"0001315695": {
"rank": 28,
"ecr": "138"
},
"0000776008": {
"rank": 29,
"ecr": "137"
},
"0001145460": {
"rank": 30,
"ecr": "129"
},
"0001307954": {
"rank": 31,
"ecr": "118"
},
"0000722104": {
"rank": 32,
"ecr": "87"
},
"0000926617": {
"rank": 33,
"ecr": "84"
},
"0001346526": {
"rank": 34,
"ecr": "77"
},
"0001386570": {
"rank": 35,
"ecr": "72"
},
"0001407038": {
"rank": 36,
"ecr": "50"
},
"0000093314": {
"rank": 37,
"ecr": "46"
},
"0001141240": {
"rank": 38,
"ecr": "46"
},
"0001037649": {
"rank": 39,
"ecr": "23"
},
"0000810509": {
"rank": 40,
"ecr": "22"
},
"0001402785": {
"rank": 41,
"ecr": "21"
},
"0001310630": {
"rank": 42,
"ecr": "18"
},
"0001119643": {
"rank": 43,
"ecr": "2.1"
},
"0001142790": {
"rank": 44,
"ecr": "0.0000013"
}
},
"2013": {
"0000907654": {
"rank": 1,
"ecr": "474"
},
"0000885462": {
"rank": 2,
"ecr": "283"
},
"0000899923": {
"rank": 3,
"ecr": "279"
},
"0000794172": {
"rank": 4,
"ecr": "273"
},
"0000073290": {
"rank": 5,
"ecr": "268"
},
"0000009326": {
"rank": 6,
"ecr": "261"
},
"0000711377": {
"rank": 7,
"ecr": "261"
},
"0000353569": {
"rank": 8,
"ecr": "259"
},
"0000811641": {
"rank": 9,
"ecr": "240"
},
"0001054905": {
"rank": 10,
"ecr": "235"
},
"0000896264": {
"rank": 11,
"ecr": "231"
},
"0001063665": {
"rank": 12,
"ecr": "229"
},
"0000744218": {
"rank": 13,
"ecr": "228"
},
"0000768408": {
"rank": 14,
"ecr": "216"
},
"0001050007": {
"rank": 15,
"ecr": "212"
},
"0000722830": {
"rank": 16,
"ecr": "211"
},
"0000926617": {
"rank": 17,
"ecr": "209"
},
"0000037785": {
"rank": 18,
"ecr": "191"
},
"0001324736": {
"rank": 19,
"ecr": "185"
},
"0001374328": {
"rank": 20,
"ecr": "179"
},
"0000874716": {
"rank": 21,
"ecr": "162"
},
"0001086303": {
"rank": 22,
"ecr": "158"
},
"0001028215": {
"rank": 23,
"ecr": "156"
},
"0001056358": {
"rank": 24,
"ecr": "153"
},
"0000074303": {
"rank": 25,
"ecr": "150"
},
"0001578932": {
"rank": 26,
"ecr": "145"
},
"0001386570": {
"rank": 27,
"ecr": "144"
},
"0001124608": {
"rank": 28,
"ecr": "138"
},
"0000949858": {
"rank": 29,
"ecr": "131"
},
"0000736822": {
"rank": 30,
"ecr": "130"
},
"0001145460": {
"rank": 31,
"ecr": "127"
},
"0001307954": {
"rank": 32,
"ecr": "121"
},
"0001566978": {
"rank": 33,
"ecr": "117"
},
"0001037649": {
"rank": 34,
"ecr": "86"
},
"0001134765": {
"rank": 35,
"ecr": "83"
},
"0001510518": {
"rank": 36,
"ecr": "79"
},
"0000810509": {
"rank": 37,
"ecr": "63"
},
"0001346526": {
"rank": 38,
"ecr": "56"
},
"0000093314": {
"rank": 39,
"ecr": "49"
},
"0001407038": {
"rank": 40,
"ecr": "43"
},
"0001310630": {
"rank": 41,
"ecr": "16"
},
"0000776008": {
"rank": 42,
"ecr": "9.7"
},
"0001141240": {
"rank": 43,
"ecr": "7.6"
},
"0001569737": {
"rank": 44,
"ecr": "6.5"
},
"0001402785": {
"rank": 45,
"ecr": "5.0"
},
"0001504678": {
"rank": 46,
"ecr": "0.42"
},
"0000880242": {
"rank": 47,
"ecr": "0.000030"
}
},
"2014": {
"0000885462": {
"rank": 1,
"ecr": "284"
},
"0000794172": {
"rank": 2,
"ecr": "282"
},
"0000899923": {
"rank": 3,
"ecr": "271"
},
"0000711377": {
"rank": 4,
"ecr": "259"
},
"0000353569": {
"rank": 5,
"ecr": "256"
},
"0000073290": {
"rank": 6,
"ecr": "252"
},
"0001086303": {
"rank": 7,
"ecr": "237"
},
"0000811641": {
"rank": 8,
"ecr": "231"
},
"0000787253": {
"rank": 9,
"ecr": "230"
},
"0001054905": {
"rank": 10,
"ecr": "229"
},
"0001321834": {
"rank": 11,
"ecr": "225"
},
"0001374328": {
"rank": 12,
"ecr": "210"
},
"0001050007": {
"rank": 13,
"ecr": "206"
},
"0000768408": {
"rank": 14,
"ecr": "195"
},
"0000037785": {
"rank": 15,
"ecr": "192"
},
"0000907654": {
"rank": 16,
"ecr": "181"
},
"0000744218": {
"rank": 17,
"ecr": "181"
},
"0001056358": {
"rank": 18,
"ecr": "165"
},
"0000009326": {
"rank": 19,
"ecr": "160"
},
"0001028215": {
"rank": 20,
"ecr": "158"
},
"0000722830": {
"rank": 21,
"ecr": "148"
},
"0001578932": {
"rank": 22,
"ecr": "142"
},
"0001141240": {
"rank": 23,
"ecr": "142"
},
"0000074303": {
"rank": 24,
"ecr": "141"
},
"0000949858": {
"rank": 25,
"ecr": "132"
},
"0000926617": {
"rank": 26,
"ecr": "129"
},
"0001145460": {
"rank": 27,
"ecr": "125"
},
"0000736822": {
"rank": 28,
"ecr": "112"
},
"0001307954": {
"rank": 29,
"ecr": "111"
},
"0000874716": {
"rank": 30,
"ecr": "109"
},
"0001045309": {
"rank": 31,
"ecr": "103"
},
"0001566978": {
"rank": 32,
"ecr": "98"
},
"0001037649": {
"rank": 33,
"ecr": "85"
},
"0001590695": {
"rank": 34,
"ecr": "77"
},
"0001134765": {
"rank": 35,
"ecr": "67"
},
"0001346526": {
"rank": 36,
"ecr": "67"
},
"0001124608": {
"rank": 37,
"ecr": "65"
},
"0001407038": {
"rank": 38,
"ecr": "52"
},
"0000093314": {
"rank": 39,
"ecr": "24"
},
"0000810509": {
"rank": 40,
"ecr": "20"
},
"0001408299": {
"rank": 41,
"ecr": "18"
},
"0001310630": {
"rank": 42,
"ecr": "15"
},
"0001119643": {
"rank": 43,
"ecr": "6.4"
},
"0001569737": {
"rank": 44,
"ecr": "5.9"
},
"0001402785": {
"rank": 45,
"ecr": "5.6"
},
"0000776008": {
"rank": 46,
"ecr": "3.9"
},
"0000880242": {
"rank": 47,
"ecr": "0.00000029"
},
"0001562733": {
"rank": 48,
"ecr": "0.00000012"
}
},
"2015": {
"0000794172": {
"rank": 1,
"ecr": "279"
},
"0000885462": {
"rank": 2,
"ecr": "278"
},
"0000711377": {
"rank": 3,
"ecr": "261"
},
"0000353569": {
"rank": 4,
"ecr": "258"
},
"0000899923": {
"rank": 5,
"ecr": "253"
},
"0000073290": {
"rank": 6,
"ecr": "249"
},
"0001054905": {
"rank": 7,
"ecr": "236"
},
"0000787253": {
"rank": 8,
"ecr": "234"
},
"0000907654": {
"rank": 9,
"ecr": "234"
},
"0000037785": {
"rank": 10,
"ecr": "223"
},
"0001050007": {
"rank": 11,
"ecr": "219"
},
"0000896264": {
"rank": 12,
"ecr": "219"
},
"0000811641": {
"rank": 13,
"ecr": "214"
},
"0001038133": {
"rank": 14,
"ecr": "210"
},
"0000768408": {
"rank": 15,
"ecr": "199"
},
"0000744218": {
"rank": 16,
"ecr": "195"
},
"0000722830": {
"rank": 17,
"ecr": "192"
},
"0001056358": {
"rank": 18,
"ecr": "181"
},
"0001324736": {
"rank": 19,
"ecr": "176"
},
"0000009326": {
"rank": 20,
"ecr": "173"
},
"0001374328": {
"rank": 21,
"ecr": "169"
},
"0001028215": {
"rank": 22,
"ecr": "166"
},
"0000949858": {
"rank": 23,
"ecr": "159"
},
"0001562733": {
"rank": 24,
"ecr": "141"
},
"0001578932": {
"rank": 25,
"ecr": "139"
},
"0001569737": {
"rank": 26,
"ecr": "132"
},
"0000926617": {
"rank": 27,
"ecr": "122"
},
"0000074303": {
"rank": 28,
"ecr": "121"
},
"0000736822": {
"rank": 29,
"ecr": "113"
},
"0001566978": {
"rank": 30,
"ecr": "98"
},
"0001045309": {
"rank": 31,
"ecr": "96"
},
"0000874716": {
"rank": 32,
"ecr": "89"
},
"0001627223": {
"rank": 33,
"ecr": "85"
},
"0001141240": {
"rank": 34,
"ecr": "83"
},
"0001590695": {
"rank": 35,
"ecr": "81"
},
"0000776008": {
"rank": 36,
"ecr": "72"
},
"0000093314": {
"rank": 37,
"ecr": "65"
},
"0001134765": {
"rank": 38,
"ecr": "54"
},
"0001037649": {
"rank": 39,
"ecr": "53"
},
"0001498380": {
"rank": 40,
"ecr": "46"
},
"0000810509": {
"rank": 41,
"ecr": "23"
},
"0000880242": {
"rank": 42,
"ecr": "18"
},
"0001310630": {
"rank": 43,
"ecr": "15"
},
"0001598323": {
"rank": 44,
"ecr": "14"
},
"0001402785": {
"rank": 45,
"ecr": "12"
},
"0001552189": {
"rank": 46,
"ecr": "4.1"
},
"0001408299": {
"rank": 47,
"ecr": "2.6"
},
"0001119643": {
"rank": 48,
"ecr": "0.59"
},
"0001142790": {
"rank": 49,
"ecr": "0.0029"
}
},
"2016": {
"0000885462": {
"rank": 1,
"ecr": "281"
},
"0000711377": {
"rank": 2,
"ecr": "262"
},
"0000899923": {
"rank": 3,
"ecr": "254"
},
"0000353569": {
"rank": 4,
"ecr": "252"
},
"0001054905": {
"rank": 5,
"ecr": "243"
},
"0001652130": {
"rank": 6,
"ecr": "237"
},
"0001351573": {
"rank": 7,
"ecr": "231"
},
"0000811641": {
"rank": 8,
"ecr": "225"
},
"0000073290": {
"rank": 9,
"ecr": "222"
},
"0000896264": {
"rank": 10,
"ecr": "222"
},
"0000787253": {
"rank": 11,
"ecr": "218"
},
"0000037785": {
"rank": 12,
"ecr": "218"
},
"0001050007": {
"rank": 13,
"ecr": "214"
},
"0001141240": {
"rank": 14,
"ecr": "212"
},
"0000794172": {
"rank": 15,
"ecr": "204"
},
"0001038133": {
"rank": 16,
"ecr": "201"
},
"0001374328": {
"rank": 17,
"ecr": "198"
},
"0001028215": {
"rank": 18,
"ecr": "188"
},
"0000093314": {
"rank": 19,
"ecr": "182"
},
"0000009326": {
"rank": 20,
"ecr": "176"
},
"0000907654": {
"rank": 21,
"ecr": "170"
},
"0001056358": {
"rank": 22,
"ecr": "170"
},
"0000744218": {
"rank": 23,
"ecr": "163"
},
"0000768408": {
"rank": 24,
"ecr": "161"
},
"0000074303": {
"rank": 25,
"ecr": "121"
},
"0001552189": {
"rank": 26,
"ecr": "116"
},
"0000949858": {
"rank": 27,
"ecr": "115"
},
"0001653477": {
"rank": 28,
"ecr": "112"
},
"0001578932": {
"rank": 29,
"ecr": "110"
},
"0001642380": {
"rank": 30,
"ecr": "107"
},
"0001045309": {
"rank": 31,
"ecr": "106"
},
"0000874716": {
"rank": 32,
"ecr": "89"
},
"0001627223": {
"rank": 33,
"ecr": "87"
},
"0001590695": {
"rank": 34,
"ecr": "87"
},
"0000722830": {
"rank": 35,
"ecr": "85"
},
"0001644440": {
"rank": 36,
"ecr": "84"
},
"0001504678": {
"rank": 37,
"ecr": "80"
},
"0001134765": {
"rank": 38,
"ecr": "55"
},
"0000926617": {
"rank": 39,
"ecr": "48"
},
"0001037649": {
"rank": 40,
"ecr": "30"
},
"0000810509": {
"rank": 41,
"ecr": "26"
},
"0001310630": {
"rank": 42,
"ecr": "16"
},
"0001408299": {
"rank": 43,
"ecr": "13"
},
"0001498380": {
"rank": 44,
"ecr": "4.1"
},
"0001586554": {
"rank": 45,
"ecr": "2.3"
}
},
"2017": {
"0000810509": {
"rank": 1,
"ecr": "620"
},
"0000885462": {
"rank": 2,
"ecr": "284"
},
"0000711377": {
"rank": 3,
"ecr": "260"
},
"0000787253": {
"rank": 4,
"ecr": "246"
},
"0001141240": {
"rank": 5,
"ecr": "243"
},
"0001054905": {
"rank": 6,
"ecr": "235"
},
"0001652130": {
"rank": 7,
"ecr": "234"
},
"0000073290": {
"rank": 8,
"ecr": "227"
},
"0000037785": {
"rank": 9,
"ecr": "221"
},
"0000896264": {
"rank": 10,
"ecr": "219"
},
"0001038133": {
"rank": 11,
"ecr": "216"
},
"0000794172": {
"rank": 12,
"ecr": "204"
},
"0000009326": {
"rank": 13,
"ecr": "197"
},
"0000811641": {
"rank": 14,
"ecr": "197"
},
"0001697834": {
"rank": 15,
"ecr": "190"
},
"0000899923": {
"rank": 16,
"ecr": "188"
},
"0000744218": {
"rank": 17,
"ecr": "179"
},
"0001351573": {
"rank": 18,
"ecr": "171"
},
"0000768408": {
"rank": 19,
"ecr": "170"
},
"0001056358": {
"rank": 20,
"ecr": "167"
},
"0001644440": {
"rank": 21,
"ecr": "158"
},
"0001522767": {
"rank": 22,
"ecr": "145"
},
"0001653477": {
"rank": 23,
"ecr": "143"
},
"0001708035": {
"rank": 24,
"ecr": "142"
},
"0001606645": {
"rank": 25,
"ecr": "139"
},
"0000074303": {
"rank": 26,
"ecr": "133"
},
"0001578932": {
"rank": 27,
"ecr": "121"
},
"0001028215": {
"rank": 28,
"ecr": "119"
},
"0001627223": {
"rank": 29,
"ecr": "112"
},
"0001045309": {
"rank": 30,
"ecr": "97"
},
"0000874716": {
"rank": 31,
"ecr": "95"
},
"0000949858": {
"rank": 32,
"ecr": "88"
},
"0000093314": {
"rank": 33,
"ecr": "84"
},
"0001632275": {
"rank": 34,
"ecr": "79"
},
"0000907654": {
"rank": 35,
"ecr": "78"
},
"0001590695": {
"rank": 36,
"ecr": "74"
},
"0000926617": {
"rank": 37,
"ecr": "68"
},
"0000722830": {
"rank": 38,
"ecr": "61"
},
"0001374328": {
"rank": 39,
"ecr": "57"
},
"0001642380": {
"rank": 40,
"ecr": "45"
},
"0001134765": {
"rank": 41,
"ecr": "18"
},
"0001310630": {
"rank": 42,
"ecr": "15"
},
"0001119643": {
"rank": 43,
"ecr": "4.1"
},
"0001498380": {
"rank": 44,
"ecr": "2.6"
}
},
"2018": {
"0000711377": {
"rank": 1,
"ecr": "268"
},
"0001742924": {
"rank": 2,
"ecr": "250"
},
"0001141240": {
"rank": 3,
"ecr": "248"
},
"0000885462": {
"rank": 4,
"ecr": "244"
},
"0000899923": {
"rank": 5,
"ecr": "242"
},
"0000787253": {
"rank": 6,
"ecr": "230"
},
"0000896264": {
"rank": 7,
"ecr": "230"
},
"0001054905": {
"rank": 8,
"ecr": "228"
},
"0001038133": {
"rank": 9,
"ecr": "223"
},
"0001652130": {
"rank": 10,
"ecr": "216"
},
"0001522767": {
"rank": 11,
"ecr": "213"
},
"0000794172": {
"rank": 12,
"ecr": "209"
},
"0000037785": {
"rank": 13,
"ecr": "204"
},
"0000073290": {
"rank": 14,
"ecr": "198"
},
"0000811641": {
"rank": 15,
"ecr": "185"
},
"0000768408": {
"rank": 16,
"ecr": "185"
},
"0001028215": {
"rank": 17,
"ecr": "171"
},
"0001606645": {
"rank": 18,
"ecr": "161"
},
"0000949858": {
"rank": 19,
"ecr": "154"
},
"0001374328": {
"rank": 20,
"ecr": "152"
},
"0001708035": {
"rank": 21,
"ecr": "143"
},
"0001307954": {
"rank": 22,
"ecr": "141"
},
"0001644440": {
"rank": 23,
"ecr": "141"
},
"0001142790": {
"rank": 24,
"ecr": "139"
},
"0001056358": {
"rank": 25,
"ecr": "139"
},
"0001653477": {
"rank": 26,
"ecr": "135"
},
"0000074303": {
"rank": 27,
"ecr": "132"
},
"0001586554": {
"rank": 28,
"ecr": "132"
},
"0001697834": {
"rank": 29,
"ecr": "125"
},
"0001709542": {
"rank": 30,
"ecr": "121"
},
"0001731348": {
"rank": 31,
"ecr": "119"
},
"0001627223": {
"rank": 32,
"ecr": "117"
},
"0000874716": {
"rank": 33,
"ecr": "107"
},
"0000744218": {
"rank": 34,
"ecr": "104"
},
"0001045309": {
"rank": 35,
"ecr": "103"
},
"0000907654": {
"rank": 36,
"ecr": "93"
},
"0000093314": {
"rank": 37,
"ecr": "84"
},
"0000926617": {
"rank": 38,
"ecr": "84"
},
"0001321834": {
"rank": 39,
"ecr": "83"
},
"0001590695": {
"rank": 40,
"ecr": "72"
},
"0001632275": {
"rank": 41,
"ecr": "33"
},
"0000810509": {
"rank": 42,
"ecr": "29"
},
"0001134765": {
"rank": 43,
"ecr": "18"
},
"0001086303": {
"rank": 44,
"ecr": "8.3"
},
"0001078799": {
"rank": 45,
"ecr": "1.1"
},
"0001498380": {
"rank": 46,
"ecr": "0.97"
}
},
"2019": {
"0000711377": {
"rank": 1,
"ecr": "269"
},
"0000885462": {
"rank": 2,
"ecr": "252"
},
"0001141240": {
"rank": 3,
"ecr": "247"
},
"0000787253": {
"rank": 4,
"ecr": "243"
},
"0001054905": {
"rank": 5,
"ecr": "230"
},
"0000896264": {
"rank": 6,
"ecr": "228"
},
"0001652130": {
"rank": 7,
"ecr": "213"
},
"0000037785": {
"rank": 8,
"ecr": "209"
},
"0000811641": {
"rank": 9,
"ecr": "207"
},
"0001374328": {
"rank": 10,
"ecr": "205"
},
"0000899923": {
"rank": 11,
"ecr": "199"
},
"0001321834": {
"rank": 12,
"ecr": "196"
},
"0000009326": {
"rank": 13,
"ecr": "195"
},
"0001742924": {
"rank": 14,
"ecr": "192"
},
"0001038133": {
"rank": 15,
"ecr": "185"
},
"0000794172": {
"rank": 16,
"ecr": "184"
},
"0001351573": {
"rank": 17,
"ecr": "183"
},
"0000907654": {
"rank": 18,
"ecr": "171"
},
"0000744218": {
"rank": 19,
"ecr": "170"
},
"0000073290": {
"rank": 20,
"ecr": "163"
},
"0001056358": {
"rank": 21,
"ecr": "155"
},
"0001642380": {
"rank": 22,
"ecr": "154"
},
"0001644440": {
"rank": 23,
"ecr": "151"
},
"0000768408": {
"rank": 24,
"ecr": "150"
},
"0001708035": {
"rank": 25,
"ecr": "149"
},
"0000949858": {
"rank": 26,
"ecr": "145"
},
"0001307954": {
"rank": 27,
"ecr": "141"
},
"0001653477": {
"rank": 28,
"ecr": "129"
},
"0000074303": {
"rank": 29,
"ecr": "122"
},
"0000874716": {
"rank": 30,
"ecr": "120"
},
"0001731348": {
"rank": 31,
"ecr": "117"
},
"0001586554": {
"rank": 32,
"ecr": "109"
},
"0001045309": {
"rank": 33,
"ecr": "102"
},
"0001697834": {
"rank": 34,
"ecr": "101"
},
"0001627223": {
"rank": 35,
"ecr": "99"
},
"0000722830": {
"rank": 36,
"ecr": "86"
},
"0001632275": {
"rank": 37,
"ecr": "84"
},
"0001386570": {
"rank": 38,
"ecr": "84"
},
"0000926617": {
"rank": 39,
"ecr": "82"
},
"0001134765": {
"rank": 40,
"ecr": "79"
},
"0001552189": {
"rank": 41,
"ecr": "77"
},
"0001606645": {
"rank": 42,
"ecr": "68"
},
"0001522767": {
"rank": 43,
"ecr": "60"
},
"0001590695": {
"rank": 44,
"ecr": "28"
},
"0001510518": {
"rank": 45,
"ecr": "19"
},
"0000810509": {
"rank": 46,
"ecr": "18"
},
"0001310630": {
"rank": 47,
"ecr": "10"
},
"0001709542": {
"rank": 48,
"ecr": "9.6"
},
"0001691430": {
"rank": 49,
"ecr": "0.53"
},
"0001078799": {
"rank": 50,
"ecr": "0.13"
}
},
"2020": {
"0000885462": {
"rank": 1,
"ecr": "267"
},
"0001141240": {
"rank": 2,
"ecr": "265"
},
"0000711377": {
"rank": 3,
"ecr": "265"
},
"0001374328": {
"rank": 4,
"ecr": "259"
},
"0001656472": {
"rank": 5,
"ecr": "243"
},
"0000907654": {
"rank": 6,
"ecr": "234"
},
"0001054905": {
"rank": 7,
"ecr": "231"
},
"0001652130": {
"rank": 8,
"ecr": "228"
},
"0000073290": {
"rank": 9,
"ecr": "214"
},
"0000949858": {
"rank": 10,
"ecr": "213"
},
"0000037785": {
"rank": 11,
"ecr": "211"
},
"0000009326": {
"rank": 12,
"ecr": "210"
},
"0001321834": {
"rank": 13,
"ecr": "203"
},
"0001038133": {
"rank": 14,
"ecr": "202"
},
"0000744218": {
"rank": 15,
"ecr": "202"
},
"0001731348": {
"rank": 16,
"ecr": "201"
},
"0000811641": {
"rank": 17,
"ecr": "197"
},
"0000794172": {
"rank": 18,
"ecr": "193"
},
"0001737927": {
"rank": 19,
"ecr": "193"
},
"0001742924": {
"rank": 20,
"ecr": "179"
},
"0000787253": {
"rank": 21,
"ecr": "177"
},
"0000768408": {
"rank": 22,
"ecr": "163"
},
"0001644440": {
"rank": 23,
"ecr": "162"
},
"0001307954": {
"rank": 24,
"ecr": "160"
},
"0001056358": {
"rank": 25,
"ecr": "154"
},
"0001697834": {
"rank": 26,
"ecr": "153"
},
"0000874716": {
"rank": 27,
"ecr": "148"
},
"0001310630": {
"rank": 28,
"ecr": "141"
},
"0001708035": {
"rank": 29,
"ecr": "136"
},
"0001653477": {
"rank": 30,
"ecr": "132"
},
"0001522767": {
"rank": 31,
"ecr": "132"
},
"0001627223": {
"rank": 32,
"ecr": "104"
},
"0000074303": {
"rank": 33,
"ecr": "98"
},
"0000093314": {
"rank": 34,
"ecr": "95"
},
"0001386570": {
"rank": 35,
"ecr": "93"
},
"0001045309": {
"rank": 36,
"ecr": "93"
},
"0001351573": {
"rank": 37,
"ecr": "84"
},
"0000926617": {
"rank": 38,
"ecr": "83"
},
"0001596946": {
"rank": 39,
"ecr": "80"
},
"0001421819": {
"rank": 40,
"ecr": "74"
},
"0001586554": {
"rank": 41,
"ecr": "73"
},
"0000810509": {
"rank": 42,
"ecr": "62"
},
"0001632275": {
"rank": 43,
"ecr": "50"
},
"0001134765": {
"rank": 44,
"ecr": "47"
},
"0001590695": {
"rank": 45,
"ecr": "41"
},
"0001746563": {
"rank": 46,
"ecr": "2.4"
},
"0001078799": {
"rank": 47,
"ecr": "2.2"
},
"0001691430": {
"rank": 48,
"ecr": "0.056"
},
"0001709542": {
"rank": 49,
"ecr": "0.0000000085"
}
},
"2021": {
"0000711377": {
"rank": 1,
"ecr": "266"
},
"0000885462": {
"rank": 2,
"ecr": "262"
},
"0001141240": {
"rank": 3,
"ecr": "260"
},
"0000744218": {
"rank": 4,
"ecr": "245"
},
"0001850902": {
"rank": 5,
"ecr": "232"
},
"0001656472": {
"rank": 6,
"ecr": "232"
},
"0001054905": {
"rank": 7,
"ecr": "226"
},
"0001652130": {
"rank": 8,
"ecr": "226"
},
"0000794172": {
"rank": 9,
"ecr": "223"
},
"0001775194": {
"rank": 10,
"ecr": "217"
},
"0000907654": {
"rank": 11,
"ecr": "216"
},
"0000009326": {
"rank": 12,
"ecr": "214"
},
"0000811641": {
"rank": 13,
"ecr": "207"
},
"0000899923": {
"rank": 14,
"ecr": "205"
},
"0001731348": {
"rank": 15,
"ecr": "204"
},
"0001038133": {
"rank": 16,
"ecr": "203"
},
"0000787253": {
"rank": 17,
"ecr": "202"
},
"0000037785": {
"rank": 18,
"ecr": "200"
},
"0001742924": {
"rank": 19,
"ecr": "192"
},
"0001813814": {
"rank": 20,
"ecr": "189"
},
"0001754195": {
"rank": 21,
"ecr": "186"
},
"0001134765": {
"rank": 22,
"ecr": "180"
},
"0000768408": {
"rank": 23,
"ecr": "174"
},
"0001307954": {
"rank": 24,
"ecr": "170"
},
"0001056358": {
"rank": 25,
"ecr": "159"
},
"0001644440": {
"rank": 26,
"ecr": "156"
},
"0000874716": {
"rank": 27,
"ecr": "154"
},
"0000073290": {
"rank": 28,
"ecr": "147"
},
"0000074303": {
"rank": 29,
"ecr": "146"
},
"0001737927": {
"rank": 30,
"ecr": "140"
},
"0001708035": {
"rank": 31,
"ecr": "135"
},
"0001653477": {
"rank": 32,
"ecr": "129"
},
"0001386570": {
"rank": 33,
"ecr": "121"
},
"0000926617": {
"rank": 34,
"ecr": "119"
},
"0001504678": {
"rank": 35,
"ecr": "115"
},
"0001627223": {
"rank": 36,
"ecr": "112"
},
"0001642380": {
"rank": 37,
"ecr": "104"
},
"0001321834": {
"rank": 38,
"ecr": "103"
},
"0001756390": {
"rank": 39,
"ecr": "103"
},
"0000949858": {
"rank": 40,
"ecr": "100"
},
"0000093314": {
"rank": 41,
"ecr": "84"
},
"0001586554": {
"rank": 42,
"ecr": "84"
},
"0001697834": {
"rank": 43,
"ecr": "81"
},
"0001596946": {
"rank": 44,
"ecr": "76"
},
"0001421819": {
"rank": 45,
"ecr": "72"
},
"0001138608": {
"rank": 46,
"ecr": "72"
},
"0001078799": {
"rank": 47,
"ecr": "59"
},
"0000810509": {
"rank": 48,
"ecr": "44"
},
"0001590695": {
"rank": 49,
"ecr": "32"
}
}
},
"rating_box": [
[
"Top rated",
"12 of 49"
],
[
"Best, worst rating",
"266 %, 31.7 %"
],
[
"New companies",
"9"
]
],
"regression_plot": "https://www.realrate-archive.com/us_medicinal_products/2021/backtesting_correlation/regression_2021.svg",
"scentences": [
"Charlie s Holdings Inc climbed 22 positions from 44 to 22 due to its excellent Revenues.",
"Achieve LIFE Sciences INC lost 30 positions from 10 to 40 due to its bad Comprehensive Net Income.",
"Alpha Teknova Inc entered the 2022 ranking at rank 5, making it the best newcomer."
],
"url_segment": "2022-us-medicinal-products",
"year": 2022,
"feature_importance": "https://www.realrate-archive.com/us_medicinal_products/2021/feature_importance/feature_importance.svg",
"obs_ecr": {
"0000037785": {
"2011": {
"obs_EconomicCapitalRatio": 1.9637052598410045
},
"2012": {
"obs_EconomicCapitalRatio": 2.2187352745223867
},
"2013": {
"obs_EconomicCapitalRatio": 2.0998789372222704
},
"2014": {
"obs_EconomicCapitalRatio": 1.641537801830664
},
"2015": {
"obs_EconomicCapitalRatio": 1.0723385245823782
},
"2016": {
"obs_EconomicCapitalRatio": 1.6108835909734713
},
"2017": {
"obs_EconomicCapitalRatio": 1.8056499758638158
},
"2018": {
"obs_EconomicCapitalRatio": 1.2287717494570867
},
"2019": {
"obs_EconomicCapitalRatio": 1.7092843014022376
},
"2020": {
"obs_EconomicCapitalRatio": 1.9284688934634902
},
"2021": {
"obs_EconomicCapitalRatio": 1.6770740146552199
},
"2022": {
"obs_EconomicCapitalRatio": 1.834863173719622
},
"2023": {
"obs_EconomicCapitalRatio": 0.9158901623685305
}
},
"0001056358": {
"2011": {
"obs_EconomicCapitalRatio": 0.18783097649548078
},
"2012": {
"obs_EconomicCapitalRatio": 0.3196597323000155
},
"2013": {
"obs_EconomicCapitalRatio": 0.7370346023559032
},
"2014": {
"obs_EconomicCapitalRatio": 1.0406162753683343
},
"2015": {
"obs_EconomicCapitalRatio": 0.7323625964348088
},
"2016": {
"obs_EconomicCapitalRatio": 0.753066668490597
},
"2017": {
"obs_EconomicCapitalRatio": 0.5232637759318683
},
"2018": {
"obs_EconomicCapitalRatio": 0.7338326629079127
},
"2019": {
"obs_EconomicCapitalRatio": 0.6223996309643847
},
"2020": {
"obs_EconomicCapitalRatio": 0.6307022721006672
},
"2021": {
"obs_EconomicCapitalRatio": 1.4634619355072704
},
"2022": {
"obs_EconomicCapitalRatio": 0.820186420650827
},
"2023": {
"obs_EconomicCapitalRatio": 0.42412588511273297
},
"2024": {
"obs_EconomicCapitalRatio": 0.6963642400059836
},
"2025": {
"obs_EconomicCapitalRatio": 0.47545840734858463
}
},
"0000074303": {
"2011": {
"obs_EconomicCapitalRatio": 0.5221628155371295
},
"2012": {
"obs_EconomicCapitalRatio": 0.5016941351915414
},
"2013": {
"obs_EconomicCapitalRatio": 0.7067485666124749
},
"2014": {
"obs_EconomicCapitalRatio": 0.5800072775923082
},
"2015": {
"obs_EconomicCapitalRatio": 0.26932516949788865
},
"2016": {
"obs_EconomicCapitalRatio": 0.4320388824657905
},
"2017": {
"obs_EconomicCapitalRatio": 0.5856850809511247
},
"2018": {
"obs_EconomicCapitalRatio": 0.3494568183316394
},
"2019": {
"obs_EconomicCapitalRatio": 0.2952768225185927
},
"2020": {
"obs_EconomicCapitalRatio": 0.48260038439530095
},
"2021": {
"obs_EconomicCapitalRatio": 1.1559183950584917
},
"2022": {
"obs_EconomicCapitalRatio": 0.9955682298738215
},
"2023": {
"obs_EconomicCapitalRatio": 0.939616887252673
},
"2024": {
"obs_EconomicCapitalRatio": 0.5703504787209263
},
"2025": {
"obs_EconomicCapitalRatio": 0.3659536949506686
}
},
"0001307954": {
"2011": {
"obs_EconomicCapitalRatio": 0.18938003655153654
},
"2012": {
"obs_EconomicCapitalRatio": 0.3154058367754545
},
"2013": {
"obs_EconomicCapitalRatio": 0.4780017903384275
},
"2014": {
"obs_EconomicCapitalRatio": 0.384792729924332
},
"2018": {
"obs_EconomicCapitalRatio": 0.5095392164405845
},
"2019": {
"obs_EconomicCapitalRatio": 0.6235372978487372
},
"2020": {
"obs_EconomicCapitalRatio": 0.6619386066086855
},
"2021": {
"obs_EconomicCapitalRatio": 0.8463350886179348
},
"2022": {
"obs_EconomicCapitalRatio": 0.7115101902118032
},
"2023": {
"obs_EconomicCapitalRatio": 0.7137373813546445
},
"2024": {
"obs_EconomicCapitalRatio": 0.5244746605193847
},
"2025": {
"obs_EconomicCapitalRatio": 0.3141640811372542
}
},
"0000874716": {
"2011": {
"obs_EconomicCapitalRatio": 5.678189619495421
},
"2012": {
"obs_EconomicCapitalRatio": 6.62985272864075
},
"2013": {
"obs_EconomicCapitalRatio": 5.637583008591172
},
"2014": {
"obs_EconomicCapitalRatio": 5.3378472038789315
},
"2015": {
"obs_EconomicCapitalRatio": 4.359021798706142
},
"2016": {
"obs_EconomicCapitalRatio": 6.735635676724686
},
"2017": {
"obs_EconomicCapitalRatio": 7.882744231502931
},
"2018": {
"obs_EconomicCapitalRatio": 10.363928250251758
},
"2019": {
"obs_EconomicCapitalRatio": 12.865202087427075
},
"2020": {
"obs_EconomicCapitalRatio": 21.31825222425334
},
"2021": {
"obs_EconomicCapitalRatio": 26.268423294328166
},
"2022": {
"obs_EconomicCapitalRatio": 13.828898358817076
},
"2023": {
"obs_EconomicCapitalRatio": 18.252894151087883
},
"2024": {
"obs_EconomicCapitalRatio": 13.560026821642062
},
"2025": {
"obs_EconomicCapitalRatio": 21.570882602865723
}
},
"0000899923": {
"2011": {
"obs_EconomicCapitalRatio": 5.286603114326388
},
"2012": {
"obs_EconomicCapitalRatio": 5.947932077650038
},
"2013": {
"obs_EconomicCapitalRatio": 4.09378437010731
},
"2014": {
"obs_EconomicCapitalRatio": 5.490507086553531
},
"2015": {
"obs_EconomicCapitalRatio": 6.944372988710795
},
"2016": {
"obs_EconomicCapitalRatio": 2.339757271124506
},
"2017": {
"obs_EconomicCapitalRatio": 2.8740508316547966
},
"2018": {
"obs_EconomicCapitalRatio": 3.0914586906825567
},
"2019": {
"obs_EconomicCapitalRatio": 1.9630081673133826
},
"2021": {
"obs_EconomicCapitalRatio": 2.606632146369483
},
"2022": {
"obs_EconomicCapitalRatio": 1.7004450020894173
},
"2023": {
"obs_EconomicCapitalRatio": 2.215290054291016
},
"2024": {
"obs_EconomicCapitalRatio": 1.823931615329854
},
"2025": {
"obs_EconomicCapitalRatio": 1.1682929523136367
}
},
"0000885462": {
"2011": {
"obs_EconomicCapitalRatio": 0.477594589877508
},
"2012": {
"obs_EconomicCapitalRatio": 0.2925556156090612
},
"2013": {
"obs_EconomicCapitalRatio": 0.5361327962905387
},
"2014": {
"obs_EconomicCapitalRatio": 0.2505281175819798
},
"2015": {
"obs_EconomicCapitalRatio": 0.43387267254203915
},
"2016": {
"obs_EconomicCapitalRatio": 0.5022902813318385
},
"2017": {
"obs_EconomicCapitalRatio": 0.34065719753844165
},
"2018": {
"obs_EconomicCapitalRatio": 0.22997496410238202
},
"2019": {
"obs_EconomicCapitalRatio": 0.1659154208060553
},
"2020": {
"obs_EconomicCapitalRatio": 0.26901950354979465
},
"2021": {
"obs_EconomicCapitalRatio": 0.2838385361778253
},
"2022": {
"obs_EconomicCapitalRatio": 0.2067987843408893
},
"2023": {
"obs_EconomicCapitalRatio": 0.11983703427943283
},
"2024": {
"obs_EconomicCapitalRatio": 0.06649192725741328
}
},
"0001054905": {
"2011": {
"obs_EconomicCapitalRatio": 1.4579074706215878
},
"2012": {
"obs_EconomicCapitalRatio": 1.7997149963883579
},
"2013": {
"obs_EconomicCapitalRatio": 1.964317914289097
},
"2014": {
"obs_EconomicCapitalRatio": 1.4734327096252018
},
"2015": {
"obs_EconomicCapitalRatio": 1.8591617658964918
},
"2016": {
"obs_EconomicCapitalRatio": 2.185789648905985
},
"2017": {
"obs_EconomicCapitalRatio": 1.7880006703658458
},
"2018": {
"obs_EconomicCapitalRatio": 1.5318875768219857
},
"2019": {
"obs_EconomicCapitalRatio": 2.6164701172132556
},
"2020": {
"obs_EconomicCapitalRatio": 2.4715120247319406
},
"2021": {
"obs_EconomicCapitalRatio": 2.201354917056966
},
"2022": {
"obs_EconomicCapitalRatio": 2.262740511238834
}
},
"0001141240": {
"2011": {
"obs_EconomicCapitalRatio": 5.502360615827963
},
"2012": {
"obs_EconomicCapitalRatio": 2.4369547526522646
},
"2013": {
"obs_EconomicCapitalRatio": 11.581935819020808
},
"2014": {
"obs_EconomicCapitalRatio": 7.5454875670319685
},
"2015": {
"obs_EconomicCapitalRatio": 5.634514556207966
},
"2016": {
"obs_EconomicCapitalRatio": 5.458003060729301
},
"2017": {
"obs_EconomicCapitalRatio": 6.7960569922086025
},
"2018": {
"obs_EconomicCapitalRatio": 4.351678898468258
},
"2019": {
"obs_EconomicCapitalRatio": 4.24355658618375
},
"2020": {
"obs_EconomicCapitalRatio": 3.6370684560423614
},
"2021": {
"obs_EconomicCapitalRatio": 4.458556769073509
},
"2022": {
"obs_EconomicCapitalRatio": 3.1784879275692157
},
"2023": {
"obs_EconomicCapitalRatio": 3.3273144132655075
},
"2024": {
"obs_EconomicCapitalRatio": 2.3178398698599603
},
"2025": {
"obs_EconomicCapitalRatio": 5.890984282760348
}
},
"0000768408": {
"2011": {
"obs_EconomicCapitalRatio": 5.715133312847765
},
"2012": {
"obs_EconomicCapitalRatio": 2.3017018284798714
},
"2013": {
"obs_EconomicCapitalRatio": 1.425277475641039
},
"2014": {
"obs_EconomicCapitalRatio": 1.8803973873475237
},
"2015": {
"obs_EconomicCapitalRatio": 1.4412650279511978
},
"2016": {
"obs_EconomicCapitalRatio": 1.0071551396713583
},
"2017": {
"obs_EconomicCapitalRatio": 1.1153169457297638
},
"2018": {
"obs_EconomicCapitalRatio": 0.924011890899123
},
"2019": {
"obs_EconomicCapitalRatio": 0.6138635192851674
},
"2020": {
"obs_EconomicCapitalRatio": 0.7664774974857526
},
"2021": {
"obs_EconomicCapitalRatio": 0.871286208388657
},
"2022": {
"obs_EconomicCapitalRatio": 0.27420450138403873
},
"2023": {
"obs_EconomicCapitalRatio": 0.26934082796065434
},
"2024": {
"obs_EconomicCapitalRatio": 0.14158948221183076
}
},
"0000787253": {
"2011": {
"obs_EconomicCapitalRatio": 2.526353775920534
},
"2012": {
"obs_EconomicCapitalRatio": 1.3160543270878733
},
"2014": {
"obs_EconomicCapitalRatio": 1.1960142220158665
},
"2015": {
"obs_EconomicCapitalRatio": 2.1497060764213507
},
"2016": {
"obs_EconomicCapitalRatio": 1.6596075035664513
},
"2017": {
"obs_EconomicCapitalRatio": 1.820275172276164
},
"2018": {
"obs_EconomicCapitalRatio": 1.4250126839098163
},
"2019": {
"obs_EconomicCapitalRatio": 0.8714870157425864
},
"2020": {
"obs_EconomicCapitalRatio": 0.8186963761612863
},
"2021": {
"obs_EconomicCapitalRatio": 0.9963355986876283
},
"2022": {
"obs_EconomicCapitalRatio": 0.4935946735445941
},
"2023": {
"obs_EconomicCapitalRatio": 0.4463203114259345
},
"2024": {
"obs_EconomicCapitalRatio": 0.21764563032603712
}
},
"0000896264": {
"2011": {
"obs_EconomicCapitalRatio": 2.987080353491173
},
"2012": {
"obs_EconomicCapitalRatio": 2.8476111068826424
},
"2013": {
"obs_EconomicCapitalRatio": 4.5724271596679005
},
"2015": {
"obs_EconomicCapitalRatio": 7.320772852461824
},
"2016": {
"obs_EconomicCapitalRatio": 2.5202405198959905
},
"2017": {
"obs_EconomicCapitalRatio": 5.400078197143357
},
"2018": {
"obs_EconomicCapitalRatio": 7.8437625855710635
},
"2019": {
"obs_EconomicCapitalRatio": 5.208661448534275
},
"2022": {
"obs_EconomicCapitalRatio": 2.794889038132937
},
"2023": {
"obs_EconomicCapitalRatio": 2.6884992698433976
},
"2024": {
"obs_EconomicCapitalRatio": 1.4865583930571376
}
},
"0001086303": {
"2012": {
"obs_EconomicCapitalRatio": 0.050408616621473605
},
"2013": {
"obs_EconomicCapitalRatio": 0.3592188918384183
},
"2014": {
"obs_EconomicCapitalRatio": 0.5202291430401021
},
"2018": {
"obs_EconomicCapitalRatio": 75.60385532024324
},
"2023": {
"obs_EconomicCapitalRatio": 5.825073650532234
}
},
"0001134765": {
"2013": {
"obs_EconomicCapitalRatio": 84.83868255676903
},
"2014": {
"obs_EconomicCapitalRatio": 93.1111485713505
},
"2015": {
"obs_EconomicCapitalRatio": 199.2672351710133
},
"2016": {
"obs_EconomicCapitalRatio": 216.93321071912177
},
"2017": {
"obs_EconomicCapitalRatio": 60.02178473917171
},
"2018": {
"obs_EconomicCapitalRatio": 12.822507944414118
},
"2019": {
"obs_EconomicCapitalRatio": 455.3649181791688
},
"2020": {
"obs_EconomicCapitalRatio": 668.0565240083155
},
"2021": {
"obs_EconomicCapitalRatio": 3.604592501252785
},
"2022": {
"obs_EconomicCapitalRatio": 3.9983823737615998
},
"2023": {
"obs_EconomicCapitalRatio": 4.432317616137024
},
"2024": {
"obs_EconomicCapitalRatio": 2.934393508015559
},
"2025": {
"obs_EconomicCapitalRatio": 7.17941906968866
}
},
"0001310630": {
"2011": {
"obs_EconomicCapitalRatio": 118.5920894437218
},
"2012": {
"obs_EconomicCapitalRatio": 90.47339849409984
},
"2013": {
"obs_EconomicCapitalRatio": 72.75975087344283
},
"2014": {
"obs_EconomicCapitalRatio": 60.05301282758653
},
"2015": {
"obs_EconomicCapitalRatio": 46.147679617159916
},
"2016": {
"obs_EconomicCapitalRatio": 37.04924725418156
},
"2017": {
"obs_EconomicCapitalRatio": 30.944660874575487
},
"2019": {
"obs_EconomicCapitalRatio": 85.1712892994052
},
"2020": {
"obs_EconomicCapitalRatio": 24.70852870017063
},
"2023": {
"obs_EconomicCapitalRatio": 90.31718007058653
},
"2024": {
"obs_EconomicCapitalRatio": 18.12427183566627
},
"2025": {
"obs_EconomicCapitalRatio": 15.788052734849284
}
},
"0001374328": {
"2011": {
"obs_EconomicCapitalRatio": 1.843040104492836
},
"2012": {
"obs_EconomicCapitalRatio": 1.406513180725925
},
"2013": {
"obs_EconomicCapitalRatio": 2.5629155706742086
},
"2014": {
"obs_EconomicCapitalRatio": 3.2200542353297674
},
"2015": {
"obs_EconomicCapitalRatio": 1.2965403490667224
},
"2016": {
"obs_EconomicCapitalRatio": 0.9353195843240845
},
"2017": {
"obs_EconomicCapitalRatio": 0.4394415225694401
},
"2018": {
"obs_EconomicCapitalRatio": 0.9423630321081906
},
"2019": {
"obs_EconomicCapitalRatio": 2.6565609559613317
},
"2020": {
"obs_EconomicCapitalRatio": 9.948498907383927
},
"2022": {
"obs_EconomicCapitalRatio": 4.994024545393992
},
"2023": {
"obs_EconomicCapitalRatio": 2.2965761578523303
},
"2024": {
"obs_EconomicCapitalRatio": 3.6843422189586965
},
"2025": {
"obs_EconomicCapitalRatio": 1.821523711080343
}
},
"0001386570": {
"2011": {
"obs_EconomicCapitalRatio": 8.338141326290996
},
"2012": {
"obs_EconomicCapitalRatio": 8.392729648541112
},
"2013": {
"obs_EconomicCapitalRatio": 26.219216155099797
},
"2019": {
"obs_EconomicCapitalRatio": 8.591985092140105
},
"2020": {
"obs_EconomicCapitalRatio": 10.063615397839953
},
"2021": {
"obs_EconomicCapitalRatio": 6.442513704241379
},
"2022": {
"obs_EconomicCapitalRatio": 2.8215640716473835
},
"2023": {
"obs_EconomicCapitalRatio": 2.6556157143776864
},
"2024": {
"obs_EconomicCapitalRatio": 9.237391489557004
},
"2025": {
"obs_EconomicCapitalRatio": 7.630478708487693
}
},
"0000711377": {
"2011": {
"obs_EconomicCapitalRatio": 5.820904874555574
},
"2012": {
"obs_EconomicCapitalRatio": 7.7503288458074415
},
"2013": {
"obs_EconomicCapitalRatio": 10.377788751403328
},
"2014": {
"obs_EconomicCapitalRatio": 9.392743252183534
},
"2015": {
"obs_EconomicCapitalRatio": 10.034849829461312
},
"2016": {
"obs_EconomicCapitalRatio": 10.103194801881472
},
"2017": {
"obs_EconomicCapitalRatio": 14.452119850474038
},
"2018": {
"obs_EconomicCapitalRatio": 8.566992718065048
},
"2019": {
"obs_EconomicCapitalRatio": 9.17563055998759
},
"2020": {
"obs_EconomicCapitalRatio": 9.88631712937769
},
"2021": {
"obs_EconomicCapitalRatio": 9.735723882656965
},
"2022": {
"obs_EconomicCapitalRatio": 5.856026588966056
}
},
"0000744218": {
"2011": {
"obs_EconomicCapitalRatio": 1.8965131603685095
},
"2012": {
"obs_EconomicCapitalRatio": 5.333855573956268
},
"2013": {
"obs_EconomicCapitalRatio": 10.230725112264693
},
"2014": {
"obs_EconomicCapitalRatio": 11.553522232787866
},
"2015": {
"obs_EconomicCapitalRatio": 8.22074780222265
},
"2016": {
"obs_EconomicCapitalRatio": 1.4980547705405713
},
"2017": {
"obs_EconomicCapitalRatio": 2.021188969442516
},
"2018": {
"obs_EconomicCapitalRatio": 0.3696518300152486
},
"2019": {
"obs_EconomicCapitalRatio": 0.48016381910130834
},
"2020": {
"obs_EconomicCapitalRatio": 5.262656817463394
},
"2021": {
"obs_EconomicCapitalRatio": 7.793666490988671
},
"2022": {
"obs_EconomicCapitalRatio": 10.883731101898258
},
"2023": {
"obs_EconomicCapitalRatio": 7.286143405813059
}
},
"0000811641": {
"2011": {
"obs_EconomicCapitalRatio": 2.136690390726703
},
"2012": {
"obs_EconomicCapitalRatio": 1.849039798017059
},
"2013": {
"obs_EconomicCapitalRatio": 2.010189247495304
},
"2014": {
"obs_EconomicCapitalRatio": 2.34474040567545
},
"2015": {
"obs_EconomicCapitalRatio": 2.4785461696903734
},
"2016": {
"obs_EconomicCapitalRatio": 1.9865134449583703
},
"2017": {
"obs_EconomicCapitalRatio": 1.6949100276813254
},
"2018": {
"obs_EconomicCapitalRatio": 1.7852801061870174
},
"2019": {
"obs_EconomicCapitalRatio": 1.5240857269328754
},
"2020": {
"obs_EconomicCapitalRatio": 1.7195565413895542
},
"2021": {
"obs_EconomicCapitalRatio": 2.367024189117178
},
"2022": {
"obs_EconomicCapitalRatio": 1.6292353884860042
},
"2023": {
"obs_EconomicCapitalRatio": 1.1622002191801761
},
"2025": {
"obs_EconomicCapitalRatio": 1.9024392280197613
}
},
"0000907654": {
"2011": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 2.2151696375266194
},
"2014": {
"obs_EconomicCapitalRatio": 1.8158262418443614
},
"2015": {
"obs_EconomicCapitalRatio": 1.28497308211443
},
"2016": {
"obs_EconomicCapitalRatio": 1.0818389503384735
},
"2017": {
"obs_EconomicCapitalRatio": 1.3032495591532267
},
"2018": {
"obs_EconomicCapitalRatio": 0.6794655548784231
},
"2019": {
"obs_EconomicCapitalRatio": 1.027889384231902
},
"2020": {
"obs_EconomicCapitalRatio": 0.7572061787169263
},
"2021": {
"obs_EconomicCapitalRatio": 0.6116995115921646
},
"2022": {
"obs_EconomicCapitalRatio": 0.8326777832489594
}
},
"0000926617": {
"2011": {
"obs_EconomicCapitalRatio": 0.936747166508658
},
"2012": {
"obs_EconomicCapitalRatio": 3.2987773210340476
},
"2013": {
"obs_EconomicCapitalRatio": 3.310250104657181
},
"2014": {
"obs_EconomicCapitalRatio": 4.317801092124128
},
"2015": {
"obs_EconomicCapitalRatio": 7.655824111431128
},
"2016": {
"obs_EconomicCapitalRatio": 8.900428301796273
},
"2017": {
"obs_EconomicCapitalRatio": 20.503758003717643
},
"2018": {
"obs_EconomicCapitalRatio": 3.2888488055796508
},
"2019": {
"obs_EconomicCapitalRatio": 8.83333842031845
},
"2020": {
"obs_EconomicCapitalRatio": 45.47327065656971
},
"2021": {
"obs_EconomicCapitalRatio": 7.933579854593867
},
"2022": {
"obs_EconomicCapitalRatio": 2.857163597552752
},
"2023": {
"obs_EconomicCapitalRatio": 3.901740100848714
},
"2024": {
"obs_EconomicCapitalRatio": 1.8703748454852225
}
},
"0000949858": {
"2011": {
"obs_EconomicCapitalRatio": 0.0
},
"2012": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 2.518997627887442
},
"2018": {
"obs_EconomicCapitalRatio": 0.7422482465262066
},
"2019": {
"obs_EconomicCapitalRatio": 0.35343147435010663
},
"2020": {
"obs_EconomicCapitalRatio": 1.3239430629183255
},
"2021": {
"obs_EconomicCapitalRatio": 2.1718168400927897
},
"2022": {
"obs_EconomicCapitalRatio": 0.9346116862802668
}
},
"0000009326": {
"2012": {
"obs_EconomicCapitalRatio": 5.656587982913678
},
"2013": {
"obs_EconomicCapitalRatio": 7.79966708407013
},
"2014": {
"obs_EconomicCapitalRatio": 2.9084764827636236
},
"2015": {
"obs_EconomicCapitalRatio": 2.8483648673741246
},
"2016": {
"obs_EconomicCapitalRatio": 3.648755401436501
},
"2017": {
"obs_EconomicCapitalRatio": 3.787889348418163
},
"2019": {
"obs_EconomicCapitalRatio": 4.035821822778718
},
"2020": {
"obs_EconomicCapitalRatio": 4.735832660774467
},
"2021": {
"obs_EconomicCapitalRatio": 6.878840843345401
},
"2022": {
"obs_EconomicCapitalRatio": 3.32579266803479
},
"2023": {
"obs_EconomicCapitalRatio": 4.327515096253764
},
"2024": {
"obs_EconomicCapitalRatio": 5.341740174720832
},
"2025": {
"obs_EconomicCapitalRatio": 4.797400698850301
}
},
"0000073290": {
"2012": {
"obs_EconomicCapitalRatio": 1.8838244732270972
},
"2013": {
"obs_EconomicCapitalRatio": 1.6432390281123206
},
"2014": {
"obs_EconomicCapitalRatio": 1.9239557658497293
},
"2015": {
"obs_EconomicCapitalRatio": 2.669474942212977
},
"2016": {
"obs_EconomicCapitalRatio": 5.686234008415378
},
"2017": {
"obs_EconomicCapitalRatio": 12.426535116483144
},
"2018": {
"obs_EconomicCapitalRatio": 6.023112230267755
},
"2019": {
"obs_EconomicCapitalRatio": 8.71810270966778
},
"2020": {
"obs_EconomicCapitalRatio": 5.758603861413226
},
"2021": {
"obs_EconomicCapitalRatio": 7.171288908839465
},
"2022": {
"obs_EconomicCapitalRatio": 6.5820905271862715
},
"2023": {
"obs_EconomicCapitalRatio": 2.3689702399551757
},
"2024": {
"obs_EconomicCapitalRatio": 0.8328246370864223
}
},
"0000093314": {
"2012": {
"obs_EconomicCapitalRatio": 17.719277991697727
},
"2013": {
"obs_EconomicCapitalRatio": 16.172791954794842
},
"2014": {
"obs_EconomicCapitalRatio": 17.12412941207431
},
"2015": {
"obs_EconomicCapitalRatio": 17.094853012648368
},
"2016": {
"obs_EconomicCapitalRatio": 7.646119704869701
},
"2017": {
"obs_EconomicCapitalRatio": 7.835630820870826
},
"2018": {
"obs_EconomicCapitalRatio": 5.69389490958303
},
"2020": {
"obs_EconomicCapitalRatio": 10.494231213006202
},
"2021": {
"obs_EconomicCapitalRatio": 9.325363829987609
},
"2022": {
"obs_EconomicCapitalRatio": 7.038632118707036
},
"2023": {
"obs_EconomicCapitalRatio": 1.692739776873626
},
"2024": {
"obs_EconomicCapitalRatio": 2.538095829463765
},
"2025": {
"obs_EconomicCapitalRatio": 1.267911014322384
}
},
"0001504678": {
"2021": {
"obs_EconomicCapitalRatio": 21.761860501462678
},
"2023": {
"obs_EconomicCapitalRatio": 7.712264043121101
},
"2024": {
"obs_EconomicCapitalRatio": 4.273885183694472
}
},
"0001321834": {
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2019": {
"obs_EconomicCapitalRatio": 0.0
},
"2020": {
"obs_EconomicCapitalRatio": 0.0
},
"2021": {
"obs_EconomicCapitalRatio": 0.0
},
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 0.25079529133050554
},
"2025": {
"obs_EconomicCapitalRatio": 0.6661650116856921
}
},
"0001627223": {
"2015": {
"obs_EconomicCapitalRatio": 0.11531512461593406
},
"2016": {
"obs_EconomicCapitalRatio": 0.5041107353269599
},
"2017": {
"obs_EconomicCapitalRatio": 0.9792616137942283
},
"2018": {
"obs_EconomicCapitalRatio": 0.5037929444305274
},
"2019": {
"obs_EconomicCapitalRatio": 0.33457321143007535
},
"2020": {
"obs_EconomicCapitalRatio": 0.5470460275521768
},
"2021": {
"obs_EconomicCapitalRatio": 0.6499364328629865
},
"2022": {
"obs_EconomicCapitalRatio": 0.5809502304277893
}
},
"0001552189": {
"2022": {
"obs_EconomicCapitalRatio": 0.051966645127577905
},
"2023": {
"obs_EconomicCapitalRatio": 0.16744960403999323
}
},
"0001653477": {
"2016": {
"obs_EconomicCapitalRatio": 2.9965230053381644
},
"2017": {
"obs_EconomicCapitalRatio": 3.7915367442390675
},
"2018": {
"obs_EconomicCapitalRatio": 2.922808947052789
},
"2019": {
"obs_EconomicCapitalRatio": 1.959253575073628
},
"2020": {
"obs_EconomicCapitalRatio": 1.5143708031469667
},
"2021": {
"obs_EconomicCapitalRatio": 1.3249257731828572
},
"2022": {
"obs_EconomicCapitalRatio": 1.1004777222391815
},
"2023": {
"obs_EconomicCapitalRatio": 0.7369191018660393
},
"2024": {
"obs_EconomicCapitalRatio": 0.7736223011953498
},
"2025": {
"obs_EconomicCapitalRatio": 1.3076730606119293
}
},
"0001586554": {
"2016": {
"obs_EconomicCapitalRatio": 0.48058259081278015
},
"2018": {
"obs_EconomicCapitalRatio": 1.4962619054091728
},
"2019": {
"obs_EconomicCapitalRatio": 0.891464023479221
},
"2020": {
"obs_EconomicCapitalRatio": 0.5424015614406267
},
"2021": {
"obs_EconomicCapitalRatio": 0.4143393157324369
},
"2022": {
"obs_EconomicCapitalRatio": 0.23894685685583492
},
"2023": {
"obs_EconomicCapitalRatio": 0.10261033505859418
}
},
"0001642380": {
"2016": {
"obs_EconomicCapitalRatio": 21.72207919293821
},
"2017": {
"obs_EconomicCapitalRatio": 21.3709545386487
},
"2019": {
"obs_EconomicCapitalRatio": 4.529546805842379
},
"2021": {
"obs_EconomicCapitalRatio": 1.6309746744371012
},
"2022": {
"obs_EconomicCapitalRatio": 0.4521509520900019
},
"2023": {
"obs_EconomicCapitalRatio": 0.3591924761920325
}
},
"0001652130": {
"2016": {
"obs_EconomicCapitalRatio": 3.199958649296
},
"2017": {
"obs_EconomicCapitalRatio": 3.3067347442937
},
"2018": {
"obs_EconomicCapitalRatio": 2.957402513032481
},
"2019": {
"obs_EconomicCapitalRatio": 4.091879539456148
},
"2020": {
"obs_EconomicCapitalRatio": 9.369785151591545
},
"2021": {
"obs_EconomicCapitalRatio": 12.780171311702386
},
"2022": {
"obs_EconomicCapitalRatio": 3.4031614469183005
}
},
"0001708035": {
"2017": {
"obs_EconomicCapitalRatio": 0.4391634781975079
},
"2018": {
"obs_EconomicCapitalRatio": 0.3838203482983531
},
"2019": {
"obs_EconomicCapitalRatio": 0.48129649674893044
},
"2020": {
"obs_EconomicCapitalRatio": 0.6013288369758395
},
"2021": {
"obs_EconomicCapitalRatio": 0.8978665871292398
},
"2022": {
"obs_EconomicCapitalRatio": 0.7567918532035208
},
"2023": {
"obs_EconomicCapitalRatio": 0.7709750516345434
},
"2024": {
"obs_EconomicCapitalRatio": 0.6033738356189466
},
"2025": {
"obs_EconomicCapitalRatio": 1.152367959333189
}
},
"0001522767": {
"2017": {
"obs_EconomicCapitalRatio": 4.28352597297854
},
"2018": {
"obs_EconomicCapitalRatio": 11.84484946199016
},
"2019": {
"obs_EconomicCapitalRatio": 1.6647152363257145
},
"2020": {
"obs_EconomicCapitalRatio": 1.8939909944990796
},
"2023": {
"obs_EconomicCapitalRatio": 0.7154614969958419
},
"2024": {
"obs_EconomicCapitalRatio": 0.2730915686403338
},
"2025": {
"obs_EconomicCapitalRatio": 0.22748336782703915
}
},
"0001731348": {
"2020": {
"obs_EconomicCapitalRatio": 1.0343902967287055
},
"2021": {
"obs_EconomicCapitalRatio": 0.9151944120269997
},
"2022": {
"obs_EconomicCapitalRatio": 0.5292237994678327
},
"2023": {
"obs_EconomicCapitalRatio": 0.5873188828335296
},
"2024": {
"obs_EconomicCapitalRatio": 0.48595324362468467
}
},
"0001656472": {
"2020": {
"obs_EconomicCapitalRatio": 2.4846037628909143
},
"2021": {
"obs_EconomicCapitalRatio": 2.1068641047612973
},
"2022": {
"obs_EconomicCapitalRatio": 1.5226433295914465
},
"2023": {
"obs_EconomicCapitalRatio": 1.2617458734917226
},
"2024": {
"obs_EconomicCapitalRatio": 1.2298351104750205
},
"2025": {
"obs_EconomicCapitalRatio": 1.6798919218022832
}
},
"0001737927": {
"2020": {
"obs_EconomicCapitalRatio": 2.2413009969523126
},
"2021": {
"obs_EconomicCapitalRatio": 0.722105723732089
},
"2022": {
"obs_EconomicCapitalRatio": 0.49880311487341555
}
},
"0001754195": {
"2025": {
"obs_EconomicCapitalRatio": 0.6572335792654658
}
},
"0001756390": {
"2021": {
"obs_EconomicCapitalRatio": 1.6656381745552173
},
"2022": {
"obs_EconomicCapitalRatio": 0.2766604451340951
},
"2023": {
"obs_EconomicCapitalRatio": 0.2521606213881799
},
"2024": {
"obs_EconomicCapitalRatio": 0.09670274277596863
},
"2025": {
"obs_EconomicCapitalRatio": 0.15693027900478207
}
},
"0001813814": {
"2022": {
"obs_EconomicCapitalRatio": 1.017428702644666
}
},
"0001850902": {
"2021": {
"obs_EconomicCapitalRatio": 5.898441690535421
},
"2022": {
"obs_EconomicCapitalRatio": 1.4117684980890728
}
},
"0001906324": {
"2022": {
"obs_EconomicCapitalRatio": 3.794104483895451
},
"2023": {
"obs_EconomicCapitalRatio": 0.8130511823271402
},
"2024": {
"obs_EconomicCapitalRatio": 0.6055538968322262
},
"2025": {
"obs_EconomicCapitalRatio": 0.4114130862644389
}
}
}
}